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Abstract 
Background: Type 2 diabetes mellitus (T2D) has become a worldwide epidemic. Although physical activity and 
cardiorespiratory fitness (CRF) are considered to be beneficial for diabetes management, there are no published 
studies reporting their relative importance, or interaction effects, in relation to glycaemic control (HBA1e) and 
cardiovascular risk factors, which are strong predictors of diabetes-related morbidity and mortality. The Early 
ACTID Study is a randomised controlled trial of diet plus exercise vs. diet alone and usual care in adults with 
type 2 diabetes, who were recruited five to eight months after diagnosis. 
Purpose: The purpose of this study was to 1) develop intervention materials to facilitate change in physical 
activity levels, 2) describe objectively measured habitual physical activity, 3) examine change in physical 
activity over six months, 4) explore the use of pedometers and diaries to monitor daily physical activity over a 
six-month period, 5) describe CRF levels, and 6) explore the independent and interactive cross-sectional 
associations of physical activity and CRF with HbA, e and the clustering of cardiovascular risk 
factors (i. e., 
metabolic syndrome) among adults with recently diagnosed T2D recruited to the Early ACTID Study. 
Methods: Anthropometric, physiological and biochemical measures were performed using standardised 
procedures at baseline and six months post randomisation. The IDF definition of the metabolic syndrome was 
used to assess the clustering of cardiovascular risk factors. Habitual physical activity was measured objectively 
using the ActiGraph GTIM accelerometer, which was worn during all waking hours for seven days. Activity 
volume was calculated as accelerometer counts per minute (CPM), and time spent in moderate to vigorous 
physical activity (MVPA) was calculated using a cut-point of 2100 CPM. CRF was estimated using a 
submaximal 1-mile track walk test. V02m, x was predicted 
from time taken to complete 1-mile, heart rate at 
completion (Polar T61 HRM), weight, age and gender using standard Rockport walking test regression 
equations. Cross-sectional associations with HbA1e and metabolic syndrome status were examined at baseline 
and six months. The use of pedometers and physical activity diaries over a six-month period was evaluated in the 
diet plus exercise group in order to assess their acceptability to people with T2D. 
Results: Three-hundred and forty participants (207 men, 133 women), aged 59.3±10.38 years, were recruited to 
the study. Of these, 54% met the IDF metabolic syndrome criteria. Accelerometer data were obtained from 321 
participants who recorded a mean of 243±97.17 CPM and 21.57±17.62 minutes of MVPA per day. Just 14% of 
participants accumulated a30 minutes of MVPA on at least five out of seven days. Ten percent of men and 14% 
of women accumulated <30 minutes of MVPA over seven days and were classified as sedentary. At six months, 
22% of diet plus exercise participants accumulated a30 minutes of MVPA on at least five days compared to 15% 
of those in the non-exercise groups ()? (1)=6.69, P=0.01). 
Compliance with keeping daily physical activity records among diet plus exercise participants was 86.3% over a 
six month period. Compared with baseline, the number of self-reported daily steps was significantly higher at six 
months (6445±2502 vs. 7405±2716, t(102)=3.80, P<0.001) and a greater proportion of participants reported 
accumulating 10,000 steps per day (7.4% vs. 17.5%, )? (1)=15.16, P=0.02). 
Fitness data were calculated for 144 men and 93 women who were not prescribed beta blockers and who 
completed the 1-mile walk test within the parameters of the estimation equation. Mean VO2maxpred was 
30.03±7.55mlkgmin" for men and 20.59±6.35mlkgmin" for women. Physical activity volume (CPM) was a 
stronger predictor of VO2max, pred than time spent 
in MVPA (R2=. 15 vs. . 10, P<0.001), and explained a greater 
proportion of the variance in VOZ,,, ax prod 
in women than men (R2=. 28 vs. . 14%, P<0.001). 
Physical activity and CRF were not associated with glycaemic control but were predictors of the metabolic 
syndrome. Compared to those not accumulating z30 minutes of MVPA on k5 days per week, the odds ratio 
(OR) of the metabolic syndrome associated with meeting this recommended level of activity was . 344 (95% CI 
. 162 to . 730). Similarly, when participants were categorised 
below or above the gender-specific VOZ,,, axprea 
median, the odds ratio of the metabolic syndrome for those in the higher-fit group compared to the lower-fit 
group was . 298 (95% Cl . 174 to . 509). When examined 
by gender, higher physical activity and fitness levels 
were more protective against the metabolic syndrome in women than in men (OR for higher physical activity: 
0.20 (0.05 to 0.80) vs. 0.47 (0.11 to 1.16); OR for higher fitness: 0.19 (0.08 to 0.46) vs. 0.39 (0.19 to 0.76), in 
women and men, respectively). 
Conclusions: Levels of physical activity and CRF were low in participants recruited to the Early ACTID Study. 
Although physical activity and CRF were not associated with glycaemic control, higher levels were associated 
with a lower prevalence of the metabolic syndrome. The protective effect of physical activity and CRF was 
stronger in women than men. The use of pedometers and diaries appears to be acceptable to adults with T2D 
who are attempting to increase their physical activity. 
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Chapter 1: Introduction 
Chapter 1. Introduction 
The present chapter will briefly discuss the background to this PhD project. The current problem of type 2 
diabetes and the potential influence of physical activity and cardiorespiratory fitness will be described. The 
chapter will close with an outline of how the study was first developed. 
1.1. Background 
Type 2 diabetes mellitus (T2D) has become a worldwide epidemic. The number of individuals with T2D 
has trebled in the last 30 years and there is no sign of this trend slowing down (Wild, Roglic, Green et al., 
2004). Increasing rates of obesity and a move towards a more sedentary lifestyle are thought to be strongly 
associated with the rising prevalence of this condition. 
The consequences of diabetes can be fatal. Fifty percent of people with the condition will die of 
cardiovascular disease (CVD) (WHO, 2004). Other risks include renal failure, blindness and lower limb 
amputation. Maintaining good glucose control and managing the clustering of cardiovascular risk factors 
typically found in people with T2D can help to reduce the risk of these complications (Stratton, Adler, Neil 
et al., 2000; UKPDS Group, 1998b) and is therefore the main aim of diabetes management. 
Weight control, healthy eating and physical activity are considered the cornerstones of initial treatment for 
T2D (Mann, 2000). As the condition progresses, medication is usually prescribed in addition to lifestyle 
modification. The premise of advising people with T2D to engage in physical activity is based on strong 
epidemiological evidence from longitudinal studies that shows physical activity is inversely associated 
with the risk of developing T2D (Folsom, Kushi and Hong, 2000; Hu, Manson, Stampfer et al., 2001 a; Hu, 
Sigal, Rich-Edwards et al., 1999; Manson, Nathan, Krolewski et at., 1992; Manson, Stampfer, Colditz et 
al., 1991; Weinstein, Sesso, Lee et at., 2004). A similar association has been reported for fitness (Lynch, 
Helmrich, Lakka et al., 1996; Sawada, Lee, Muto et al., 2003; Wei, Gibbons, Mitchell et at., 1999). Several 
large randomised controlled trials have shown that in people with impaired glucose tolerance, a pre- 
diabetic state, a combination of diet and physical activity can reduce the incidence of T2D by up to 58% 
(Diabetes Prevention Program Research, 2002; Pan, Li, Hu et al., 1997; Ramachandran, Snehalatha, Mary 
et at., 2006; Tuomilehto, Lindstrom, Eriksson et al., 2001). Additionally, two of these studies included a 
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medication only group, which was reported to have a higher incidence of T2D than the diet plus activity 
group (Diabetes Prevention Program Research, 2002; Ramachandran et al., 2006). 
Prospective observational evidence shows that both physical activity (Batty, Shipley, Marmot et al., 2002; 
Gregg, Gerzoff, Caspersen et al., 2003; Hu, Stampfer, Solomon et al., 2001b; Hu, Jousilahti, Barengo et al., 
2005; Hu, Qiao, Tuomilehto et al., 2004b; Tanasescu, Leitzmann, Rimm et al., 2003) and cardiorespiratory 
fitness (CRF) (Blair, Kohl, Paffenbarger et al., 1989; Church, Cheng, Earnest et al., 2004; Kohl, Gordon, 
Villegas et al., 1992; Wei, Gibbons, Kampert et al., 2000) can protect against cardiovascular and all-cause 
mortality in people with T2D. Furthermore, evidence from intervention studies shows that increased 
physical activity (Boule, Haddad, Kenny et al., 2001; Di Loreto, Fanelli, Lucidi et al., 2003; Kirk, Mutrie, 
Maclntyre et al., 2004a; Snowling and Hopkins, 2006; Thomas, Elliott and Naughton, 2006) and CRF 
(Boule, Kenny, Haddad et al., 2003) may produce improvements in glycaemic control and other metabolic 
and physiological outcomes. 
Reported associations with health-related outcomes tend to be stronger for CRF than physical activity. This 
may be attributable to the differences in measurement error between the two exposures, as self-reported 
methods are typically used for the assessment of physical activity, while fitness will almost certainly 
always be measured directly, either by submaximal or maximal testing procedures. Measuring physical 
activity is challenging because of its complex nature. Self-reported measures tend to be crude and 
imprecise, and they are likely to weaken the strength of observed associations with health-related 
outcomes. The discrepancy in measurement precision between physical activity and CRF thus complicates 
the interpretation of results from epidemiological studies. 
Objective measures of physical activity using sensitive instruments, such as accelerometers, provide more 
accurate data that can enhance our understanding of the association between different dimensions of 
physical activity and health. Unfortunately, very few data have been published that describe objectively- 
measured habitual physical activity levels in adults with T2D. Moreover, the independent cross-sectional 
associations of objectively-determined physical activity and CRF with glycaemic control and other 
physiological outcomes in T2D have not yet been established. It is therefore currently unknown whether 
physical activity or CRF is most important in T2D. 
The accurate quantification of activity levels in this population is required in order to inform activity 
promotion and intervention strategies. Furthermore, determining the relative importance of physical 
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activity and CRF in relation to important health-related outcomes in people with T2D is required for the 
translation of research findings into clinical management, policy and practice recommendations. 
1.2. Conception of the current project 
In 2004 Diabetes UK, the largest diabetes research charity in the UK, agreed to fund six academics 
(Appendix 2) from the University of Bristol to conduct a randomised controlled trial (RCT) involving up to 
750 adults with a recent diagnosis of T2D. The study, called Early ACTID, which stands for Early 
ACTivity In Diabetes, aimed to compare the effect of a one-year programme of dietary advice plus home- 
based exercise with dietary advice only and usual care on glycaemic control, blood pressure, blood plasma 
lipids and weight status. In addition, the grant included funding for a PhD project as part of the RCT. This 
thesis will focus on the PhD project, rather than the Early ACTID Study as a whole. 
The broad aims of the PhD were to: 
0 develop intervention materials for the purpose of facilitating the initiation and maintenance of physical 
activity in diet plus exercise participants recruited to the Early ACTID Study, 
" describe objectively measured physical activity in people participating in the Early ACTID Study, 
" examine the six-month change in physical activity among participants in the Early ACTID Study, 
" explore the use of pedometers and diaries to monitor daily physical activity over a six-month period 
among participants randomised to the diet plus exercise intervention of the Early ACTID Study, 
" describe CRF levels in people participating in the Early ACTID Study, 
" explore the independent associations of objectively measured physical activity and CRF with MAI, 
and the clustering of cardiovascular risk factors in people participating in the Early ACTID Study, and 
" investigate whether there is an interaction effect between physical activity and CRF on HbAI, and the 
clustering of cardiovascular risk factors in people with newly diagnosed T2D. 
3 
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1.3. Contribution to the Early ACTID Study 
This PhD project was closely linked to the Early ACTID RCT. The PhD researcher, herein described as the 
researcher, was solely responsible for developing the Early ACTID physical activity intervention 
programme. This involved: 1) developing a home-based activity programme suitable for adults with T2D, 
2) developing and piloting participant materials that were based on physical activity behaviour change 
principles, 3) producing a detailed standard operating procedure for each participant visit that enabled the 
nurses to deliver the physical activity intervention and monitor adherence to the physical activity goals, and 
4) providing training for the nurses and dietitians relating to the delivery of the physical activity 
intervention. 
Once recruitment to the Early ACID study commenced in November 2005, the assessment of physical 
activity was the primary responsibility of the researcher. This involved developing measurement protocols, 
participant information sheets, initialising and downloading all activity monitors, and cleaning and 
analysing the physical activity data. 
The measurement of cardiorespiratory fitness (CRF) was not part of the original Early ACTID Study 
proposal and the addition of this measure by the researcher thus added a unique aspect to the study. The 
researcher developed CRF measurement protocols, participant information sheets and data collection tools. 
The researcher administered 288 out of the 558 fitness tests (45%) that have been analysed for the purpose 
of this PhD thesis. The researcher also administered 51 12-month fitness tests; however, the data from 
these are not presented within this thesis. 
A Gantt chart outlining the timescales for this PhD project can be seen in Appendix 3. 
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Chapter 2. Literature review 
This chapter will start by providing an overview of the central themes of this thesis: type 2 diabetes (T2D), 
the clustering of risk factors associated with T2D, physical activity and cardiorespiratory fitness (CRF). 
Definitions, prevalence, health implications and measurement issues will be described. The subsequent 
sections will discuss some of the key observational and intervention studies that have examined 
associations between physical activity, CRF and T2D. Evidence for associations with glycaemic control, 
the clustering of risk factors and mortality in T2D will be presented. Although data from small 
experimental studies have contributed to the evidence base, this review will focus on the best available 
evidence, namely large epidemiological studies and well-designed intervention trials. The independent 
associations with physical activity will be reviewed first, followed by the associations with CRF. The 
relative importance of, and interaction between, these variables in relation to type 2 diabetes will then be 
examined. The final sections of this chapter will consider the evidence for promoting the adoption and 
maintenance of physical activity in people with T2D, focusing primarily on the components of previous 
intervention studies that have been successful at increasing participants' activity levels. 
2.1. Literature search strategy 
An extensive search of the literature pertaining to diabetes, physical activity and cardiorespiratory fitness 
was performed electronically through the Cochrane Central Register of Controlled Trials (CENTRAL), the 
Cochrane Database of Systematic Reviews (Cochrane Reviews), MEDLINE, EMBASE and PubMed. 
MEDLINE and EMBASE databases were combined through OVID to avoid repeating searches 
unnecessarily. In order to build on and update existing reviews, all databases were searched from January 
1996 to August 2008, using the search strategy specified in Appendix 4. Searches were restricted to the 
titles of English language articles that were related to humans. In addition to the electronic searches, the 
reference lists of selected articles were checked for potential papers. The titles of articles were assessed for 
relevance. Where no clear decision could be made based on the title of the paper, the abstract and, when 
necessary, the full text was obtained for further evaluation. Articles that could not be obtained locally were 
ordered. 
5 
Chapter 2: Literature Review 
2.2. Central themes 
2.2.1. Type 2 diabetes 
Definition and prevalence 
Diabetes mellitus is a chronic, progressive metabolic disorder characterised by elevated blood glucose 
levels. The disorder is rapidly increasing on a global scale. Worldwide prevalence is estimated at 171 
million, which is predicted to double by 2030 (WHO, 2003). In the UK, 2.3 million adults are diagnosed 
with diabetes, and as many as 750,000 remain undiagnosed (The Information Centre for Health and Social 
Care). 
Care of people with diabetes uses 5% of the total NHS budget and 10% of hospital inpatient resources 
(Wanless, 2002). People with diabetes are twice as likely to be admitted to hospital and stay twice as long. 
Once discharged, their care by community social services costs five times that of unaffected individuals 
(Bagust, Hopkinson, Maslove et al., 2002). 
T2D is the most common clinical form of diabetes, accounting for approximately 90% of all cases in the 
UK. The proportion of people with this type of diabetes increases with age (Department of Health, 2003a), 
and it is strongly associated with obesity (Chan, Rimm, Colditz et at., 1994; Colditz, Willett, Rotnitzky et 
al., 1995), physical inactivity and family history of diabetes. Rates of T2D are much higher among ethnic 
minority communities, including those of South-Asian, African and African-Caribbean descent (WHO, 
2003). Prevalence rates also appear to be higher in men than in women (Department of Health, 2003a; 
Wild et al., 2004). While the condition was previously seen only in middle-aged and older adults, T2D is 
being identified in younger age groups, including adolescents and children. 
Diagnosis and measurement 
The diagnosis of diabetes requires a random venous plasma glucose (RPG) test, a fasting venous plasma 
glucose (FPG) test, or an oral glucose tolerance test (OGTT) to be within the diabetic range shown in Table 
2.1 (WHO, 1999). In the presence of diabetic symptoms (e. g. thirst, polyuria, unexplained weight loss, 
recurrent infections, neuropathic symptoms, vision changes, etc. ) a single test is sufficient for diagnosis. 
However, in asymptomatic individuals, at least one additional abnormal plasma glucose concentration is 
required to confirm a clinical diagnosis (WHO, 1999). 
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Table Z. l. World Health Organization (WHO) diagnostic Ihres holds for venous plasma glucose (mmolJl) 
Random Plasma Fasting Plasma Oral Glucose Tolerance 
Glucose (RPG) Glucose (FPG) Test (OGTT) 
Diabetes Mellitus 211.1 Z7.0 2l 1.1 
Impaired glucose tolerance (IGT) N/A <7.0 Z7.8 and <11.1 
Impaired fasting glycaemia (IFG) N/A Z6.1 and <7.0 <7.8 
(WHO, 2006) 
Impaired glucose tolerance (IGT) and impaired fasting glycaemia (IFG) are additional categories of 
abnormal glucose tolerance which refer to metabolic states between normal glucose homeostasis and 
diabetes mellitus. Although they are not considered clinical entities, plasma glucose values within IGT and 
IFG ranges indicate that glucose is not being metabolised efficiently within the body. As such, the presence 
of IGT or IFG places individuals at high risk of developing diabetes and/or CVD (Alberti, 1996). 
Following a diagnosis of diabetes, glycated haemoglobin (HbA,, ) can be measured to provide an objective 
indication of a patient's overall blood glucose control for the preceding six to eight weeks (Goldstein, 
Little, Wiedmeyer et al., 1986). Over the lifetime of a red blood cell (90 to 120 days), glucose binds to 
haemoglobin through a process called glycosylation. HbA1c is a measure of the percentage of glucose- 
bound haemoglobin in the blood, and is considered one of the best measures of glycaemic control. The 
normal range found in healthy persons is between 3 and 5.9%. People with diabetes often have higher 
values, which can be categorised according to the ranges published by NICE (National Institute of Clinical 
Excellence (NICE), 2002), as outlined in Table 2.2. Higher HbA1 values are associated with increased risk 
of diabetes-related complications (UKPDS Group, 1998a). 
Table 2.2. NICE guidelines for HbAI, values (%) In people with diabetes 




Poor > 7.5 
(National Institute of Clinical Excellence (NICE), 2002) 
Pathoplzrsiology and ac'liology 
Although the exact pathogenesis and aetiology of 7213 remains unclear, evidence from prospective cohort 
studies suggests that the main causes leading to its development are defects in insulin action and insulin 
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secretion (Saad, Knowler, Pettitt et al., 1991a). Insulin acts on cells in the liver, skeletal muscle and 
adipose tissue by binding to its specific receptor on the plasma membrane, triggering a series of 
intracellular protein phosphorylation steps that lead to glucose uptake. An inadequate effect of circulating 
insulin on glucose and fat metabolism is referred to as insulin resistance. Ultimately, insulin resistance 
leads to a reduced ability of insulin to promote glucose uptake in muscle and adipose cells, and to suppress 
liver glucose production after meals, which results in hyperglycaemia. Initially, the beta cells in the 
pancreas compensate for this by producing extra insulin (hyperinsulinaemia) in order to lower glucose 
levels. Eventually, due to partial failure of the pancreatic beta cells, insulin levels gradually decline, 
causing hyperglycaemia and glycated haemoglobin (HbA,, ) to rise steadily (Kahn, 2003). In some 
individuals, usually in the late stages of T2D, insulin production may even cease altogether. 
Whereas insulin resistance, characterised by elevated levels of circulating insulin, is thought to be the 
primary defect that leads to impaired glucose tolerance, beta cell exhaustion is considered to play an 
essential role in the progression from impaired glucose tolerance to T2D (Saad et al., 1991a). Data from 
prospective observational studies have shown that normoglycaemic offspring of parents with diabetes have 
slower glucose removal rates and higher insulin levels in response to glucose tolerance tests when 
compared with offspring of parents without diabetes. Poor glucose removal rates and high serum insulin 
levels were found to independently increase the risk for developing diabetes among the offspring of 
diabetic parents (Ramachandran, Snehalatha, Premila et al., 1990; Warram, Martin, Krolewski et al., 1990). 
These data suggest impaired glucose tolerance is already present one or two decades prior to a diagnosis of 
T2D. This is accompanied by compensatory hyperinsulinaemia, suggesting that the primary defect is an 
inadequate action of insulin, rather than beta cell dysfunction. 
The aetiology of T2D is a complex multifactorial process with both lifestyle and genetic origins. The 
aggregation found in non-diabetic families suggests insulin resistance is genetically determined (Sakul, 
Pratley, Cardon et at., 1997). However, the rapidly increasing prevalence of T2D over recent years 
indicates that non-genetic factors have significant influence in determining its onset. The most dramatic 
increases in T2D are occurring in societies in which there have been major changes in lifestyle. These 
changes include reductions in physical activity, increases in overweight and obesity, and a move towards 
diets that typically are energy-dense, high in total fat and saturated fatty acids and low in fibre. These 
lifestyle factors are thought to be key underpinnings in the aetiology of this chronic disease (King, Aubert 
and Herman, 1998). 
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Epidemiological data suggest that the main risk factors for T2D are age, obesity, centrally distributed 
excess adiposity, family history, physical inactivity and dietary factors (WHO, 2003). The presence of 
maternal diabetes, including gestational diabetes and intrauterine growth retardation, particularly when 
paired with later rapid catch-up growth, appears to also increase the risk of subsequent development of 
T2D (Dabelea, Hanson, Lindsay et al., 2000). 
Consequences 
In the UK, T2D is the leading cause of renal failure, one of the leading causes of blindness, and is the 
second leading cause of lower limb amputation (Department of Health, 2001). Furthermore, individuals 
with diabetes have up to a five fold increased risk of cardiovascular mortality (Valabhji and Elkeles, 2003). 
These microvascular and macrovascular complications, due to vessel damage, are independently and 
additively associated with long-term glycaemic and blood pressure control, with no evidence of any 
threshold of risk (Khaw, Wareham, Luben et al., 2001; Stratton, Cull, Adler et al., 2006; Stratton et al., 
2000). In the UK Prospective Diabetes Study (UKPDS), patients with T2D were followed for ten years. 
Each 1% reduction in HbAj, was associated with reductions in risk of 21% for any endpoint related to 
diabetes, 21% for deaths related to diabetes, 14% for myocardial infarction and 37% for microvascular 
complications. The lowest risk of complications was associated with HbA1, values in the normal range 
(<6.0%) (Stratton et al., 2000). 
i lunag eneenl 
Blood glucose levels have been shown to increase progressively from diagnosis in people with T2D. Due 
to the increasing risk of morbidity and mortality associated with poor glycaemic control, the primary aim 
of diabetes management is to reduce hyperglycaemia. Weight reduction through energy restriction, 
exercise and oral hypoglycaemic medication remain the cornerstones of T2D management. The association 
between obesity and risk of developing T2D is well established. Furthermore, in people with T2D, obese 
individuals are at a greater risk of mortality than their non-obese counterparts. Weight loss in this patient 
population is strongly associated with improved insulin sensitivity, glycaemic control, blood pressure 
control and blood lipid profiles. 
Exercise is encouraged as part of diabetes management, since evidence suggests that it may improve 
glycaemic control as well as risk factors for CVD. Physical activity is also associated with a lower risk of 
all-cause and cardiovascular mortality both in those with (Batty et al., 2002; Gregg et al., 2003; Hu et al., 
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2001b; Hu et al., 2005; Hu et al., 2004b; Tanasescu et al., 2003)and without T2D (LSllgen, BSckenhoff and 
Knapp, 2009; Nocon, Hiemann, Muller-Riemenschneider et al., 2008) (insert references here to support 
this statement). When lifestyle modification fails to maintain sufficient glycaemic control, pharmacological 
treatment is prescribed, which can be effective in reducing glycaemia and thus in managing the disease. 
Several oral hypoglycaemic agents are now available, each differing in action and side-effects. The 
UKPDS examined the effects of different treatments for T2D, and found that diabetes control deteriorated 
over time, regardless of the type of pharmacological treatment used (UKPDS Group, 1998c). This was 
shown to be related to a gradual increase in insulin resistance combined with a decrease in insulin 
secretion. Much of the increased insulin resistance was due to weight gain, a side-effect of many oral 
treatment strategies in diabetes (LeRoith, 2002). 
An ideal treatment for T2D would therefore improve glycaemic control and other risk factors for diabetes- 
related complications, including obesity, hypertension and hyperlipidaemia, without the presence of 
adverse side-effects. To date, no pharmacological treatment has satisfied these criteria. Physical activity, 
conversely, has few side-effects and has been shown to favourably influence risk factors in people with 
impaired glucose tolerance (IGT), a pre-diabetic condition. Thus, physical activity potentially represents 
the ideal first line treatment for T2D. 
2.2.2. Clustering of risk factors associated with type 2 diabetes 
Definition and prevalence 
The `Metabolic Syndrome' is a term used to describe a clustering of interrelated risk factors for CVD 
(Alberti, 2005). Typically, these risk factors include central obesity, hyperinsulinaemia, dyslipidaemia, 
hypertension and glucose intolerance (Alexander, Landsman, Teutsch et at., 2003). 
The ultimate importance of recognising the metabolic syndrome is that it helps to identify individuals at 
high risk of both T2D and CVD. Until recently, however, there were no internationally agreed diagnostic 
criteria. Definitions have been produced by a number of groups, including the World Health Organization 
(WHO, 1999), The European Group for the Study of Insulin Resistance (EGIR) (Balkau and Charles, 
1999), The National Cholesterol Education Program-Third Adult Treatment Panel (NCEP ATP III) 
(Grundy, Cleeman, Daniels et at., 2005), and, more recently, the International Diabetes Federation (IDF) 
(International Diabetes Federation, 2006). The definitions presented by these different groups have varied 
somewhat in specific elements or cut points, but in general they include a combination of common 
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cardiovascular risk factors. Table 2.3 shows the criteria proposed by these different organisations for the 
diagnosis of the metabolic syndrome. Only those criteria that may be appropriately applied to people with a 
diagnosis of diabetes are presented. Thus, the EGIR definition has been excluded because it was proposed 
for non-diabetic individuals only. 
The existence of multiple definitions for the metabolic syndrome has caused confusion and has prevented 
the direct comparison of data between studies. The most recent definition, proposed by the IDF, was 
developed in an attempt to address both clinical and research needs by producing a universally accepted 
diagnostic tool suitable for worldwide use (International Diabetes Federation, 2006). 
The prevalence of the metabolic syndrome inevitably depends on the definition and criteria used as 
different definitions are likely to identify different individuals (Cameron, Shaw and Zimmet, 2004). 
Generally, earlier definitions (NCEP ATP III) identify fewer individuals (-19%) than more recent 
definitions, such as the IDF (-31%) (Moebus, Hanisch, Aidelsburger et al., 2007). It is estimated that 
approximately 20-25% of the world's adult population have the metabolic syndrome (International 
Diabetes Federation, 2006). Data from European prospective cohort studies suggest the prevalence in men 
and women without diabetes is approximately 16% and 14%, respectively, when using a modified WHO 
definition (Hu et al., 2004b). In people with T2D, it is considered to be much more prevalent, with figures 
estimated to be as high at 80% (Ford, Giles and Dietz, 2002; Isomaa, Almgren, Tuomi et al., 2001). 
Survey data obtained from a nationally representative sample of the US population between 1988 and 1994 
found that the metabolic syndrome prevalence increased with age, rising from 7% among participants aged 
20 years to approximately 43% among those in their 60s. Ethnicity and gender differences were also 
reported. In African Americans and Mexican Americans only, the prevalence was higher among women 
than men (Ford et al., 2002). In other ethnic groups there appears to be a trend for higher rates in men. 
Prevalence is also thought to vary depending on the level of physical activity or fitness. Cross-sectional 
data show lower odds for the clustering of risk factors associated with the metabolic syndrome among 
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Diagnosis and nreasureneent 
The diagnosis of the metabolic syndrome depends on the definition, but will involve measuring the 
independent components, including obesity, waist circumference, blood pressure, fasting plasma glucose, 
triglycerides and plasma-lipoprotein cholesterol levels. 
Patkoplkrsiology and aetiology 
While the pathogenesis of the metabolic syndrome and each of its components is complex and not well 
understood, central obesity and insulin resistance are considered to be important causative factors 
(Anderson, Critchley, Chan et al., 2001). While obesity contributes to hypertension, high serum 
cholesterol, low high-density lipoprotein (HDL) cholesterol and hyperglycaemia, central obesity, otherwise 
known as abdominal obesity, appears to have an even stronger association with metabolic risk factors 
(Balkau, Deanfield, Despres et al., 2007; Carr, Utzschneider, Hull et al., 2004; Grundy, Brewer, Cleeman 
et al., 2004), and in particular with insulin resistance (Despres, 2001). Several investigators have argued 
that insulin resistance is more important than obesity in the pathogenesis of the metabolic syndrome 
(Reaven, 1997). However, the close association between insulin resistance and obesity causes difficulties 
when attempting to identify their unique roles. The interaction of genetics, ethnicity, physical inactivity, 
ageing, a proinflammatory state and hormonal changes may also have a causal effect, although more 
research is required in order to determine the contributory role of each factor (Liese, Mayer-Davis and 
Haffner, 1998; Saad, Lillioja, Nyomba et al., 1991b). 
Consequences 
The most important dimension of the metabolic syndrome is its association with the risk of developing 
CVD. Since many people with the syndrome have some degree of insulin resistance, there is also an 
elevated risk of developing T2D. While each individual component of the metabolic syndrome is 
associated with increased CVD risk, it has been postulated by some that as a combination they become 
much more powerful (Hanefeld, Koehler, Gallo et al., 2007; Kaplan, 1989) in increasing risk of all cause 
and cardiovascular mortality (Benetos, Thomas, Pannier et at., 2008; Golden, Folsom, Coresh et at., 2002; 
Hu et al., 2004b). The issue relating to the potentially synergistic nature of the clustering of risk factors is 
contentious {Alexander, 2003 #638; McNeill, 2005 #759; Yarnell, 1998 #764 (include refs here to support 
this statement); however, the increased risk of CVD associated with the presence of the metabolic 
syndrome is well recognised. 
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In people without T2D, the metabolic syndrome is associated with a one and a half times greater risk of all 
cause mortality and a two-fold increased risk of cardiovascular mortality compared to those without the 
metabolic syndrome (Najarian, Sullivan, Kannel et al., 2006). In individuals with T2D, the coexistence of 
other metabolic syndrome factors denotes a much higher risk for the future development of CVD than those 
without additional factors (Alexander et al., 2003; Grundy et al., 2005; Najarian et al., 2006). 
Management 
The primary management for the metabolic syndrome is lifestyle modification that includes weight loss, 
changes in dietary composition and increased physical activity (Lindstrom, Louheranta, Mannelin et al., 
2003). However, in individuals for whom lifestyle change is not sufficient, and who are considered to be at 
high risk for CVD, pharmacological therapy may be required. Since there is no specific treatment for the 
metabolic syndrome, it is necessary to manage the individual abnormal components of the syndrome in 
order to lower the overall CVD and diabetes risk. 
2.2.3. Physical activity 
Definitions and prevalence 
Daily total energy expenditure (TEE) is comprised of three main components: basal metabolic rate (BMR), 
diet-induced thermogenesis and physical activity. The BMR represents the energy expended for normal 
cellular and organ function while at rest in a neutrally temperate environment, in the post-absorptive state. 
The BMR is primarily predicted by lean body mass and in sedentary populations is thought to account for 
approximately 60-75% of TEE (Levine, 2005 #766). Although there is considerable variation between 
individuals in terms of TEE, reports suggest that, under respiratory chamber conditions, in which dietary 
intake and physical activity were both controlled, variations in BMR between individuals with similar body 
weights are limited and range between 7.9 and 12% of the population mean (Shetty, 2005). 
Diet-induced thermogenesis relates to energy expended as a result of digestion, absorption and storage of 
food, and accounts for approximately 5%-10% of TEE (Donahoo, Levine and Melanson, 2004). Physical 
activity, which consists of both volitional and spontaneous activities, such as fidgeting, is the most variable 
component of TEE as the intensity and volume of activity varies considerably within and between persons. 
Consequently, physical activity can account for between 15% and 75% of daily total energy expenditure 
(Westerterp, 1998). 
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While physical activity refers to a behaviour and is defined by `... any force exerted by skeletal muscle that 
results in energy expenditure above resting level' (Caspersen, Powell and Christensen, 1985), exercise is a 
subset of physical activity and tends to be `volitional, planned, structured, repetitive, and aimed at 
improvement or maintenance of any aspect of fitness or health' (Caspersen et al., 1985). 
Over the past 20 or 30 years there has been a decrease in physical activity as part of daily life (Department 
for Transport, 2001). This decline has occurred at the same time as other societal changes, such as a 
reduction in manual jobs and developments in technology. Current national physical activity guidelines 
recommend that healthy adults should aim to be moderately active for at least 30 minutes on five or more 
days per week (Department of Health, 2004). Moderate intensity activities have an energy cost of between 
3.5 and 7 kcal/min, or 3-6 METs (metabolic equivalent), and include brisk walking, cycling and other 
activities that increase the breathing and heart rate (Ainsworth and Youmans, 2002). 
Figure 2.1 illustrates data collected from the 2005 Health Survey for England (HSE) (Department of 
Health, 2007), which show that just 35% of men and 24% of women reported achieving the recommended 
minimum level of physical activity. For both men and women, the proportion reaching recommended 
levels of activity was inversely associated with age. A particular concern raised by the survey's findings is 
that approximately one third of men and half of women reported doing less than 30 minutes of activity per 
week. These men and women can be classed as inactive or sedentary. Recently, The National Travel 
Survey (Department for Transport, 2006) found that 25% of all respondents reported taking walks of z20 
minutes less than once per year or never. 
tssociations with health 
A wealth of epidemiological evidence shows a clear dose-response relationship between physical activity 
and all-cause morbidity and mortality. In 2004, the Department of Health in England published the Chief 
Medical Officer's report `At least five a week: Evidence on the impact of physical activity and its 
relationship to health' (Department of Health, 2004). The report highlighted the inverse relationship 
between physical activity and the development of diseases such as coronary heart disease, stroke, T2D, 
obesity and cancer. In addition, the evidence demonstrated that physical activity is associated with 
increased risk of hypertension, hyperlipidaemia, musculoskeletal disorders, impaired psychological well- 
being and mental illness. Low levels of physical activity have therefore become a major public health 
concern, particularly in western societies. 
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Figure 2.1. Percentage of adults achieving 30 minutes of moderate intensity physical activity on five or 















(Department of Health, 2007) 
The World Health Organization (WHO) reported that physical inactivity is one of the ten leading causes of 
death in developed countries, producing 1.9 million deaths worldwide per year (WHO, 2002). In terms of 
public health, the greatest reduction in risk can occur when people move from being sedentary to engaging 
in low to moderate levels of activity. Evidence shows that physical activity resulting in a weekly energy 
expenditure of between 500 and 1,000 kcals can reduce the risk of premature death by 20-30% (Lee and 
Skerrett, 2001). 
A recent study calculated the costs of inactivity in the UK and reported that it was responsible for 3.1% of 
morbidity and mortality, and contributed over £1 billion per year to the direct health cost burden to the UK 
National Health Service (Allender, Foster, Scarborough et al., 2007). Other calculations of the cost of 
physical inactivity in England, which include the direct costs of health care and the indirect costs resulting 
from earnings lost due to inability to work and premature death, suggest the amount is £8.2 billion per year 
(Department of Culture Media and Sports Strategy Unit, 2002). Furthermore, this does not include the 
contribution of inactivity to obesity, which has been estimated to cost the NHS £0.5 billion annually, and 
the economy as a whole £2 billion. 
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Although the health benefits associated with a physically active life are well documented, occasionally 
physical activity can have adverse effects, such as injury. More serious, 
but fortunately rare, risks, 
including heart attack and sudden death, occur among predominantly sedentary individuals who 
occasionally perform vigorous exercise. Data from large-scale epidemiological studies show that 
the 
absolute risk of sudden death during a bout of exercise is extremely low (less than one 
death per 1.51 
million exercise episodes in middle-aged men) and that habitual exercise diminishes this risk substantially 
(Albert, Mittleman, Chae et al., 2000; Thompson, Buchner, Pina et al., 2003; Thompson, Franklin, Balady 
et al., 2007; Vuori, 1995). As such, it is generally accepted that the potential health benefit resulting 
from 
engaging in regular, moderate-intensity activity, which is built up gradually, far outweighs any potential 
risks. 
Measurement 
The multidimensional nature of physical activity makes it a complex exposure to measure. As outlined 
in 
the WHO report (WHO, 2002), opportunities for activity exist in four major domains. These include work, 
transport, domestic duties, and leisure-time. This creates many challenges in terms of measurement, 
particularly when quantification of lifestyle or incidental activity is required. A variety of assessment 
methods have been used in physical activity research and can be broadly categorised as either subjective or 
objective (Lagerros and Lagiou, 2007). Subjective methods include questionnaires, recalls, logs and 
records, which all rely on self-report. Objective methods require the use of motion sensors, heart rate 
monitoring, indirect calorimetry, or the frequently considered gold standard method, doubly-labelled water. 
Each method has its own strengths and limitations, and the selection of a particular measure is determined 
by the scale and scope of the research study. Thus, choosing the appropriate method is a balance between 
validity, reliability and practicability (Lagerros and Lagiou, 2007). 
Large scale epidemiologic studies typically use validated questionnaires due to the ease of distribution and 
the limited time and money that is required compared with more labour-intensive methods associated with 
objective assessments. In general, these questionnaires focus on either occupational or leisure-time 
activities, rather than assessing total physical activity, which also includes unstructured activities of daily 
living. As such, measures obtained through subjective methods are crude, imprecise and subject to error, 
and are likely to reduce the strength of observed relationships between physical activity and health, and to 
weaken the measured effect of interventions. 
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Objective measures of physical activity using sensitive instruments provide more accurate data that can 
enhance our understanding of the association between total physical activity and health. In particular, 
validated and reliable measures that provide information about the key dimensions of physical activity, 
including frequency, intensity and duration, can allow us to identify causal associations with health 
outcomes, which can lead to the formulation of clear policy and practice recommendations. 
Accelerometers can provide such a measurement of physical activity as they are able to measure 
accelerations in up to three planes (vertical, mediolateral and antero-posterior) (Tudor-Locke and Myers, 
2001a), therefore sensing all human motion while suppressing high accelerations that could only be 
attributable to non-human motion. Most accelerometers have a real-time internal clock that enables them to 
start recording data at a desired time and to sum data over a user-defined interval (epoch). The output 
generated is the summed amount and magnitude of accelerations for each epoch, displayed as counts, 
which can then be used to estimate the intensity of physical activity at a specific time. 
Considerable research has been conducted to examine the validity and reliability of various accelerometers. 
One of the best monitors is the ActiGraph, which has been shown to strongly correlate with measured 
oxygen uptake under both laboratory (Brage, Wedderkopp, Franks et at., 2003; Freedson, Melanson and 
Sirard, 1998) and field (Brage et al., 2003; Hendelman, Miller, Baggett et at, 2000) conditions. 
Furthermore, in a comparison of four accelerometers across multiple trials, the ActiGraph monitor showed 
the least variability and the highest overall reliability when assessing physical activity in adults (Welk, 
Schaben and Morrow, 2004). In another recent study, the reliability between different ActiGraph monitors 
worn at the same time under free-living conditions was examined. Intraclass correlations were . 97 for 
counts and ranged from . 98 to . 99 for minutes of different intensities (McClain, Sisson and Tudor-Locke, 
2007). Intraclass correlations >. 80 are generally considered highly reliable. The small and light design of 
the ActiGraph monitor means it is unobtrusive to wear, which, in addition to its other attributes, makes it 
one of the best assessment tools available for measuring free-living activity in adults. 
2.2.4. Cardiorespiratoryfitness 
Definitions 
Cardiorespiratory fitness (CRF), also referred to as cardiorespiratory endurance or aerobic capacity, is `the 
ability of the circulatory and respiratory systems to supply oxygen during sustained physical activity' 
(Sigal, Kenny, Wasserman et al., 2004). CRF is an attained physiological state and the major component of 
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physical fitness that is inversely related to all-cause mortality. It is therefore considered an important 
health-related indicator. CRF is measured as VO2m , which reflects the maximum rate that oxygen can be 
taken up and utilised by the body during exhaustive exercise. VO2max is typically expressed as the total 
volume of oxygen used per kilogram of body weight per minute (ml-kg-min'), which enables individuals 
of different body masses to be compared. 
Determinants 
CRF varies considerably between untrained individuals. Inter-individual variation is attributable to a 
number of both non-modifiable and modifiable factors (American College of Sports Medicine, 1995). Non- 
modifiable factors include genetics, gender and age. Genetics are thought to be the most significant 
determinant, accounting for up to 50% of the variance between individuals (Bouchard, Daw, Rice et at., 
1998; Bouchard, Dionne, Simoneau et al., 1992). Gender is also influential, with VO2max values typically 
15-25% lower in females than males. This difference has been ascribed to higher body fat percentages 
(Drinkwater, 1984), lower levels of haemoglobin in the blood (Cureton, Bishop, Hutchinson et al., 1986), 
and smaller hearts relative to body size in women compared with men (Mitchell, Tate, Raven et at., 1992). 
Evidence derived from cross-sectional and, more recently, longitudinal studies shows age to be inversely 
associated with CRF (Dehn and Bruce, 1972; Fleg, Morrell, Bos et al., 2005; Ogawa, Spina, Martin et al., 
1992). This is illustrated in Table 2.4, which shows normative VO2m data, divided into equal groups using 
quintiles for both men and women in different age categories (Heyward, 2006). Modifiable factors that 
influence CRF include body mass, body composition and exercise habits (Blair, Cheng and Scott Holder, 
2001). 
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Table 2.4. Gender and age-specific VOZ, ,, categories 
Female (values in ml-kg-min") 
Age Very poor Poor Fair Good Excellent Superior 
13-19 <25.0 25.0-30.9 31.0-34.9 35.0-38.9 39.0-41.9 >41.9 
20-29 <23.6 23.6-28.9 29.0-32.9 33.0-36.9 37.0-41.0 >41.0 
30-39 <22.8 22.8-26.9 27.0-31.4 31.5-35.6 35.7-40.0 >40.0 
40-49 <21.0 21.0-24.4 24.5-28.9 29.0-32.8 32.9-36.9 >36.9 
50-59 <20.2 20.2-22.7 22.8-26.9 27.0-31.4 31.5-35.7 >35.7 
60+ <17.5 17.5-20.1 20.2-24.4 24.5-30.2 30.3-31.4 >31.4 
Male (values in ml-kg"min"') 
Age Very poor Poor Fair Good Excellent Superior 
13-19 <35.0 35.0-38.3 38.4-45.1 45.2-50.9 51.0-55.9 >55.9 
20-29 <33.0 33.0-36.4 36.5-42.4 42.5-46.4 46.5-52.4 >52.4 
30-39 <31.5 31.5-35.4 35.5-40.9 41.0-44.9 45.0-49.4 >49.4 
40-49 <30.2 30.2-33.5 33.6-38.9 39.0-43.7 43.8-48.0 >48.0 
50-59 <26.1 26.1-30.9 31.0-35.7 35.8-40.9 41.0-45.3 >45.3 
60+ <20.5 20.5-26.0 26.1-32.2 32.3-36.4 36.5-44.2 >44.2 
(Heyward, 2006) 
As well as inter-individual variation in untrained states, there is considerable variation between individuals 
in terms of adaptation or response to a programme of training. Data from 481 sedentary adults from 98 
two-generation families participating in the HERITAGE Family Study showed considerable heterogeneity 
in the VO2m,,, response to a standardised 20-week training programme, with some individuals experiencing 
little or no gain, and others experiencing vast improvements in fitness. These data led the authors to 
suggest that 47% of the age and sex adjusted VO2m response to the programme of exercise was hereditary 
(Bouchard, An, Rice et al., 1999). Subsequently, in a review of studies reporting inter-individual variation 
in responsiveness to standardised and controlled exercise-training programmes, Bouchard and Rankinen 
(2001) found that age, gender and ethnic origin only contributed to -11% of the variance in response to 
regular physical activity, and that familial factors had a considerable influence in training responses. 
Associations with health 
Strong epidemiological evidence shows that, in both men and women, a strong inverse relationship exists 
between CRF and morbidity and mortality (Blair, Kampert, Kohl et al., 1996; Farrell, Cheng and Blair, 
2004; Laukkanen, Lakka, Rauramaa et al., 2001; Myers, Prakash, Froelicher et al., 2002). Furthermore, 
higher levels of CRF have been shown to reduce the harmful effects of other risk factors for CVD and all- 
cause mortality, including smoking, high cholesterol and hypertension (Blair et al., 1996). For CRF, there 
appears to be a minimum threshold for protection against CVD and all-cause mortality, whereby the 25% 
of the population with the lowest levels of CRF are at particular risk (Williams, 2001). Improvements in 
20 
Chapter 2: Literature Review 
CRF have been shown to be associated with improvements in health (Blair, Kohl, Barlow et al., 1995; 
Erikssen, Liestol, Bjarnholt et al., 1998). 
Measurement 
The gold-standard method of measuring cardiorespiratory fitness is directly measured maximal oxygen 
uptake (VO2m), involving analysis of expired air samples collected while an individual performs exercise 
of progressing intensity. Although this method provides the most accurate determination of VO2maX, it 
requires sophisticated equipment, is costly, labour intensive and time-consuming, and is therefore used 
infrequently in field research. Estimating VO2m using heart rate during maximal exercise testing is 
considered to be the next most accurate method. However, such testing requires individuals to exercise to 
the point of volitional fatigue, and is likely to pose risks for individuals with T2D, of whom many are 
obese, predominantly sedentary, and already experiencing diabetic complications. 
In an attempt to overcome the limitations of maximal testing, submaximal tests have been developed, 
which allow the prediction of VO2,,, without the cost, risk, time and effort on the part of the subject 
(Astrand and Ryhming, 1954; Kline, Porcari, Hintermeister et at., 1987). Many of these submaximal tests 
use the heart rate at different work loads to predict VO2max, while others predict VO2max from multiple 
regression equations that include various parameters, such as age, gender and weight. The central tenet of 
submaximal tests is that heart rate-a marker of relative effort-is linearly related to oxygen consumption. 
Submaximal tests have been developed for several modes of exercise, including walking, cycling and 
running. Walking tests are particularly useful however, since walking is an acceptable exercise mode for 
most adults, is used almost universally, and is suitable for testing various populations (Laukkanen, Oja, 
Ojala et al., 1992). Furthermore, submaximal tests based on walking are generally safe and are considered 
more feasible than tests based on running or jogging (Oja, Manttäri, Pokki et al., 2001). For the purpose of 
testing on a large number of people, the test ought to be simple, reproductive and cost-effective. 
2.2.5. The relationship between physical activity, cardiorespiratoryfitness and health 
It is acknowledged that both physical inactivity and low fitness can be considered as major and equally 
important risk factors for a wide range of chronic diseases in adulthood (Department of Health, 2004). 
Several large prospective observational studies provide strong evidence of an inverse dose-response 
gradient across both activity and fitness categories for morbidity from coronary heart disease (CHD), 
stroke, CVD and cancer. A similar association is also evident for CVD, cancer and all-cause mortality 
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(Blair et at., 2001). In a review of prospective observational studies reporting both physical activity and 
CRF in relation to health outcomes, Blair and colleagues (2001) identified just nine studies. When the 
inverse gradient between mortality and physical activity and CRF were compared, fitness appeared to be 
more strongly related with mortality than physical activity. However, it should be noted that none of the 
analyses reported from the studies included both activity and fitness in multivariable models. Furthermore, 
physical activity was assessed using self-report methods in the epidemiological studies reviewed. Fitness, 
on the other hand, is more precisely measured through maximal or submaximal exercise tests and the 
stronger association of mortality with CRF compared with physical activity could be attributed to the 
difference in measurement precision between the two exposures. 
2.3. Physical activity and type 2 diabetes 
2.3.1. Physical activity levels and type 2 diabetes 
Observational evidence 
Early cross-sectional observations of differences in the prevalence of T2D between rural and urban areas 
first indicated that there was an association with physical activity (Zimmet, Faaiuso, Ainuu et al., 1981). In 
the last 15 years, however, compelling data from large prospective studies have demonstrated that a 
sedentary lifestyle may play a role in the development of T2D. Heimrich and colleagues (1991) presented 
data from one of the first large-scale observational studies, involving 5,990 male University of 
Pennsylvania alumni, aged 39-68 years. In an average of 14 years follow-up, 202 cases of diabetes 
occurred. With each 500 kcal increase in reported weekly leisure-time physical activity energy expenditure, 
up to 3,500 kcal-week"', a 6% decrease in the age-adjusted risk for the development of diabetes was 
observed (P<0.01) (Heimrich et al., 1991). The protective effect of physical activity was most pronounced 
in individuals at highest risk of T2D, including those with a high body mass index (BMI), history of 
hypertension or a parental history of diabetes. 
In a cohort of 21,271 US male physicians, reported participation in vigorous exercise five or more times 
per week was associated with a 42% reduction in the age-adjusted risk of T2D compared with those who 
exercised less than once per week (Manson et al., 1992). A dose-response relationship between increased 
exercise frequency and reduced risk for T2D was observed. Similar findings have been reported for 
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women. In 87,253 women participating in the US Nurses Health Study, the risk of developing T21) was 
33% lower in participants who reported exercising vigorously at least once per week, compared with those 
who reported no weekly exercise (Manson et al., 1991). The reduction in risk for T2D was weakened after 
adjusting for BMI, but remained significant. 
In a more recent analysis, where 534,928 female nurses were followed for eight years, a higher volume of 
self-reported physical activity attributable to walking was also associated with reduced relative risk for 
diabetes, and an inverse risk of developing the condition was reported across quintiles of reported physical 
activity (Hu et al., 1999). After adjusting for BMI, these relative risks corresponded to 1.00 (referent), 0.84, 
0.87,0.77 and 0.74, respectively. A study of combined lifestyle factors and risk of diabetes in this cohort 
identified that while overweight or obesity were the single most important predictors of diabetes, lack of 
exercise, a poor diet and current smoking were all associated with significantly increased risk, even after 
adjustment for BMI (Hu et al., 2001a). This study supports the notion that a significant proportion of cases 
of T2D could be prevented by the adoption of a healthier lifestyle. 
European studies have reported similar results, although these studies have been limited to male 
participants. Swedish men reporting at least 40 minutes per week of moderate intensity activity had a 50% 
lower risk of diabetes than those who reported not participating in moderate activities or who participated 
for shorter durations (Lynch et al., 1996). The apparent protective effects of exercise were most 
pronounced in individuals at high risk for developing T2D, who had a 64% lower risk of developing the 
disorder compared with those who did not exercise to this level. In the UK, the British Regional Heart 
Study followed 5,159 men, aged 40 to 59 years, for an average of 16.8 years and found that there was a 
decreased incidence of diabetes with increasing levels of various recreational physical activity, ranging 
from regular walking and cycling to sporting or vigorous activities (Wannamethee, Shaper and Alberti, 
2000). 
The majority of the participants in these studies are Caucasian. However other ethnic groups have been 
observed, including African-American men and women (James, Jamjoum, Raghunathan et al., 1998), and 
Japanese-American men (Burchfiel, Sharp, Curb et al., 1995), in whom similar associations between 
physical inactivity and development of diabetes have been reported. Interestingly, one study reporting 
prospective observations among Hispanic and Asian women found no significant association between 
physical activity and diabetes risk (Hsia, Wu, Allen et al., 2005). Conversely, however, cross-sectional data 
from The San Luis Valley Diabetes Study, involving 219 Hispanic and non-Hispanic white men and 
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women with IGT, found that among all participants, higher self-reported physical activity levels were 
associated with lower mean insulin areas, independent of obesity, fat distribution and age (P<0.001) 
(Regensteiner, Shetterly, Mayer et al., 1995a). 
In recent years, several cross sectional studies have aimed to quantify the number of people with T2D 
achieving recommended levels of physical activity. In a nationally representative survey of US adults, 39% 
of respondents with diabetes reported engaging in 150 minutes of physical activity a week compared to 
58% of adults without diabetes (Morrato, Hill, Wyatt et al., 2007). Similarly, just 32% of 1,614 Canadian 
adults with T2D reported achieving the weekly recommendation of 150 minutes. The investigators found 
that a younger age, male gender, higher education, higher income and lower BMI were associated with 
achieving the recommended level of activity (Plotnikoff, Taylor, Wilson et al., 2006). An earlier study 
reported similar correlates of physical activity in 260 adults, aged 55 years and above, with T2D. Based on 
data from an interviewer-administered survey, Hays and Clark (1999) found that 55% of respondents 
reported doing zero minutes of weekly physical activity. While female respondents were more likely to 
report zero minutes of activity compared with men (58.3 vs. 47.4%), a younger age, higher level of 
education, fewer motivational barriers, and greater perceived health and performance expectations were 
correlated with higher levels of physical activity. 
Over the past few years, increasing attention has been given to daily step recommendations. Although not 
evidence-based, the accumulation of 10,000 steps per day has been promoted as a useful activity target for 
the general population. The daily guideline of 30 minutes of at least moderate intensity activity translates to 
approximately 3,000-4,000 steps, providing they are 1) at least moderate intensity (i. e. 100 stepsminute ") 
(Tudor-Locke, Sisson, Collova et al., 2005), 2) accumulated in at least 10-minute bouts, and 3) taken over 
and above some minimal level of physical activity, below which individuals could be classified as 
sedentary (Tudor-Locke, Hatano, Pangrazi et al., 2008). At present, <5000 steps daily is generally 
considered sedentary. Thus, in addition to a minimal level of activity, accumulating 30 minutes of brisk 
walking a day is likely translate to 8000-9000 daily steps (Tudor-Locke et al., 2008). 
Tudor-Locke and colleagues (2002a) conducted a cross-sectional study to assess pedometer-determined 
activity in 160 free-living men and women (mean age 52.4 ± 5.3 years and BMI 32.3 ± 5.7 kg/m2) with 
T2D (mean duration 1.9 ± 5.3 years). Participants were instructed to wear the pedometer over three 
consecutive days, which included two week days and one weekend day. On average, participants 
accumulated 6662 ± 3077 steps per day, which are fewer steps compared to participants without diabetes 
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(7370 t 3080) (Tudor-Locke, Ainsworth, Whitt et al., 2001). While daily steps did not differ significantly 
between men and women or by age, they were found to be inversely associated with BMI (r--0.27, 
P<0.01). When analysed by BMI category, the greatest differences in daily steps were identified between 
normal weight participants and those with morbid obesity (F=2.96, P<0.05). 
As well as differences in physical activity volume, differences in walking intensity have also been reported 
between people with and without T2D. Although a walking speed of 4.0 km/hr is widely accepted as 
moderately intense physical activity (Ainsworth, Haskell, Whitt et al., 2000), in a small study of 19 
participants with T2D (mean age 54.1 ± 7.7 years and BMI 33.4 ± 4.9 kg/r2), who had recently completed 
a self-paced walking programme, the median walking speed was 3.3 km/hr (Johnson, Tudor-Locke, 
McCargar et al., 2005). Despite accumulating an average of 9150 steps per day over the 3-day 
measurement period, the slow walking speed may mean that potential health benefits are not fully 
achieved. Unfortunately, since the relative intensity of the walking was not measured it is unknown 
whether the walking speed of 3.3km/hr was sufficient to reach the desirable intensity considered beneficial 
for health. 
Prospective studies suggest that people who exercise have a 33-50% lower risk of developing T2D (Lynch 
et al., 1996; Manson et al., 1992) and the greater the volume of exercise, the lower the risk of developing 
the disease (Manson et al., 1992; Manson et al., 1991). Walking and cycling levels are also associated with 
reduced risk of T2D (Hu et al., 1999; Wannamethee et al., 2000). The reduction in risk can be seen across a 
range of physical activity patterns and intensities, although the precise type, intensity, frequency, duration 
or volume of activity needed to protect against T2D are unknown. 
Cross-sectional data show that fewer adults with diabetes report achieving recommended levels of activity 
compared with healthy adults. Reported pedometer data provide further evidence that people with diabetes 
perform less activity than their healthy counterparts. Additionally, self-selected walking speed appears to 
be slower in those with diabetes compared to those without the condition. 
Intervention evidence 
In recent years, several clinical trials have assessed whether regular physical activity, with or without 
dietary intervention, can prevent the development of T2D in people with impaired glucose tolerance (IGT). 
The Da Qing Study (Pan et al., 1997) was the first RCT to evaluate a lifestyle intervention for the 
prevention of T2D. In this study 577 Chinese men and women (mean age 45 years) with IGT were 
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randomised by clinic into control conditions or one of three treatment groups, including diet only, exercise 
only, and diet plus exercise. The study was performed in community health clinic settings, using both 
group sessions and individual counselling to deliver the interventions. Participants in the exercise groups 
were encouraged to increase their leisure-time physical activity to 150 minutes per week. Activity was self- 
reported through forms and interviews. The cumulative incidence of diabetes at six years was 67.7% in 
controls compared with 43.8% in the diet group, 41.1% in the exercise group and 46% in the diet plus 
exercise group. The relative decrease in rate of development of diabetes in the treatment groups was similar 
when subjects were stratified as lean (BMI <25kg/m2) or overweight (BMI 2! 25kglm2). After adjustment 
for baseline BMI and fasting glucose level, the diet, exercise, and diet plus exercise interventions were 
associated with 31%, 46% and 42% reductions in risk for developing diabetes. 
In the Finnish Diabetes Prevention Study (Tuomilehto et al., 2001) a total of 522 overweight men and 
women with IGT were randomised to intervention or control conditions. Intervention participants received 
individualised counselling aimed at increasing physical activity, reducing weight, and modifying diet. 
Participants were also offered a supervised programme of circuit-type resistance exercises. Achievement of 
physical activity goals was self-reported in a questionnaire. During a mean follow up period of 3.2 years, 
the cumulative incidence of diabetes was 11% in the intervention group, compared with 23% in controls, 
which equates to a reduction in risk of 58%. When analysed by gender, the incidence of diabetes was 63% 
lower among men and 54% lower among women in the intervention group. Although the independent 
effect of diet and exercise were not examined, 86% of intervention participants and 71% of the control 
participants reported achieving the physical activity goals. It is therefore likely that the questionnaire used 
to assess attainment of the physical activity goals encouraged misclassification of activity levels. 
The U. S. Diabetes Prevention Program (Diabetes Prevention Program Research, 2002) is the largest 
randomised clinical trial comparing diet plus exercise to treatment with Metformin, an oral antidiabetic 
agent, in 3,234 people (68% female; mean age 50.6 years; mean BMI 34.0) with IGT. Participants were 
randomised to placebo, Metformin or a lifestyle-modification programme. The lifestyle programme goals 
were a weight loss of at least 7% and at least 150 minutes of physical activity per week. Participants 
received sixteen individualised, one-to-one counselling sessions covering diet, exercise and behaviour 
modification designed to assist participants in achieving these goals. Subsequent monthly individual and 
group sessions were used to reinforce the behavioural changes. Self-reported levels of physical activity 
were assessed annually. 
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After an average follow-up of 2.8 years the lifestyle intervention was found to be significantly more 
effective than Metformin, with the incidence of T2D reduced by 58% in the lifestyle group and 31% in the 
Metformin group compared with placebo. By the end of the study, 38% of participants in the lifestyle 
group achieved a weight loss >_7% and 58% reported achieving the physical activity goals. Treatment 
effects did not vary significantly by either race or gender, with the lifestyle intervention highly effective in 
all subgroups. The study was not designed to test the relative contribution of dietary changes, increased 
physical activity and weight loss to the reduction of risk of diabetes, and the independent effects of these 
components remain to be determined. 
Physical activity is thought to reduce the risk for T2D by exerting favourable changes in insulin sensitivity 
and the metabolic syndrome, including reducing body weight, blood pressure, plasma levels of 
triglycerides, inflammation, fibrinolysis, and endothelial dysfunction, and increasing plasma levels of 
HDL-cholesterol (Hu, Lakka, Kilpelainen et al., 2007). An increasing body of evidence demonstrates that 
regular physical activity can improve insulin sensitivity and other components of the metabolic syndrome 
(Mayer-Davis, D'Agostino, Karter et al., 1998; Wannamethee et al., 2000), in addition to reducing the risk 
of developing the metabolic syndrome (Laaksonen, Lakka, Salonen et al., 2002). 
Published data from the trials described above show that lifestyle interventions, including physical activity, 
dietary modification and weight loss, can reduce the risk of developing T2D by up to 58% among adults 
with impaired glucose tolerance. In addition to a reduced risk of T2D, favourable changes in several 
cardiovascular risk factors, such as a reduction in body weight, blood pressure, plasma levels of 
triglycerides and fasting and 2-hour glucose and HbA,,, and an increase in HDL-cholesterol have been 
reported. 
2.3.2. Physical activity and health-related outcomes in type 2 diabetes 
Observational evidence 
Observational evidence from several prospective studies shows that physical activity also offers protection 
in people with established T2D. In the Whitehall Study, 352 men were identified with T2D at baseline. At 
the 25-year follow-up, self-reported walking pace and leisure activity were inversely related to all-cause 
and CHD mortality after adjustment for a range of covariates. A linear trend was observed for both walking 
pace (P<0.05) and leisure activity (P<0.02) across activity levels, and the association was steeper in 
individuals with T2D, when compared with normoglycaemics (Batty et al., 2002). 
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Data from a National Health Interview survey of 2,896 adults with diabetes were examined to determine 
the association between time spent walking and the risk of all-cause mortality (Gregg et al., 2003). 
Compared with inactive individuals, those who reported spending at least 2 hrs-wk4 walking had a 39% 
lower all-cause mortality rate and a 34% lower rate of CVD mortality. This difference persisted after 
correcting for sex, age, BMI, and smoking. Walking for 3 to 4 hrs-wk'' was associated with the lowest rates 
of mortality, as was walking that involved moderate increases in heart and breathing rates. 
Prospective observational evidence also exists for the joint associations of physical activity and 
conventional cardiovascular risk factors with total and cardiovascular mortality among patients with 
diabetes (Hu, Jousilahti, Antikainen et al., 2007; Hu et al., 2005). A total of 3,708 Finnish adults, aged 25- 
74 years, with T2D were followed for a mean duration of 18.7 years. A moderate or high level of self- 
reported physical activity, including occupational, commuting and leisure-time activity, was associated 
with a reduced risk of total and CVD mortality. Obesity, high blood pressure and current smoking were 
independently associated with an increased risk of total and CVD mortality. A high serum total cholesterol 
level was associated with an increased risk of CVD mortality only. Interestingly, the protective effect of 
physical activity was evident regardless of BMI, blood pressure, cholesterol and smoking status. 
Other prospective studies have reported similar findings among men and women with T2D, and have 
provided further evidence that physical activity is inversely associated with incidence of cardiovascular 
events and mortality from all causes and CVD in a dose-response manner (Hu et al., 2001b; Hu, Lindstrom, 
Valle et al., 2004a; Tanasescu et al., 2003). 
/uterrention evidence 
Over the past decade there has been increased interested in the use of exercise as a means of managing 
glycaemic control in T2D. Until recently, all intervention trials of exercise in people with established T2D 
had fewer than 25 patients, most were not randomised, used poorly validated measures of glycaemic 
control and employed different exercise regimens. A meta-analysis of these studies was first published in 
2001 (Bould et al., 2001). Included studies were restricted to randomised and non-randomised controlled 
clinical trials that lasted at least eight weeks, in which it was possible to quantify the type, frequency, 
duration and intensity of the exercise intervention. A total of 14 trials were eventually analysed, describing 
interventions (mean duration 18 ± 15 weeks) in 504 people with T2D (mean age 55 ±7 years, duration of 
T2D 4.3 ± 4.6 years). The exercise interventions typically prescribed three sessions per week, each lasting 
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a mean of 53 ± 17 minutes, including ten minutes of warm-up and cool-down. The intensity of the aerobic 
exercise was moderate and generally consisted of walking or cycling. Progressive resistance training was 
used in two intervention studies. Eleven of 14 trials were randomised, but when the results were compared 
in sensitivity analyses, no significant differences were detected between the randomised and non- 
randomised controlled trials. The quality of the trials was assessed as moderate to low. 
Post intervention HbA1, was significantly lower in exercise than control groups (7.65% vs. 8.31%), with a 
weighted mean difference of -0.66% (95% confidence interval (CI) -0.98 to -0.20, P<0.001). Differences in 
HbA1c between exercise and control groups were similar after both aerobic training and resistance training 
interventions. The change in HbA1, reported in this meta-analysis is a clinically significant reduction that 
would be expected to reduce the risk of diabetic complications (Stratton et al., 2000). No post-intervention 
statistical differences were found in body mass between the two groups, suggesting that the reduction in 
MAI, was independent of change in BMI. 
Although this meta-analysis has attempted to quantify the effect of exercise on HbA1, , 
in people with T2D, 
the reported reduction in HbA1, should be interpreted with caution as some non-randomised trials were 
included, and also some trials in which a programme of exercise plus diet was compared with a standard 
control programme that did not include diet (Agurs-Collins, Kumanyika, Ten Have et al., 1997; Fujii, 
Okuno, Okada et at., 1982; Vanninen, Uusitupa, Siitonen et at., 1992). Thus, it is not possible to determine 
the effects of exercise per se, and the inclusion of these studies could have led to an over-estimation of the 
magnitude of HbA1, response to an exercise intervention. Furthermore, it should be noted that the majority 
of the included studies lasted less than three months, and generalising these findings to longer durations is 
therefore not appropriate. 
A further meta-analysis was published in 2006, which aimed to explore the independent effect of exercise 
on a range of health outcomes in people with T2D (Thomas et al., 2006). Fourteen randomised controlled 
trials met the inclusion criteria. Trials ranged from eight weeks to 12 months in duration and involved 377 
participants. The number of participants in a single study ranged from 16 to 49. The reviewed exercise 
interventions typically involved three sessions per week with exercise occurring on non-consecutive days. 
Both resistance and aerobic exercise was included. Compared with control conditions, HbA, a was 
significantly lower after an exercise intervention (-0.6%, 95% CI -. 09 to -0.3, P<0.05), with subgroup 
analyses revealing greater reductions with interventions less than three months' duration. Additionally, the 
meta-analysis found a reduction in visceral adipose tissue (-45.5cm2,95% CI -63.8 to -27.3) and a decrease 
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in plasma triglycerides (-0.25 mmoVL, 95% Cl -0.48 to -0.02). No significant difference was found 
between groups in body mass, plasma cholesterol, blood pressure, VO2max or quality of life. 
An additional meta-analysis, published in the same year, examined the effects of different modes of 
exercise training on glucose control and risk factors for complications in adults with T21) (Snowling and 
Hopkins, 2006). The meta-analysis included 27 controlled intervention studies, lasting between five and 
104 weeks. A total of 1,003 participants (mean age 55 ±7 years) with T2D were included. An overall 
reduction in MAI, of 0.8% (95% Cl -1.3 to -0.2) was reported for training that lasted at least 12 weeks. 
Although the effects of covariates were generally trivial or unclear, the authors noted small additional 
benefits of exercise on glucose control with increased disease severity. Differences among the effects of 
aerobic, resistance, and combined training on HbAI, were trivial. 
A summary of the best available intervention evidence for the effects of exercise on glycaemic control is 
presented in Table 2.5. The largest exercise intervention in people with T2D was conducted by Di Loreto 
and colleagues (2003). The RCT was designed to validate a counselling strategy that could be used by 
physicians to promote physical activity to patients. A total of 340 patients (mean age 62 years) were 
randomised to either the usual care or intervention group. Usual care participants received 30 minutes of 
standard counselling for diet and physical activity and a 15-minute outpatient appointment once every three 
months. In addition to this, intervention participants received 30 minutes of structured physical activity 
counselling, and monthly telephone calls to discuss perceived barriers. Physical activity was assessed using 
questionnaires. At the 2-year follow-up, participants in the intervention arm reported significantly more 
activity than those in the control arm (P<0.001). Furthermore, HbAIc was significantly lower in the 
counselling group compared to the control group (7.0 ± 0.1% vs. 7.6 t 0.1%, P<0.001), and this was 
positively related to the reported increase of energy expenditure through voluntary physical activity 
(r=. 63). 
Subsequently, the investigators published post-hoc analyses of the long-term effects of different amounts 
of reported increased energy expenditure of 179 adults (mean age 62 years) randomised to the physical 
activity counselling intervention (Di Loreto, Fanelli, Lucidi et al., 2005). Based on the 2-year change in 
reported physical activity, participants were divided into six groups, corresponding to the following 
increments in METs hour per week (METs-hf'-wk"'): group 0 (no activity, n=28), group 1-10 (6.8 f 0.3, 
n=27), group 11-20 (17.1 1 0.4, n=31), group 21-30 (27.0 ± 0.5, n=27), group 31-40 (37.5 f 0.5, n=32), 
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groups 11-20,21-30,31-40, and >40, HbA,,, blood pressure, total serum cholesterol, triglycerides, and 
estimated percent of 10-year coronary heart disease risk improved (P<0.05). In group 21-30,31-40, and 
>40, body weight, waist circumference, heart rate, fasting plasma glucose, serum low-density lipoprotein 
(LDL) and HDL-cholesterol also improved (P<0.05). METs-hf1-wk"1 correlated positively with changes of 
HDL-cholesterol and inversely with those of other parameters (P < 0.001). The authors concluded that 
reported energy expenditure >10 METs"hr 1-wk' obtained through aerobic leisure-time physical activity is 
sufficient to elicit improvements in health-related outcomes in T2D, however a greater range of 
improvements are achieved with energy expenditure >20 METs-hf`-wk"'. 
In another physical activity counselling intervention (Kirk et al., 2004a), 70 participants (mean age, 57.6 f 
7.9 years; women, 50%) with T2D were randomised to either receive standard written exercise information 
or physical activity counselling involving two 30-minute discussions with a trained researcher. Physical 
activity was objectively measured using an ActiGraph accelerometer and blood samples were analysed to 
determine MAI, At the six-month follow-up, the counselling group had significantly increased physical 
activity (P<0.01), which was maintained through to 12 months. Follow-up physical activity levels in the 
control group were significantly lower compared with baseline (P<0.03). The mean difference between 
groups in HbA1, change from baseline to six months was -0.7% (95% CI -1.23 to -0.07). Furthermore, 
between group differences were also reported for a range of cardiovascular risk factors, including systolic 
blood pressure, fibrinogen and total cholesterol, with the exercise group faring more favourably (P<0.05). 
This is the only identified study that used accelerometers to assess physical activity in people with T2D. 
The studies described above support the use of exercise for the purpose of improving glycaemic control. 
Current evidence suggests that HbA1, can be reduced by approximately 0.6% in response to a programme 
of exercise. The magnitude of this reduction is clinically significant. Limited evidence suggests exercise 
may also be useful for improving other risk factors in people with T2D, although there is a need for larger 
efficacy studies to establish the magnitude of resulting improvements. 
2.3.3. Summary 
It is well established that the incidence of T2D is higher in less active populations. Over recent years, data 
from large-scale prospective studies provide compelling evidence for the independent role of physical 
activity in the prevention of T2D. The benefits of physical activity are apparent in both men and women, 
and in younger and older individuals, even after controlling for various potential confounders, such as 
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gender, age and BMI. Despite methodological limitations, such as reliance on self-reported physical 
activity levels, several large intervention studies have since added to this body of evidence, showing clearly 
that increasing levels of physical activity, together with the adoption of a healthy diet, can prevent, or at 
least delay the development of T2D in people who are at high risk of the disorder. Moreover, evidence 
shows that a healthy lifestyle in people with IGT can offer greater protection against T2D than oral 
hypoglycaemic agents alone. 
Cross-sectional evidence shows that people with T2D report being less active than the general population, 
and chose to perform activities at a lower intensity than those without the condition. Furthermore, fewer 
people with T2D report meeting current physical activity guidelines compared to people without diabetes. 
In people with T2D, prospective observational evidence shows a general dose-response relationship 
between physical activity level and protection against diabetes-related morbidity and mortality in both men 
and women. Moreover, this association between physical activity and cardiovascular and all-cause 
mortality appears to be even stronger among people with T2D compared with the general population (Batty 
et al., 2002). Current intervention evidence suggests that a range of physical activities and exercise 
intensities can produce a clinically and statistically significant improvement in glycaemic control in people 
with T2D. These improvements are independent of weight loss, and have been reported after relatively 
short time-periods, such as a few months. Generally, shorter intervention periods have produced greater 
reductions in glycaemia compared with longer interventions. 
Although data suggest that physical activity is associated with improved glycaemic control, various 
methodological limitations require the data to be interpreted with caution. The use of subjective 
questionnaire-based methods for assessing physical activity is one such limitation. Self-reported physical 
activity is known to be imprecise and leads to misclassification. Consequently, the true association between 
physical activity and health-related outcomes is likely to be underestimated, making it difficult to interpret 
the findings or quantify the dose-response relationship. The absence of a controlled diet or the 
measurement of diet in some of these published trials could have resulted in the strength of the association 
being overestimated. Finally, the lack of post-intervention follow-up in most of the short-term studies 
means it is not possible to determine whether the more marked improvements in glycaemic control are 
maintained long-term. 
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There is a lack of data on objectively-measured physical activity levels in people with T2D. Accurate 
quantification of habitual activity in this population, and the association with health-related outcomes, is 
necessary to inform future interventions and policy and practice recommendations. 
2.4. Cardiorespiratory fitness and type 2 diabetes 
2.4.1. Fitness levels and type 2 diabetes 
Observational evidence 
Evidence for the association between objectively measured CRF at baseline and subsequent diabetes risk is 
based on a just a few large prospective studies (Bjornholt, Erikssen, Liestol et al., 2001; Carnethon, 
Gidding, Nehgme et al., 2003; Eriksson and Lindgarde, 1996; Lynch et al., 1996; Sawada et al., 2003; Wei 
et al., 1999). One of the first of these to assess CRF by exercise testing involved 897 middle-aged Finnish 
men who were followed for four years (Lynch et al., 1996). CRF was measured with ventilatory gas 
analysis during a maximal bicycle ergometry test. A total of 202 T2D cases were diagnosed from 2-hour 
postload glucose concentrations. After adjusting for several confounders, odds ratios for incident diabetes 
in the first, second, third and fourth quartile of CRF, were 1.00 (referent), 0.77,0.26, and 0.15, 
respectively. 
In the Aerobics Center Longitudinal Study (ACLS) 8,633 US men, aged 30-79 years, were followed for an 
average of six years. Compared with those in the high-CRF group (most fit 40%), as determined by a 
maximal treadmill test, participants in the lowest-CRF group (least fit 20%) at baseline had a 1.9-fold risk 
for impaired fasting glucose (IFG), and a 3.7-fold risk for T2D (Wei et al., 1999). The inverse gradient 
occurred in men with high or normal BMI, those with or without a family history of diabetes, and those 
with normal or impaired fasting glucose (IFG) at baseline. 
More recently, a 14-year prospective study of 4,747 Japanese men, aged 20-40 years, has been published 
(Sawada et al., 2003), which investigated the association between VO2m$X, predicted from a cycle 
ergometer test, and the incidence of T2D. During the 14-year follow-up, 280 cases of T2D were identified 
based on three diagnostic parameters, including glucose tolerance testing, fasting blood glucose testing, or 
the reporting of hypoglycaemic therapy. The adjusted relative risks (RRs) of developing diabetes across 
increasing quartiles of fitness were 1.00 (referent), 0.78,0.63, and 0.56. 
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The Coronary Artery Risk Development in Young Adults (CARDIA) study of 2,478 men and women in 
the United States, aged 18 to 30 years, assessed whether low fitness predicted the development of T2D or 
the metabolic syndrome over 15 years of follow-up (Carnethon et al., 2003). Additionally, change in fitness 
over a seven-year period was examined in relation to risk. After multivariate adjustments, participants with 
low fitness (bottom 20%) were approximately twice as likely to develop T2D or the metabolic syndrome 
compared to those with high fitness (top 40%). Improving fitness over seven years was associated with a 
60% reduction in subsequent risk for T2D and 50% reduction for the metabolic syndrome. 
Until recently there was a dearth of data on fitness and risk of T2D among women; however a 17-year 
observational prospective study of 6,249 women, aged 20-79 years, has been published within the past year 
(Sui, Hooker, Lee et al., 2008). All women were free of CVD, cancer and diabetes at baseline. CRF was 
measured using a maximal treadmill exercise test. Women were categorised into tertile groups based on 
their baseline fitness. Compared with the least fit group, BMI-adjusted hazard ratio (HR) was 0.86 (95% CI 
0.59 to 1.25) for the moderately fit group and 0.61 (95% CI 0.38 to 0.96) for the most fit group. The 
authors found that low CRF and high BMI were independently associated with the incidence of T2D. 
On average, individuals with T2D have VO2max values that are 20-25% below that reported in age- and sex- 
matched sedentary individuals without T2D (Regensteiner, Sippel, McFarling et al., 1995b). While it is 
thought that the reduced fitness is at least partly due to an excess fat mass in this population, differences in 
the region of 20% have also been found in comparison to healthy controls that were matched for body 
weight (Regensteiner, Bauer, Reusch et al., 1998). 
Fitness has a large genetic component with predispositions to muscle fibre type and lung volume, and, 
when combined with the genetic component of insulin resistance and diabetes, it results in an inherited 
impaired exercise capacity of first degree relatives of diabetic individuals (Thamer, Stumvoll, Niess et al., 
2003). A normoglycaemic population, half without a family history and half with a first degree relative 
with T2D were compared in terms of their habitual activity, VO2m. and glucose control. Despite 
comparable levels of habitual activity, the relatives were found to have significantly reduced V02.,,, and 
elevated blood glucose levels after adjustment for age and body weight. The use of questionnaires to assess 
habitual activity, and higher rates of obesity in relatives, means that some of this discrepancy may be 
explained by recall bias in the reporting of activity. 
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No intervention studies were located that investigated VO2max response to a programme of exercise in 
relation to the development of T2D. 
Until recently, data reporting the association between cardiorespiratory fitness and the risk of developing 
T2D were derived mainly from men. Associations appear to be similar to those found in studies of physical 
activity, however associations for fitness appear to be stronger. Larger magnitudes of association with 
fitness could be due to the use of more precise measures for this exposure. Furthermore, biological factors 
can influence both CRF and health (Blair et al., 2001). 
2.4.2. Cardiorespiratoryfitness and health-related outcomes in type 2 diabetes 
Observational evidence 
Several longitudinal data sets provide evidence showing that CRF predicts cardiac mortality in people with 
T2D. Wei et at. (2000) examined the association of low CRF and physical inactivity with mortality in 
1,263 men (mean age 50 years) with T2D from the ACLS cohort. CRF was measured by a maximal 
treadmill test. Men were then categorised as either unfit or fit according to whether their fitness value was 
below or above the median. Participants were also categorised according to self-reported activity within the 
previous three months. Active men were those reporting at least one bout of walking, jogging or aerobic 
exercise, while those reporting no such activity were classed as inactive. Between 1970 and 1994,180 
deaths occurred. After adjusting for confounders, the RR of mortality was 2.1 and 1.7 with low levels of 
objectively determined fitness and reported physical activity, respectively. 
An updated study from the same research team has been published subsequently, with almost twice as 
many men (Church et al., 2004). Since obesity is strongly associated with T2D, and is thought to increase 
risk of mortality among people with the disorder, data from 2,196 men (mean age 49.3 years) with T2D 
were analysed to quantify the relation of fitness to mortality, adjusting for BMI. After adjustment for 
confounders, the RR across quartiles of CRF was 1.00 (referent), 0.63,0.36, and 0.22. The men were also 
grouped according to BMI-defined categories, including normal weight, overweight and obese. A steep 
inverse association was seen across quartiles of fitness within each BMI category, suggesting that the 
inverse relationship between CRF and mortality is independent of BMI. 
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Evidence also exists that shows improvements in CRF over time are associated with lower subsequent 
mortality rates, and deterioration in CRF is associated with higher subsequent mortality rates (Blair et al., 
1995; Erikssen et al., 1998). 
Kohl and colleagues (1992) analysed prospective data from 8,715 men (mean age 42 years) in order to 
determine the association between baseline CRF and all-cause mortality across a range of blood glucose 
levels. Included men underwent maximal-exercise treadmill testing at baseline and were followed for an 
average of 8.2 years. The investigators found that age-adjusted death rates increased with higher levels of 
fasting blood glucose. However, fit men were found to have lower age-adjusted all-cause mortality rates 
than their less fit counterparts, regardless of glycaemic status. This association was also found in men with 
T2D. Multivariate analyses that controlled for risk factors of mortality, including age, resting systolic blood 
pressure, serum cholesterol, BMI, family history of heart disease, follow-up interval and smoking habit, 
showed a higher risk of death due to all causes for unfit compared with fit men. Multivariate relative risks 
(RR) of death associated with low fitness, compared with high fitness, in the three glycaemic status groups 
were: 1.38 (95% Cl 1.09-1.74) for fasting plasma blood glucose (FPG) <6.4 mmol/l, 1.61 (95% Cl 0.91 to 
2.86) for FPG 6.4-7.8 mmol/l, and 1.92 (95% Cl 0.75 to 4.90) for FPG Z7.8 mmol/l or with T2D. These 
data suggest that even when glucose control is poor, fitness may still protect against mortality. 
In a recent cross-sectional study, Kadoglou and colleagues (2008) examined the interaction between 
cardiorespiratory capacity and cardiovascular risk factors in 40 men and 52 women with T2D. 
Cardiorespiratory capacity was assessed during a symptom-limited incremental ergometer exercise test, 
with continuous gas exchange measurement. All patients were overweight or obese (BMI >25), with poor 
glycemic control (HbAic >7%), but free from overt diabetic vascular complications. Based on the median 
VOzpeak value, participants were placed into a low fitness (n=46) or moderate fitness group (n=46). After 
adjustment for age and gender, exercise capacity correlated with systolic (r=-. 349) and diastolic blood 
pressure (r=-. 441), waist circumference (r=-. 345), total cholesterol (r=-0.348), HDL-cholesterol (r=. 362) 
and homeostasis model assessment (HOMA-IR) (r=-. 467) (P<0.05). Compared to the low fit group, 
patients with moderate fitness showed significantly higher levels of HDL-cholesterol and lower blood 
pressure, waist circumference and HOMA-IR (P<0.05). These data indicate that low cardiorespiratory 
fitness seems to be independently associated with most traditional cardiovascular risk factors in patients 
with T2D. 
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Overall, findings of an inverse association for CRF and mortality in men and women with T21) are 
generally consistent and indicate that protection against mortality may be provided by moderate to high 
levels of fitness, irrespective of body weight and glycaemic control. Since CRF appears to offer significant 
protection against mortality in diabetes, analyses have been performed in an attempt to quantify the volume 
of physical activity associated with moderate fitness (Stofan, DiPietro, Davis et al., 1998). A total of 
17,000 mainly non-diabetic participants from the ACLS completed physical activity diaries in addition to 
undergoing maximal exercise testing. The mean time per week spent exercising was 130 minutes for men 
and 148 minutes for women who were classified as moderately fit (21st to 60th percentile for age) and 
whose only reported exercise was walking. Comparisons between people with diabetes and non-clinical 
groups have not been located. 
Intervention evidence 
As mentioned previously, cardiorespiratory fitness is determined both by genetic factors and by habitual 
physical activity. Improvements in CRF in response to identical structured aerobic exercise programmes 
can vary considerably between individuals (Bouchard et al., 1999), and until recently the degree to which 
VO2max could be improved in response to increased exercise in people with T2D was unknown. In order to 
address this, a meta-analysis quantifying the effect of structured, supervised exercise training on CRF in 
men and women with T2D was performed by Bould and colleagues (2003). Randomised controlled trials 
(RCTs) evaluating the effect of interventions lasting at least eight weeks on CRF (as determined directly or 
derived from an equation after maximal testing) were included. A total of seven studies that presented data 
for nine training programmes were analysed, representing 266 adults (mean age 55.7 years, mean duration 
of T2D 4.1 years), of whom 40% were female. The quality of the trials was assessed as moderate to low. 
Physical activity programmes lasted for a mean duration of 20 weeks, and typically consisted of three bouts 
of walking or cycling per week, with each bout lasting approximately 40 minutes. Exercise intensities 
ranged from 50% to 75% of VO2ma, while exercise volume ranged from 8.75 to 24.75 METs"hr''"wk'1. 
Mean baseline VO2max was 22.4 ml-kg-min' with no significant difference between groups. Overall, there 
was an 11.8% increase in VO2max in the exercising groups and a 1.0% decrease in VO2max in the control 
groups (post intervention standardised mean difference=0.53; 95% Cl 0.18 to 0.88, P=0.003). Compared 
with no difference at baseline, post intervention HbA1,, values were lower in the exercise groups than 
control groups (weighted mean difference=-. 71%; 95% Cl -1.1 to -0.32, P=0.0004). Post-intervention 
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standardised mean difference in VO2m was significantly associated with weighted mean difference in 
HbAI, (r=-. 72, P=0.04). 
Meta-regression analyses were performed to detect associations between the standardised mean difference 
in VO2m. and specific training characteristics. Only the association between mean difference in VO2max 
and exercise intensity reached borderline significance (r=. 28, P=0.08). No significant associations were 
found with exercise volume per week (MET-hrs"wk7) (r=-. 03, P=0.94), total exercise volume (MET"hrs) 
(r=-. 35, P=0.35), bout frequency (r=-. 10, P=0.79), bout duration in minutes (r--. 28, P=0.15), or duration of 
programme (r=-. 38, P=0.32). 
Eight out of the nine comparisons included in the meta-analyses reported HbAI, values (n=250). The 
exercise characteristic showing the strongest correlation with the weighted mean difference in HbA,,, 
between the exercise and control groups was relative exercise intensity (r=-. 91, P=0.002). There was no 
significant correlation between difference in HbA1, and absolute intensity (r=-. 33, P=0.42), exercise 
volume per week (MET"hrs-wk71) (r=-. 46, P=0.26), or total volume (MET"hrs) (r=-. 12, P=0.8). 
Despite low CRF levels at baseline, the meta-analysis by Boule and colleagues demonstrates that aerobic 
fitness can be improved in people with T2D to an extent that is comparable with reported improvements in 
older healthy individuals (Nelson, Rejeski, Blair et al., 2007). The meta-analysis showed a strong and 
significant association between mean change in VO2,,, 8,, and HbA,, response to a programme of exercise, 
and reported that these changes tended to be correlated with intensity of exercise. However, these results 
should be interpreted with caution, since many of the included studies had small sample sizes and variable 
results (Dunstan, Daly, Owen et al., 2002; Tessier, Menard, Fulop et al., 2000; Vanninen et al., 1992). It is 
also likely that the analysis was biased by the inclusion of one study (Mourier, Gautier, De Kerviler et al., 
1997) that featured unequivocally high-intensity exercise (75% of VO2max), resulting in the greatest 
increase of VO2max (40.9%) and the greatest reduction in MAI, (1.5%). Furthermore this study included 
the youngest participants, which might have influenced their response to a training programme. This 
intensity is likely to be difficult to sustain in people with T2D, many of whom are obese and predominantly 
sedentary. 
2.4.3. Summary 
Longitudinal evidence from just a few large cohort studies suggests there is a strong, independent inverse 
association between objectively measured CRF and risk of developing T2D, which remains after adjusting 
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for potentially confounding variables, including age, BMI, family history of diabetes, and diagnosis of IGT 
at baseline. No intervention evidence was located that examined the relationship between CRF and 
development of T2D. 
In people with T2D, longitudinal data show CRF is inversely correlated with all-cause and cardiac 
mortality, irrespective of body weight, and glycaemic control. Evidence also shows that improvement in 
fitness is associated with reduced subsequent risk of mortality. Equally, reduced fitness related to increased 
risk. 
Limited data from intervention studies demonstrate that aerobic fitness can be improved in people with 
T2D, and that increased VO2max, produced by a programme of relatively vigorous, structured aerobic 
exercise training, is strongly associated with clinically significant improvements in HbA,, There is now a 
need to assess the efficacy of home-based, moderate-intensity exercise for improving HbA1c and other 
important health outcomes in diabetes. Moreover, examining the cross-sectional association between 
objectively-measured habitual physical activity and CRF may allow effective targeting of intervention 
programmes. 
2.5. Relationships between physical activity, cardiorespiratory fitness and health-related outcomes 
in diabetes 
A number of epidemiological studies have examined the association between both physical activity and 
cardiorespiratory fitness with health outcomes related to diabetes. Both exposures are inversely related to 
the development of T2D and also premature mortality among those with T2D. As mentioned in previous 
sections, prospective observational data suggest that health is more strongly related to fitness than physical 
activity (Blair et al., 2001; Blair and Church, 2003; Laaksonen et al., 2002; Lakka, Laaksonen, Lakka et al., 
2003; Oja, 2001; Wei et al., 2000). However, compared to CRF, which is measured objectively and 
reliably, physical activity measures are usually based on self-reported methods, which are typically crude 
and imprecise. Imprecise measures will undoubtedly lead to misclassification of the exposure, and this in 
turn will weaken the observed association with outcomes, and thus underestimate the strength of the true 
relationships. 
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In order to compare and explore the independent and combined associations of fitness and physical activity 
with health outcomes, comparable measures of the exposures are required. Objective, valid and reliable 
methods of measuring physical activity are therefore necessary. Since few objectively-determined physical 
activity and CRF data exist in adults with T2D, this section will highlight the findings of studies in non- 
diabetic populations that may have implications for those with the condition. 
In a cross-sectional study of 589 Danish children (mean age 9.6 years), Brage and colleagues (2004) 
examined the relationship between the metabolic syndrome and objectively measured physical activity. A 
potential modification effect of CRF on this relationship was also assessed. Physical activity was measured 
using accelerometry and fitness was measured using a maximal cycle test. Metabolic risk, computed based 
on blood pressure, degree of adiposity and fasting levels of insulin, glucose, triglycerides and HDL- 
cholesterol, was inversely related to physical activity (P=0.008). However, the strength of this association 
was weakened after adjustment for fitness. Examination of the interaction between physical activity and 
fitness showed that the association between activity and metabolic risk was greatest in children with lower 
cardiorespiratory fitness levels. 
Franks and colleagues (2004) explored similar associations in adults. Presented data were based on 874 
healthy participants from the Ely Study, which is a prospective population-based cohort study of the 
aetiology and pathogenesis of T2D and related metabolic disorders. Physical activity was measured 
objectively by individually calibrated heart rate monitoring over a 4-day period, while VO2mac was 
predicted from a submaximal exercise test with direct assessment of oxygen uptake. A metabolic syndrome 
score was computed by summing standardised values for obesity, hypertension, hyperglycaemia, insulin 
resistance, hypertriglyceridaemia, and the inverse level of HDL-cholesterol. After adjusting for 
confounders and bivariate measurement error, there was a strong and significant inverse relationship 
between physical activity energy expenditure (PAEE) and metabolic syndrome score (P=0.004). The 
relationship between VO2and metabolic syndrome score was much weaker and reached only borderline 
significance (P=0.06). However, when the data were stratified above and below the median for V02.. and 
by quartile for PAEE, the authors found that VO2m. significantly modified the association between the 
metabolic syndrome score and PAEE, even after adjustment for age, sex and bivariate error correction 
(P=0.036). The inverse association between physical activity and metabolic syndrome risk was present 
only in those who were below the median in CRF. 
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The same study group subsequently described the prospective association over a 5.6 year period between 
objectively-measured PAEE and aerobic fitness with the metabolic syndrome (Ekelund, Brage, Franks et 
at., 2005). Data were presented for 605 middle-aged men and women who were free of the metabolic 
syndrome at baseline. The group reported that PAEE predicts progression towards the metabolic syndrome 
in a dose-dependent manner and that this association is not explained by obesity, level of aerobic fitness, or 
other potential confounding factors. After adjusting for physical activity level, the investigators did not 
observe an association between aerobic CRF and the metabolic syndrome. 
Conversely, previous prospective studies have found CRF to be independently predictive of the metabolic 
syndrome (Laaksonen et al., 2002), although adjustment for physical activity level was not performed. 
In order to separate the effects of fitness and physical activity energy expenditure in the aetiology of the 
metabolic cardiovascular syndrome, Wareham et al (1998) estimated 4-day energy expenditure and CRF in 
a cross-sectional population-based study of 162 adults aged 30-40 years. Individuals were categorised as 
having the metabolic syndrome if at least one of four risk factors were present, including hypertension, 
hypertriacylglycerolaemia, low HDL-cholesterol and glucose intolerance. Heart rate (HR) monitoring with 
individual calibration was used to measure mean resting energy expenditure and total energy expenditure, 
which has been validated previously. VO2, was assessed during submaximal testing on a cycle 
ergometer. Twelve men (16.4%) and 16 women (18.0%) were defined as having one or more features of 
the metabolic cardiovascular syndrome. The univariate odds ratio for each increasing quartile of physical 
activity level (PAL) was 0.64 (95% Cl 0.43 to -0.94) and 0.49 (95% CI 0.32 to 0.74) for VO2max, 
suggesting that the association with the metabolic syndrome was stronger for fitness than for PAL. 
Conversely, after adjustment for obesity, sex, and correction for exposure measurement error, the odds 
ratio per quartile for PAL was 0.32 (95% Cl 0.13 to 0.83) and 0.44 (95% CI 0.24 to 0.78) for VO2m . 
These findings suggest that PAL is a major determinant of the metabolic syndrome, although the small 
sample size and cross-sectional nature of these data requires caution to be applied when interpreting the 
results. 
25.1. Summary 
Few data have been published comparing the influence of physical activity and CRF on glycaemic control, 
cardiovascular risk factors or mortality in people with T2D. Analyses that have attempted this comparison 
suggest the relationship is stronger for CRF than physical activity. However, these analyses are based on 
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self-reported physical activity data and thus, it is not surprising that a stronger relationship has been 
reported with CRF, particularly since CRF is often used as an objective surrogate measure of physical 
activity due to the well-recognised limitations of self-reported behaviour. Since CRF is a function of both 
physical activity and non-modifiable genetic factors, without accurate knowledge of activity level, it is 
impossible to compare the independent associations of these exposures with health-related outcomes in 
diabetes. Finally, it is unknown whether physical activity and CRF interact in a unique and independent 
manner with metabolic and cardiovascular risk factors in people with T2D. Unfortunately, data on these 
objectively-determined variables are currently unavailable in this clinical population. 
2.6. Promoting physical activity in people with type 2 diabetes 
2.6.1. Interventions and strategies to increase physical activity in people with type 2 diabetes 
It is well acknowledged that participation in regular physical activity offers many benefits to health and 
wellbeing, yet achieving greater participation in physical activity remains a major challenge, and the 
successful adoption and maintenance of physical activity is notoriously difficult to achieve, particularly in 
people with diabetes (Ford and Herman, 1995; Hays and Clark, 1999; Krug, Haire-Joshu and Heady, 
1991). 
A number of theoretical models have attempted to explain physical activity behaviour, and understanding 
the factors that influence this behaviour is imperative for the development of effective interventions (Kirk 
and De Feo, 2007). Although consensus regarding the best theoretical model for understanding exercise 
behaviour has not yet been achieved, one theory that has been particularly useful is the transtheoretical 
model (Prochaska and Marcus, 1994). While the model was initially applied to areas such as smoking 
cessation and dietary modification, a meta-analysis reviewing its application in the area of exercise 
behaviour provides strong support for its use in facilitating adoption and maintenance of physical activity 
(Marshall and Biddle, 2001). 
The transtheoretical model, otherwise referred to as the stages of change model, postulates that there are 
five different cognitive stages regarding readiness to changing a behaviour. These stages include 
precontemplation, contemplation, preparation, action and maintenance. The implication of this model is 
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that interventions designed to facilitate adoption and maintenance of a particular behaviour should be 
tailored to the stage of readiness of the individual concerned. 
Three factors are hypothesized to mediate the change process. These include self-efficacy for change, the 
decisional balance of perceived advantages and disadvantages of change, and the strategies and techniques 
(the processes of change) used to modify behaviour. The importance of self-efficacy for initiating and 
maintaining a pattern of regular physical activity derives from social-cognitive theories of behaviour 
(Bandura, 1977). Self-efficacy refers to a person's perceived confidence in their ability to successfully 
perform a particular behaviour, and consistent evidence demonstrates that exercise self-efficacy is 
positively related with stage of change and level of physical activity (Marshall and Biddle, 2001). 
Behaviour change is assumed to involve a systematic evaluation of the potential gains (pros) and losses 
(cons) associated with the new behaviour (Marcus, Rakowski and Rossi, 1992), whereby perceived pros 
increase and perceived cons decrease with progression through the stages. Thus, an individual is more 
likely to be active if their perceived pros outweigh their perceived cons of the behaviour. 
Ten processes of change that describe the strategies and techniques people use to modify their behaviour 
have been proposed. Five of these are said to be experiential and include consciousness-raising, dramatic 
relief, environmental re-evaluation, self-re-evaluation and social liberation. The other five processes are 
described as behavioural and include counter-conditioning, helping relationships, reinforcement 
management, self-liberation and stimulus control (Prochaska, Velicer, DiClemente et at., 1988). 
Large-scale, randomised intervention trials involving sedentary adults have shown that the promotion of 
cognitive and behavioural intervention strategies can result in significantly increased levels of physical 
activity. Cognitive and behavioural strategies that are most strongly associated with physical activity 
include goal setting, self-monitoring, feedback, support, evaluation of progress and identification of 
barriers for relapse prevention (Calfas, Sallis, Oldenburg et al., 1997; Writing Group for the Activity 
Counseling Trial Research Group, 2001). 
A systematic review of physical activity interventions confirmed the importance of cognitive and 
behavioural strategies in terms of facilitating physical activity adoption and maintenance at an individual 
level (Kahn, Ramsey, Brownson et al., 2002). 
Recently, guidelines for conducting physical activity consultations in people with insulin resistance and 
T2D have been published (Kirk and De Feo, 2007; Kirk, Barnett and Mutrie, 2007). Physical activity 
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consultation is primarily based on the transtheoretical model and employs key strategies and techniques 
shown to promote and maintain behaviour change that are tailored to each particular stage. Effective 
promotion of physical activity for up to two years has been demonstrated with this type of intervention and 
has been shown to also improve health-related outcomes in adults with T2D (Di Loreto et al., 2003; Kirk, 
Mutrie, Maclntyre et al., 2003; Kirk et al., 2004a; Kirk, Mutrie, Maclntyre et al., 2004b). Interventions 
employing similar strategies have also been effective in increasing exercise among people at high risk of 
developing T2D (Diabetes Prevention Program Research Group, 2002). 
Interventions based on physical activity consultation typically involve a person-centred one-to-one 
discussion on at least one occasion. The consultation approach is semi-structured to ensure that the key 
elements of the transtheoretical model are covered and that the intervention is tailored to the individual's 
stage of change and particular needs. It is agreed that stage-specific strategies should be employed in order 
to facilitate physical activity behaviour change. Table 2.6 presents these strategies. It is also recommended 
that an individual's self-efficacy should be assessed and explored. The agreement of short-term, 
intermediate-term and long-term physical activity goals is a key component of the consultation, and these 
goals should be specific, measurable, acceptable and realistic. 
A small pilot study in adults with T2D indicates that feedback may further facilitate adoption and 
maintenance of physical activity (Paschali, Goodrick, Kalantzi-Azizi et al., 2005). Of 26 adults (mean age 
48.1 years) receiving physical activity counselling for three months, half were randomised to receive 
accelerometer feedback on their physical activity while the other half were blind to accelerometer data. 
Those without feedback received counselling based on their self-reported activity data. The non-feedback 
group were found to have increased activity six weeks post-randomisation but reverted back to baseline 
levels at three months. The feedback group, on the other hand, increased activity at three months, however 
this change was only borderline significant (P<0.08), which could have been attributable to the small 
sample size. 
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Table 2.6. Stages of exercise behaviour change and appropriate strategies for facilitating change, 
adapted from Kirk and De Feo (2006) 




Inactive and not thinking about becoming . Information/advice on risks of 
more active within the next 6 months inactivity and benefits of activity 
Inactive and thinking about becoming 
more active within the next 6 months 
" Decisional balance (weight up pros 
and cons of becoming active) 
" Discuss and overcome barriers 
Doing some physical activity and 
preparing to do more within the next 
month 
" Develop realistic activity goals 
" Establish support 
Action Doing enough physical activity but have " Reinforce successful attempts 
done so for less than six months " Re-emphasise experience benefits 
" Overcome experience barriers 
Maintenance Has made physical activity a habit for six " Relapse prevention 
months or longer " Alternative activities 
While theoretical models have proved essential for the development of interventions that aim to increase 
physical activity, the type of physical activity promoted is also an important consideration. Evidence 
appears to support the use of lifestyle activity, and in particular walking, compared to more structured 
programmes of exercise (Dishman, 1994; Dunn, Marcus, Kampert et al., 1999). Walking is the most 
prevalent form of activity, and its widespread use lies in the fact that it requires no special skills or 
facilities and is achievable by most people. Indeed, walking accounts for a substantial proportion of the 
energy expenditure associated with physical activity in sedentary individuals and is often reported as their 
preferred type of activity (Crespo, Keteyian, Heath et al., 1996). 
2.6 2. Pedometers 
In recent years, pedometers have become a popular tool for use in physical activity intervention 
programmes, since they are relatively inexpensive, easy to use, and have been reported to be motivational 
to those using them while attempting to adopt a more active lifestyle (Heesch, Dinger, McClary et al., 
2005). Most electronic pedometers consist of a horizontal spring-suspended lever arm that moves with the 
vertical acceleration of the hips during ambulation (Tudor-Locke, Williams, Reis et al., 2004). These 
instruments display the number of steps taken on a digital screen and a reset button allows the user to sum 
steps over any desired duration. 
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Bravata et al. (2007) performed a systematic review to evaluate the association of pedometer use with 
physical activity and health outcomes among outpatient adults. Twenty-six studies (eight RCTs, 18 
observational), with a total of 2,767 participants, were included in the review. The mean intervention 
duration was 18 weeks. Overall, pedometer users increased physical activity by 26.9% over baseline. 
Intervention participants from the RCTs increased their physical activity by 2,491 steps per day (95% Cl 
1098 to 3885, P<0.0001) compared with controls, while pedometer users from observational studies 
increased daily steps by 2,183 (95% CI 1571 to 2796, P<0.001). 
The authors of the systematic review also used meta-regression to evaluate participant and intervention 
characteristics that predicted improvements in physical activity among pedometer users. No specific 
participant characteristics (gender, age, ethnicity, BMI or baseline physical activity) were found to 
significantly predict increases in physical activity. Of the intervention characteristics, Bravata and 
colleagues found that having step goals and diaries were key characteristics associated with increased 
physical activity (P=0.001). Participants without a step goal did not increase physical activity. 
Interestingly, no significant increase in activity was found among participants in the three studies that did 
not include step diaries. Five of the included studies evaluated participants' adherence with keeping step 
diaries, and a mean of 83% ± 20% was reported. Rather surprisingly, the authors did not find that physical 
activity counselling increased daily steps. However, this could be attributed to the heterogeneity of the 
counselling provided and is not consistent with the findings of studies in people with T2D that compared 
activity counselling with no counselling, without the use of pedometers (Di Loreto et al., 2003; Kirk et al., 
2004b). Furthermore, some of the included studies that provided counselling may not have reported doing 
so. 
In 30 participants with T2D, Araiza and colleagues (2006) conducted a six-week randomised controlled 
trial. Intervention participants (n=15) were instructed to walk at least 10,000 steps per day on five or more 
days per week for six weeks, while control participants were asked to maintain baseline physical activity 
levels for the duration of the trial. The intervention group increased steps by 69% during the intervention, 
from 7220 ± 2792 to 10410 ± 4162 (P=0.002), while there was no change in the control group. Although 
this study is small, it shows that a simple intervention of providing a pedometer and step target promotes 
significant increases in walking over at least six weeks. 
Gleeson-Kreig (2006) found that monitoring activity using daily records may also be useful for promoting 
self-efficacy, which has been shown to predict physical activity levels. A total of 58 adults (40-65 years) 
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with T2D were randomly assigned to control conditions or six weeks of pedometer use and self-monitoring 
using daily activity records. Although follow-up physical activity levels were not different between the two 
groups, those using records reported significantly increased self-efficacy compared to controls, which was 
maintained throughout the six-week intervention period. The authors concluded that daily physical activity 
records were acceptable to participants. 
In a small eight-week pilot study of the First Step Program, a lifestyle physical activity intervention, 
Tudor-Locke et al. demonstrated the potential effectiveness of a pedometer-based intervention for 
promoting physical activity in nine people with T2D (mean age 53 years; BMI 32.9 kg/m2). As well as 
significant increases in walking compared with baseline (mean difference 34.3min-day's), participants 
described pedometers as a "novel and highly useful motivator" (Tudor-Locke, Myers, Bell et al., 2002b). 
Two years later, the findings from the full 16-week intervention study were published (Tudor-Locke, 
Bassett, Swartz et at., 2004). Out of 60 participants initially randomised in the study, a total of 47 
overweight and obese sedentary individuals (mean age 52.7 years; BMI 33.3 kg/m) completed baseline 
and post-intervention measures. Participants were randomly assigned to either the control group or the First 
Step Program, which is based on theoretical principles of self-efficacy and social support, and includes 
goal-setting, self-monitoring and feedback. The intervention programme consisted of weekly group 
meetings during the initial four weeks, where participants were provided with pedometers and the 
programme manual containing goal-setting and problem-solving exercises, as well as calendars for self- 
monitoring daily steps. Participants were requested to monitor steps for the remaining 12 weeks of the 
intervention. 
Among intervention participants, compliance with record keeping was 100% at the start of the 16 weeks, 
88% after the first four weeks, and 58% during the last four weeks. First Step Program participants 
increased their physical activity by 3370 t 3780 steps per day (<0.001), which was a significant 
improvement compared to control participants -675 ± 2574 (P<0.0001). Participants were also followed up 
at 24 weeks, eight weeks after contact had discontinued. Although daily steps remained higher in the 
intervention group compared with the control group (7924 ± 3308 vs. 6557 t 2742), the difference was 
non-significant. 
These findings suggest that relatively short-term programmes of pedometer use and self-monitoring can 
elicit immediate and significant increases in the number of daily steps reported by participants with M. 
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However, the efficacy of pedometers in maintaining increased activity over the long-term, without 
additional support, has yet to be demonstrated. 
2.6.3. Summary 
Behaviour change interventions should be based on theory. Goal setting and self-monitoring are essential 
for the adoption and maintenance of physical activity. Self-monitoring allows the assessment of progress 
towards achieving goals. Walking, which is the activity most frequently performed by people with T2D, 
could be challenging to monitor as it is often less structured and salient than planned physical activities. 
However, pedometers offer timely and accurate self-monitoring of walking behaviour and have been 
shown to be useful at facilitating the adoption of physical activity. Moreover, their use appears to be 
feasible and acceptable to people with T2D. 
2.7. Study rationale 
Recent large cohort studies and intervention trials provide strong evidence for the value of physical activity 
and CRF in protecting against the development of T2D, particularly in individuals who are at high risk due 
to impaired glucose tolerance, obesity and family history of the disorder. Prospective observational 
evidence also shows that both physical activity and CRF are inversely associated with cardiovascular and 
all-cause mortality among people with T2D. Furthermore, evidence from intervention studies demonstrates 
that increased physical activity and improved CRF may be associated with improvements in glycaemic 
control and other metabolic and physiological outcomes in people with T2D. 
Reported associations with health outcomes tend to be stronger for CRF than physical activity. This may be 
attributable to the differences in measurement error between the two exposures, as self-reported methods 
are typically used for the assessment of physical activity, while fitness will almost certainly be measured 
directly, either by submaximal or maximal testing procedures. Measuring physical activity is challenging 
because of its complex nature. Self-reported measures tend to be crude and imprecise, and they are likely to 
weaken the strength of observed associations with health-related outcomes. Consequently, the deficiencies 
in the measurement of physical activity complicate the interpretation of the results of epidemiological 
studies, and thus make it difficult to design appropriate interventions and to estimate the resultant benefit 
that could be expected. 
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Objective measures of physical activity using sensitive instruments, such as accelerometers, provide more 
accurate data that can enhance our understanding of the association between different dimensions of 
physical activity and health. Unfortunately, very few data have been published that describe objectively- 
determined habitual physical activity levels in adults with T2D. Moreover, the discrepancy in measurement 
precision between physical activity and CRF means the true independent cross-sectional associations of 
these with glycaemic control and other physiological outcomes in T2D remain unclear. It is therefore 
currently unknown which of physical activity and CRF is most important in managing the condition. 
Accurate quantification of habitual activity in this population is required to inform activity promotion and 
intervention strategies. Furthermore, determining the relative importance of physical activity and CRF in 
relation to important health outcomes in people with T2D is necessary for the translation of research 
findings into clinical management, policy and practice recommendations. 
The purpose of this study was to 1) develop intervention materials for the purpose of facilitating the 
initiation and maintenance of physical activity, 2) describe objectively measured habitual physical activity, 
3) examine change in physical activity over six months, 4) explore the use of pedometers and diaries to 
monitor daily physical activity over a six-month period, 5) describe CRF levels, and 6) explore the 
independent and interactive cross-sectional associations of physical activity and CRF with MAI, and the 
clustering of cardiovascular risk factors among people with recently diagnosed T2D recruited to the Early 
ACTID Study. 
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Chapter 3. Methods 
Whilst it is beyond the scope of this thesis to provide a detailed description of the Early ACTID 
methodology, the first section will offer an overview of the trial's methods, in order to put into context this 
PhD project. Subsequent sections will focus on the methods employed to conduct this PhD study and to 
meet the objectives outlined at the end of Chapter 1. 
3.1. The Early ACTID Study 
3.1.1. Background 
The Early ACTID Study is an ongoing randomised controlled trial, designed to comply with the 
CONSORT guidelines. The aim of the study is to compare aI -year programme of diet plus home-based 
exercise with diet only and usual care on glycaemic control, blood pressure, lipids and weight status in 550 
adults with newly-diagnosed T2D. The study protocol was approved by Bath NHS Research Ethics 
Committee in September 2005. 
3.1.2. Methods 
Participants 
The participant inclusion and exclusion criteria for the Early ACTID Study are summarised in Table 3. I. 
Table 3.1. Inclusion and exclusion criteria for the recruitment of participants to the Early ACTID Study 
Inclusion criteria Exclusion criteria 
" T2D " HbA,, >10% 
" Between 5 and 8 months from clinical " Ketosis 
diagnosis " Resting blood pressure >180/100mmHg 
" BMI >25 kg/m2 " LDL cholesterol >4mmol/1 
" Aged between 30 and 80 years at " Already receiving a maximum dose of a sulphonylurea diagnosis 
" Current diagnosis of unstable angina 
" Myocardial infarction within the previous three months 
" Pregnant or planning to conceive within 18 months 
" Unable to increase physical activity 
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Sample size 
Sample size was calculated by Dr. A Montgomery and Prof. T Peters at The Department of Primary Care, 
University of Bristol. Sample size was based upon the primary outcomes, HbA, c and blood pressure. The 
standard deviation of HbA1,. among patients with diabetes has been reported as 1.87%, and a change of 
0.5% in HbA, c is regarded as the smallest worthwhile clinical difference (UKPDS Group, 1998). This 
equates to a standardized difference of 0.267. For systolic and diastolic blood pressure, with an observed 
standard deviation of 17 mmHg and 10 mmHg respectively, a standardised difference of 0.267 relates to a 
target difference of 4-5 mmHg for systolic blood pressure and 2-3 mmHg for diastolic blood pressure, both 
of which would be considered clinically important. With 80% power and 5% two-sided alpha, 217 
participants were required in each group in order to detect these differences in the primary outcomes for the 
primary comparison of diet plus exercise versus diet alone. For the secondary comparisons of each of these 
versus standard care, an additional 62 participants randomised to standard care provides 45% power to 
detect a difference of about 0.4 standard deviations, allowing for multiple comparisons. Allowing for an 
attrition rate of approximately 10%, the target recruitment sample size was calculated to be 550. 
Recruitment 
Participants were recruited to the Early ACTID Study from the following South West NHS regions 
between November 2005 and June 2008: 
" Taunton and Somerset NHS trust, covering Somerset; 
" United Bristol Healthcare NHS trust, covering North Somerset; 
" North Bristol NHS trust, covering the North Bristol; and 
" Gloucestershire Hospitals NHS trust, covering Gloucestershire. 
Each of the four regions had a dedicated consultant endocrinologist, a specialist diabetes dietitian, and a 
research nurse employed by the study who were based at the hospital site. The study's nurses were 
responsible for recruiting participants through regular T2D education courses run at local General 
Practitioner (GP) practices. Regular searches were also performed on GP database records. Treatment and 
follow-up of participants are planned to continue until July 2009. 
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Screening, and informed consent 
Individuals who expressed an interest in participating in the trial underwent telephone screening 
administered by a study nurse. Participants fulfilling the inclusion criteria were sent relevant information 
about the study. After having 14 days to read through the information, individuals had the opportunity to 
discuss the study with the research nurse during a follow-up telephone call. Participants who wished to 
enrol in the study were invited to attend a screening visit (Visit 1) that formally assessed their eligibility for 
the trial. 
Once written consent was obtained by the research nurse at the start of the screening visit, participants had 
their height, weight and blood pressure measured. A non-fasting blood sample was then taken to assess 
participants' HbA1 , lipid profile, liver function, thyroid function and full blood counts. Finally, 
questionnaires obtaining demographic and general health information were administered. At the end of the 
visit, the nurse arranged the baseline measurements and randomisation appointments. 
Randomisation and allocation 
Randomisation was stratified by centre and minimised on gender, age, fitness category, blood pressure and 
HbA,,. Minimisation was used to limit differences between groups and reduce the risk of type 1 error 
(Keenan, Viscoli, Makuch et al., 1999). An automated system randomly allocated participants to one of the 
following groups during Visit 4 with the study dietitian: 
I. Usual care 
II. Dietary intervention 
III. Dietary intervention plus exercise 
Protocol 
Usual cure group 
Individuals randomly allocated the usual care group had ten scheduled visits throughout the study, which 
are outlined in Figure 3.1. Participants were given the opportunity to arrange an appointment with their 
study nurse between visits in the event of any problems. 
Participants in this study arm received a Participant Record File (PRF) containing contact details for the 
Early ACTID staff taking over their care; information about the study, their study group and appointments; 
information on healthy eating principles for diabetes; and space for recording their medications, 
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Figure 3.1. Flow diagram of participant progress through the Early ACTID Study 
Weeks from randomisation 
-6 Visit 1: Consent & screenin 
4 Visit 2: Fitness assessment 
I -mile walk test; 7-day ActiGraph 
-2 Visit 3: Baseline measurements 
clinical details & examination; fasting 
blood tests; urine; diet, exercise, sleep 
& well-being uestionnaires 
0 Visit 4: Clinical review 
RANDOMISATION & dietary advice 
Usual care n=70 Diet onl n=240 Diet+ exercise n= 
2 ý- Visit 5: Nurse Visit 5: Nurse 
4 Visit 6: Dietician; Nurse Visit 6: Dietician; Nurse 
Carbohydrates & fats Carbohydrates & fats 
Exercise histo pros & cons 
6 Visit 7: Nurse Visit 7: Nurse 
Triggers and cues for eating Triggers and cues for eating 
Lifestyle activity 
8 Visit 8: Nurse Visit 8: Nurse 
Relapses and lapses with diet Relapses, and lapses with diet/exercise 
14 Visit 9: Dietician; Nurse Visit 9: Dietician; Nurse 
Portion sizes & food labelling Portion sizes & food labelling 
Exercise maintenance 
20 Visit 10: Nurse Visit 10: Nurse 
Eating & shopping habits Eating & shopping habits 
Exercise maintenance 
26 Visit 5: Fitness assessment 1-mile walk Visit 11: Fitness assessment F Visit 11: Fitness assessment 
test; 7-day ActiGraph 1-mile walk test ; 7-da ActiGra h 1-mile walk test; 7-da ActiGra h 
28 Visit 6: 6-month measurements Visit 12: 6-month measurements Visit 12: 6-month measurements 
32 Visit 7: Clinical review Visit 13: Clinical review; Dietician; Visit 13: Clinical review; Dietician; 
Nurse. Nurse. 
Cooking food & special occasions Cooking food & special occasions 
Exercise maintenance 
38 Visit 14: Nurse Visit 14: Nurse 
Alcohol Alcohol 
Exercise maintenance 
42 Visit 15: Dietician; Nurse Visit 15: Dietician; Nurse 
Healthy eating & weight control Healthy eating & weight control 
Exercise maintenance 
46 Visit 16: Nurse Visit 16: Nurse 
Healthy eating on the go F Healthy eating on the go Exercise maintenance 
52 Visit 8: Fitness assessment 1-mile walk Visit 17: Fitness assessment F Visit 17: Fitness assessment 
test; 7-day ActiGra h l-mile walk test; 7-da ActiGraph 1-mile walk test; 7-day ActiGraph 
54 Visit 9: 12-month measurements Visit 18: 12-month measurements Visit 18: 12-month measurements Progress review Progress review 
58 Visit 10: Clinical review; Dietician Visit 19: Clinical review; Dietician Visit 19: Clinical review; Dieticiar 
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measurement results, and personal notes. This version of the PRF was based on recommendations 
in the 
National Service Framework for Diabetes Delivery Strategy (Department of Health, 2003b) and by 
Diabetes UK (Diabetes UK, 2003), which relate to patient-held records. During the baseline dietitian 
appointment (Visit 4), participants were given standard advice about healthy eating, which, at the time, was 
provided by South West NHS trusts. This advice included eating regular meals, cutting down on 
fat, eating 
more fruit and vegetables, limiting sugar, using less salt, drinking alcohol in moderation, losing weight, 
and not buying special diabetic food. At their last trial visit (Visit 10), participants in the usual care group 
received a full set of PRF inserts (see Appendix 5 for a listing), which were developed for the intervention 
arms. These included comprehensive information on healthy eating, physical activity, self-monitoring, 
changing behaviours, and overcoming barriers (see Appendix 6). 
Intervention groups 
After randomisation, participants assigned to either the diet only or diet plus exercise group received five 
individually tailored sessions with their study dietitian at weeks 4,14,32,42 and 58, and ten sessions with 
their study nurse at weeks 2,4,6,8,14,20,32,38,42, and 46. Each session lasted approximately 30 
minutes and had a pre-planned topic to focus discussion, as outlined in figure 3.1. During nurse visits in the 
diet plus exercise group, time was equally divided between healthy eating and physical activity. In the diet 
only group, the nurse spent half of the visit discussing topics unrelated to the trial, in order to ensure that 
contact time between the intervention groups was equal. In total, participants in the intervention arms had 
19 visits during the study. 
Diet only group 
The primary study goals for participants randomly assigned to the diet only group included 1) achieving a 
weight reduction of 5-10% of initial body weight within the first six months through healthy eating, and 2) 
maintaining the weight reduction of 5-10% of initial body weight in the second six months through healthy 
eating. 
Previous studies have shown that a weight loss of 5-10% lowers plasma glucose and improves 
cardiovascular risk factors, with an apparent dose-response relationship between the magnitude of weight 
reduction and the improvement in these parameters (Colditz, Willett, Stampfer et al., 1990; Poirier, Giles, 
Bray et al., 2006; Selwyn, 2007). The recommended pace of weight loss was 0.5 to lkg per week, which is 
considered to be safe, effective and feasible. Participants were encouraged to achieve the weight loss goals 
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by establishing a hypo-energetic diet, based on an energy deficit of approximately 500 kcal-day''. Although 
participants were weighed on a digital scale at the start of each nurse visit, they were also encouraged to 
weigh themselves at home once a week and to record their weight using the appropriate materials. 
Diet plus exercise group 
In addition to the dietary programme detailed above, participants randomly assigned to the diet plus 
exercise group received an exercise intervention, with the primary goal of engaging in an extra 30 minutes 
of brisk walking on five or more days of the week, performed in bouts of at least ten minutes. 
Walking is the most frequently reported form of physical activity (Institute of European Food Studies, 
1999) and has been found to promote better adherence than more intensive exercise (Dishman, 1994). Its 
widespread application lies in the fact that it requires no special skills or facilities and is achievable by 
virtually all age groups with little risk of injury. Walking has been described as `the most convenient, low 
impact mode of physical activity for people with T2D' (American College of Sports Medicine, 2000) and 
`the best medicine for diabetes' (Hu and Manson, 2003). 
To enable the self-monitoring of physical activity, which has been shown to be positively associated with 
initiation and maintenance of physical activity (Bravata et at., 2007), diet plus exercise participants 
received a Yamax Digi-Walker (SW-200) pedometer, instruction materials for wearing and using the 
pedometer, and activity diaries (see Appendix 6, PA9 and 10) for use throughout the intervention. The 
Digi-Walker pedometer is a small device worn on a belt or waistband that measures vertical acceleration 
during bodily movements, and it is one of the most accurate pedometers available (Bassett, Ainsworth, 
Leggett et at., 1996). Due to their motivational nature, the pedometers were used primarily as an 
intervention tool, rather than an outcome measure. 
Participants were instructed to wear the pedometer during all waking hours, except when showering, 
bathing or swimming, for the duration of the intervention. Participants were also asked to use the physical 
activity diaries, provided by the study, ensuring that each day they recorded: 1) the times that the 
pedometer was worn, 2) the duration of any bouts of activity lasting at least ten minutes, 3) the number of 
steps accumulated during activity bouts, 4) the final pedometer reading at the end of the day, and 5) any 
moderate-intensity activities that were performed in addition to walking, e. g. swimming. 
During Visit 5, participants were shown how to locate the most accurate position for their pedometer. The 
long-term study goal of brisk walking for 30 minutes, accumulated in bouts of at least ten minutes, was 
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discussed with each participant. This volume and intensity of the exercise goal is in line with national 
guidelines (Department of Health, 2004) and has been shown to produce improvements in CRF, weight, 
percentage body fat, and overall health in non-clinical populations (Hardman, 2001). Participants were 
advised to achieve the goal gradually over five weeks in a step-wise fashion and then maintain the activity 
level for the remainder of the study. Long-term step goals were calculated on the basis that ten minutes of 
brisk walking (3-4 miles per hour) (Ainsworth et al., 2000) equates to approximately 1000 steps (Welk, 
Differding, Thompson et al., 2000). Since the aim of the activity intervention was to perform an additional 
30 minutes of brisk walking on at least five days per week, participants were asked to accumulate an extra 
3000 steps of brisk walking on most days. 
Clinical measurements and questionnaires 
Table 3.2 shows the clinical measurements, conducted by the research nurse, and the questionnaires 
completed by participants at baseline, six and 12 months. Protocols were developed for each measurement 
to ensure standardisation across sites and between visits. These protocols were developed by the principal 
investigator and research nurses. 
Table 3.2. Clinical measurements and questionnaires completed at baseline, sir and 12 months 
Clinical details 
" Diabetes history 
" Past medical history 
" Drug history 
" Family history 
" Social history 
Clinical examination 
" Cardiovascular, respiratory, gastrointestinal and 
central nervous system examinations 
" Height 
" Weight 
" Waist circumference 
" Body fat content (Bio-impedance) 
" Blood pressure 
Fasting blood tests 
" Blood lipids, including cholesterol, HDL cholesterol, 
LDL cholesterol and triglycerides 
" Insulin resistance and insulin secretion (2 fasting 
glucose and insulin tests, 5 minutes apart) 
" Inflammatory markers (e. g. Adiponectin, high 
sensitivity CRP, IL6 and ILI0) 
" EDTA blood for DNA extraction 
" EDTA blood for MAI, 
Other investigations 
" Early morning urine sample (Albumin/Creatinine 
ration and Dipstick) 
Questionnaires 
" Stage of change towards diet 
" Self efficacy towards diet 
" Physical activity readiness questionnaire (PARQ) 
" Stage of change towards exercise 
" Self-efficacy towards exercise 
" Process of change for exercise 
" Social support for physical activity scale 
" Decisional balance for exercise 
" Outcome expectations for exercise 
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3.2. PhD aims and hypotheses 
The measurement of cardiorespiratory fitness was not part of the original study proposal and the addition 
of this measure by the researcher thus added a unique aspect to the study. In addition, the researcher was 
responsible for developing a physical activity intervention programme suitable for individuals with T2D 
based around the use of a participant-held record file (PRF). 
As highlighted at the end of the Introduction chapter, the aims of the PhD were to: 
0 develop intervention materials for the purpose of facilitating the initiation and maintenance of physical 
activity in diet plus exercise participants of the Early ACTID Study, 
0 describe objectively measured physical activity levels in people with newly diagnosed T2D, 
0 examine the six-month change in physical activity among participants in the Early ACTID Study. 
" explore the use of pedometers and diaries to monitor daily physical activity over a six-month period in 
participants randomised to the diet plus exercise intervention of the Early ACTID Study, 
0 describe CRF levels in people with newly diagnosed T2D, 
0 explore the independent associations of objectively measured physical activity and CRF with HbA10 
and the clustering of cardiovascular risk factors in people with newly diagnosed T2D, and 
0 investigate whether there is an interaction effect between physical activity and CRF on HbA1, and the 
clustering of cardiovascular risk factors in people with newly diagnosed T2D. 
The hypotheses for this study are shown below. Exposure and outcome variables for each hypothesis are 
detailed in the `Data and analyses' section of this chapter. 
H1. Physical activity is associated with HbA10 in people with T2D 
H2. VO2max. prcd is associated with I-IbA,, in people with T2D 
H3. VO2maxp«a modifies the association between physical activity and HbA,, 
H4. Physical activity is associated with the metabolic syndrome in people with T2D 
H5. VO2max. pred is associated with the metabolic syndrome in people with T2D 
H6. VO2maxpred modifies the association between physical activity and the metabolic syndrome in people 
with T2D 
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3.3. Study design 
This thesis will present cross-sectional data from the Early ACTID Study cohort. Cross-sectional data 
obtained at both baseline and six months will be presented in order to illustrate the consistency of 
relationships. Although change in physical activity over a six-month period has been examined in order to 
assess compliance with the physical activity study goals, at the time of writing the Early ACTID RCT was 
ongoing and it was therefore not considered appropriate to analyse data to determine differences in key 
clinical outcomes between study groups. Data have therefore been analysed to examine differences 
between cohort subgroups and these will be presented in the following chapter of this thesis. 
3.4. Participants 
Baseline analyses included participants who had undergone baseline measurements by June 2007. Follow- 
up analyses included participants who remained in the study at six months. Physical activity diary data 
from participants in the diet plus exercise group are reported for the first six months of the intervention. 
3.5. Intervention materials 
3. S. 1. Features of the intervention groups 
Key features of the interventions are outlined in Table 3.3. These features were based on previous studies 
that have been successful in facilitating long-term lifestyle change among participants with impaired 
glucose tolerance (Diabetes Prevention Program Research Group, 2002) and T2D (Di Loreto et al., 2003; 
Kirk et al., 2004b). 
The goal of both interventions was to provide participants with the necessary knowledge and skills to 
achieve gradual behavioural changes that could be sustained permanently. Specifically, the interventions 
had been designed to incorporate strategies and techniques that are known to influence the mediators of 
change, including self-efficacy, decisional balance, and processes of change (Marcus and Simkin, 1994), as 
described in the previous chapter. 
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Table 3.3. Key features of the Early ACTID Study's Interventions 
" Frequent contact 
" Structured protocol, with the flexibility to tailor strategies individually 
" Clearly defined long- and short-term goals 
" Interactive participant-held record files (PRF) 
" Education 
" Self-monitoring tools 
" Problem solving 
" Relapse prevention 
" Ongoing, individually-tailored intervention 
Frequent contact and ongoing support were considered essential components of the diet only and diet plus 
exercise interventions, particularly in the initial few months while participants made significant changes to 
their lifestyles. To ensure standardisation across sites and between appointments, the researcher developed 
a standard operating procedure (SOP) for each visit (see Appendix 7) and a pre-planned curriculum of 
topics was agreed (see figure 3.1). Although a structured protocol and curriculum was required to ensure 
that all participants were provided with the same information, the SOP also allowed the nurses and 
dietitians to tailor sessions according to each participant's individual needs, thus maintaining a patient- 
centred approach. 
3.5.2. Development and use of the participant record file 
Rationale and purpose of the PRF 
Patient-held records are increasingly being used in healthcare settings as they are thought to encourage 
partnership between healthcare professionals and patients. Interventions that involve patient collaboration 
are considered to be more effective than didactic interventions in improving glycaemic control, weight and 
lipid profiles (Norris, Engelgau and Venkat Narayan, 2001). In diabetes care, the empowerment and 
engagement of the individual with the condition is one of the 12 standards in the National Service 
Framework (NSF) for Diabetes (Department of Health, 2001). Self-management is often described as the 
cornerstone of good diabetes control and, hence, the patient's involvement in decision-making is clearly an 
important part of diabetes care. The NSF's vision is to `offer care that is structured and pro-active, 
providing people with the support they need to manage their own condition' (Department of Health, 
2003b). To assist with this, the NSF's delivery strategy recommends 'a personal diabetes record containing 
a clinical record of care, treatment and management that is held by the person with diabetes and used by 
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Counterweight Project Team, 2004a; The Counterweight Project Team, 2004b) and Steps to better health 
(The Cooper Institute, 2003). 
The tools and materials forming the basis for the development of the Early ACTID PRF were primarily 
grounded in theories and principles of behaviour change and physical activity counselling and 
consultations (Kerr, Weitkunat and Moretti, 2005; Kirk and De Feo, 2007; Kirk et at., 
2007; Kirk et at., 
2004b; Marcus and Forsyth, 2003; Rollnick, Butler, McCambridge et al., 2005; Rollnick, Mason and 
Butler, 2002). 
Figure 3.2 Development of the Early ACTID Study participant record file (PRF) materials 
Nov-Dec 2004 1 Literature review 
Jan-March 2005 1 First draft of participant record file (PRF) compiled 
Dec 2004-Feb 2005 1 Recruitment of panel to review contents of PRF 
March-April 2005 1 Draft materials reviewed by voluntary panel of people with diabetes 
May-June 2005 1 Draft materials revised based on feedback from panel 
July 2005 1 2nd draft reviewed by Early ACTID nurses, dietitians and consultants 
August-Sept 2005 
I 2°a draft materials revised based on feedback from Early ACTID health 
nrnfaccinnalc 
Nov 2005-March 2006 3d draft piloted by participants recruited to Early ACTID Study 
March 2006 Materials revised based on feedback from participants 
April 2006 
Final version of PRF materials printed and used by all participants recruited to the 
Early ACTID Study 
Theorelical framework 
The reviewed materials from interventions that have reported significant increases in physical activity are 
primarily based on the transtheoretical model, which emphasises the importance of three mediators of 
change, including self-efficacy, decisional balance and processes of change, as described in the previous 
chapter. This model proposes that interventions designed to facilitate adoption and maintenance of a 
particular behaviour should be tailored to the stage of readiness of the individual concerned. Since all Early 
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them and the diabetes team' (p14-15) (Department of Health, 2003b). The strategy suggests the record 
should include: 
" an agreed care plan, including education and the personal goals of the person with diabetes; 
" how their diabetes is to be managed until their next review to foster greater understanding and 
ownership of the goals of diabetes care; 
0 the identification of health, social care and educational needs, how they will be met and who will 
be responsible; 
"a named contact. 
The use of patient-held records as part of diabetes care is also advocated by Diabetes UK, and their 
potential role in encouraging patient involvement and engagement has been acknowledged (Diabetes UK, 
2002). Consequently, a patient-held record could be viewed as a useful diabetes management and 
communication tool that benefits both healthcare professionals and the patient. A pateint-held record file 
(PRF) thus represented a relatively inexpensive, practical intervention tool that could be used to faciltate 
behavioural change in participants recruited to the Early ACTID Study. 
In the present study, the main purpose of the PRF was two-fold: 1) to facilitate participant involvement and 
behavioural change, and 2) to assist the nurses in delivering the intervention by providing structure for 
participant visits and interactive materials that enabled the nurses to support participants in adopting and 
maintaining new health behaviours. The materials themselves were developed to encourage self- 
monitoring and to increase motivation to change and self-efficacy to make and maintain changes (see 
Appendix 6). 
Det'elopinent process 
Figure 3.2 outlines the different stages of the PRF development process. With the exception of the dietary 
information materials, which were developed by a team from the Nutrition and Health Research Group at 
the MRC, the PRF contents were designed and developed by the researcher. In addition to reviewing 
recommendations and suggestions relating to the clinical contents of a patient-held record, materials from 
interventions and programmes that have been successful at facilitating the adoption and maintenance of 
physical activity were reviewed. Resources from interventions involving adults with T2D or impaired 
glucose tolerance were prioritised. The reviewed materials included the Diabetes Prevention Program 
study (Wing and Gillis, 1996), The Counter Weight Programme (The Counterweight Project Team; The 
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Counterweight Project Team, 2004a; The Counterweight Project Team, 2004b) and Steps to better health 
(The Cooper Institute, 2003). 
The tools and materials forming the basis for the development of the Early ACTID PRF were primarily 
grounded in theories and principles of behaviour change and physical activity counselling and 
consultations (Kerr, Weitkunat and Moretti, 2005; Kirk and De Feo, 2007; Kirk et al., 2007; Kirk et al., 
2004b; Marcus and Forsyth, 2003; Rollnick, Butler, McCambridge et at., 2005; Rollnick, Mason and 
Butler, 2002). 
Figure 3.2 Development of the Early ACTID Study participant record file (PRF) materials 
Nov-Dec 2004 1 Literature review 
Jan-March 2005 1 First draft of participant record file (PRF) compiled 
Dec 2004-Feb 2005 Recruitment of panel to review contents of PRF 
March-April 2005 1 Draft materials reviewed by voluntary panel of people with diabetes 
May-June 2005 Draft materials revised based on feedback from panel 
July 2005 1 2nd draft reviewed by Early ACTID nurses, dietitians and consultants 
August-Sept 2005 
I 2°° draft materials revised based on feedback from Early ACTID health 
professionals 
Nov 2005-March 2006 1 3rd draft piloted by participants recruited to Early ACTID Study 
March 2006 Materials revised based on feedback from participants 
April 2006 
Final version of PRF materials printed and used by all participants recruited to the 
Early ACTID Study 
Theoretical frainework 
The reviewed materials from interventions that have reported significant increases in physical activity are 
primarily based on the transtheoretical model, which emphasises the importance of three mediators of 
change, including self-efficacy, decisional balance and processes of change, as described in the previous 
chapter. This model proposes that interventions designed to facilitate adoption and maintenance of a 
particular behaviour should be tailored to the stage of readiness of the individual concerned. Since all Early 
's 
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ACTID participants had volunteered to enter a study in which a willingness to increase physical activity 
was an inclusion criterion, the materials were predominantly tailored towards the contemplation, 
preparation and action stages, since one of their main aims was to facilitate behavioural change. 
Studies have shown that the cognitive and behavioural strategies which are most strongly associated with 
physical activity include self-monitoring, goal setting, feedback, support, evaluation of progress and 
identification of barriers for relapse prevention (Calfas et al., 1997; Writing Group for the Activity 
Counseling Trial Research Group, 2001). These strategies formed the basis of the PRF physical activity 
materials, which are described below. 
Format and contents of the PRF 
The PRF consisted of 106 double-sided pages containing information, worksheets, charts and records. The 
file comprised of five colour-coded sections: 1) Information, 2) Healthy eating, 3) Physical activity, 4) 
Progress reports, and 5) Personal notes. In line with Diabetes UK care recommendations on patient-held 
records (Department of Health, 2003b), the ring binder file was A5 size, so that it could be easily 
transported to and from appointments, and the binder itself was made of clear frosted polypropylene, in 
order to protect it from general wear and tear over the course of the programme. The contents of the file 
were produced as individual loose leaves so that pages could be added or removed at different times 
throughout the study. 
During the year-long Early ACTID programme, the physical activity inserts were given only to those 
participants randomised to the diet plus exercise group. At the end of the programme, participants 
randomised to the other two groups were offered all materials developed for the interventions. 
The physical activity section of the PRF was primarily based on principles of behaviour change and key 
components of interventions that have been successful at increasing physical activity levels among 
participants and maintaining increased levels over time. The main aim of the PRF materials was to 
facilitate participant involvement and behavioural change. Interactive materials were developed for the 
participant record file (PRF) to encourage self-monitoring and to increase motivation to change and self- 
efficacy to make and maintain changes (see Appendix 6). The physical activity section of the PRF 
consisted of the following four subsections: 
1) Keeping track 
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Previous studies have demonstrated the effectiveness of pedometers and activity diaries in terms of 
eliciting immediate and significant increases in physical activity (Bravata et al. 2007). Furthermore, they 
have been found to enhance self-efficacy (Gleeson-Kreig, 2006) and appear to be acceptable to adults with 
diabetes (Tudor-Locke, Myers, Bell et al., 2002b). Self-monitoring using these tools was a key feature of 
the intervention programme and was one of the first topics addressed with diet plus exercise participants 
after randomisation. The `Keeping track' subsection of the PRF aimed to highlight the importance of 
monitoring physical activity levels. All inserts within this section were provided in Visit 5. A pedometer 
was also provided at this visit and participants were asked to wear it daily and to record their total daily 
steps and bouts of physical activity using the diaries provided in the `Physical activity diary' subsection. A 
physical activity graph was available for recording the total number of steps walked day-by-day. The 
purpose of this graph, found in the `Progress reports' section, was to enable participants to easily see their 
progress over time. During each visit, the nurse briefly reviewed the self-monitoring sheets with the 
participants and reinforced any positive changes. All physical activity diary data was entered into a 
database by the nurse at each visit so that adherence to the intervention could be monitored over the course 
of the programme. Once the data had been entered, the diaries were returned to the participants. 
2) Goals and plans 
Bravata and colleagues (2007) found that step goals and diaries were key intervention characteristics 
associated with increased physical activity. As such, personalised goal setting was a key aspect of the 
intervention and was a key feature of each visit. Participants were encouraged to set specific and 
measurable goals that were acceptable and realistic within the context of their life. 
Choosing achievable and realistic goals is important for enhancing self-efficacy, since positive mastery 
experiences are associated with increased confidence, which, in turn, is fundamental to successful 
behavioural change (Marcus and Forsyth, 2003; Rollnick et al., 2002). Equally, the failure to achieve goals 
will adversely affect an individual's confidence in their ability to reach a particular goal, and thus gradually 
increasing physical activity levels over a number of weeks was an important phase of the intervention. 
The long-term intervention goal for participants in the diet plus exercise group was to engage in an 
additional 30 minutes of moderate intensity activity on five or more days each week. In order to prevent 
compensatory behaviour, where individuals may increase the time spent in discrete bouts of activity but not 
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increase the overall volume of daily activity, participants were advised to build up to accumulating at least 
an additional 3000 steps, on top of what they were accumulating at baseline. 
Physical activity counselling principles recognise that an individual's motivation and confidence in relation 
to a goal must be reasonably high if the goal is to be achieved. A useful strategy for assessing these 
involves the scoring of each on a 0-10 scale, where 0 is not at all motivated or confident and 10 is 
extremely motivated or confident. This strategy was incorporated into the `physical activity goals' 
worksheet in an attempt to encourage participants to select achievable and realistic goals. To further 
enhance self-efficacy, participants were supported in planning when, where and how they were going to 
achieve their goals. 
At each visit, the nurse and participant reviewed the goals set at the previous visit. Successes and 
difficulties in relation to achieving their goals were discussed and recorded in their file (PA. 16). Successes 
were addressed because performance accomplishment or mastery is known to be strongly influence self- 
efficacy, which in turn predicts physical activity behaviour. Addressing difficulties allowed the participant 
and nurse to discuss how these could be minimised or avoided in the future. 
3) Information sheets 
The `Information sheets' subsection contained general information that was related to participating in the 
diet plus exercise intervention. Materials covered troubleshooting the pedometer, facts about walking, foot 
care, illness, hypoglycaemic episodes and stretching. There were no interactive materials in this subsection. 
4) Gaining confidence 
The aim of this subsection was to reinforce motivation to increase physical activity and to enhance self- 
efficacy to make and maintain changes. Materials were based on cognitive-behavioural strategies that have 
been shown to influence physical activity behaviour. The majority of inserts were interactive so that they 
could be tailored to the participant's own situation. The first five inserts were provided over the course of 
three visits. These related to the following topics: 
" Physical activity history 
" Benefits and perceived pros and cons of physical activity 
" Lifestyle activity 
" Opportunities to be active 
" Preventing relapses 
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The final four inserts were optional materials that could used to help participants overcome their perceived 
barriers to physical activity. These inserts were used from visit 7 onwards and included: 
" Barriers to physical activity 
" Personal time diary 
" People to help you achieve your goals 
" Local exercise opportunities 
Piloting 
To ensure that the record file materials were appropriate for people with newly diagnosed T2D volunteers 
from a local Diabetes UK support group were asked to read the draft PRF materials and to comment on 
their readability and content. A brief description of what would be involved was provided to all members 
of the group (see Appendix 7) and those who indicated an interest were sent an email or letter inviting them 
to attend a short presentation, which provided an overview of the research project and explained the 
purpose of reviewing the draft materials. Potential volunteers were advised that they would not be required 
to use or complete the materials. In order to minimise inconvenience, the presentation took place before the 
start of their usual support group meeting. After the presentation, seven adults with T2D volunteered to 
review the draft PRF contents. Volunteers included both individuals with a recent diagnosis and individuals 
with established T2D. Each volunteer was given at least two weeks to read through the materials and 
consider 1) readability, 2) content, and 3) additional items that would be useful for people recently 
diagnosed with T2D. Volunteers were asked also to review five sample pages at the end of the document. 
Each page was typed using a different font and volunteers commented on the font's readability and 
indicated their preferred options. One-to-one meetings were held with the volunteers in order to discuss 
their comments in detail. 
Where appropriate, the PRF materials were revised according to the feedback obtained from the volunteers. 
The second draft version was reviewed by a number of health professionals, including nurses, dietitians 
and consultants who provide diabetes care. After additional revisions, based on feedback provided by the 
health professionals, the PRF materials were piloted with the first 30 participants randomised to the trial. 
Between two and three months after randomisation, qualitative feedback about the materials was obtained 
from a sub-sample of ten participants who participated in a telephone interview. The final version of the 
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PRF contains five colour-coded sections and several subsections. A list of materials developed for the PRF 
is provided in Appendix 5. 
Use of the participant record file 
Sessions delivered by the nurse were structured according to the standard operating procedures developed 
by the researcher (see Appendix 8) and were based around inserts developed for the PRF (see Appendix 5 
and 6). In general, each nurse session included the following: 
" Bodyweight measurement 
" Review of previous self-monitoring goals 
" Discussion of successes and difficulties/barriers in relation to previously agreed goals 
" Presentation of a new topic with corresponding PRF materials 
" Agreement of new behavioural goals and action plans 
3.5.3. Monitoring physical activity levels 
After randomisation, participants in the diet plus exercise group were asked to maintain their usual activity 
levels during the first two weeks of using the pedometer and diaries in the PRF. Once the physical activity 
logs had been returned at the following visit, the nurse entered the recorded data into a Microsoft Excel 
workbook (see Appendix 9), developed by the researcher, specifically for the entry of physical activity 
diary data. Physical activity entered for the initial two weeks of recording was used as a baseline measure 
of steps. 
For the purpose of monitoring compliance, all recently completed activity logs were reviewed and entered 
into the study's database after each visit. A summary page on the database showed the total and daily 
average steps, time spent brisk walking, and time spent in other moderate physical activities for each 
participant (see Appendix 9). The number of days per week that the step and time targets had been 
achieved were also calculated and shown on the summary page. Perceived barriers were explored with 
participants who were not achieving the physical activity goal, and appropriate materials from the PRF 
were used to help overcome barriers and facilitate physical activity adoption and maintenance. 
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3.6. Measurements 
3.6.1. Physiological and metabolic outcomes 
All outcome measures were performed at baseline and at six months post randomisation. Height and 
weight were assessed by the study nurses using standardised procedures. Participants were barefoot and 
wore only light indoor clothing for anthropometric measurements. Height was measured to the nearest 1 cm 
using a stadiometer (SECA). Weight was recorded to the nearest 0.1kg using calibrated digital scales. BMI 
was calculated as weight in kilograms divided by the square of height in metres (kg/m2) and classified 
according to the following NICE criteria (National Institute for Health and Clinical Excellence, 2006), as 
shown in Table 3.4. 
Table 3.4. Classification of weight status according to BMI 
BMI (kg/m2) Classification 
<18.5 Underweight 
18.5-24.8 Healthy weight 
25.0-29.9 Overweight 
30.0-34.9 Obese I 
35.0-39.9 Obese II 
z40 Obese III (morbidly obese) 
Prior to the physiological and metabolic measurements, participants were required to: 1) fast, with the 
exception of water, for at least ten hours, 2) not take any morning medication, and 3) abstain from smoking 
for at least 30 minutes. The research nurse performed these measurements using standardised measurement 
protocols developed by the trial's nurses and doctors. Blood pressure was assessed according to 
measurement protocols adapted from the British Hypertension Society (BHS) Guidelines (Williams, 
Poulter, Brown et al., 2004). Briefly, once the participant had been supine for five minutes, three measures 
were taken at five-minute intervals using an automated blood pressure monitor (Omron 711) and 
appropriately-sized cuff, which was placed on the non-dominant arm. A mean of the three measurements 
was calculated. 
Blood specimens were taken using appropriate vacutainer bottles to assess the parameters in Table 3.2. 
Once samples had been collected and handled appropriately (centrifuge where necessary) they were stored 
locally in hospital freezers at minus 80 degrees. Dry-ice was used for the transfer of samples from the local 
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centres to the co-ordinating centre to ensure samples were not affected by thawing. At the co-ordinating 
centre, samples were placed in designated freezers. Aliquots of the samples were sent 
in batches from the 
co-ordinating centre to the analytical and collaborating laboratories. Once the samples 
had been tested, the 
remainder of the aliquot was destroyed by the commercial testing laboratory. The remaining samples were 
retained at the co-ordinating centre. 
Data Reduction 
For the purpose of describing the study population, and also for performing exploratory analyses, 
glycaemic control was assessed by categorising the continuous variable HbA10 according to guidelines 
published by NICE (National Institute of Clinical Excellence (NICE), 2002), as shown in Chapter 2. 
A dichotomous metabolic syndrome variable was created according to the International Diabetes 
Federation (IDF) consensus definition of the metabolic syndrome (International Diabetes Federation, 
2006). Participants with a BMI 2: 30 and at least one of the factors listed below were categorised as having 
the metabolic syndrome: 
" Triglycerides 2: 1.7mmol/L 
" HDL-cholesterol 51.03mmol. /L in men and 51.29mmol/L in women 
" Systolic blood pressure Z130mmHg or diastolic blood pressure Z85mmHg, or treatment of 
previously diagnosed hypertension 
The diagnosis of diabetes in all participants excluded the use of the NCEP ATP III criteria for classifying 
participants in this study population with or without the metabolic syndrome. Of those definitions that are 
appropriate for people with diabetes (IDF, NCEP ATP III, and WHO), only the IDF criteria account for 
anti-hypertensive and anti-hyperlipidaemic medication use, which was highly prevalent among participants 
in the Early ACTID Study. Furthermore, the incomplete ascertainment of waist circumference provided an 
additional reason for the preclusion of the NCEP ATP III definition. Consequently, the IDF criteria were 
considered to be the only suitable criteria for assessing metabolic syndrome status within this study cohort. 
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3.6.2. Physical activity (ActiGraphs) 
ActiGraph accelerometer 
Habitual physical activity was assessed objectively with the ActiGraph GT1M activity monitor over a 
seven-day period. The ActiGraph monitor is a uniaxial accelerometer, which has a real-time internal clock 
that enables the monitor to start recording data at a desired time and to sum data over a user-defined 
interval (epoch). To begin collecting data, the monitor is initialised using ActiGraph software on a 
computer. Once the monitor has been downloaded on the computer, data collection automatically ends and 
the stored data can be viewed. The ActiGraph output is the summed amount and magnitude of 
accelerations for each epoch, displayed as counts, which can then be used to estimate the intensity of 
physical activity over time. 
Procedure 
Each ActiGraph was initialised, according to the manufacturer's instructions, to start summing physical 
activity counts at 60-second intervals from 5am the morning following the participant's fitness assessment. 
At the end of each fitness appointment, the ActiGraph was provided in a pouch on an elastic belt that could 
be adjusted according to the size of the participant's waist. An information sheet about the ActiGraph was 
also provided, together with an activity diary (Appendix 10) where each day participants were asked to 
record the day, date, time the monitor was put on and taken off, and whether the monitor was removed 
during waking hours. The diary also contained space for recording details of any physical activities 
performed that the ActiGraph was not able to record accurately, including seated and water-based exercise. 
The ActiGraph was positioned over the right hip and worn during all waking hours for seven consecutive 
days, except during water activities, commencing the day following the fitness assessment. Participants 
were advised to maintain their usual lifestyle and level of physical activity during the measurement period. 
The ActiGraph and physical activity diary were returned to the participant's Early ACTID nurse at the 
following appointment, which was scheduled between eight and 14 days after the fitness assessment. Once 
returned, these were passed to the researcher so that the monitors could be downloaded for subsequent 
analysis. 
70 
Chapter 3: Methods 
Data Reduction 
The ActiGraph data were reduced with a custom macro, written in Microsoft Excel, that was developed for 
processing accelerometer data. The macro summed minute-by-minute activity counts for each hour of 
measurement. In addition, the macro was able to calculate the number of minutes of moderate to vigorous 
physical activity (MVPA) accumulated during each registered hour, using a cut point of 22100 ct-min', 
which has been established in previous calibration studies of the ActiGraph monitor involving healthy 
participants (Brage et al., 2003; Freedson et al., 1998; Matthews, 2005; Yngve, Nilsson, Sjostrom et al., 
2003). 
For comparison of weekday and weekend activity, all files were aligned Monday through to Sunday, with 
5am defining the start of each day. Periods of zero values for one hour or more were excluded from the 
analyses. To ensure the daily data were representative, only those days that contained at least ten registered 
hours (defined as >0 ct"h" recorded) were included. The criterion of Z 10 hours in order to constitute a valid 
measurement day was applied to maximise reliability and validity, as demonstrated by a number of studies 
(Corder, Brage and Ekelund, 2007; Esliger and Tremblay, 2006; Macfarlane, Lee, Ho et al., 2006). A 
measure of activity volume was calculated for each measurement period by dividing total activity counts 
by the number of registered hours to provide a mean value of counts per hour. This was then converted to 
mean counts per minute to allow comparisons with other studies. Once reduced (See Appendix 11 for the 
Actigraph reduction protocol), all summary data were entered into the Statistical Package for Social 
Science (SPSS) version 14.0, which was used to perform the analyses. 
For the purpose of comparing outcomes between groups based on different activity levels, physical activity 
was categorised in three ways: 1) quartiles of activity volume, 2) quartiles of time spent in MVPA, and 3) 
achievement of physical activity recommendations, including i) accumulating 150 minutes of MVPA over 
seven days, or ii) accumulating Z30 minutes of MVPA on at least five out of seven days. Sedentary levels 
of activity were defined as <30 minutes of MVPA over seven days (Department of Health, 2004). 
Pedometers 
Each participant in the diet plus exercise group received a Digi walker pedometer at the start of the 
intervention programme. Daily logs of physical activity were recorded by participants and handed in at 
each visit. Data recorded in the diaries were entered into a Microsoft Excel workbook, developed by the 
researcher, and analysed to assess compliance (see Appendix 9). 
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Data reduction 
Total steps and the daily average steps per week were entered into SPSS for analysis. The number of days 
that each participant walked an extra 3000 steps above baseline values was also examined, since 3000 steps 
are thought to correspond with approximately 30 minutes of brisk walking (Welk et al., 2000)(reference 
needed here to support this statement). Thus, participants were asked to walk an additional 3000 steps on at 
least five out of seven days per week. Baseline values were calculated from the first two weeks of 
monitoring. Six-month values were calculated using means from data recorded during the preceding month 
(weeks 23 to 26). 
3.6.3. Cardiorespiratoryfitness (1-MTW) 
The 1-llile Track {Wilk test 
The 1-Mile Track Walk (1-MTW) test, also referred to as the Rockport Fitness Test, is a widely used and 
validated submaximal field test that requires subjects to walk on a level track at a brisk and steady pace for 
one mile (Kline et al., 1987). Regression equations for the 1-MTW, which use body weight, age, gender, 
walk time, and post exercise heart rate, have been developed based on data collected from a sample of 390 
healthy adults, aged 30 to 69 years, who performed a minimum of two 1-MTWs on separate days, and a 
maximal treadmill test (Kline et al., 1987). The reliability of the 1-MTW time and heart rates for the two 
track walks were . 93 (SEE=0.26 minute) and . 92 (SEE=7.6 bpm), respectively (Kline et al., 1987). The 
validity of the regression equation, established by correlating the predicted V02m&x (VO2max. pred) and actual 
VO2max was . 93 (SEE=0.325 L"min'1) for the validation group (n=174) and . 92 (SEE=0.355 L"min 
l) for the 
cross-validation group (Kline et al., 1987). 
The 1-MTW test eliminates the need for expensive equipment and maximal effort from the individual 
being tested, minimises associated risks, and offers the opportunity to identify potential participants who 
would be unable to increase their walking. Furthermore, it enables VO2m, x to be estimated across a range of 
age groups and fitness levels. As such, the 1-MTW was deemed the most appropriate test for predicting 
cardiorespiratory fitness in participants recruited to the Early ACTID Study. 
Procedure 
Each participant attended their fitness assessment between seven and 14 days after their screening 
appointment (Visit 1). They were provided with information sheets detailing what the fitness test involves, 
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how they should prepare beforehand, a description of the `Rating of Perceived Exertion' scale (Borg, 
1973), and directions to the visit site (see Appendix 12). After Visit 1, the Early ACTID nurse completed a 
participant information form for the fitness test researcher, which detailed participant contact and 
appointment information, as well as gender, date of birth, height, weight and medication. Any other health 
conditions that were present were recorded also. Each assessment lasted approximately 30 minutes and was 
conducted on an indoor level track located at a sports centre within the region of the participant's hospital. 
Specific site and track details can be located in Appendix 13. Participants were asked to wear casual 
clothing and comfortable, supportive shoes appropriate for walking. 
A measurement protocol for conducting the fitness appointment (Visit 2) was developed by the researcher 
to ensure standardisation (see Appendix 13). In order to assist the researcher administering the assessment, 
the data entry form completed during the visit was designed to also incorporate protocol prompts (See 
Appendix 14). 
Once the participant arrived for their assessment, they were greeted and taken to the 1-MTW area. The area 
for testing was reserved for the fitness test appointments and closed to other individuals. The appointment 
started with a series of health and safety questions, detailed on the data entry form, to determine whether 
there were any reasons why the test should not be started. A heart rate monitor (Polar T61) was then fitted, 
comprising a transmitter strap worn around the chest and a receiver watch on the wrist, which was used to 
measure the participant's heart rate at rest and during the 1-MTW. A full briefing about what to expect and 
the opportunity to ask any questions was given prior to starting the warm-up. 
The warm-up walk was performed by all participants and involved walking approximately 120 meters 
round the indoor track, starting slowly and gradually increasing the pace to a brisk walk. During the warm- 
up, the participant was asked how hard they felt they were exercising based on the `Rating of Perceived 
Exertion' scale. The researcher used the participant's rating to indicate whether they should increase or 
reduce their walking speed for the actual 1-MTW, to ensure they were exercising between 13 ('Somewhat 
hard') and 15 ('Hard') on the Borg Scale (Borg, 1973), which is an intensity considered appropriate for 
predicting VO2ni. At the end of the warm-up, the participant was asked to march briskly on the spot, while 
the researcher recorded their post warm-up heart rate. The participant was then instructed to start the 1- 
MTW, and timing (using a stopwatch) began as soon as the participant's foot crossed the start line. 
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During the test, standardised encouragement was provided at the end of each lap, together with the number 
of laps completed and remaining, e. g. `ten down and four to go; well done'. Every time another lap was 
walked, the elapsed time and participant's heart rate was recorded on the data entry form. At each quarter- 
mile point, the participant was asked to rate their perceived exertion. Participants who reported a rating 
below 13 or above 15 were advised to adjust their walking speed accordingly. As soon as the participant 
crossed the 1-mile marker, their heart rate and total time taken was recorded. For those individuals who 
were unable to complete the 1-mile distance, the time to complete the last full lap was recorded and used to 
predict 1-mile time (Donnelly, Jacobsen, Jakicic et al., 1992). A non-completion code was recorded on the 
data entry sheet, with a brief description of the reason(s). Indications for stopping the walk test included the 
onset of chest pain or angina-like symptoms, unusual or severe shortness of breath, unusual or severe 
musculoskeletal discomfort, symptoms of hypoglycaemia, physical or verbal manifestations of severe 
fatigue, participant's request, or failure of the testing equipment. 
Upon completion of the test, the participant continued to walk at a slower pace for several minutes, until 
the heart rate had stabilised. Once stabilised, the participant was offered stretches and was then provided 
with an ActiGraph accelerometer. At the end of the appointment, the heart rate monitor was removed and 
the participant was free to rest. Changing room and shower facilities were available at all sites. 
Data reduction 
Data collected during the 1-MTW were entered into a Microsoft Excel worksheet designed to estimate 
VO2max from the following regression equation. 
132.853 - (0.0769 X Weight[lbs]) - (0.3877 x Age[yrs]) + (6.315 x Gender[female, 0; male, 1]) - (3.2649 x 
Time to complete 1 mile[mins]) - (0.1565 x Final heart rate[bpm]) 
Participants were categorised according to the six gender- and age-specific fitness groups, presented in 
Table 2.4 in chapter 2, which are based on cut off points derived from the Aerobics Center Longitudinal 
Study cohort. For the purpose of analysing the association between CRF and outcome variables, alternative 
fitness categories were created by dividing participants into gender-specific CRF quartile groups based on 
valid predicted V02m values. Values were considered to be valid if the participant: 1) completed the 1- 
mile distance within 20 minutes, 2) was not prescribed beta blockers, and 3) had a final heart rate that was 
not higher than 100% of their age-predicted maximum. For some analyses, the two lower and two higher 
fitness groups were also combined to represent individuals with low fitness and high fitness, respectively. 
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3.7. Data and analyses 
3.7.1. Data checking 
All analyses were performed using SPSS version 14.0. A missing value code was entered for variables with 
missing data. The distributions of the demographic variables and each exposure and outcome variables 
were examined for possible errors and outliers. This involved checking ranges and using appropriate 
graphical illustrations, such as histograms and scatter plots. Possible errors were checked against original 
records and corrected accordingly. Existing cases with values that were not viable were replaced with a 
missing value code. Borderline cases, where the value was an outlier but not considered impossible, 
remained unchanged. The distribution of each variable was re-examined to check that required corrections 
had been made. 
Skewness and kurtosis were examined for each variable to assess departures from normality. Since the 
sample size in this study was considered to be large (>200), formal tests to assess the distribution of 
variables were not considered appropriate because large samples will give rise to small standard errors and 
significant values will arise from even small deviations from normality (Kirkwood and Sterne, 2003). 
Consequently, the shape of the distribution was assessed visually to identify departures from normality. 
With the exception of MVPA, all variables were considered to be normally distributed. A square root 
transformation successfully removed the positive skewness for the purpose of parametric analyses. Since 
one of the main outcomes was the metabolic syndrome, whereby participants were either classified with or 
without the condition, the distribution of variables was additionally examined by group. No further 
transformations were required. 
3.7.2. Exposure and outcome variables and type of analysis 
The exposure and outcome variables, type of analysis and potential covariates are described for each study 
hypothesis below. 
Hl. Physical activity is associated with HbA1, 
Exposure: Physical activity (continuous variable) 
Outcome: HbA1, (continuous variable) 
Analysis: Unadjusted linear regression and adjusted linear regression 
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Covariates: Age (continuous), sex (nominal), BMI (continuous), diabetes medication (dichotomous) 
H2. VO2maxpied is associated with MAI, 
Exposure: VO2m Fred (continuous variable) 
Outcome: HbA,, (continuous variable) 
Analysis: Unadjusted linear regression and adjusted linear regression 
Covariates: Age (continuous), sex (nominal), BMI (continuous), diabetes medication (dichotomous) 
H3. VO2max, Pred modifies the association between physical activity and HbA1, 
Exposure: Interaction between VO2max. p«d and physical activity (continuous variable) 
Outcome: HbA1, (continuous variable) 
Analysis: Unadjusted linear regression and adjusted linear regression 
Covariates: Age (continuous), sex (nominal), BMI (continuous), diabetes medication (dichotomous) 
H4. Physical activity is associated with the metabolic syndrome 
Exposure: Physical activity (continuous and dichotomous variables) 
Outcome: Metabolic syndrome (dichotomous variable) 
Analysis: Unadjusted logistic regression and adjusted logistic regression 
Covariates: Age (continuous), sex (nominal) 
H5. VO2max pied is associated with the metabolic syndrome 
Exposure: VO2max Fred (continuous and dichotomous variables) 
Outcome: Metabolic syndrome (dichotomous variable) 
Analysis: Unadjusted logistic regression and adjusted logistic regression 
Covariates: Age (continuous), sex (nominal), physical activity CPM (continuous) 
H6. VO2ma. P«d modifies the association between physical activity and the metabolic syndrome 
Exposure: Interaction between V02m, x, prcd and physical activity (continuous variable) 
Outcome: Metabolic syndrome (dichotomous variable) 
Analysis: Unadjusted logistic regression and adjusted logistic regression 
Covariates: Age (continuous), sex (nominal) 
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3.7.3. Descriptive analyses 
Descriptive data are expressed as means f standard deviations or 95% confidence intervals, unless 
otherwise stated. Appropriate tables and graphs are presented in the results chapter to illustrate these data. 
3.7.4. Statistical analyses 
Associations and comparative analyses 
Relations between continuous variables were examined using Pearson correlation coefficients when data 
were parametric and Spearman correlation coefficients when data were non-parametric. A number of tests 
were used to examine differences between exposure sub-groups. Continuous outcome data that adhered to 
parametric assumptions were examined using independent samples t-tests or analysis of variance 
(ANOVA), depending on whether there were two or more exposure groups. The Mann-Whitney U Test 
was chosen for non-parametric continuous outcome data. Associations between dichotomous/nominal 
exposures and outcomes were explored using the Chi Square Test. Within-group differences were analysed 
with paired samples t-tests. 
Univariable analyses 
After checking for evidence of collinearity, Pearson-product moment correlation coefficients and 
Spearman correlation coefficients were used to examine the relationship between two variables (see 
Appendix 15). Exposure and outcome variables were entered into linear regression models in their 
continuous form to examine associations. 
i !, i1tiº'ariable analyses 
Exposure and outcome variables were entered into multivariable linear regression models in their 
continuous form to examine exposure effects, with adjustments made for confounders. Confounders were 
defined as covariates relating to both exposure and outcome variables, and included a priori covariates, 
such as age and BMI, and covariates identified through exploratory analyses, involving the examination of 
correlation coefficient tables (see Appendix 15). 
Logistic analtyses 
Continuous exposure and binary outcome (metabolic syndrome status) variables were entered into logistic 
regression models to examine exposure effects, with adjustments made for confounders, as defined above. 
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Odds ratios were computed to examine the influence of physical activity or predicted VOZ, ax on the 
metabolic syndrome. When the exposure was categorical, odds were estimated relative to the lowest 
physical activity level or fitness level. The statistical significance of each regression parameter coefficient 
was evaluated using the Wald test. 
Interaction analyses 
In order to investigate an interaction effect between two exposure variables on an outcome variable, the 
exposure values were multiplied together to create an interaction variable that was entered into the 
regression model. 
Interpretation and reporting of analyses 
Regression coefficients are reported along with 95% confidence intervals and P values. AP value <0.05 
was interpreted as statistically significant. Appropriate tables and graphs are presented to illustrate 
associations. 
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Chapter 4. Results 
This chapter will present the main results of this PhD study. Recruitment and follow-up of participants will 
be described, followed by a description of the participants' characteristics. Physical activity and 
cardiorespiratory fitness levels in the study cohort will be covered in detail, since these are the main 
exposure variables under examination. Finally, the relationship between physical activity, cardiorespiratory 
fitness and metabolic and cardiovascular outcomes will be explored and presented. 
4.1. Recruitment and follow-up 
Recruitment to the study commenced in November 2005. At the time of analysing data presented in this 
thesis, 347 participants had undergone baseline assessment for the Early ACTID trial. Figure 4.1 illustrates 
the flow of participants from the first baseline assessment (Visit 2) to the six-month follow-up. 
Figure 4.1. Flow ofparticipants from baseline to sir months 
Visit 2: Baseline fitness assessment (N=347) 
& physical activity measurement (N=340) 
Excluded (n=6) 
Not meeting inclusion criteria (n=2) 
Refused to participate (n=4) 
Visit 3: Clinical measurements (n=341) 
Excluded (n=11) 
Not meeting inclusion criteria (n=5) 
Refused to participate (n=6) 
Visit 4: RANDOMISATION (n=330) 
Lost to all follow-up due to withdrawal (n=11) 
Missed measurements: 
Clinical (n=3) 




Physical activity (n=276) 
Seven individuals were found to be ineligible before randomisation. Of the 340 eligible individuals, ten 
decided not to participate in the study. Three-hundred and thirty participants were randomised to one of the 
three groups. Eleven participants (3.3%) withdrew in the first six months and did not undergo follow-up 
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assessment. At the six-month follow-up, 266 participants (80.6% of those randomised) underwent all 
clinical, cardiorespiratory fitness (CRF) and physical activity measures. Twenty-seven participants (8.2%) 
missed the physical activity assessment only, seven (2.1%) missed the CRF testing only, and 16 (4.8%) 
missed both the physical activity and CRF measures. Two participants (0.6%) failed to attend only the six- 
month clinical assessment, and one participant (0.3%) performed only the CRF test. 
4.2. Participant characteristics and physiological outcomes 
The characteristics of the study participants at baseline and six-months are summarised in Table 4.1a and 
4.1b, respectively. Demographic data are shown for participants who met the study inclusion criteria and 
had undergone at least one of the following baseline measurements: 1) clinical, 2) fitness, or 3) physical 
activity. All participants had a BMI z24 kg/rn2. Forty-one percent (n=140) of participants were categorised 
as normal weight or overweight (BMI 20-29.9), 50% (n=169) as obese (BMI 30.0-39.9), and 9% (n=31) as 
morbidly obese (BMI 240.0). 
A blood pressure measurement was obtained for 335 participants. Of these, according to the World Health 
Organization guidelines (WHO, 1999), 17% (n=57) had optimal blood pressure (<120/80mmHg), 17% 
(n=58) had normal blood pressure (120-129/80-84mmHg), 30% (n=103) had high-normal blood pressure 
(130-139/85-89mmHg) and 34% (n=117) had hypertension (140-179/90-109mmHg). No participants were 
categorised as having severe hypertension (>180/110mmHg), as this was one of the Early ACTID Study 
exclusion criteria. At the time of entering the study, 52% (n=176) of participants were prescribed anti- 
hypertensive medications. 
Baseline HbA,, values were obtained for 335 participants. In relation to the NICE classification of MAI, 
values, almost one quarter of the sample (n=80) had optimal HbA,, values, which were less than 6%. 
Twenty-nine percent (n=97) had good control (6-6.49%), 32% (n= 108) had acceptable control (6.5-7.49%), 
and 15% (n=50) had poor glycaemic control, with values k7.5%. One third of participants (n=110) were 
prescribed diabetes medications. Just 28.8% of participants (n=98) were not prescribed medication for their 
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Chapter 4: Results 
The prevalence of each individual component of the IDF criteria for the classification of the metabolic 
syndrome (International Diabetes Federation, 2006) was examined in the study cohort. These components 
include: 1) a diagnosis of diabetes, 2) obesity (BMI ? 30kg/m2), 3) triglycerides >1.7mmol/I or the 
treatment for dyslipidaemia, 4) HDL-cholesterol <l. lmmol/l in men and <1.3mmol/l in women, or 
treatment of dyslipidaemia, and 5) systolic blood pressure >130mmHg or diastolic blood pressure 
>85mmHg, or treatment of hypertension. Figure 4.2 shows the percentage of participants meeting the 
criteria for each individual component of the metabolic syndrome, while Figure 4.3 shows the percentage 
of participants by the number of components that meet the criteria. 
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A total of 336 participants had sufficient data to determine the prevalence of the metabolic syndrome. A 
BMI Z30, or a waist circumference Z94cm for men and Z80cm for women, is an essential component of the 
IDF criteria, and individuals are required to have at least two other factors for the classification of the 
metabolic syndrome. One of the additional IDF factors includes a fasting plasma glucose Z5.6mmol/l or 
diagnosed T2D. Since all of the participants in this study met this criterion, just one other factor in addition 
to a BMI z30 was necessary. Fifty-four percent (n=151) of participants met the full metabolic syndrome 
criteria. The prevalence of the condition was higher in women than men (60% vs. 50%, x2 (1)=3.58, 
P=0.07), although this difference reached only borderline significance. Of those participants with a BMI 
Z30,92% were classified with the metabolic syndrome. Of these, 35% met just one additional criterion, 
35% met two additional criteria, and 27% met all three additional criteria, and thus, met all individual 
criteria of the IDF metabolic syndrome definition. Of those participants with a BMI <30,17% did not have 
any of the additional metabolic syndrome components, 39% met one criterion, 25% met two criteria, and 
19% had all three additional criteria. 
Table 4.2 shows participant characteristics of those classified with and without the metabolic syndrome at 
baseline. Participants meeting the criteria were significantly heavier, and they had higher BMIs, higher 
fasting insulin levels and higher HOMA scores compared to those without the metabolic syndrome. There 
were no significant between-group differences for the other participant characteristics reported in Table 
4.2. Although blood pressure did not differ significantly between the two groups, the proportion of 
participants prescribed antihypertensive medication was higher in the group with the metabolic syndrome 
compared to the group without the metabolic syndrome (59.1% vs. 44.5%, x2 (1)=7.14, P=0.009). The 
proportion of participants prescribed diabetes and lipid medication did not differ between groups. The 
relationship between physical activity, cardiorespiratory fitness and the metabolic syndrome will be 
described in section 4.5. 
At six months, 313 participants had sufficient data to determine the prevalence of the metabolic syndrome. 
Of these, 47% (n=147) met the metabolic syndrome criteria. Among those participants with sufficient data 
to determine the presence of the metabolic syndrome at both baseline and six months (n=312), chi square 
analyses revealed that significantly fewer participants met the metabolic syndrome criteria at six months 
than at baseline (52.9% vs. 47.1%, x2 (1)=150.07, P<0.001). The difference in the metabolic syndrome 
prevalence between women and men was slightly more pronounced at six months (54.5% (n=66) vs. 42.2% 
(n=81), x2 (1)=4.55, P=0.02). 
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(mean ± SD) 
No Yes 
BETWEEN-GROUP DIFFERENCE 
P value 95% Confidence interval 
DEMOGRAPHICS 
Age (years) 59.89 ± 10.25 58.74 t 10.42 0.309 -1.07 3.38 
Height (meters) 1.70±0.10 1.69 ± 0.09 0.087 0.00 0.38 
Weight (kilograms) 81.78 ± 11.08 100.32 ± 16.16 <0.001 -21.79 -15.90 
Body Mass Index (kg/m2)* 28.02 ± 2.32 35.37 f 5.39 <0.001 -8.22 -6.48 
PHYSIOLOGICAL 
Systolic blood pressure (mmHg)t 133.99116.04 134.61 ± 14.23 0.713 -3.91 2.68 
Diastolic blood pressure (mmHg)t 78.48 ± 8.27 79.28: 18.51 0.388 -2.62 1.02 
BIOCHEMICAL 
HbA1, (%) 6.65 ± 1.04 6.56 ± 0.93 0.432 -0.13 0.30 
Cholesterol (mmol/1) 4.39 ± 0.92 4.39 ± 0.91 0.999 -0.20 0.20 
Triglycerides (mmol/1)t 1.60 ± 0.88 1.77: k 1.10 0.127 -0.39 0.05 
HDL cholesterol (mmol/l)t 1.35 ± 0.33 1.30 ± 0.34 0.124 -0.02 0.13 
LDL cholesterol (mmolll) 2.31 ± 0.82 2.31 ± 0.77 0.938 -0.18 0.17 
Glucose (mmol/1) 7.40 ± 1.53 7.33 ± 1.55 0.647 -0.26 0.41 
Insulin (mU/L) 12.21 ± 5.64 20.86: k 13.25 <0.001 -10.81 -6.50 
HOMA 4.07 ± 2.26 6.86 f 4.97 <0.001 -3.61 -1.97 
HbA,,, glycated haemoglobin; HDL, high-density lipoprotein; LDL low-density lipoprotein; * BMI ? 30 is an essential component of 
the IDF definition of the metabolic syndrome; t Additional components of IDF metabolic syndrome definition, of which at least one, 
in addition to BMI ? 30, is required in people with a diagnosis of T2D. 
4.3. Physical activity 
4.3.1. Compliance with the measurement protocol 
Baseline measurement 
At the time of performing analyses, an ActiGraph had been given to 340 participants undergoing baseline 
assessments. Five (1.5%) monitors were not returned by participants. Of the 335 returned ActiGraphs, 
seven (2.1%) could not be downloaded due to a technical fault and seven (2.1%) had no registered days of 
recording, suggesting the monitor had not been worn. Accelerometer data were therefore obtained from 
321 participants (198 men, 123 women) at baseline. 
Two-hundred and sixty-two participants (81.6%) wore the accelerometer for at least ten registered hours on 
seven days, as requested, and 43 (13.4%) recorded six days of measurement. Recent reports on 
85 
Chapter 4: Results 
accelerometry in free-living individuals indicate that ten or more hours of recording on at least three week 
days and one weekend day of measurement provide the most reliable estimate of physical activity (Corder 
et al., 2007). As such, participants providing baseline ActiGraph data were categorised according to the 
number of days where at least ten registered hours of recording had been obtained. The criteria of having at 
least three valid weekdays and one weekend day were met by 314 participants (97.8%). No significant 
difference in mean daily monitor wear, physical activity volume or MVPA was found between the two 
groups. Therefore, all participants providing accelerometer data are included in the analyses presented in 
this thesis. Baseline physical activity data are shown in Table 4.3a. 
Six-month measurement 
Three-hundred and nineteen participants remained in the study at six months. Of these, accelerometer data 
were obtained for 276 participants (86.5%). Eleven (3.2%) ActiGraphs were not returned by participants, 
three (0.9%) could not be downloaded due to a technical fault, and six (1.8%) had no registered days of 
recording. Twenty-three participants (7.2%) were not provided with an ActiGraph at six months, either 
because of prolonged ill-health or injury, or because of non-attendance at their six-month fitness test. 
One-hundred and ninety-one participants (69.2%) wore the accelerometer for at least ten registered hours 
on seven days, and 49 (17.8%) recorded six days of measurement. Table 4.3b shows the six-month 
physical activity data. A total of 164 participants provided seven valid days of accelerometry data at both 
baseline and six months. 
4.3.2. Levels of physical activity 
Baseline physical activity 
A one-way repeated measures test revealed there were no significant differences in physical activity 
between individual weekdays (CPM: F(3.7,951.1)=. 430, P=0.78; MVPA: F(3.8,111.8)=1.21, P=0.31). 
Similarly, a paired t-test showed no significant difference between the two weekend days (t(278)=1.61, 
P=0.11).. As such, data for these two periods were combined as mean weekday and mean weekend day 
values. Physical activity volume, as determined by mean counts per minute (CPM), was 4% lower during 
weekend days compared with week days (t(315)=1.933, P=0.05). Differences between the two periods 
were more pronounced for time spent in MVPA, with participants spending 15% less time performing this 
intensity of activity during weekend days than week days (t(315)=. 991, P<0.001). 
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Chapter 4: Results 
Figure 4.4 shows the percentage of participants accumulating different amounts of MVPA per day at 
baseline. Of those participants with seven days of recording (163 men, 99 women), 81 (49.7%) men and 29 
(29.3%) women accumulated at least 150 minutes of moderate to vigorous physical activity (MVPA) 
during the recording period, which is the minimum weekly total recommended in national guidelines for 
physical activity (Department of Health, 2004). When the data were analysed to determine the number 
accumulating >_30 minutes on at least five days per week, just 26 (16.0%) men and II (11.1%) women 
achieved this level of activity. Seventeen (10.4%) men and 14 (14.1%) women accumulated <30 minutes 
of MVPA during the 7-day recording period, which is the amount considered sedentary or inactive 
(Department of Health, 2004). Of these, six men and three women did not have any registered minutes of 
MVPA. Of those participants providing at least one valid accelerometer measurement day (n=321), 60 
(30.3%) men and 24 (19.5%) women recorded a mean of at least 30 minutes of MVPA accumulated per 
day. Nine (4.5%) men and six (4.9%) women had no registered minutes of MVPA. 
Figure 4.4. Percentage of participants accumulating different amounts of MVPA per day at baseline, as 
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At six months, differences between weekday and weekend day physical activity levels were only 
significant for time spent in MVPA (P=0.003). Differences in physical activity volume were not 
significant. A total of 48.2% (51.9% men, 40.3% women) of participants providing seven days of 
accelerometer data accumulated at least 150 minutes of MVPA. Four participants (2.1%) did not register 
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any MVPA minutes during the seven days of measurement. Eighty-four (30.7%) participants (37.1% men 
and 19.2% women) with at least one valid measurement day accumulated a mean daily average of 30 
minutes of MVPA. When only those participants providing data at both baseline and six months were 
examined, the proportions accumulating 150 minutes per week or 30 minutes per day were fairly similar 
(47.0 vs. 48.2% and 26.8 vs. 30.9%, respectively). 
4.3.3. Physical activity by demographic characteristics 
Significant independent demographic predictors of physical activity volume (CPM) were age (ß=-. 283, 
t(319)=-5.26, adjusted R2=. 077, P<0.001), BMI (ß=-. 203, t(319)=-3.709, adjusted R2=. 038, P<0.001) and 
gender (ß=. 113, t(319)=2.038, adjusted RZ=. 010, P=0.042). Predictors of time spent in activity of at least 
moderate intensity were BMI (p=-. 074, t(319)=-3.750, adjusted R2=. 040, P<0.001), age (ß=-. 029, t(319)=- 
2.788, adjusted R2=. 021, P=0.006) and gender (ß=. 549, t(319)=2.471, adjusted R2=. 016, P=0.014). There 
appeared to be an age-BMI interaction for both CPM (ß=-. 099, t(319)=-7.713, adjusted R2=. 155, P<0.001) 
and MVPA (ß=-. 002, t(319)=-5.749, adjusted R2=. 091, P<0.001). 
Gender 
Gender differences in levels of physical activity are shown in Table 4.3a at baseline and 4.3b at six months. 
Briefly, at baseline women were 9% less active than men (t(319)=-2.038 CPM, P=0.04) and spent 20% less 
time in MVPA (t(319)=-2.471 mean minutes-day", P=0.01). These gender differences were slightly more 
pronounced at six months (11%, P=0.05 and 25%, P=0.002, respectively). 
Age 
There was a moderate inverse association between age and physical activity volume, as determined by 
mean accelerometer counts per minute (r=-. 283, P<0.001), and time spent in MVPA (r--. 154, P=0.006). 
Associations between age and volume and intensity of physical activity were slightly weaker at six months 
(r=-. 194, P=0.001 and r=-. 111, P=0.07, respectively). When participants were divided into three equal age 
groups, corresponding to 31-54 years (mean 47 years), 55-65 years (mean 60 years) and 65-81 years (mean 
70 years), mean CPM were 275.7 f 89.8,244.8 ± 98.4 and 208.9 ± 92.1, and mean daily MVPA minutes 
were 24.6 ± 17.2,21.0 ± 17.6 and 19.1 t 17.8, respectively. An ANOVA test revealed significant between- 
group differences in physical activity volume (F(2,318)=13.71, P<0.001) and time spent in MVPA 
(F(2,318)=3.16, P=0.04). As mentioned above, there was an interaction between age and BMI. 
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Examination of the associations by BMI category revealed that the inverse association between age and 
physical activity was much stronger among morbidly obese (BMI Z40kg/m2) participants 
(CPM, r=-. 629; 
MVPA, r--. 734, P<0.001) than obese (BMI 30.00-39.99kg/m2) (CPM, r=-. 245, P=0.002; 
MVPA, r=-. 167, 




Differences in physical activity between overweight, obese and morbidly obese BMI groups were 
examined using a one-way ANOVA test. There were significant differences in mean weekly 
CPM between 
BMI groups (F(2,318)=5.48, P=0.005), with post-hoc Bonferroni analyses showing the greatest 
difference 
between the overweight (M=258.30 ± 95.21 CPM) and morbidly obese groups (M=192.96 ± 87.95 CPM) 
(P=0.004,95% CI 16.59 to 114.09). Differences between the overweight and obese groups (M=239.23 ± 
97.53 CPM) were non significant. Differences in CPM were more pronounced at the weekend 
(F(2,315)=9.17, P<0.001). 
There was also a significant difference between BMI groups in time spent in MVPA (F(2,318)=5.67, 
P=0.009, with post-hoc analyses showing that the morbidly obese group accumulated fewer minutes of 
MVPA per day than the overweight groups (M=13.88 ± 14.88 vs. 24.48 t 17.73, P=0.013). Differences in 
MVPA were also more pronounced at the weekend, with the overweight group spending significantly more 
time in MVPA (M=23.60 ± 20.56) than both the obese (M=16.69 ± 18.51, P=0.006) and morbidly obese 
groups (M=8.17 ± 8.63, P<0.001). There were no other significant differences in physical activity CPM or 
minutes of MVPA between BMI groups. A two-way ANOVA revealed no interaction between gender and 
BMI in relation to physical activity. 
The number of participants meeting the physical activity recommendation of accumulating 30 minutes of 
moderate intensity activity on at least five days per week was also examined by BMI status. The 
accelerometer counts indicated that 21.7% (n=25) of overweight, 9.6% of (n=12) of obese, and 0% of 
morbidly obese participants accumulated these recommended levels of activity over the 7-day recording 
period. The difference between groups was statistically significant (f (2)=1 1.23, P=0.004). 
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4.3.4. Physical activity by study group assignment 
There was no significant difference between baseline and six-month physical activity volume or times 
spent in MVPA when the Early ACTID Study cohort was examined as one group. In order to assess the 
feasibility of increasing levels of physical activity in a group of adults with recently diagnosed T2D, mean 
six-month activity levels of those randomised to the diet plus exercise group were compared to mean levels 
of those allocated non-exercise (diet only and usual care) groups. Differences within and between groups 
were examined using dependent and independent t-tests, respectively. Although cross-sectional differences 
between groups were not significant at either baseline or six-months, within-group six-month changes in 
CPM and MVPA were statistically significant between groups. These differences are shown in Table 4.4. 
Between baseline and six months, mean CPM increased by 11.1% (P=0.02) and time spent in MVPA 
increased by 25.34% (P=0.001) within the diet plus exercise group. Within the non-exercise group, mean 
CPM decreased by 3% and time spent in MVPA by 1.5%. These changes were non-significant. 
Table 4.4. Within group change in physical activity from baseline to six months among participants in 
the Early ACTID Study 
NON-EXERCISE DIET + EXERCISE BETWEEN-GROUP DIFFERENCE 
GROUP GROUP 
PHYSICAL ACTIVITY n Mean ± SD n Mean f SD P value 95% Confidence 
OUTCOME interval 
Counts minute' 169 -7.5 ± 81.1 96 25.3 ± 79.7** 0.002 12.6 53.1 
Counts minute'-wk"day'' 169 -7.7 ± 79.5 96 20.1 ± 79.7* 0.007 7.8 47.9 
Counts minute'-we -day" 157 -9.6± 132.7 94 37.1 ± 118.1** 0.005 13.9 79.3 
MVPA minutes'-day' 169 -0.4 ± 15.3 96 5.1 ± 14.0** 0.005 1.7 9.2 
MVPA minutes"-wk-day-1 169 -0.6 ± 16.2 96 3.9 ± 15.6* 0.031 0.4 8.5 
MVPA minutes'-we"day-' 157 -1.0 t 25.9 94 7.7 ± 20.3** 0.006 2.5 14.8 
* Significant within-group difference P<0.05; ** P<0.01 
Figure 4.5 shows the percentage of non-exercise group and diet plus exercise group participants who 
accumulated 150 minutes of MVPA at baseline and six months. Only data from participants providing 
seven days of accelerometry at both time points are presented (n=191). At baseline, there was no 
significant difference between the groups; however, at six months a significantly greater proportion of 
participants randomised to the diet plus exercise group were accumulating the recommended 150 minutes 
compared to the non-exercise group ()? (1)=6.18, P=0.017). 
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Figure 4.5. Percentage of participants accumulating 150 minutes of MVPA at baseline and six months 
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All participants were categorised according to whether they increased or decreased the volume of physical 
activity and daily time spent in MVPA over the first six months of the Early ACTID Study. Four categories 
were created and the percentage of participants within each category is shown by group in Figure 4.6. 
Over half of the diet plus exercise group increased both their volume of activity, as assessed by mean 
CPM, and the amount of time spent in MVPA. However, almost one quarter of participants performed less 
overall activity and spent less time in MVPA at six months compared to baseline. The majority (over one 
third) of non-exercise group participants registered a lower volume of activity and less MVPA at six 
months than at baseline. These data indicate that an increase in one aspect of physical activity, e. g. volume, 
does not necessarily guarantee an increase in another. 
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4.3.5. Self-monitoring and reporting of physical activity 
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Self-reported physical activity data were obtained from 121 participants in the diet plus exercise 
intervention group. One-hundred and fifteen participants (95%) from this group remained in the study at 
six months. Out of a possible 19,796 days between Week 3 and Week 26, physical activity diaries were 
kept on 17,086 days. This represents 86.3% compliance with keeping physical activity records. 
Compliance did not differ significantly between men (86.5%) and women (83.0%). Figure 4.7 shows the 
weekly compliance level up to six months. A dependent t-test showed that compliance with record keeping 
was significantly lower at Week 26 compared with Week 3 (mean difference -1.48 ± 2.81 days, t(114)=- 
5.65, P<0.001). 
Reasons for not providing activity records over a prolonged period (>2 weeks) were reported by six 
participants. Reasons included injuries (n=2), bilateral foot surgery (n=l), depression (n=l), family 
bereavement (n-1), losing the completed records (n= l ), and forgetting to use the diaries (n-1). Two 
participants refused to complete the records, but agreed to wear the pedometer for the duration of the 
intervention period. 
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Figure 4.7. Compliance with physical activity diary recording from week 3 to week 26, as determined by 
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The weekly variation in reported mean daily steps up to six months is shown in Figure 4.8. Reported mean 
daily steps were significantly higher between Week 22 and 26 (7405.1 ± 2716.0) compared with Week 3 
(6444.6 t 2502.3) (t(102)=3.80, P<0.001). Daily steps peaked at Week 14 (8018.8 ± 3226.7). Just 7.4% of 
participants recording their steps at Week 3 accumulated a mean of at least 10,000 steps per day. This 
proportion increased significantly to 17.5% at six months (weeks 23 to 26) (x' (l)=15.16, P-0.02). 
Participants were asked to walk ? 3000 steps per day above values recorded in week 3 on at least five days 
per week. This equates to 71.4% of total days. Participants reported achieving the goal on 25.5 ± 21.7% 
(min 0%, max 91.2%) of the days where activity was recorded. Only seven (6%) participants reported 
meeting the goal on the target number of days. 
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There was a strong correlation between accelerometer counts and reported pedometer steps at both baseline 
(r=. 57, P<0.001) and six months (r-. 67, P<0.001). Figure 4.9 shows the association at baseline. Similar 
associations were found between pedometer steps and minutes of MVPA, as determined by accelerometry. 
Figure 4.9. Scatter plot and correlation line of baseline mean steps per day versus mean accelerometer 
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Table 4.5 shows the reported mean daily steps for participants who accumulated less than and greater or 
equal to 30 minutes of MVPA per day at baseline and at six months, as measured by the ActiGraph 
accelerometer. There was a significant difference in reported steps between groups at both time points 
(mean difference at baseline 2184.6, SE 510.3, t(113)=4.28, P<0.001, mean difference at six months 
2508.4, SE 49.6, t(89)=5.1, P<0.001). 
Table 4.5. Self-reported mean steps per day at week 3 and week 26 in relation to accumulating 30 
minutes of MVPA per day, as measured by the ActiGraph among participants randomised to the diet 
plus exercise group 
Baseline Six-months 
N Mean ± SD Min Max N Mean± SD Min Max 
Accumulating <30 89 6152.4 ± 2408 0 
1130. 14188 
55 6162.9 f 2302.6 
1733. 11052 
. minutes of MVPA per day 0 .0 0 .4 
Accumulating? 30 0f 1809 8 26 8337 5570. 12318 3407. 36 8671.3 f 2337.7 
13318 
. . minutes of MVPA per day 0 .0 1 .7 
4.4. Cardiorespiratory fitness 
4.4.1. Compliance with the measurement protocol 
Baseline measurement 
Baseline cardiorespiratory fitness data are presented in Table 4.6a. With the exception of two participants 
who completed a cycle test due to peripheral neuropathy that contraindicated the walking test, all 
participants started the 1-MTW. Fitness data resulting from the two cycle tests have been excluded from 
analyses due to their incomparable nature. Twenty participants (5.9%) starting the walk test were unable to 
complete the 1-mile distance. Musculo-skeletal discomfort was reported by 14 participants as the reason 
for early termination, cardiorespiratory difficulty reported by two participants, `other' reasons reported by 
three participants and for one participant there was a technical malfunction with the timing equipment. 
Mile end heart rate (HR) was lost for one participant due to a technical malfunction with the HR monitor. 
One-mile time was recorded for all participants starting the walk test. For those 20 participants who were 
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estimate the 1 -mile time. Table 4.6 shows the mean 1-mile time for all participants starting the walk test, 
the mean 1-mile time for participants completing the 1-mile distance only (considered valid mile time) 
(94%), and finally the mean time for only those completing the 1-mile distance within 20 minutes (87%), 
which is the cut point for appropriate use of the equation to predict VO2m,,,. Compared with participants 
completing the 1-mile distance within 20 minutes, those taking longer than 20 minutes had significantly 
higher BMIs (U=4644, P=0.005), were less active (U=2020, P<0.001) and spent less time in MVPA 
(U=1999, P<0.001). 
Valid VO2max. pred data are presented for the 237 (70%) participants who completed the 1-mile distance 
within 20 minutes, were not prescribed beta-blocker medication at the time of testing, and had a final heart 
rate that was not greater than 100% of their age predicted maximum. Participants whose fitness data did 
not meet the inclusion criteria were significantly older (U=6936, P<0.001), heavier (U=10379.5 P=0.01), 
had higher BMIs (U=9620.5, P=0.004), were less active (U=6109, P<0.001), and spent less time in MVPA 
(U=6926, P=0.001) compared with those who met the inclusion criteria. 
Sir-month measurement 
Six-month cardiorespiratory fitness data are presented in Table 4.6b. A total of 298 participants started a 
fitness test at six months. Of these, two performed a cycle test due to peripheral neuropathy and fitness data 
for these participants are not presented. Two-hundred and eighty-six participants completed the 1-mile 
walk test. Out of the ten participants unable to complete the 1-mile distance, seven reported 
musculoskeletal discomfort as the reason for early termination. A reason for early termination was not 
recorded for three non-completers. Twenty-one (6.6%) of the 319 participants remaining in the study at six 
months did not undergo fitness testing because of either illness or injury, or because of non-attendance at 
the appointment. 
One-mile time was recorded for all participants starting the walk test. For those participants who were 
unable to walk the 1-mile distance (n=10,3.4%), the total time taken to complete the distance covered was 
used to estimate the 1-mile time. 
98 
Chapter 4: Results 
4.4.2. Levels of cardiorespiratoryfitness 
Figure 4.10 shows the percentage of participants within each age and gender-specific CRF category 
(Heyward, 2006). Data from participants prescribed beta blockers (n=53,16%) have been excluded from 
this figure because of the attenuating effect on heart rate, which is used to predict VO2max, and thus fitness 
category. Overall, 38% (n=108) of the study group were categorised as having `very poor' fitness, 20% 
(n=57) as `poor', 25% (n=73) as `fair' and 15% (n=43) as `good' fitness. Just 1.7% (n=5) of participants 
had an `excellent' level of fitness and 0.3% (n=1) had a `superior' fitness level. 
Figure 4.10. Percentage of participants within each age and gender-specific CRF category at baseline, 
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Six-north cardiorespiratorrfitness 
Overall, out of the 250 participants not prescribed beta blocker medication at the six-month 
fitness test, 
32% (n=79) were categorised as having `very poor' fitness, 14% (n=34) as `poor', 30% 
(n=74) as `fair', 
20% (n=50) as `good', and 4% (n=11) as `excellent' fitness. Just 0.8% (n=2) had a `superior' 
fitness level. 
The fitness profiles of participants at six months were slightly more favourable, with 25% 
in the top three 
fitness categories, compared with baseline profiles where just 17% of participants were categorised 
in the 
top three groups. 
Change in cardiorespiratoryfitness bly study group 
Mile time data were considered valid if they represented the actual time taken to complete a full mile, as 
opposed to a predicted mile time based on a part-completed mile. A valid mile time at both baseline and six 
months was obtained from 276 participants (93% of participants who performed the walk test at six 
months). As one group, participants took less time to complete the 1-mile distance at six months compared 
to baseline (mean difference -0.45 (1.07) minutes, t(275)=7.02), P<0.001). There was a strong association 
between the two times (r=. 89, P<0.001). 
There were 205 participants with valid VO2m pred data at both time points. This represents 69% of those 
performing the 1-mile walk test at six months. A small but statistically significant increase in VO2max, P«d 
was observed between baseline and six months post randomisation (mean difference 1.53 (3.24) mllkg/min 
', t(204)=5.75 P<0.001), and a strong association existed between the two measures (r-. 921, P<0.001). 
Independent t-tests revealed no significant differences between participants randomised to the diet plus 
exercise group and non-exercise groups in terms of 1-mile completion time or VO2,,,, x, P«a. 
4.4.3. Cardiorespiratory fitness by demographic characteristics 
Significant independent demographic predictors of 1-mile completion time were gender (0=-1.637, 
t(316)=-6.455, adjusted W=. 114, P<0.001), age (ß=. 092, t(316)=7.951, adjusted R2=. 164, P<0.001), BMI 
(ß=. 127, t(316)=5.013, adjusted RZ=. 071, P<0.001), CPM (ß=-. 010, t(299)=-7.898, adjusted R2=. 170, 
P<0.001), and MVPA (ß=-. 482, t(299)=-7.501, adjusted R2=. 158, P<0.001). As a model physical activity 
volume (CPM), age, gender and BMI explained 41% of the variance in 1-mile completion time during the 
submaximal fitness test. 
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Since the VO2m, x prediction equation 
incorporates gender, age and weight, these variables, as well as BMI, 
were not entered into simple linear regression models. Accelerometer counts predicted VO2max. P«d (ß=. 034, 
t(224)=6.323, adjusted R2=. 148, P<0.001), while MVPA as a predictor was slightly weaker but still highly 
significant (ß=1.405, t(224)=5.111, adjusted R2=. 10, P<0.001). 
Gender 
Women walked at a slower pace during the I -MTW (t(316)=6.46, P<0.001), worked at a higher percentage 
of the age predicted maximal heart rate (t(235)=2.67, P=0.008) and had a lower VO2max, P«d (t(235)=-10.44, 
P<0.001) than men. Similar gender differences were found at six months. There was no significant 
difference between men and women in the rating of perceived exertion at the end of the 1-mile walk, and 
no gender differences were found in the six-month change in variables. 
Age 
Age was found to be strongly associated with time taken to complete the 1-mile distance (men, r=. 501, 
P<0.001; women r=. 403 P<0.001). As expected, since it is a component of the VO2m, x prediction equation, 
age was inversely related with VO2max, prcd (men, r=-. 577, P<0.001; women, r=-. 384, P<0.001). A weak 
inverse association between age and rating of perceived exertion was found in women at baseline only (r=- 
. 196, P=0.03). 
The strength of these reported relationships was similar at six months. There was no 
association between age and mile-end percentage of age-predicted maximal heart rate. 
B1111 status 
Differences between standard BMI groups, including normal/overweight (BMI <29.9), obesity (30.00- 
39.99) and morbid obesity (z40), were examined by a one-way ANOVA, which showed a significant 
between-group difference in time to complete the 1-MTW (F(2,315)=9.35, P<0.001) and VO2max, pred 
(F(2,234)=27.07, P<0.001). Post-hoc Bonferroni analyses revealed that normal/overweight participants 
completed the 1-mile walk in a shorter time than both obese (P=0.009) and morbidly obese participants 
(P<0.001). Although morbidly obese participants walked more slowly than obese participants, differences 
were only borderline significant (P=0.08). Post-hoc analyses showed a significant difference in VO2max, P«d 
between all BMI groups (P<0.001), with BMI being inversely related to VO2maxprcd. Differences between 
BMI groups did not differ between men and women. There were no significant differences between BMI 
groups in terms of the percentage of maximal heart rate at the end of the test and rating of perceived 
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exertion. This indicates that, despite the slower walking pace and lower predicted VO2max, the relative 
intensity of the walk test was similar between BMI groups. 
Physical activity level 
Time to complete the 1-mile fitness test was inversely associated with physical activity volume 
(accelerometer CPM) (r=-. 415, P<0.001) and time spent in MVPA (r=-. 349, P<0.001). The strength of the 
associations were slightly weaker for predicted VO2i m (CPM, r°-. 348, P<0.001; MVPA, r=. 298, P<0.001), 
but still highly significant. Table 4.7 shows univariate linear regression analyses of physical activity 
volume (accelerometer CPM) and time spent in moderate to vigorous physical activity as predictors of 1- 
mile completion time and predicted VO2m in men and women. Although physical activity explained a 
similar proportion of the variance in 1-mile completion time in both men and women, physical activity was 
a much stronger predictor of VO2max in women than men. In both genders, physical activity volume 
appeared to be more important than time spent in MVPA. The associations between CPM and V02,,, are 
illustrated graphically in Figure 4.11. 
Table 4.7. Univariate linear regression of physical activity volume (accelerometer CPM) and time spent 
in MVPA on 1-mile completion time and VO2m. p,, d at 
baseline and six months 
MEN WOMEN 




Baseline -. 414 -6.169 <0.001 . 167 -. 391 -4.518 <0.001 . 145 
Six month -. 337 -4.576 <0.001 . 108 -. 397 -4.176 <0.001 . 149 
Time spent in MVPA 
Baseline -. 363 -5.278 <0.001 . 127 -. 397 -4.591 <0.001 . 150 
Six month -. 376 -5.175 <0.001 . 136 -. 488 -5.359 <0.001 . 230 
V02ma: 
CPM 
Baseline . 376 4.737 <0.001 . 135 . 533 5.842 <0.001 . 276 
Six month . 345 4.009 <0.001 . 112 . 449 4.357 <0.001 . 191 
Time spent in MVPA 
Baseline . 236 2.827 0.005 . 049 . 491 5.229 <0.001 . 232 
Six month . 291 3.316 0.001 . 077 . 556 5.754 <0.001 . 300 
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Figure 4.11. Scatterplot and correlation line of mean accelerometer counts per minute versus VO2ma, p, ed 
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4.5. Associations between physical activity, cardiorespiratory fitness, glycaemic control and the 
metabolic syndrome 
Glycaemic control (1-ibA1J was not associated with either physical activity volume (accelerometer CPM 
r=-. 083) or time spent in MVPA (r=-. 131) at baseline. Nor was it associated with either predicted VO2max 
(r=. 02) or 1-mile completion time (r=. 12). Six month data also showed no relationship between these 
variables. Consequently, no further analyses were undertaken with glycaemic control as an outcome, and 
the primary research hypotheses stating that physical activity and cardiorespiratory fitness are associated 
with HbA, c were rejected. The remaining section will explore associations between physical activity, 
fitness and the clustering of cardiovascular risk factors. 
4.5.1. Physical activity and cardiovascular risk factors 
A univariate logistic regression model was fitted to the data to test the research hypothesis that physical 
activity volume predicted the presence of the metabolic syndrome. The physical activity exposure 
variables, accelerometer CPM and the time spent in MVPA, were entered in their continuous form. Table 
4.8 shows the unadjusted odds ratios of the metabolic syndrome, according to IDF criteria, for each 
physical activity exposure at baseline (n=318) and six months (n=272). The odds of the metabolic 
syndrome show that as CPM or MVPA increase, the odds of the metabolic syndrome decrease. The odds 
did not change after adjustment for age and gender. 
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Figure 4.11. Scatterplot and correlation line of mean accelerometer counts per minute versus VO2mx. pred 
in men and women at baseline 
Men 
45 -- ------. -- -1, 
40 40 
wý 
30 " " 30 
25 
ý5 20 
v 1{ ": 






0 100 200 300 400 500 600 1 
Aleau CPTI 
\Vouien 
0 100 200 300 400 500 600 
Mean C'Pnl 
4.5. Associations between physical activity, cardiorespiratory fitness, glycaemic control and the 
metabolic syndrome 
Glycaemic control (HbA1J was not associated with either physical activity volume (accelerometer CPM 
r=-. 083) or time spent in MVPA (r=-. 131) at baseline. Nor was it associated with either predicted VO, n, a, 
(r=. 02) or 1-mile completion time (r=. 12). Six month data also showed no relationship between these 
variables. Consequently, no further analyses were undertaken with glycaemic control as an outcome, and 
the primary research hypotheses stating that physical activity and cardiorespiratory fitness are associated 
with HbAic were rejected. The remaining section will explore associations between physical activity, 
fitness and the clustering of cardiovascular risk factors. 
4.5.1. Physical activity and cardiovascular risk factors 
A univariate logistic regression model was fitted to the data to test the research hypothesis that physical 
activity volume predicted the presence of the metabolic syndrome. The physical activity exposure 
variables, accelerometer CPM and the time spent in MVPA, were entered in their continuous form. Table 
4.8 shows the unadjusted odds ratios of the metabolic syndrome, according to IDF criteria, for each 
physical activity exposure at baseline (n=318) and six months (n=272). The odds of the metabolic 
syndrome show that as CPM or MVPA increase, the odds of the metabolic syndrome decrease. The odds 
did not change after adjustment for age and gender. 
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Table 4.8. Unadjusted odds of the metabolic syndrome by accelerometer CPM and time spent in MVPA 
at baseline and six months 
EXP(ß) 
Predictor SE p Wald x2 P value (95% Confidence interval) 
CPM 
Baseline -. 003 . 001 
6.362 0.012 . 997 (. 
995-. 999) 
Six month -. 004 . 001 12.096 0.001 . 
996 (. 993-. 998) 
Time spent in MVPA 
Baseline -. 166 . 
060 7.624 0.006 . 
847 (. 753-. 953) 
Six month -. 326 . 
070 21.476 <0.001 . 722 (. 
629-. 829) 
As can be seen in Figure 4.12, the proportion of participants with the metabolic syndrome generally 
decreased among increasing physical activity quartiles. This trend was evident for both physical activity 
volume and time spent in MPVA. Chi square analyses revealed that differences between quartile groups 
were significant in women only (CPM x2 (3)=11.56, P=0.009; MVPA x` '(3)=8.71, P=0.033). 
Figure 4.12. Percentage of participants with the metabolic syndrome by gender and physical activity 
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Chapter 4: Results 
Table 4.9 shows the unadjusted odds ratios of the metabolic syndrome by quartile of physical activity 
volume and time spent in MVPA at baseline. Compared to the lowest physical activity quartile, which was 
entered as the reference group, increasing physical activity quartiles were associated with significantly 
lower odds of the metabolic syndrome in women. Men also appeared to have lower odds of the metabolic 
syndrome with increasing physical activity levels, however the 95% confidence intervals crossed 1.0, 
indicating that the associations were not significant. 
Table 4.9. Unadjusted odds ratios of the metabolic syndrome by physical activity quartile at baseline and 
six months 
Predictor 
Odds ratio (95% Confidence interval) 
All Men Women 
CPM 
Baseline 
Quartile 1: Very inactive 1.0 1.0 1.0 
Quartile 2: Inactive . 499 (. 257-. 970)* . 774 (. 326-1.836) . 331 (. 110-. 989)* 
Quartile 3: Active . 339 (. 175-. 655)** . 774 (. 326-1.836) . 175 (. 061-. 501)** 
Quartile 4: Very active . 394 (. 203-. 764)** . 576 (. 247-1.343) . 323 (. 101-1.030) 
Six months 
Quartile 1: Very inactive 1.0 1.0 1.0 
Quartile 2: Inactive . 918 (. 464-1.819) . 913 (. 378-2.204) . 900 (. 299-2.710) 
Quartile 3: Active . 423 (. 213-840)* . 419 (. 174-1.010) . 437 (. 143-1.334) 
Quartile 4: Very active . 293 (. 145-. 595)** . 368 (. 156-. 867)* . 197 (0.53-. 732)* 
MVPA 
Baseline 
Quartile 1: Very inactive 1.0 1.0 1.0 
Quartile 2: Inactive . 783 (. 406-1.511) . 986 (. 411-2.365) . 595 (. 214-1.654) 
Quartile 3: Active . 395 (. 206-. 758)* . 586 (. 255-1.347) . 244 (. 082_. 724)** 
Quartile 4: Very active . 395 (. 206-. 758)* . 554 (. 244-1.259) . 282 (. 091-. 879)* 
Six months 
Quartile 1: Very inactive 1.0 
Quartile 2: Inactive 
. 370 (. 183-. 751)** 
Quartile 3: Active 
. 393 (. 194-. 796)** 
Quartile 4: Very active . 139 (. 065-. 296)** 
1.0 1.0 
. 346 (. 135-. 887)** . 485 (. 160-1.471) 
. 548 (. 215-1.395) . 247 (. 081-. 751)* 
. 150 (. 057-. 396)** . 150 (. 057-. 396)** 
* P<0.05, ** P<0.01 
Table 4.10 shows the unadjusted odds ratios of the metabolic syndrome by achievement of recommended 
levels of physical activity, including: 1) accumulating 150 minutes of at least moderate intensity activity 
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Chapter 4: Results 
week. Sufficient data to examine these associations were provided by 260 participants at baseline and 188 
participants at six months. Odds ratios were estimated relative to not meeting the recommended levels of 
activity. As one cohort, accumulating 2150 minutes of at least moderate intensity physical activity over 
seven days was associated with significantly lower odds of the metabolic syndrome at both baseline and six 
months, compared to those not accumulating 2150 minutes. Accumulating 230 minutes of at least 
moderate intensity activity on five or more days per week was associated with even lower odds of the 
metabolic syndrome; however, these were not significant at six months. 
When examined by gender, engaging in recommended activity levels appeared to be associated with 
significantly lower odds of the metabolic syndrome in women only. Although in men there was a trend for 
lower odds in those meeting the recommended level of physical activity, this was not significant. 
4.5.2. Cardiorespiratory fitness and cardiovascular risk factors 
Univariate logistic regression models were fitted to the data to test the research hypothesis that 
cardiorespiratory fitness predicted the presence of the metabolic syndrome. The exposure variables, 1-mile 
completion time and predicted VO2mi, were entered in their continuous form. Table 4.11 shows the 
unadjusted odds of the metabolic syndrome, according to IDF criteria, for each fitness exposure at baseline 
and six months. The analyses show that both mile time and VO2max. pred were significant predictors of the 
metabolic syndrome. Higher mile times and lower VO2max. p«d values were associated with higher odds of 
the metabolic syndrome. Although age was identified in the previous chapter as a potential covariate, 
correlation matrices showed no association between this and mile time, and so it was not entered as a 
confounder into the regression model. Furthermore, the VO2max model was not adjusted for age, BMI and 
gender since these are used in the VO2mim prediction equation. 
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Table 4.11. Unadjusted odds of the metabolic syndrome by 1-mile completion time and V02inp, j by 
gender at baseline and six months 
Exp(ß) 
Predictor SE ß Wald P value (95% Confidence interval) 
MEN 
Mile time 
Baseline (n=193) . 198 . 073 7.400 0.007 1.219 (1.057-1.406) 
Six month (n=173) . 142 . 062 5.205 0.023 1.153 (1.020-1.303) 
VO2max 
pred 
Baseline (n=143) -. 096 . 
028 12.280 <0.001 . 908 (. 860-. 958) 
Six month (n=126) -. 070 . 031 5.199 . 023 . 933 (. 878-. 990) 
WOMEN 
Mile time 
Baseline (n=121) . 227 . 098 5.390 0.020 1.255 (1.036-1.520) 
Six month (n=110) . 307 . 104 8.795 0.003 1.360 (1.110-1.666) 
VO2max 
pred 
Baseline (n=92) -. 141 . 041 11.778 0.001 . 869 (. 802-. 941) 
Six month (n=89) -. 105 . 033 10.151 0.001 . 900 (. 844-. 960) 
The presence of the metabolic syndrome was examined by gender-specific CRF quartile group. The mean 
VO2max. pred values in men were 20.86 ± 4.73,28.19 ± 1.28,32.50 f 1.47 and 38.57 ± 2.60 ml kg*min'' for 
the very unfit, unfit, fit and very fit groups, respectively. In women, the corresponding VO2max, pr d values 
were 12.31 ± 2.99,18.61 f 1.57,22.82 t 1.48 and 28.50 ± 2.85 ml kg-min-1, respectively. As can be seen in 
Figure 4.13, the proportion of participants with the metabolic syndrome decreased with each increasing 
CRF group. Chi square analyses revealed that differences between groups were highly significant in both 
men (x2 (3)=13.94, P=0.002) and women ()? (3)=14.55, P=0.002). 
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Table 4.12 shows the unadjusted odds ratios of the metabolic syndrome by gender-specific quartile of 1- 
mile completion time and predicted VO-, Max. The group taking the most time to complete the I-mile 
distance was entered as the reference group in the logistic regression model. Although there was a trend for 
the 1-mile completion time to predict the presence of the metabolic syndrome in the whole group, with the 
lowest odds associated with the fastest mile time, when analysed by gender this trend was not significant in 
women. 
Compared to the lowest predicted VO,, nax quartile, which was entered as the reference group, increasing 
CRF quartile groups were associated with significantly lower odds of the metabolic syndrome in women 
(P<0.01). Men also appeared to have lower odds of the metabolic syndrome with increasing CRF levels, 
however, only the highest fitness quartile was associated with odds that were significantly lower than the 
reference group. Predicted VO2max appears to be a stronger predictor of the metabolic syndrome than I- 
mile walk time. 
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Table 4.12. Unadjusted odds ratios of the metabolic syndrome by VO2m p ed quartile at baseline and six 
months 
Odds ratio (95% Confidence interval) 
Predictor All Men Women 
Mile time 
Baseline 
Quartile 1: Very slow time 1.0 1.0 1.0 
Quartile 2: Slow time . 916 (. 481-1.745) . 712 (. 317-1.600) 1.437 (. 154-1.243) 
Quartile 3: Fast time . 521 (. 276-. 986)* . 
580 (. 259-1.297) . 438 (. 154-1.243) 
Quartile 4: Very fast time . 350 (1.83-. 671)** . 328 (. 142-. 754)** . 382 (. 134-1.090) 
Six months 
Quartile 1: Very slow time 1.0 1.0 1.0 
Quartile 2: Slow time . 481 (. 245-. 944)* . 
551 (. 235-1.290) 
. 357 (. 109-1.166) 
Quartile 3: Fast time . 481 (. 245-. 944)* . 572 (. 243-1.344) . 
330 (. 102-1.065) 




Quartile 1: Very low CRF 1.0 1.0 1.0 
Quartile 2: Low CRF . 673 
(. 316-1.433) . 674 (. 263-1.729) . 635 (. 168-2.402) 
Quartile 3: High CRF . 349 (. 165-. 741)** . 569 (. 223-1.453) . 142 (. 040-. 549)** 
Quartile 4: Very high CRF . 162 (. 073-. 361)** . 154 (. 053-. 445)** . 148 (. 040-. 549)** 
Six months 
Quartile 1: Very low CRF 1.0 1.0 1.0 
Quartile 2: Low CRF . 549 (. 255-1.179) . 401 (. 145-1.112) . 804 (. 219-2.943) 
Quartile 3: High CRF . 424 (. 197-. 915)* . 604 (. 224-1.624) . 241 (. 069-. 848)* 
Quartile 4: Very high CRF . 234 (. 103-. 533)** . 269 (. 090-. 802)* . 175 (. 048-. 641)** 
* P<0.05, ** P<0.01 
Table 4.13 shows the unadjusted odds ratios of the metabolic syndrome by level of fitness at baseline and 
six months. Fitness level was determined by stratifying valid VO2m,, pred values above and below the 
gender-specific median. Sufficient data to examine these associations were provided by 92 women and 143 
men at baseline and 89 women and 126 men at six months. The mean VO2max pied values in men were 24.52 
± 5.05 and 35.54 ± 3.70 ml kg'miri' for the low fit and high fit groups, respectively. In women, the 
corresponding VO2max, pred values were 15.46 ± 3.97 and 25.60 ± 3.63 ml kgmiri 1, respectively. Odds ratios 
were estimated relative to being in the low fitness category. As one cohort, the high fit group had much 
lower odds of the metabolic syndrome than the low fit group. When analysed by gender, fitness category 
appeared to be a stronger predictor of the metabolic syndrome in women than men. Although this trend 
was also apparent at six months, the lower odds of the metabolic syndrome associated with the high fit 
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Chapter 4: Results 
4.5.3. Relative importance and interaction effects of physical activity and cardiorespiratory fitness on 
cardiovascular risk factors 
In order to determine the relative importance of physical activity and CRF with the metabolic syndrome, 
both exposure variables were entered into the linear regression model in their continuous form. The model 
was not adjusted for age, BMI and gender since these are used to predict VO2m. When entered together, 
physical activity was no longer a significant predictor of the metabolic syndrome (ß=1.0,95% Cl . 998 to 
1.005); however, the strength of the relationship with CRF remained (ß=. 902,95% CI . 866 to. 
940). 
With the purpose of determining whether there was an interactive effect between physical activity and CRF 
on the metabolic syndrome, univariate logistic regression models were fitted to the data to test the research 
hypothesis that there was an interaction effect of predicted VO2max and physical activity volume (CPM) on 
the presence of the metabolic syndrome. Both predictors were multiplied together in their continuous form 
and entered into the model as an interaction exposure. No significant interaction effect was found. Figure 
4.14 illustrates this. No further interaction analyses were performed. 
Figure 4.14. Percentage of participants with the metabolic syndrome by fitness status and physical 
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Chapter 5. Discussion 
This chapter will summarise the principal findings of the study and then discuss these in relation to 
previous literature. Subsequently, the strengths and limitations of the study will be considered, followed by 
a discussion of the potential implications of the study's findings. 
5.1. Interpretation of findings 
S. I. I. Principal findings 
The aims of this study were to: 1) develop intervention materials to facilitate change in physical activity levels, 
2) describe objectively measured habitual physical activity, 3) examine change in physical activity over six 
months, 4) explore the use of pedometers and diaries to monitor daily physical activity over six months, 5) 
describe CRF levels, and 6) explore the independent and interactive cross-sectional associations of physical 
activity and CRF with HbA,,. and the clustering of cardiovascular risk factors among adults with recently 
diagnosed T2D recruited to the Early ACTID Study. 
Glycaetnic control and the clustering of cardiovascular risk factors 
Three-hundred and forty participants with a diagnosis of T2D within the previous 5-8 months were 
recruited to the present study. Of these, 24% had optimal HbA, c values (<6%) and a further 29% had 
values between 6 and 6.49%, which represents good control. Despite relatively well controlled HbA,,, 54% 
of participants were categorised as having the metabolic syndrome according to IDF criteria. 
Objectively measured habitual physical activity 
Accelerometry data were obtained from 321 participants at baseline. Physical activity volume was assessed 
by mean accelerometer counts per minute (CPM), while intensity was assessed by time spent in moderate 
to vigorous physical activity (MVPA) using a cut point of 2100 CPM. The study cohort registered a mean 
of 243 ± 97.17 CPM and 21.57 ± 17.62 minutes of MVPA per day at baseline. Among obese and morbidly 
obese participants only, daily physical activity levels were lower during the weekend compared with week 
days. Only 14% of participants (16% of men and 11% of women) accumulated Z30 minutes of MVPA on 
at least five out of seven measurement days, which is the national recommendation for physical activity. 
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Almost 12% of participants (10% of men and 14% of women) were classed as sedentary, since they 
accumulated less than 30 minutes of MVPA per week. 
Significant demographic predictors of participants' physical activity were age, BMI and gender. Women 
were 9% less active than men and spent 20% less time in MVPA. There was a significant interaction 
between age and BMI on level of physical activity. The strength of the inverse association between age and 
physical activity volume increased with increasing BMI. Although there was a strong inverse association 
between age and MVPA among participants within the morbidly obese BMI category, there was no such 
association in participants within the obese or normal/overweight BMI categories. BMI status was 
inversely related to physical activity volume and MVPA. Differences between BMI categories in CPM and 
time spent in MVPA were more pronounced at the weekend than during the week. Unsurprisingly, the 
proportion of participants meeting recommended levels of physical activity (Z30 minutes of MVPA on 2t5 
days per week) decreased among increasing BMI groups. 
Cardiorespiratory fitness 
Just 70% of participants undergoing baseline fitness assessment provided data within the parameters of the 
VO2max estimation regression equation. Mean VO2max. pred was 30.03 ± 7.55 ml kg-miri 
1 for men and 20.59 f 
6.35 mlkg, min 1 for women. When participants' predicted VO2ma,, values were classified according to six 
age and gender-specific CRF categories, which are based on normative data from a healthy population 
(Heyward, 2006), just 17% of participants had values that placed them in the top three fitness groups. 
Physical activity volume (CPM) appeared to be a stronger predictor of VO2ma, P«d than time spent in 
MVPA, and it explained a greater proportion of the variance in VO2max. pied in women than men (27.6% vs. 
13.5%). 
Associations between physical actirity, cardiorespiralory frtuess and metabolic and cardiovascular risk 
factors 
Data from this study found no evidence of an association between MAI, and physical activity or 
cardiorespiratory fitness. In fact, MAI, was not found to be associated with age, gender, weight or BMI in 
this study population. As such, the first three study hypotheses, as described in Chapter 3, were rejected. In 
contrast, the presence of the metabolic syndrome, as defined according to IDF criteria, was inversely 
associated with physical activity and cardiorespiratory fitness. Compared to those not accumulating 2! 30 
minutes of MVPA on 2: 5 days per week, the unadjusted odds ratio of the metabolic syndrome associated 
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with meeting the recommended level of activity was . 344 (95% Cl . 196 to . 658). Similarly, when 
participants were categorised below or above the gender-specific VO2m , p«d median, the odds ratio of the 
metabolic syndrome for those in the high fit group compared to the low fit group was . 298 (95% CI . 174 to 
. 509). When examined by gender, 
low physical activity and low fitness were much stronger predictors of 
the metabolic syndrome in women than men. When both physical activity and VO2max Pied were entered into 
the logistic regression model, physical activity was no longer significantly associated with the metabolic 
syndrome. No interaction effect was observed between physical activity and cardiorespiratory fitness on 
the presence of the metabolic syndrome. 
Use of pedomelers and daily pl tvsical activity records 
Pedometer data were obtained from 121 participants in the diet plus exercise group. Compliance with 
keeping daily physical activity records was 86.3% over a six month period. Compliance at six months 
(76%) was lower compared with baseline (97%, P<0.001). Although pedometer and accelerometer data 
were not collected during the same week, since the pedometers were an intervention tool rather than an 
outcome measure, self-reported pedometer steps were moderately associated with objectively measured 
physical activity at both baseline (r=. 57, P<0.001) and six months (r=. 67, P<0.001). Compared with 
baseline, the number of self-reported daily steps was significantly higher at six months (6445 t 2502 vs. 
7405 ± 2716, t(102)=3.80, P<0.001) and a greater proportion of participants reported accumulating 10,000 
steps per day (7.4% vs. 17.5%). 
Physical activity level among diet plus exercise participants 
Between baseline and six months, mean CPM increased by 11.1% (P=0.02) and time spent in MVPA by 
25.24% (P=0.001) within the diet plus exercise group. The discrepancy in the increase between CPM and 
MVPA could indicate that some compensatory changes in levels of spontaneous physical activity took 
place, whereby some participants may have increased their overall sedentary time. 
S. 1.2. Comparisons with previous literature 
Glycaenlic control and the clustering of cardiovascular risk factors 
In this study, the prevalence of the metabolic syndrome in men and women with recently diagnosed T2D 
was 60% and 50%, respectively, which is lower than the 80% prevalence estimated from large 
epidemiological studies (Hanefeld et al., 2007; Isomaa et al., 2001). There are a number of possible 
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explanations for this. The present study applied the relatively recent definition from the IDF, which will 
not have been used in studies undertaken prior to its publication in 2006. The use of different definitions 
between studies prevents direct comparisons from being drawn and will undoubtedly lead to differences in 
estimated prevalence rates. Nevertheless, recently published analyses of data from NHANES suggest that 
using the IDF definition of the metabolic syndrome results in a significantly higher prevalence compared 
with using the NCEP ATP III definition. This difference was consistent in both sexes and across all fitness 
levels. 
The use of a BMI >30kg/m2 to identify central obesity instead of waist circumference also could explain 
the identification of fewer people. Previous studies have found this can lead to substantially lower 
prevalence rates (Isomaa et al., 2001). Additionally, it is reasonable to expect a lower prevalence in people 
with a recent diagnosis of T2D compared to those who have had established diabetes for longer durations. 
Indeed, the prevalence figures in this study are similar to the 50% prevalence rate reported for people with 
impaired fasting glucose and/or impaired glucose tolerance (Isomaa et al., 2001). Finally, the fact that 
participants had volunteered to take part in a diet plus exercise intervention study means that this cohort is 
unlikely to be representative of the general diabetes population. 
The higher prevalence of the metabolic syndrome in women than men is also inconsistent with prevalence 
figures reported previously for European adults (Hu et al., 2004b; Isomaa et al., 2001), and this may well 
be attributable to the self-selecting nature of the study population. Interestingly, among participants with 
T2D who had volunteered to participate in a long-term lifestyle intervention in the United States, the 
prevalence of the metabolic syndrome was also higher in women (94.8%) than men (92.9%) (Ribisl, Lang, 
Jaramillo et al., 2007). 
Objectively measured habitual physical activity 
The volume of physical activity registered by accelerometers in this study (243 ± 97 CPM) is much lower 
compared to the volume recently reported in a study population of healthy Swedish adults (376 ± 141 
CPM) (Hagstromer, Oja and Sjostrom, 2007). Hagstromer and colleagues collected seven-day 
accelerometer data from 1114 healthy Swedish adults between 18 and 69 years (mean age 45 f 15 years; 
mean BMI 25.0 ± 3.8). Daily MVPA was also lower in the Early ACTID cohort compared to the Swedish 
study population (17.8 (25th-75th percentile 8.2-30.9) vs. 29 (17-44) minutes), as was the proportion of 
people accumulating at least 30 minutes of MVPA daily (26% vs. 52%). While 36% of the Swedish 
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participants were overweight and 7% were obese, the majority had a healthy BMI, which could explain the 
difference in physical activity levels between the two groups, given the inverse association between BMI 
and physical activity found in both this study and several others (Cooper, Page, Fox et al., 2000; Plotnikoff 
et al., 2006). 
In this present study, morbidly obese participants were consistently less active than their obese and 
normal/overweight counterparts. These differences were seen for the total volume of activity and time 
spent in MVPA, which is consistent with previous studies in both non-diabetic (Cooper et al., 2000) and 
diabetic participants (Tudor-Locke et at., 2002a). Furthermore, lower levels of daily physical activity at the 
weekend compared with during the week were evident in obese and morbidly obese participants only, and 
this too provides support to findings reported in a study of adults without diabetes (Cooper et at., 2000). 
This evidence suggests that obese individuals may choose to be less active than non-obese individuals in 
periods that are most likely to be free time. 
Compared with published data from normal-weight, overweight and obese adults employed in sedentary 
occupations (Cooper et al., 2000), physical activity volume and time spent in MVPA was substantially 
lower in participants with T2D. There were considerable differences in the overweight group on both week 
days ((T2D) 258.6 vs. (non-T2D) 389.9 CPM and 24.9 vs. 40.3 minutes of MVPA) and weekend days 
(257.6 vs. 400.2 CPM and 23.6 vs. 40.1 minutes of MVPA). Among obese participants, differences 
between those with T2D and those without the condition existed on weekdays only (242.1 vs. 279.1 CPM 
and 21.7 vs. 32.3 minutes of MVPA). Although these comparisons indicate that, even when matched for 
BMI, individuals with T2D are much less active than those who are otherwise healthy, it should be noted 
that , compared to the 
Early ACTID cohort, the participants in the non-diabetic study were younger (mean 
age 38.6 ± 9.3), and were all in employment. Furthermore, the obese group in the Cooper et al. study 
included just 12 individuals, and thus the comparisons highlighted here should be interpreted with caution. 
Age was found to explain 5% of the variance in mean CPM and MVPA, while BMI explained 4%. The 
strength of the inverse relationship found between accelerometer-determined activity and age (r=-. 28) and 
BMI (r=-. 20) in this study is consistent with reports from adults without diabetes (r=-. 30) (Cooper et al., 
2000; Harris, Owen, Victor et al., 2008; Hays and Clark, 1999; Plotnikoff et al., 2006; Tudor-Locke et al., 
2001). Although gender predicted time spent in MVPA, it was not a significant predictor of physical 
activity volume, which supports the findings in non-diabetic groups (Hagstromer et al., 2007). 
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Recoin, nended plgrsical acrrvihr levels 
Compared to self-reported data from the Health Survey for England (HSE) (Department of Health, 2007), 
the objectively measured physical activity levels were lower in the participants of this study. In the Health 
Survey for England, 35% of men and 24% of women reported achieving 30 minutes of activity on five or 
more days per week. In comparison, just 16% of men and 11% of women in the present study achieved this 
activity level. This finding is not surprising given that self-reported activity levels are often over estimated 
and that participants in the present study were from a clinical population with a condition associated with 
obesity and sedentary behaviour. However, an unexpected finding was that just 10% of men and 14% of 
women could be classified as sedentary due to accumulating less than 30 minutes of MVPA per week. This 
is much lower than the 33% of male respondents and 50% of female respondents in the HSE who reported 
doing less than 30 minutes per week. 
Based on self-reported physical activity levels, 71.9% of 1,614 Canadian adults with T2D were not 
achieving the recommended 150 minutes of physical activity per week (Plotnikoff et at., 2006). A younger 
age, male gender, higher education, higher income and lower BMI were associated with achieving the 
recommended level of physical activity. 
The study of accelerometer-determined physical activity patterns in normal-weight, overweight and obese 
individuals without diabetes using accelerometry reported that 2150 minutes of MVPA were accumulated 
per week by 81.9% and 58.3% of non-obese and obese participants, respectively (Cooper et al., 2000). 
When the accelerometer data from this present study were examined using similar criteria (accumulating 
2150 minutes of MVPA per week), 53.0%, 36.8% and 13.6% of normal/overweight, obese and morbidly 
obese achieved recommended activity levels, respectively. These proportions are substantially lower than 
those reported in non-diabetic groups. 
Pedometer ilafa 
This study found a moderately strong relationship between accelerometer counts and self-reported steps per 
day (r--. 57 at baseline and r=. 67 at six months, P<0.01), despite accelerometer and pedometer measurement 
periods taking place during different weeks. Even stronger associations (r=. 74, P<0.0001; r=. 78, P=0.02) 
have been reported previously (Sugden, Sniehotta, Donnan et al., 2008; Tudor-Locke et al., 2002a), 
although this is likely to be attributable to the accelerometer and pedometer measures taking place 
concurrently. In the study reported by Tudor-Locke and colleagues (2002a), which involved evaluating 
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agreement between ActiGraph accelerometer outputs and Yamax pedometer outputs assessed under free- 
living conditions in 52 participants, accumulating an average of 32.7 ± 14.4 minutes of moderate intensity 
activity per day equated to a mean of 8064 ± 766 steps per day. This is consistent with the findings from 
the present study, which found that participants accumulating an average of z30 minutes of MVPA per day 
reporting a mean of 8337 ± 1809 steps at baseline and 8671 ± 2338 steps per day at six months. 
The mean steps per day reported by participants in the diet plus exercise group at baseline (6445 ± 2502) 
were higher than the 4,194 steps per day reported by Bjorgaas and colleagues (2005), but were remarkably 
similar to the pedometer values previously reported from a similar group of adults with T2D (6662 f 3080) 
(Tudor-Locke et al., 2002a). These values are slightly lower in comparison to samples without reported 
diabetes (Tudor-Locke and Myers, 2001b), including a bi-ethnic sample of 109 adults with a mean age of 
44.9 ± 15.8 years (7370 ± 3080) (Tudor-Locke et al., 2001) and a study sub sample of 58 healthy adults, 
aged 22-82 (7781 f 2807) (McClung, Zahiri, Higa et al., 2000). The values for free-living individuals in 
this present study are, however, higher than those reported for hospital-based individuals with T2D prior to 
a pedometer-based intervention study (Yamanouchi, Shinozaki, Chikada et at., 1995). Interestingly, the 
intervention group in the hospital-based study reported accumulating an average of 19,200 steps daily over 
six to eight weeks, which is much higher than the increase found within the diet plus exercise participants 
in this present study. Nevertheless, the shorter intervention duration and the use of hospital in-patients in 
the study reported by Yamanouchi and colleagues means that comparisons should be interpreted 
cautiously. 
Compliance with keeping physical activity diaries was 86.3% over the initial six months of the physical 
activity intervention, which is 3% higher than the adherence to record keeping noted in the meta-analysis 
(Bravata et al., 2007). Additionally, the studies reporting diary use as part of the physical activity 
intervention included in the meta-analysis were shorter than the Early ACTID intervention, and thus these 
findings are particularly encouraging in terms of application, since the meta-analysis found that diary use 
was associated with increased physical activity. 
Change in physical aclivitr 
Although the diet plus exercise group registered a significant increase in daily physical activity over the 
six-month period compared to non-exercise participants (P<0.05), this change was modest (25.3 ± 79.7 
CPM and 5.07 ± 13.95 minutes of MVPA per day). Few diet plus exercise participants met the study goal 
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of performing an additional 150 minutes of MVPA throughout the week. Although there are relatively few 
studies reporting long-term effects of physical activity interventions in people with T2D, increased 
physical activity is notoriously difficult to maintain in the general population, but individuals with T2D 
report an even higher frequency of relapse (Krug et al., 1991). In a 12-month physical activity and dietary 
intervention involving repeated encouragement and follow-up using exercise records, Vanninen et al. 
(1992) reported no significant increase in physical activity or aerobic capacity in diabetic patients. Similar 
findings were reported by Uusitupa (1996). 
Conversely, Kirk et at (2003) observed a 28% increase in accelerometer-determined physical activity over 
six months in adults with T2D receiving physical activity counselling, while the control group experienced 
a 12% decrease in physical activity. However, in a subsequent publication reporting 12-month data for the 
same study, increases in physical activity were not maintained and differences between baseline and 12- 
months did not reach statistical significance. Despite this, controls experienced a significant decrease over 
12-months, resulting in the counselling group recording higher physical activity levels at both time points. 
Di Loreto (2003) also reported increased physical activity in 182 participants with T2D after two years of a 
physical activity counselling programme, compared to 158 control participants who had been referred to a 
diabetes outpatient diabetes centre. A seven-fold increase in self-reported physical activity was found 
among the intervention participants, which demonstrates the potential effectiveness of physical activity 
counselling in T2D. 
Cardiorespiratory fitness 
A low level of cardiorespiratory fitness observed in the participants of this study supports previous 
observations published by Regensteiner et al. (1995b) and Bjorgaas et al. (2005). This diminishment has 
been related to an impaired uptake of glucose into skeletal muscle blood flow (Regensteiner, Bauer and 
Reusch, 2005), an observation also noted in the first degree relatives of people with T2D (Thamer et al., 
2003). The mean VO2mRX value found in this present study (26.32 ml kg-min ) is only marginally higher 
than the mean baseline value reported in the meta-analysis examining the effect of an exercise programme 
on VO2i ax in people with T2D (22.4 ml kg-min") (Boule et al., 2003), despite the latter value resulting from 
maximal exercise testing procedures. Furthermore, the average duration of diabetes of those participants 
included in the meta-analysis was 4.1 years. During baseline measurements in this study, Early ACTID 
participants were between five and eight months post diagnosis. 
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Associations between physical activit),, cardiorespiratory+ fitness and metabolic and cardiovascular risk 
factors 
Cross-sectional analyses in this study showed that glycaemic control was not associated with either 
physical activity or cardiorespiratory fitness. This finding is inconsistent with recent reports from the Look 
AHEAD Study, a multicentre randomised trial to determine whether participation in a lifestyle weight loss 
intervention can reduce the risk of cardiovascular morbidity and mortality (Look Ahead Research Group, 
Wadden, West et al., 2006). Analyses of baseline data from 5,145 overweight or obese individuals (mean 
age 58.7 years) with T2D (mean duration 6.8 years) showed that CRF, determined through maximal 
testing, was more strongly associated with HbAI, than fatness (The Look Ahead Research Group, Wing, 
Jakicic et al., 2007). Relative to those in the most fit tertile, the adjusted odds ratio of having HbAI' >7% 
for those in the least fit group was 1.44 (95% Cl 1.25 to 1.67). Mean HbAI, in the Look AHEAD study 
population was 7.3 ± 1.2%. Significant differences in HbAIc . of 
0.23% and 0.29% were found in women 
and men, respectively, between the lowest and highest fitness quintile groups. Higher HbA1, values and a 
much larger study cohort could explain the difference in findings between Look AHEAD and this present 
study. 
Early ACTID participants with the metabolic syndrome had significantly lower levels of fitness compared 
to those without the syndrome (23.55 ± 7.86 vs. 28.95 ± 7.72 ml kg-mii 1). This finding is consistent with 
recent reports from the Look AHEAD Group (Ribisl et al., 2007) and data from an earlier cross-sectional 
study (Carroll et al., 2000). This present study found that low physical activity and low fitness were much 
stronger predictors of the metabolic syndrome in women than in men. Conversely, analyses of the US 
NHANES data from a relatively healthy group of US adults found that the odds of the metabolic syndrome 
were significantly lower in moderate and high CRF categories versus the low CRF category in men only. 
In women there were no significant relationships between CRF and the metabolic syndrome (Brien, 
Janssen and Katzmarzyk, 2007). 
Although physical activity was significantly associated with the metabolic syndrome, the relationship was 
attenuated and non-significant when fitness was also entered into the model. This attenuation has also been 
reported in children (Brage et al., 2004), but is inconsistent with both cross-sectional (Franks et al., 2004) 
and prospective data (Ekelund et al., 2005) reported from the Ely Study. The Ely study group found that 
physical activity energy expenditure predicted progression toward the metabolic syndrome in 605 middle- 
aged men and women over a period of 5.6 years, independent of aerobic fitness, obesity and other 
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confounding factors. Furthermore, the authors reported that VO2max was not an independent predictor of the 
metabolic syndrome after adjustment for physical activity. The interaction between physical activity and 
CRF on the clustering of metabolic risk factors, which has been reported previously (Brage et al., 2004; 
Franks et al., 2004), was not supported by data from this present study. 
5.2. Strengths and limitations of the study 
5.2.1. Strengths 
While many studies reporting physical activity levels in people with T2D have relied upon self-report 
methods, which tend only to identify leisure-time physical activity, this present study measured physical 
activity objectively using accelerometry. Accelerometers measure volume and intensity of all ambulatory 
activity, not just leisure-time activity. Compared to self-report methods, which are likely to reduce the 
strength of observed relationships between physical activity and health, using accelerometers offers a more 
precise measure of daily activity that is likely to enhance our understanding of associations with health. 
related outcomes. 
The majority of studies reporting objectively-measured physical activity in adults with T2D involve the use 
of pedometers (Bjergaas et al., 2005; Bjergaas, Vik, Stolen et al., 2008; Tudor-Locke, Bell, Myers et al., 
2003; Tudor-Locke et al., 2002a; Tudor-Locke et al., 2002b). While pedometers are able to provide more 
accurate data on habitual physical activity volume than questionnaires, they are not able to provide 
information on intensity or patterns of physical activity. Just two studies were identified that reported 
accelerometer data in a sample of adults with T2D (Kirk et al., 2004a; Kirk, Higgins, Hughes et al., 2001). 
To the author's knowledge, the present study is one of only a few to describe in detail accelerometer- 
determined habitual physical activity in adults with T2D. 
Compliance with the physical activity measurement protocol was high, with participants wearing the 
accelerometer for an average of almost 16 hours per day during the measurement period. High compliance 
was also reflected by the number of days that the ActiGraph was worn. Eighty-two percent of participants 
wore the monitor for at least ten hours per day on all seven days, as requested, and a further 13.4% wore 
the monitor on at least six days. Consequently, at least six days of valid measurement (210 hours per day) 
was obtained from 95% of participants. It is therefore reasonable to assume that the obtained data are 
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representative of participants' usual physical activity levels during that period of time. Furthermore, the 
high rate of compliance suggests that the use of accelerometers for the requested duration was acceptable 
to participants in the study. 
One of the major criticisms of epidemiological studies that have reported a stronger relationship between 
health outcomes and fitness compared to physical activity is that fitness is usually measured objectively, 
while physical activity assessment is often based on self-reported methods, which are imprecise and subject 
to error. A unique aspect of this study was the objective assessment of both cardiorespiratory fitness and 
physical activity. A comparison of their relationships with important health outcomes in type 2 diabetes has 
not been reported before. 
5.2.2. Limitations 
Study design 
The cross-sectional nature of these analyses limits the ability to make causal conclusions. Physical activity 
and cardiorespiratory fitness can be both outcomes and determinants of health, and relationships between 
exposures and outcomes cannot be causally linked without longitudinal data. Data from good quality 
intervention studies are required to obtain a greater understanding of the relationships between physical 
activity, cardiorespiratory fitness and health-related outcomes in T2D. 
Study population 
The study sample was comprised of individuals who had volunteered to participate in 1-year diet plus 
exercise intervention that involved up to 19 visits. While volunteers where made aware that they may not 
be randomised to the diet plus exercise group, this sample is likely to represent a group of adults who were 
particularly motivated to diet and exercise compared to the general population of men and women with 
recently diagnosed T2D. It is not known whether individuals who did not participate differ from the sample 
studied; caution should therefore be used when generalising these findings to the wider population. 
Approximately 95% of the study population were white, and the majority were well educated and of 
middle to upper socioeconomic status. The homogeneity of our study sample on socioeconomic 
characteristics may be considered a strength of the study since it reduces the likelihood of confounding by 
these variables. However, whether the findings apply to members of other ethnic groups or persons of low 
socioeconomic status remains unknown. 
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Physical activity measurement 
Although the use of accelerometers allowed the assessment of daily physical activity volume and intensity, 
they are not able to measure all activities. Non-weight bearing activity, such as cycling, and walking at a 
pace under 1 mph are not measured well. Furthermore, participants were asked to remove the monitors 
when in contact with water and so water-based activities would not have recorded for participants 
performing these. This may have led to some participants' activity levels being underestimated. While this 
is a potential limitation, the ActiGraph diaries suggest that non-weight bearing activities occurred relatively 
infrequently, which is consistent with previously published literature (American College of Sports 
Medicine, 2000; Institute of European Food Studies, 1999). 
Accelerometer data were examined to determine the proportion of participants engaging in recommended 
levels of physical activity. The Microsoft Excel macro used to reduce the raw ActiGraph data files summed 
the number of individual minutes of MVPA activity accumulated per day by each participant. The summed 
number of minutes spent in MVPA made it possible to calculate the number of participants accumulating at 
least 30 individual minutes of MVPA on at least five days per week, or at least 150 individual minutes per 
week. Since guidelines actually stipulate that the 30 minutes of moderate-intensity activity should be 
accumulated in bouts of at least ten consecutive minutes, the numbers reported here are likely to over 
estimate the number engaging in levels of activity that meet current recommendations. More sophisticated 
macros have since been developed, thus it would be possible to re-examine these data in future. 
While collecting both accelerometer and pedometer data in a subgroup of the Early ACTID cohort could be 
considered a strength of this study, the accelerometer and pedometer data were not collected during the 
same time period. The reported association between the two measures is therefore likely to be weaker than 
if they had been obtained simultaneously. Although pedometer data were not collected for the purpose of 
examining associations with health-related outcomes, it may have been useful to ask all participants to 
wear a pedometer and record daily steps during the ActiGraph measurement period at baseline and six 
months. This would have allowed a more accurate assessment of the association between the two measures, 
and may also have allowed the association between reported pedometer data and health-related outcomes 
to be examined. In terms of interpreting the association between physical activity volume and health. 
related outcomes, pedometer data are perhaps more meaningful to health professionals than accelerometer 
counts per minute and thus may have greater potential in terms of clinical application in T2D management. 
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Cardiorespiratorr fitness measurement 
Although maximal assessment of cardiorespiratory fitness is more precise, submaximal methods were 
selected for this study since they were considered to be more safe and feasible for adults with M. While 
the Rockport 1-mile track walk was chosen to ensure a measure of fitness was obtained for all participants, 
only 70% of participants had fitness data that met the parameters of the V02m,,, regression equation.. The 
main reason was beta blocker medication use, which was highly prevalent in the study cohort. 
Furthermore, 12.6% of participants were unable to complete the 1-mile walk in less than 20 minutes, which 
is the cut-off for appropriate use of the regression equations to predict V02m,, based on a healthy 
population. Compared to participants completing the distance within the required time, those unable to do 
so had higher BMIs, were older and less active. Musculoskeletal discomfort was the most common reason 
cited by participants who were unable to complete the 1-mile distance. The prevalence of musculoskeletal 
disorders is known to increase with both BMI and age (Department of Health, 2002; Wearing, Hennig, 
Byrne et al., 2006). Almost 60% of participants were obese and only 20% were under the age of 50 years. 
Some participants found it hard to judge the appropriate walk speed that could be maintained for the 1-mile 
distance. This led to some participants walking slower than required, and some rushing in the first few laps 
leaving themselves unable to maintain the speed or having to stop prematurely. Regensteiner and 
colleagues (1995b) have previously found that, compared to women without T2D, those with the condition 
have a reduced maximal walking time. Slow walking paces in this study group could have led to the 
underestimation of VO2max, which could prevent true relationships between CRF and outcome variables 
from being observed. 
While maximal tests have been used successfully in men with T2D previously (Wei et al., 2000), 
participants were younger than those in the Early ACTID cohort. Furthermore, since it was not possible to 
obtain a valid predicted VO2max value for 30% of participants using submaximal methods, it is likely that 
maximal testing procedures would have been inappropriate for an even greater proportion of the study 
population. 
health-related outcomes 
Participants of this study had relatively well-controlled HbA, c values, which could have reduced the ability 
to detect associations with different exposures. Furthermore, only 30% of participants were not prescribed 
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any medication. The prevalence of medication use could have obscured relationships between exposure 
and outcome variables. 
Due to the high number of missing waist circumference values for this study population, BMI was used as 
a surrogate measure for central obesity. Although the IDF criteria state that central obesity can be assumed 
if a BMI is >30kg/m2, waist circumference may have been a more sensitive measure in this population, 
which could have resulted in different individuals being classified with the metabolic syndrome. This could 
have influenced the observed associations between physical activity, cardiorespiratory fitness and the 
metabolic syndrome. Furthermore, the use of BMI as a component of the metabolic syndrome criteria 
means that one must be cautious when interpreting the association between the metabolic syndrome and 
predicted VO2,,, ex, since weight is also used in the VO2m, x estimation regression equation. It 
is thus possible 
that the strength of the association was, in part, attributable to some degree of collinearity. 
Confounding factors 
Confounding factors are particularly difficult to control in studies of free-living populations. While data 
were collected on diet, ethnicity, occupation, specific medications, smoking status, family medical history 
and additional health-related outcomes, such as inflammatory markers and proteinuria, these were not fully 
accessible at the time of analysing the data presented within this thesis. As such, associations between 
exposures and outcomes were not adjusted for the full range of confounders that have been cited in 
previously published literature. Consequently, the strength of the presented associations may have been 
different had all potential confounders been included in the regression models. 
Since obesity is an essential component of the metabolic syndrome classification, it was not possible to 
control for BMI when examining the relationship between the metabolic syndrome and various exposures. 
BMI was found to be strongly associated with both physical activity and, of course, predicted VO2max. lt is 
therefore possible that the inverse association between physical activity, CRF and the metabolic syndrome 
was mediated through BMI. This could be considered a major flaw of these analyses; although it should be 
noted that previous studies that have been able to control for obesity in their analyses found that excluding 
obesity from the outcome and adjusting for it as an exposure did not significantly change the observed 
associations (Ekelund et al., 2005). 
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5.3. Implications of findings 
5.3.1. Assessment of physical activity 
The lack of clarity in physical activity epidemiology hinders the development of appropriate public health 
interventions. Objective assessment of habitual physical activity using accelerometry appears to be feasible 
and acceptable in adults with newly diagnosed T2D, and offers researchers the opportunity to more clearly 
define the relationship between physical activity and health-related outcomes in this population. 
The low levels of objectively-measured physical activity found in participants of the Early ACTID cohort 
suggest that people with recently diagnosed T2D are a particularly inactive population group. Since 
participants had volunteered to participate in a long-term lifestyle intervention, it is reasonable to assume 
that physical activity levels in the wider population of adults with T2D will be even lower. Potentially, 
adults with T2D stand to benefit significantly in terms of health-related outcomes if they are to increase 
their activity to moderate levels. Evidence suggests that the greatest improvement in health occurs when 
the least active become moderately active (Haskell, 1994). 
Although increases in physical activity among participants randomised to the diet plus exercise group were 
statistically significant over the six-month period (CPM 11%, time in MVPA 25%), the magnitude of 
change is relatively small. In light of the fact that participants received ongoing, one-to-one sessions with 
the study nurse that were based on behaviour change principles, the level of change emphasises the 
challenge facing health professionals who are responsible for facilitating physical activity adoption and 
maintenance in people with T2D. 
5.3.2. Use of pedometers and diaries 
The relatively high rate of compliance with recording self-monitored daily pedometer steps over a six- 
month period indicates that this is acceptable to people with recently diagnosed T2D who are attempting to 
increase physical activity levels. Furthermore, the fairly strong correlation between reported steps and 
accelerometer counts per minute suggests that pedometry may be a reasonably reliable method of 
determining overall physical activity volume in this population when the use of accelerometry is not 
possible. Thus, pedometers may offer large scale epidemiological studies a more accurate method of 
assessing physical activity volume compared with questionnaire-based methods and may also offer a more 
economical alternative to accelerometers where the intensity of activity is not required. Additionally, health 
127 
Chapter 5: Discussion 
professionals could potentially use pedometers to gauge how active their patients are prior to and during 
physical activity counselling, thereby monitoring activity patterns, or adherence to goals, in populations 
where walking appears to be the most popular and acceptable form of activity. 
The comparison of accelerometer and pedometer data in this study showed that participants accumulating 
at least 30 individual minutes of MVPA per day reported a mean daily total of just over 8000 steps, which 
is consistent with reports based on data from non-diabetic populations (Tudor-Locke et al., 2008). Previous 
literature has shown that step targets appear to be acceptable, and are perhaps more easily monitored by 
both patients and health professionals than time spent in moderate-intensity activity. Furthermore, step 
targets may be more effective than time targets for increasing activity. Indeed, a short-term intervention 
study showed that a target of 10000 steps per day elicited greater increases in activity compared to a target 
of 30 minutes per day (Hultquist, Albright and Thompson, 2005). 
Step targets may also reduce the risk of compensatory physical activity behaviour. This type of behaviour 
can occur when individuals increase their time spent in moderate to vigorous physical activity, but reduce 
incidental activity throughout the day. This results in only small increases in overall physical activity 
volume. Some compensatory behaviour was evident in the diet plus exercise group of this study. While 
time spent in MVPA increased by 25% over the six-month period, accelerometer counts per minute 
increased by just 11%. This discrepancy highlights the need to emphasise the importance of ensuring that 
increased time spent in moderate-intensity activity is accompanied by similar increases in overall physical 
activity volume. 
5.3.3. Cardioresplratoryfitness 
The mean VO2max found in this present study is not intended to be representative of all people with T2D, 
since the values reported are based on people volunteering for a diet plus exercise intervention. Thus, while 
CRF was low in the Early ACTID cohort compared to levels reported from healthy populations, it is likely 
that the exercise capacity in a representative sample of people with T2D would be even lower. Although it 
is acknowledged in the literature that people with T2D may have a genetic predisposition to low CRF, 
physical activity was found to be moderately associated with VO2max. prcd within participants, suggesting that 
physical activity levels do have some influence in this population. 
Interestingly, the relationship between VO2m. x. pred and physical activity volume (CPM) was slightly 
stronger than the relationship with time spent in MVPA. While it is an encouraging finding, since high- 
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intensity exercise may be unsuitable or not acceptable to many individuals with T2D, it would be 
inappropriate to infer from these data that volume is more important that intensity, since this finding is 
likely to be attributable to a greater spread of data for CPM than MVPA, which enhances the ability to 
detect associations. 
5.3.4. Relationship between physical activity, cardiorespiratoryfitness and health-related outcomes in 
type 2 diabetes 
The finding that HbA,, was not associated with either physical activity or CRF is inconsistent with 
previous research and these relationships require further investigation for the purpose of translation into 
policy and practice recommendations. The present study found that low levels of physical activity and CRF 
were independently predictive of the metabolic syndrome. The crude odds ratios reported in this thesis 
suggest that the difference in odds of the metabolic syndrome between quartiles of activity volume and 
time spent in MVPA is greatest between the least active and next active group. This provides support to 
suggestions that the greatest potential gain in public health could be achieved by those who are least active 
becoming moderately active. 
The apparent protective effect of physical activity and CRF appears to be much greater in women. Women 
feature less often than men in studies examining relationships between physical activity, fitness and health- 
related outcomes, and it is suggested that gender differences are examined in future studies as findings may 
prove useful in planning, targeting and evaluating interventions. 
In light of the findings reported in this thesis, and also the increasing body of evidence showing that higher 
levels of physical activity and CRF are associated with a lower risk of mortality in people with T2D, it is 
felt that physical activity should be strongly promoted in diabetes care. Indeed there is no evidence to 
suggest that physical activity could be harmful in diabetes management, and thus, it should also be 
promoted as an adjunct to pharmacological treatment. 
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5.4. Conclusions and recommendations for future research and practice 
To the author's knowledge, this is one of the few studies to describe in detail objectively-measured habitual 
physical activity in adults with T2D. Furthermore, it is the first study to investigate the relative importance 
of objectively measured physical activity and cardiorespiratory fitness in relation to metabolic and 
physiological outcomes in type 2 diabetes. 
The excellent compliance with accelerometers demonstrated in this study highlights the feasibility for 
assessing habitual physical activity objectively in this population, and thus it should be utilised more 
extensively in the future. Despite this study group consisting of adults volunteering for a diet and exercise 
intervention, objectively measured physical activity levels were well below the recommended 30 minutes 
of moderate-intensity activity on most days of the week. This emphasises the need to increase physical 
activity in people with T2D and in particular those who are obese. 
The magnitude of increased physical activity observed among participants in the diet plus exercise group 
over a six-month period is relatively small. The discrepancy between increases in time spent in MVPA and 
overall volume of activity among these participants suggests that compensatory behaviour may have taken 
place. More focus on strategies for facilitating and promoting the adoption of physical activity, without 
compensatory behaviour, and optimising maintenance of increased activity in people with 72D should be 
prioritised in future research. 
Cardiorespiratory fitness (CRF) levels were also very low in this study population. A moderate association 
was found between physical activity and CRF, whereby the most active tended to have higher levels of 
fitness compared to the least active. Interestingly, CRF was more strongly related to physical activity 
volume than time spent in moderate to vigorous physical activity, although this may be a function of the 
differences in the spread of data between the two activity dimensions, rather than a reflection of the true 
associations. A further finding was that physical activity appeared to explain a much greater proportion of 
the variance in CRF in women than men. 
Although this study found no evidence that glycaemic control was associated with either physical activity 
or CRF, both were predictors of the metabolic syndrome, defined according to IDF criteria. These 
predictors were stronger in women than in men. When physical activity and CRF were compared, CRF was 
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a stronger predictor. The apparent stronger association between the metabolic syndrome and physical 
activity and fitness in women than in men is interesting and justifies further exploration. 
While this study does not prove a causal pathway between physical activity, fitness and the metabolic 
syndrome in T2D, these data suggest that people with recently-diagnosed diabetes, and in particular 
women, may benefit from regular physical activity and higher levels of fitness. In contrast to previous 
research, the lack of an association between glycaemic control and habitual physical activity or CRF found 
in this study highlights the need for larger studies to assess these relationships more fully. 
Randomised controlled trials are recommended for determining the relative importance of physical activity 
and CRF in the aetiology of T2D and whether modifiable factors, such as CRF, influence the magnitude of 
response in metabolic and physiological outcomes to increased exercise in this clinical population. 
Understanding these relationships more fully would inform future interventions. 
The high compliance with using pedometers and recording self-monitored physical activity over a six- 
month period indicates that these are acceptable to people with recently diagnosed T2D who are attempting 
to change physical activity behaviour. Furthermore, the fairly strong correlation between reported steps and 
accelerometer counts per minute suggests that pedometry may be a reasonably reliable method of 
determining overall physical activity volume in this population. Participants accumulating 30 minutes of at 
least moderate-intensity activity reported accumulating just over 8000 steps per day. This is consistent with 
previous reports in people with T2D and thus may have useful applications in clinical practice. 
Studies using valid and reliable objective measures of physical activity are becoming more widespread, but 
they appear to be underused in people with diabetes. This study opens the door for future research to 
further explore the relationships between objectively-determined physical activity, CRF and health-related 
outcomes in type 2 diabetes. Accurate quantification of exposures and outcomes enables true relationships 
to be assessed. Identification of these relationships is essential for the development of policy and practice 
recommendations relating to the use of physical activity in the management of diabetes. 
The findings outlined in this thesis can be translated into a number of recommendations for practice which 
are highlighted below. 
0 Pedometers and self-reported steps correlate well with accelerometers and offer a reasonable 
assessment of a patient's overall physical activity volume. 
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0 Pedometers and diaries appear to be acceptable to patients with type 2 diabetes and may 
be a 
useful means of facilitating physical activity adoption and maintenance. 
" Negotiating step goals with patients rather than time-based goals, e. g. 3000 extra steps vs. 30 extra 
minutes, may lower the risk of compensatory behaviour, whereby an increase in structured 
activity can sometimes be accompanied by a reduction in overall physical activity volume. 
" Recommending a walking pace of 1000 steps per 10 minutes is reasonable for people with type 2 
diabetes and offers a useful indication of `brisk' walking for this population. Patients in the 
present study reported that this was a useful message. 
0 Adults with type 2 diabetes accumulating <8000 steps/day are unlikely to be meeting the 
recommended 30 minutes of moderate-intensity activity. Thus, patients should be encouraged to 
accumulate >8000 steps on most days. 
" Physical activity levels decline with each increasing BMI category and morbidly obese patients 
are likely to be the most sedentary. Differences in physical activity levels between BMI groups are 
greatest at the weekend. This may be a useful time for patients to consider increasing their 
physical activity. 
0 The present study found that physical activity volume was associated with cardiorespiratory 
fitness. Both of these were independently associated the metabolic syndrome. It may be useful, 
therefore, to emphasise the importance of increasing the volume of physical activity in patients 
with type 2 diabetes before focusing on intensity. 
" The greatest reduction in risk of the metabolic syndrome was apparent between the two lowest 
physical activity and fitness quartile groups. A further reduction in risk was seen with each 
increasing quartile group. Accordingly, the greatest public health benefit may occur when the 
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Appendix 1. List of abbreviations and acronyms 
%HR,,,, X Percentage of predicted maximum 
heart rate 
1-MTW 1-mile track walk submaximal fitness test 
ACLS Aerobics Center Longitudinal Study 
BMI Body mass index 
CI Confidence interval 
CRF Cardiorespiratory fitness 
CT Controlled trial 
DPP Diabetes Prevention Program 
Early ACTID Early Activity In Diabetes 
FPG Fasting plasma Glucose 
HbA, c Glycated haemoglobin 
HDL cholesterol High-density lipoprotein cholesterol 
HR Heart rate 
IFG Impaired fasting glucose (pre-diabetic condition) 
IGT Impaired glucose tolerance (pre-diabetic condition) 
LDL cholesterol Low-density lipoprotein cholesterol 
MET Metabolic equivalent 
MVPA Moderate to vigorous physical activity 
NICE National Institute of Health and Clinical Excellence 
NIDDM Non-insulin dependent diabetes mellitus 
NS Non-significant 
OGTT Oral glucose tolerance test 
OR Odds Ratio 
PA Physical activity 
PAEE Physical activity energy expenditure 
PRF Participant-held record file 
RCT Randomised controlled trial 
RPE Rating of perceived exertion 
RPG Random plasma glucose 
RR Relative risk 
SOP Standard operating procedure 
SD Standard deviation 
SPSS Statistical Package for Social Science 
T2DM Type 2 diabetes mellitus 
TEE Daily total energy expenditure 
TC Total cholesterol 
TG Triglycerides 
UKPDS UK Prospective Diabetes Study 
VO2max Maximal oxygen uptake 
VO2max. pad Predicted maximal oxygen uptake 
WHO World Health Organization 
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Appendix 2. Co-investigators of the Early ACTID Study 
Name Title 
Dr Rob Andrews Trial Principal Investigator; Consultant senior lecturer in Exercise, Diabetes 
and Endocrinology 
Dr Ashley Cooper Head of Department, Exercise, Nutrition and Health Sciences; Senior Lecturer 
in Exercise, Nutrition and Health Sciences 
Dr Alan Montgomery Senior Lecturer in Primary Care Research 
Professor Tim Peters Professor of Primary Care Health Services Research 
Professor Debbie Sharp Professor of Primary Health Care 
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Appendix 4. Literature search terms and strategy 
ELECTRONIC SEARCH TERMS 
Type 2 diabetes mellitus 
1. type 2 diabetes. tw. 
2. type II diabetes. tw. 
3. Adult onset diabetes. tw. 
4. niddm. tw. 
5. non-insulin dependent diabetes. tw. 
6. metabolic syndrome. tw. 
7. syndrome x. tw. 
8.1 or2or3or4or5or6or7 
Physical activity 
9. physical activity. tw 
10. exercise. tw. 
11. training. tw. 
12. walking. tw 
13. cycling. tw. 
14. aerobic. tw. 
15. pedomet$ 
16.9 or 10 or 11 or 12 or 13 or 14 or 15 
Cardiorespiratory fitness 
17. fitness. tw. 
18. aerobic capacity. tw. 
19. exercise capacity. tw. 
20. V025. tw. 
21.17 or 18 or 19 or 20 
Behaviour change 
22. adopti$. tw 
23. initiat$. tw. 
24. behaviour. tw. 
25. behavior. tw 
26. promot$. tw 
27. barrier$. tw 
28. motivate$. tw 
29. chang$. tw 
30. counsel$. tw 
31. consult$. tw 
32.22 or 23 or 24 or 25 or 27 or 27 or 28 or 29 or 30 or 31 
COMBINED SEARCHES 
'Type 2 diabetes mellitus' AND 'physical activity' 
33.8 and 16 
'Type 2 diabetes mellitus' AND 'cardiorespiratory fitness' 
34.8 and 21 
`Type 2 diabetes mellitus' AND `physical activity' AND `cardiorespiratory fitness' 
35.8 and 16 and 21 
`Physical activity' AND 'behaviour change' 
36.16 and 32 
tw., text word; $, any character(s) 
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Appendix 5. List of materials developed by the researcher for the participant-held record file (PRF) 
VISIT SECTION INSERT UC DD+E 
3 INFORMATION SECTION DIVIDER & CONTENTS    
3 Personal SUB-SECTION FRONT PAGE    
3 Welcome & contact details    
3 Medication    
3 Early ACTID goals    
4 Introducing your Early ACTID group: Control  
4 Introducing your Early ACTID group: Healthy Eating -  
4 Introducing your Early ACTID group: Healthy Eating and Physical Activity - -  
4 Early ACTID group goals: Healthy eating -  . 
4 Early ACTID group goals: Healthy Eating and Physical Activity - -  
5 Working together as a team -   
3 Appointments SUB-SECTION FRONT PAGE    
4 Appointments: Control  . 
4 Appointments: Intervention groups   
4 Appointment overview (Control)  - - 
4 Appointment overview (Diet only)  . 
4 Appointment overview: (Diet + exercise)  
3 Glossary SUB-SECTION FRONT PAGE    
3 Glossary of terms    
3/5 HEALTHY EATING SECTION DIVIDER AND CONTENTS    
3 Keeping track SUB-SECTION FRONT PAGE    
3 Recording your food intake with a diary    
3 Food diary: Sample   
5 Recording your weight   
5 Recording your weight on a graph -   
3 Diary SUB-SECTION FRONT PAGE    
3 Diary: Intervention    
3 Food and food associations    
3 Goals and plans SUB-SECTION FRONT PAGE    
4 Goal setting _   
4+ Weight loss goals & Areas to focus on - agreed with your dietitian   
5+ Healthy eating goals & Successes/difficulties   
3 Information sheets SUB-SECTION FRONT PAGE    
4 Introduction to healthy eating principles (Control)  . 
4 Introduction to healthy eating principles (Diet only; Diet + exercise)   
4 Introduction weight control/loss & Key points   
5 Reviewing your food diary & Changing eating behaviours   
5 Setting goals   
6 Healthy eating part 11   
7 Triggers and cues for eating & Key points   
8 Relapses   
8 Difficult situations & Key points -   
9 Portion sizes   
9 Food labels & Key points   
10 Eating habits & Key points   
13 Preparing and cooking food   
13 Holidays, eating out and special occasions & Setting goals & key points -   
14 Alcohol & Key points   
15 Recap of healthy eating & weight control   
16 Eating on the go - Healthier snacking & Key points   
19 Sources of information 
-   UC, usual care; D, diet only, D+E, Diet plus exercise. 
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VISIT SECTION INSERT UC DD+E 
5 PHYSICAL ACTIVITY SECTION DIVIDER & CONTENTS -- 
5 Keeping track SUB-SECTION FRONT PAGE -- 
5 Pedometers -- 
5 Recording your physical activity with a diary -- 
5 Physical activity diary: Sample -- 
5 Recording your physical activity on a graph -- 
5 Diary SUB-SECTION FRONT PAGE -- 
5 Diary -- 
5 Goals and plans SUB-SECTION FRONT PAGE -- 
6 Setting physical activity goals -- 
6 Other brisk activities  
5+ Physical activity goals -- 
5+ Physical activity plan -- 
5 Information sheets SUB-SECTION FRONT PAGE -- 
5 Trouble shooting your pedometer -- 
6 Facts about walking -- 
6 Staying safe: Foot care -- 
6 Staying safe: Prevention and Illness -- 
6 Staying safe: Hypos - 
6 Staying safe: Stretching -- 
5 Gaining confidence SUB-SECTION FRONT PAGE -- 
6 Physical activity history - 
6 Benefits of physical activity and Pros & Cons -- 
7 Lifestyle activity -- 
7 Opportunities to be active -- 
8 Preventing relapses - 
7+ Barriers to physical activity' -- 
7+ Personal time diary' - 
7+ People to help you achieve your goals' -- 
7+ Local exercise opportunities' - 
3 PROGRESS REPORTS SECTION DIVIDER & CONTENTS    
3 General health record    
5 Weight chart   
5 Weight graph   
5+ Physical activity graph  
17/19 Reviewing your progress & planning ahead    
3 PERSONAL NOTES SECTION DIVIDER & CONTENTS    
3 Personal notes    
UC, usual care; D, diet only, D+F. Diet plus exercise; * Optional materials used to address perceived barriers to physical activity 
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Welcome to the Early ACTID study. This is your personal diabetes record 
file, which has been developed to support you in managing your diabetes, 
with the help of your Early ACTID nurse, dietitian and doctor. 
At each visit with the nurse and dietitian, you will be given handouts to 
keep in this file. Some of the handouts contain information only, whilst 
others may involve short tasks. Your nurse and dietitian will assist with 
these tasks, which have been designed to help you review your progress, 
and think about how best to manage your diabetes. 
As part of your programme, you will be asked to keep records of your 
eating habits and activity levels. It is important that you complete these 
honestly, so that we can help you as best as possible. 
Please complete all the relevant details, or ask the nurse to do so for you. 
This record file is an important part of your Early ACTIb 
programme. 
PLEASE BRING IT TO ALL YOUR APPOINTMENTS WITH 
THE NURSE AND DIETITIAN. 
I. 1 Continued over/onf 
io 
Contact details 1.111 
Your name : 
Early ACTID ID number: 
GP name : 
Address: 
Telephone number: 




Early ACTIb dietitian: 
Telephone number: 
Early ACTID doctor: 
I. 2 
Medication 
I: AItl. l 
W("1'11) 







Early ACTID goals I: ýIZ1.1 
Your Early ACTIb goals will be to: 
1. eat healthily, 
2. take regular exercise, 
3. take any medication that is prescribed for you, and 
4. attend all of your appointments. 




V3G 1.5 Continued overleaf 
I. 6 
Introducing your Early ACTIO group 
Jam. '...:.. ýc: _.. ý.. ý.. ý_. W. _s ?ýyý -", r, ,: ý. ; . 
ý; _ 
The healthy eating and physical activity group 
You have been randomised to the HEALTHY EATING AND PHYSICAL 
ACTIVITY GROUP, which is one of three groups in the Early ACTID study. 
In this group, the focus is on making healthy food choices and increasing 
daily physical activity to try and manage your diabetes and prevent 
complications. 
In this programme, we will help you: 
" change your eating habits and physical activity levels for the long term, 
0 improve your diabetes control, 
" improve your general health, 
0 achieve worthwhile weight loss, and 
0 maintain the weight loss. 
During this programme you will see the following diabetes specialists: 
"A doctor, who will take a medical history, examine you, and look after 
your medication. 
"A dietitian, who will give you advice about healthy eating. 
"A nurse, who will take your measurements, discuss your diabetes 
treatment and support you in making healthy changes to your eating 
patterns and level of physical activity. 
In total, you will see us on 19 occasions. 
V4DE 1.7 Continued overleaf 
Introducing your Early ACTIO group continued \K1.1 
\(Tll 
Making lifestyle changes to help control your diabetes and your weight can 
be difficult. Lifestyle habits are formed over many years and changing 
these for good takes a lot of effort. 
What will you learn? 
This programme emphasises the need to make long-term changes to your 
eating habits and physical activity patterns. The information provided 
during your appointments will be tailored to your individual needs, but is 
likely to include: 
Healthy Eating Physical activity 
" Healthy eating principles and " The benefits of physical activity 
the benefits for diabetes for health 
" Why weight control is " How to monitor and record your 
important for health physical activity 
" How to read food labels " How to create opportunities to 
0 Shopping and cooking tips 
be active 
How to overcome your personal " 
How to overcome your personal 
barriers to healthy eating 
barriers to physical activity 
How to prevent relapses " How to prevent relapses 
Your success with this programme will depend on how committed you are, 
and how much you want to change and take control of your health. 
1.8 Continued overleaf 
A. 
Healthy eating & physical activity group goals 
Your specific long-term HEALTHY EATING goals will be to: 
1. Understand what healthy eating is and the benefits for diabetes. 
2. Understand what factors contribute to overweight and obesity. 
3. Adopt a healthy approach towards food and eating. 
4. Lose 5-10% of your starting body weight within the first 6 months. 
5. Maintain this weight loss for the second 6 months. 
Your healthy eating goals are NOT to: 
1. Make drastic dietary changes. 
2. Achieve an unrealistic "ideal weight" 
3. Lose weight for short term goals such as a special occasion. 
Your specific long-term PHYSICAL ACTIVITY goal will be to: 
1. Do 30 minutes of brisk walking (or an appropriate alternative) on 
five days of the week, OVER AND ABOVE what you were doing when 
you entered the study. This amounts to an EXTRA 22 hours each week. 
V4DE 1.9 Continued overleaf 
Healthy eating and physical activity goals continued 
Your long-term goals are safe and realistic, and can be achieved by makinc 
gradual changes to your eating habits. Reaching these goals can help you: 
control your diabetes, and may reduce the need for medication; 
reduce your risk of complications in the future; 
control your weight; 
lower blood pressure and improve cholesterol; 
feel better and more healthy in general. 
We will help you reach your goals 
I. 10 
Working together as a team 
Your nurse will: 
Q Answer your questions 
Q Look at your keeping track records during your appointments 
Q Acknowledge what you are doing well and identify difficulties 
Q Support and help you reach your goals 
Q Be honest and realistic 
Q Other 
Q Other 
V5DDE I. 11 Continued overleaf 
Working together as a team continued 
Your nurse will ask you to: 
Q Come to appointments and bring your record file 
Q Call in advance if you are going to miss an appointment 
Q Do your best to reach your goals 
Q Keep track 
Q Let them know if you have any problems 
Q Be honest and realistic 
Q Other 
Q Other 
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I. 14 
Appointment overview 
During the course of this programme, you will be learning about different 
aspects of diabetes, diet, physical activity and lifestyle change. At each 
visit, you will be introduced to new topics, and you will receive new handouts 
to keep in your file. At the end of each visit, you will set yourself new 
short-term goals for the following weeks until your next appointment. 
At each session, there will be time for you to ask any questions that you 
may have. If you have any concerns between your visits, you may contact 
the nurse for advice. 
The table overleaf outlines the focus of each appointment during the study. 
1 
"" . ý. sr 
. wý , 
ý: <:.. . 




Appointment overview I: tRI 
Wks Visit Appointment Focus 
-6 1 Nurse " Consent and screening 
-4 2 Fitness " Baseline fitness assessment 
" ActiGraph monitor, diary and questionnaires 
-2 3 Nurse " Consent and baseline measurements 
" Record file 







" Baseline review 
" Randomisation 
" Overview of intervention 
" Healthy eating and diabetes (part 1) 
" Introduction to weight loss and control 
" Areas to focus on and weight loss targets 
" Changing eating behaviours 
" Setting realistic goals 
" Keeping track of your weight 
" Food diary 
" Keeping track of your physical activity 
" Healthy eating (part 2: Carbohydrate and 
fats) 
" 
" Setting physical activity goals 
" Your physical activity history 
" Benefits of physical activity 
" Identifying and dealing with triggers/cues 
for eating 
" Lifestyle physical activity 
1.16 Continued overleaf A 
Appointment overview EARIA 
Wks Visit Appointment Focus 
88 Nurse " Relapses and coping with difficult situations 
" Food diary 
" Relapses and coping with difficult situations 
14 9 Dietitian " Portion sizes 
" Understanding food labels 
Nurse " 
" Overcoming barriers to physical activity 
20 10 Nurse " Eating and shopping habits 
26 11 Fitness 
28 12 Nurse 
" Maintaining change 
" 6-month fitness assessment 
" ActiGraph monitor, diary and questionnaires 
" 6-month measurements 
" Food and sleep diaries 
32 13 Doctor " 6-month review 
Dietitian " Preparing and cooking food 
" Holidays 
" Eating out and special occasions 
Nurse 
38 14 Nurse 
" 
" Maintaining change 
" Alcohol 
" Food diary 
" Maintaining change 
42 15 Dietitian 
Nurse 
" Review healthy eating and weight control 
" Maintaining change 
ME 1.17 Continued overleaf 
b 
Appointment overview 
Wks Visit Appointment Focus 
EtItI: 
46 16 Nurse " Healthy eating on the go 
" Maintaining change 
52 17 Fitness " 12-month fitness assessment 
" ActiGraph monitor, diary and questionnaires 
54 18 Nurse " 12-month measurements 
" Food and sleep diaries 
" Maintaining change 
58 19 Doctor " 12-month review 
" Discharge plan 
Dietitian " Maintaining dietary change and weight 
control 






Glossary of terms 
EARIA WHD 
Here are some words that you may come across when reading about 
diabetes. This is for your information only, and it is not necessary to 
know what all the words mean. 
A 
V 14W l"1y Continued overleaf 
Acute - describes something that happens suddenly and for a short time. 
Opposite of chronic. ' 
Adipocytes - fat cells. 2 
Albumin: Creatinine - this ratio is a useful measure of renal function and is 
measured using an early morning urine sample. 
Albuminuria -a condition in which the urine has more than normal amounts of a 
protein called albumin. Albuminuria may be a sign of nephropathy (Kidney 
disease). ' 
Alpha cells -a type of cell in the pancreas. Alpha cells make and release a 
hormone called g/ucogon. The body sends a signal to the alpha cells to make 
glucagon when blood glucose falls too low. Then glucagon reaches the liver 
where it tells it to release glucose into the blood for energy. ' 
Alpha-glucosidase inhibitor -a class of oral medicine for type 2 diabetes that 
blocks enzymes that digest starches in food. The result is a slower and lower 
rise in blood glucose throughout the day, especially right after meals. (Generic 
names: acarbose and miglitol. )' 
Antibodies - proteins made by the body to protect itself from "foreign" 
substances such as bacteria or viruses. People get type 1 diabetes when their 
bodies make antibodies that destroy the body's own insulin-making beta cells. ' 
Antigen -a molecule found either inside or on the surface of a cell that can 
induce an immune response by stimulating the production of antibodies. 
Antigens are used by the body's immune system to recognise whether the cell 
is a dangerous foreign intruder or a harmless part of the body. They are like 
molecular labels. ' 
Arteries - large blood vessels that carry blood with oxygen from the heart to 
all parts of the body. ' 
Arteriosclerosis - hardening of the arteries. ' 
Glossary of terms 
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Atherosclerosis - clogging, narrowing, and hardening of the body's large 
arteries and medium-sized blood vessels. Atherosclerosis can lead to stroke, 
heart attack, eye problems, and kidney problems. ' 
Autoimmune - disorder of the body's immune system in which the immune 
system mistakenly attacks and destroys body tissue that it believes to be 
foreign. ' 
Autonomic neuropathy -a type of neuropothyaffecting the lungs, heart, 
stomach, intestines, bladder, or genitals. ' 
Beta cells -a cell that makes insulin. Beta cells are located in the islets of the 
pancreas. ' 
Biguanide -a class of oral medicine used to treat type 2 diabetes that lowers 
blood glucose by reducing the amount of glucose produced by the liver and by 
helping the body respond better to insulin. (Generic name: metformin. )' 
Blood glucose - the main sugar found in the blood and the body's main source 
of energy. Also called blood sugar. ' 
Blood glucose levels - the amount of glucose in a given amount of blood. It is 
noted in millimoles per litre, or mmo///. 1 
Blood pressure - the force of blood exerted on the inside walls of blood 
vessels. Blood pressure is expressed as a ratio (example: 120/80, read as "120 
over 80"). The first number is the systolic pressure, or the pressure when the 
heart pushes blood out into the arteries. The second number is the diastolic 
pressure, or the pressure when the heart rests. ' 
Blood vessels - tubes that carry blood to and from all parts of the body. The 
three main types of blood vessels are arteries, veins, and capillaries. ' 
Body Fat percentage - the proportion of a person's body that is fat. 
Body mass index (BMI) -a measure used to evaluate body weight relative to a 
person's height. BMI is used to find out if a person is underweight, normal 
weight, overweight, or obese. ' 
Calories -a unit representing the energy provided by food. Carbohydrate, 
protein, fat, and alcohol provide calories in the diet. Carbohydrate and protein 
have 4 calories per gram, fat has 9 calories per gram, and alcohol has 7 calories 
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Carbohydrate - one of the three main nutrients in food. Foods that provide 
carbohydrate are starches, vegetables, fruits, dairy products, and sugars. ' 
Cardiovascular disease - disease of the heart and blood vessels (arteries, veins, 
and capillaries). ' 
Cerebrovascular disease - damage to blood vessels in the brain. Vessels can 
burst and bleed or become clogged with fatty deposits. When blood flow is 
interrupted, brain cells die or are damaged, resulting in a stroke. ' 
Cholesterol -a type of fat produced by the liver and found in the blood; it is also 
found in some foods. Cholesterol is used by the body to make hormones and build 
cell walls. ' 
High density lipoprotein (HOL) cholesterol -a fatfound in the blood 
that takes extra cholesterol from the blood to the liver for removal. 
Sometimes called "good" cholesterol! 
Low density lipoprotein (LOL) cholesterol -a fat found in the blood 
that takes cholesterol around the body to where it is needed for cell 
repair and also deposits it on the inside of artery walls. Sometimes 
called "bad" cholesterol. ' 
Total cholesterol - the total amount of cholesterol carried in the blood. 
Chronic - describes something that is long-lasting. Opposite of acute. ' 
Complications - harmful effects of diabetes such as damage to the eyes, heart, 
blood vessels, nervous system, teeth and gums, feet and skin, or kidneys. Studies 
show that keeping blood glucose, blood pressure, and low-density lipoprotein 
cholesterol levels close to normal can help prevent or delay these problems. ' 
Creatinine -a waste product from protein in the diet and from the muscles of 
the body. Creatinine is removed from the body by the kidneys, as kidney disease 
progresses, the level of creatinine in the blood increases. ' 
C-reactive protein (CRP) -a protein present in blood serum in various abnormal 
states (as inflammation). 
Diabetes mellitus -a condition characterized by hyperglycaemia resulting f ram 
the body's inability to use blood glucose for energy. In type 1 diabetes, the 
pancreas no longer makes insulin and therefore blood glucose cannot enter the 
cells to be used for energy. In type 2 diabetes, either the pancreas does not 
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make enough insulin or the body is unable to use insulin correctly. ' 
Diabetes nurse - health professional specialising in the education and support 
of patients with diabetes. 
Diabetic ketoacidosis (OKA) - an emergency condition in which extremely high 
blood glucose levels, along with a severe lack of insulin, result in the breakdown 
of body fat for energy and an accumulation of ketones in the blood and urine. 
Signs of DKA are nausea and vomiting, stomach pain, fruity breath odour, and 
rapid breathing. Untreated DKA can lead to coma and death. ' 
Diabetic retinopathy - diabetic eye disease; damage to the small blood vessels 
in the retina. Loss of vision may result. ' 
Diabetologist -a doctor who specializes in treating people who have diabetes. ' 
Dialysis - the process of cleaning wastes from the blood artificially. This job is 
normally done by the kidneys. If the kidneys fail, the blood must be cleaned 
artificially with special equipment. The two major forms of dialysis are 
haemodialysis and peritoneal dialysis. ' 
Haemodialysis - the use of a machine to clean wastes from the blood 
after the kidneys have failed. The blood travels through tubes to a 
dialyser, a machine that removes wastes and extra fluid. The cleaned 
blood then goes back into the body. ' 
Dietitian -a health care professional who advises people about meal planning, 
weight control, and diabetes management. A registered dietitian (RD) has more 
training. ' 
D-phenylolanine derivative -a class of oral medicine for type 2 diabetes that 
lowers blood glucose levels by helping the pancreas make more insulin right 
after meals. (Generic name: nateglinide. )1 
Endocrine gland -a group of specialized cells that release hormones into the 
blood. For example, the islets in the pancreas, which secrete insulin, are 
endocrine glands. 1 
Endocrinologist -a doctor who treats people who have endocrine gland 
problems such as diabetes. ' 
Enzyme - protein made by the body that brings about a chemical reaction, for 
example, the enzymes produced by the gut to aid digestion. ' 
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Erectile dysfunction - See impotence. 
' 
Fasting blood glucose test -a check of a person's blood glucose levelaf ter 
the person has not eaten for 8 to 12 hours (usually overnight). This test is used 
to diagnose pre-diabetes and diabetes. It is also used to monitor people with 
diabetes! 
Fat - 1. One of the three main nutrients in food. Foods that provide fat are 
butter, margarine, salad dressing, oil, nuts, meat, poultry, fish, and some dairy 
products. 2. Excess calories are stored as body fat, providing the body with a 
reserve supply of energy and other functions. ' 
Glomerulus -a tiny set of looping blood vessels in the kidney where the blood 
is filtered and waste products are removed. ' 
Glucagon -a hormone produced by the alpha cells in the pancreas. It raises 
blood glucose. An injectable form of glucagon, available by prescription, may be 
used to treat severe hypoglyoemia.. l 
Glucose - One of the simplest forms of sugar. ' 
Glycaemic index -a ranking of carbohydrate-containing foods, based on the 
food's effect on blood glucose compared with a standard reference food. ' 
Glycogen - the form of glucose found in the liver and muscles. ' 
Glycosuria - the presence of glucose in the urine. ' 
Glycosylated haemoglobin (HBA1C) -a test that measures a person's average 
blood glucose level over the past 2 to 3 months. The test shows the amount of 
glucose that sticks to the red blood cell, which is proportional to the amount of 
glucose in the blood. ' 
Haemoglobin - the part of a red blood cell that carries oxygen throughout the 
body. ' 
Heart attack - see myocardial infarction. 
Hormone -a chemical produced in one part of the body and released into the 
blood to trigger or regulate particular functions of the body. For example, 
insulin is a hormone made in the pancreas that tells other cells when to use 
glucose for energy. Synthetic hormones, made for use as medicines, can be the 
some or different from those made in the body. ' 
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Hyperglycaemia - excessive blood glucose. Fasting hyperglycaemia is blood 
glucose above a desirable level after a person has fasted for at least 8 hours. 
Postprandial hyperglycaemia is blood glucose above a desirable level 1 to 2 
hours after a person has eaten. ' 
Hyperinsulinaemia -a condition in which the level of insulin in the blood is 
higher than normal. Caused by overproduction of insulin by the body. Related to 
insulin resistance. ' 
Hyperlipidoemia - higher than normal fat and cholesterol levels in the blood. 
' 
Hypertension -a condition present when blood flows through the blood vessels 
with a force greater than normal. Also called high blood pressure. 
Hypertension can strain the heart, damage blood vessels, and increase the risk 
of heart attack, stroke, kidney problems, and death. ' 
Hypoglycaemia (Hypo) -a condition that occurs when one's blood glucose is 
lower than normal, usually lower than 4 mmo//% Signs include hunger, 
nervousness, shakiness, perspiration, dizziness or light-headedness, sleepiness, 
and confusion. If left untreated, hypoglycaemia may lead to unconsciousness. 
Hypoglycaemia is treated by consuming a carbohydrate-rich food such as a 
glucose tabletor juice. It may also be treated with an injection of glucagon if 
the person is unconscious or unable to swallow. Also called an insulin reaction. ' 
Hypotension - low blood pressure or a sudden drop in blood pressure. 
Hypotension may occur when a person rises quickly from a sitting or reclining 
position, causing dizziness or fainting. ' 
Hypo warning signals - When the level of glucose in a person's blood falls too 
low the person often experiences 'warning signs', which occur as the body tries 
to raise the blood glucose level. These warning signs vary from person to 
person, but often include feeling shaky, sweating, tingling in the lips, going pale, 
heart pounding, confusion and irritability. 2 
Impaired fasting glucose (IFG) -a condition in which a blood glucose test, 
taken after an 8- to 12-hour fast, shows a level of glucose higher than normal 
but not high enough for a diagnosis of diabetes. IFG, also called pre-diabetes, 
is a level of 6.1 mmo///to 7 mmo//% Most people with pre-diabetes are at 
increased risk for developing type 2 diabetes' 
Impaired glucose tolerance (I&T) -a condition in which blood glucose levels 
are higher than normal but are not high enough for a diagnosis of diabetes. 
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IGT, also called pre-diabetes, is a level of 7.8 mmo///to 11.1 mmo//12 hours 
after the start of an oral glucose tolerance test Most people with pre- 
diabetes are at increased risk for developing type 2 diabetes. Other names 
for IGT that are no longer used are "borderline", "subclinical, ", "chemical, " or 
"latent" diabetes. ' 
Impotence - the inability to get or maintain an erection for sexual activity. 
Also called erectile dysfunction. ' 
Insulin -a hormone that helps the body use glucose for energy. The beta cells 
of the pancreas make insulin. When the body cannot make enough insulin, 
insulin is taken by injection or through use of an insulin pump. ' 
Insulin resistance - the body's inability to respond to and use the insulin it 
produces. Insulin resistance may be linked to obesity, hypertension, and high 
levels of fatin the blood. ' 
Islets - groups of cel Is located in the pancreas that make hormones that help 
the body break down and use food. For example, alpho cells make g/ucogon and 
beta ce//s make insulin. Also called islets of Langerhans. ' 
Ketoocidosis - see diabetic ketoacidosis. 
Ketone -a chemical produced when there is a shortage of insulin in the blood 
and the body breaks down body fat for energy. High levels of ketones can lead 
to diabetic ketoocidosisand comp. Sometimes referred to as ketone bodies. ' 
Ketonuria -a condition occurring when ketones are present in the urine, a 
warning sign of diabetic ketoacidosis. 1 
Ketosis - ketone build-up in the body that may lead to diabetic ketoacidosis. 
Signs of ketosis are nausea, vomiting, and stomach pain. ' 
Kidney disease - see nephropothy. 
Kidney failure -a chronic condition in which the body retains fluid and harmful 
wastes build up because the kidneys no longer work properly. A person with 
kidney failure needs dialysis or a kidney transplant. Also called end-stage renal 
disease or ESRD. 1 
Kidneys - the two bean-shaped organs that filter wastes from the blood and 
form urine. The kidneys are located near the middle of the back. They send 
urine to the bladder. ' 
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Lipids -a term for fat in the body 
used for energy. ' 
Lipids can be broken down by the body and 
Lipid profile -a blood test that measures total cholesterol, triglycerides, and 
HDL cholesterol LDL cholesterol is then calculated from the results. A lipid 
profile is one measure of a person's risk of cardiovascular disease. ' 
Liver - an organ in the body that changes food into energy, removes alcohol and 
poisons from the blood, and makes bile, a substance that breaks down fats and 
helps rid the body of wastes. ' 
Macrovascular disease - disease of the large blood vessels, such as those 
found in the heart. Lipids and blood clots build up in the large blood vessels and 
can cause atherosclerosis, coronary heart disease, stroke, and peripheral 
vascular disease. ' 
Meglitinide -a class of oral medicine for type 2 diabetes that lowers blood 
glucose by helping the pancreas make more insulin right after meals. (Generic 
name: repaglinide. )' 
Metabolic syndrome - the tendency of several conditions to occur together, 
including obesity, insulin resistance, diabetes or pre-diabetes, hypertension, 
and high lipids' 
Metabolism - the term for the way cells chemically change food so that it can 
be used to store or use energy and make the proteins, fats, and sugars needed 
by the body. ' 
Metformin - an oral medicine used to treat type 2 diabetes. It lowers blood 
glucose by reducing the amount of glucose produced by the liver and helping 
the body respond better to the insulin made in the pancreas. Belongs to the 
class of medicines called biguanides. (Brand names: Glucophage, Glucophage XR; 
an ingredient in Glucovance. )1 
Microalbumin - small amounts of the protein called albumin in the urine 
detectable with a special lab test. ' 
Microvascular disease - disease of the smallest blood vessels, such as those 
found in the eyes, nerves, and kidneys. The walls of the vessels become 
abnormally thick but weak. Then they bleed, leak protein, and slow the flow of 
blood to the cells. ' 
Mitochondria - The powerhouses of the cell that convert glucose into energy. z 
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mmol/I - millimoles per litre, a unit of measure that shows the concentration of a 
substance in a specific amount of fluid. l 
Mononeuropathy - neuropathyaffecting a single nerve. 
' 
Myocardial infarction -a sudden interruption in the blood supply to the heart 
because of narrowed or blocked blood vessels. Also called a heart attack. ' 
Nephropathy - disease of the kidneys. Hyperglycaemia and hypertension can 
damage the kidneys' g/omeru/i. When the kidneys are damaged, protein leaks out 
of the kidneys into the urine. Damaged kidneys can no longer remove waste and 
extra fluids from the bloodstream. ' 
Neuropathy - disease of the nervous system. The three major forms in people 
with diabetes are periphery/ neuropothy, autonomic neuropathy, and 
mononeuropothy. The most common form is peripheral neuropathy, which affects 
mainly the legs and feet. ' 
Obesity -a condition in which a greater than normal amount of fat is in the body; 
more severe than overweight, having a body mass indexof 30 or more. ' 
Ophthalmologist -a medical doctor who diagnoses and treats all eye diseases and 
eye disorders. Opthalmologists can also prescribe glasses and contact lenses. ' 
Optometrist -a primary eye care provider who prescribes glasses and contact 
lenses. Optometrists can diagnose and treat certain eye conditions and diseases. ' 
Oral glucose tolerance test (OGTT) -a test to diagnose pre-diabetes and 
diabetes. The OGTT is given by a health care professional after an overnight 
fast. A blood sample is taken, then the patient drinks a high-glucose beverage. 
Blood samples are taken at intervals for 2 to 3 hours. Test results are compared 
with a standard and show how the body uses glucose over time. ' 
Oral hypoglycaemic agents - medicines taken by mouth by people with type 2 
diabetes to keep blood glucose levels as close to normal as possible. Classes of 
oral hypoglycaemic agents are alpha g/ucosidose inhibitors, biguonides, D- 
pheny/o/anise derivatives, meg/itinides, su/fony/ureas, and thiazolidinediones. l 
overweight - an above-normal body weight; having a body mass indexof 25 to 
29.9.1 
Pancreas - an organ that makes insulin and enzymes for digestion. The pancreas is 
located behind the lower part of the stomach and is about the size of a hand. ' 
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Peripheral neuropathy - nerve damage that affects the feet, legs, or hands. 
Peripheral neuropathy causes pain, numbness, or a tingling feeling. 1 
Peripheral vascular disease (PVD) -a disease of the large blood vessels of the 
arms, legs, and feet. PVD may occur when major blood vessels in these areas 
are blocked and do not receive enough blood. The signs of PVC) are aching pains 
and slow-healing foot sores. ' 
Plaque -a fatty deposit on the inner lining of an arterial wall, characteristic of 
atherosclerosis. 
Polydipsia - excessive thirst; may be a sign of diabetes. 
' 
Polyphogia - excessive hunger; may be a sign of diabetes. 
' 
Polyurin - excessive urination; may be a sign of diabetes. ' 
Postprandial blood glucose - the blood glucose /eve/taken 1 to 2 hours after 
eating. ' 
Pre-diabetes -a condition in which blood glucose levels are higher than normal 
but are not high enough for a diagnosis of diabetes. People with pre-diabetes 
are at increased risk for developing type 2 diabetes and for heart disease and 
stroke. Other names for pre-diabetes are impaired glucose tolerance and 
impaired fasting glucose. ' 
Protein - 1. One of the three main nutrients in food. Foods that provide protein 
include meat, poultry, fish, cheese, milk, dairy products, eggs, and dried beans. 
2. Proteins are also used in the body for cel I structure, hormones such as 
insulin, and other functions. ' 
Proteinurin - the presence of protein in the urine, indicating that the kidneys 
are not working properly. ' 
Renal - having to do with the kidneys. A renal disease is a disease of the 
kidneys. Renal failure means the kidneys have stopped working. ' 
Retina - the light-sensitive layer of tissue that lines the back of the eye. ' 
Retinopathy - see diabetic retinopathy. l 
Risk factor - anything that raises the chances of a person developing a 
disease, e. g. age. ' 
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Saturated fat -a type of fat that is generally solid at room temperature, and 
is found in animal products such as whole milk, eggs, and meats. Saturated fats 
are the biggest dietary cause of high LDL levels ("bad cholesterol"). 
Secondary diabetes mellitus -a type of diabetes caused by another disease 
or certain drugs or chemicals. ' 
Side effects - the unintended action(s) of a drug. 
' 
Starch - another name for carbohydrate, one of the three main nutrients in 
food. l 
Statins - Any of a class of lipid-lowering drugs that reduce serum cholesterol 
levels by limiting the amount of cholesterol the body can make. 
Stroke - condition caused by damage to blood vessels in the brain; may cause 
loss of ability to speak or to move parts of the body. ' 
Sugar - 1. A class of carbohydrates with a sweet taste; includes glucose, 
fructose, and sucrose. 2. A term used to refer to blood glucose. ' 
Sulphonylurea -a class of oral medicine for type 2 diabetes that lowers blood 
glucose by helping the pancreas make more insulin and by helping the body 
better use the insulin it makes. (Generic names: acetohexamide, 
chlorpropamide, glimepiride, glipizide, glyburide, tolazamide, tolbutamide. )' 
Syndrome x- see insulin resistance and metabolic syndrome. 
Thiozolidinedione -a class of oral medicine for type 2 diabetes that helps 
insulin take glucose from the blood into the cells for energy by making cells 
more sensitive to insulin. (Generic names: pioglitazone and rosiglitazone. )' 
Triglycerides - the storage form of fat in the body. High triglyceride levels 
may occur when diabetes is uncontrolled. ' 
Thyroid gland -a gland in the front of the neck that produces hormones to 
regulate the body's metabolism. 
Type 1 diabetes mellitus -a condition characterized by high blood glucose 
/eve/s caused by a total lack of insulin. Occurs when the body's immune system 
attacks the insulin-producing beta cells in the pancreas and destroys them. 
The pancreas then produces little or no insulin. Type 1 diabetes develops most 
often in young people but can appear in adults. ' 
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Type 2 diabetes mellitus -a condition characterized by high blood glucose 
/eve/s caused by either a lack of insulin or the body's inability to use insulin 
efficiently. Type 2 diabetes develops most often in middle-aged and older 
adults but can appear in young people. ' 
Unsaturated fat -a type of fat that can help to lower blood cholesterol when 
used in place of saturated fats. There are two types: mono-unsaturated and 
polyunsaturated. Most liquid vegetable oils are unsaturated. 
Urea -a waste product found in the blood that results from the normal 
breakdown of protein in the liver. Urea is normally removed from the blood by 
the kidneys and then excreted in the urine. ' 
Urine - the liquid waste product filtered from the blood by the kidneys, 
stored in the bladder, and expelled from the body by the act of urinating. ' 
Urine testing - also called urinalysis; a test of a urine sample to diagnose 
diseases of the urinary system and other body systems. In people with 
diabetes, a doctor may check for: 
1.6/ucose, a sign of diabetes or other diseases. 
2. Protein, a sign of kidney damage, or nephropathy. (Also see albuminuria. ) 
3. White blood cells, a sign of urinary tract infection. 
4. Ketones, a sign of diabetic ketoocidosis or other conditions. 
Urine may also be checked for signs of bleeding. Some tests use a single urine 
sample. For others, 24-hour collection may be needed. And sometimes a sample 
is "cultured" to see exactly what type of bacteria grows. ' 
000090000*000000000000000000000000 
1. National Institutes of Health. Diabetes Dictionary. National Diabetes 
Clearing House (NDIC): A service of the National Institute of Diabetes 
and Digestive and Kidney Diseases (NIDDK), NIH. 
Website (www. diabetes. niddk. nih. gov/dm/pubs/dictionary/index. htm) 
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Pedometers : Instructions for use EAR] 
" For accurate readings, your pedometer must be in an upright vertical 
position at all times, with the clip against your body. When you open 
the cover, the screen should face you. 
0 To prevent your pedometer falling off, attach the security strap's clip 
onto a belt loop, belt or waistband. 
How do you open the pedometer? 
" With your pedometer attached to your waistband or belt, grasp the 
top of the clip with one hand and use the other hand to push the cover 
away from the clip. 
How do you reset the pedometer? 
" To clear the data on your pedometer's screen, push the 'RESET button. 
" You should press 'RESET each night, AFTER you have recorded your 
daily total steps and taken the pedometer off. 
" You should press 'RESET" also at the start of the day, as soon as you 
have attached your pedometer. This will ensure you start the day with 
zero on the screen. 
How do you check that your pedometer is recording accurately? 
" Put the pedometer on, reset to '0' and close the cover. 
" Walk forward 20 steps (right and left counts as two steps). 
0 Without removing the pedometer, carefully open the cover. 
" If the pedometer does not read 19-21 steps and is not in a slanted 
position, move it to a different spot on the waistband, either further 
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Physical activity diary 
Recording on the 'Physical activity diary the STEP READINGS from your 
pedometer and the AMOUNT OF TIME you spend being active each day will 
allow you to keep track of your physical activity. 
Instructions for using the physical activity diary 
You should record the fol lowing on the front page (PA. 9) of the diary: 
Time 
" The TIME YOU PUT THE MONTIOR ON in the morning and the TIME 
YOU TAKE THE MONITOR OFF before bed. 
" The TIME AT START and TIME AT END of each walking SESSION 
lasting at least 10 minutes. 
" The DURATION of each walking SESSION, recorded in hrs: mins, which 
must be at least 10 minutes in duration to count toward your daily goal. 
The DAILY TOTAL TIME (hrs: mins) spent walking briskly. 
. The WEEKLY TOTAL TIME spent walking briskly. 
Steps 
. The STEP READING AT START and END of each walking SESSION. 
The TOTAL STEPS walked in each SESSION. 
The DAILY TOTAL STEPS walked. This should be the last reading on your 
pedometer when you take it off before bed. 
WEEKLY TOTAL STEPS (calculated by adding the end of day readings). 
Always remember to RESET your pedometer last thing at night, 
AFTER you have recorded your END OF DAY READING. 
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You should record ACTIVITIES OTHER THAN WALKING on the back 
page (PA. 10) of the physical activity diary, including: 
ob 
" The TYPE OF ACTIVITY. 
" The TIME AT START and TIME AT END of each activity SESSION 
lasting at least 10 minutes. 
9 The DURATION of activity SESSION, recorded in hrs: mins. 
" The DAILY TOTAL TIME (hrs: mins) spent in other activities. 
" The WEEKLY TOTAL TIME spent in other activities (calculated by 
adding the daily totals). 
5ee the sample entry overleaf. 
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ö 














































































































































3 a } O ýn o 




















































































N . -ý 
v 14- r_ O 
4- `y) 
-n ze O ýn OO ýn ý/1 
LNmQmd V1 * rl (Z pM 
c0 K 00 ma 





-3ýäOOoOO Lr Ln dO V) vi v~ .OOO 
>. ON? ONyONZONOOQONONJ 
do3~ `ý Y 
V5DE PA. 5 Continued overleaf 
I 




4- o 0 0 0 0 0 0 0 O O ýn O O O OM 
) Ö Ö Ö Ö Ö Ö 
"ý 
Öp 
ýý O O 
ß 
v 




















0 7 1 
,0 
PA. 6 
Recording your physical activity on a graph 
Physical activity graph 
Monitoring the number of steps you walk day-by-day and month-by-month 
on a graph will enable you to easily see your progress over time. At a 
glance, you will see where you started and what you have been able to 
achieve. You may have episodes when you do not do as much activity, which 
will happen from time to time as you come across obstacles. This is normal 
and can help you prepare to overcome future barriers. What is important 
is that, overall, the trend is moving in the right direction. 
Instructions for using the physical activity graph 
" Your 'Physical activity graph' is in the 'Progress Reports'section of 
your file. 
" Plot the total number of steps walked each day. This will be the 
reading recorded in the last column on PA. 9 of your diary. 
" Find the day of the month along the bottom of the graph and then find 
the number of steps up the left hand side of the graph. Mark where 
these two meet. 
0 Join the points plotted each day with a line. 
" See the sample entry overleaf. 
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Setting physical activity goals 
«t(iuI) 
Why type of physical activity should you do? 
Brisk walking has been chosen for this intervention study because it is an 
affordable, enjoyable and easy exercise that almost everyone can do. No 
matter what your age, fitness level or lifestyle, you can benefit from brisk 
walking. And all you need to do it is a comfortable pair of shoes. 
What is brisk walking? 
" Brisk walking/physical activity should make you feel warm and slightly 
breathless. 
" Your heartbeat will become a little faster, but should not race. We 
also call this moderate-intensity physical activity. 
" You should feel some exertion but should be able to carry on a 
conversation comfortably during the activity. 
How much? 
" Your long-term goal is to do at least 30 minutes of brisk walking on 5 
or more days a week, OVER AND ABOVE any activity that you were 
doing when you entered the study. This amounts to an extra 2.5hrs 
each week 
" YOU DO NOT HAVE TO DO THE EXTRA 30 MINUTES ALL IN 
ONE GO. Doing 3 bouts of 10 minutes will have the same benefits. 
" Activities that last less than 10 minutes will NOT count towards your 
long-term daily goal of 30 minutes. However, doing any activity in 
addition to your 30 minutes is likely to provide further benefit. 
V6DE PA. 11 Continued overleaf 
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Setting physical activity goals continued EAR 
Starting gradually 
Start off gradually, even if it is just walking for 5 minutes on a few days 
the first week. It is important that you give yourself time to adjust, so i 
may take several weeks to build up to doing 30 minutes on 5 days a week. 
Below is a chart suggesting how you can do this. 
Week # Total amount of physical Examples 
activity 
4 Do something active on 3 to 4 Walk to the local shops 
days 
5 60 minutes over 4 to 6 days 10 minutes per day on 6 days 
6 90 minutes over at least 5 15 minutes per day on 6 days 
days 
7 120 minutes over at least 5 20 minutes per day on 6 days 
days 
8 150 minutes over at least 5 30 minutes per day on 5 days 
days 
9& At least 150 minutes over 5 30 minutes or more per day on 
onwards days or more 5 days 
Remember that 10 minutes of continuous brisk walking is approximately 
equal to 1000 steps. 
PA. 12 
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Other brisk activities FtI(I I 
Here are some other brisk activities that will provide extra benefit when 
done in addition to your walking. 
Q Vacuuming 
Q Going up the stairs 
Q Cleaning windows 
Q Carrying small children 
Q Raking leaves 
Q Gardening 
Q Washing the car 
Q Decorating 
Q Exercise videos 
Q Other 
Work 
Q Stair climbing Q Other 
Q Building work 
Leisure 
Q Cycling <10mph on flat ground Q Rowing 
Q Continuous dancing (Line or ball 
room) 
Q Low-impact aerobics 
Q Water aerobics 
Q Walking in water (Widths across 
shallow end) 
Q Swimming 
Q Golf (without buggy) 
Q Racquet games ( badminton, 
tennis, table tennis) 
Q Canoeing 
Q Roller-skating/ice-skating 
Q Team sports (football, netball, 
cricket) 
Q Other 
V6DE PA. 13 
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Signed .................................................................................................. Participant 
Signed ................................................................................................... Nurse 
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Successes and difficulties 
4 %(TID 
Visit 
What are the successes since the previous visit? Remember that a 
success can be wearing a pedometer everyday during waking hours, keeping 
a physical activity diary every day, any increase in physical activity, or 
reaching a physical activity goal. 
lb 
Were there any difficulties? 
How can these be avoided in the future? 
PA. 16 
Physical activity plan 
W/C Week # 
I 
I: t It 1.1 
t("I'11) 
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Physical activity plan SARI 
W/C Week # 
Weekly goal: Daily goal 
Day Activity When Where Duration 








Total time for the week (hrs: mins) 
PA. 18 
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Troubleshooting your pedometer 
The clip has broken 
Contact your Early ACTIFD nurse for a replacement clip. 
The pins that hold the clip on the pedometer have come out 
I; ýItl. l 
%("1'11) 
Reinsert the pins or if you have lost them, contact the Early ACTIb office. 
The display is dim, flashing or showing dashes 
Check to make sure the battery is making proper contact. If it is still not 
working properly, contact the Early ACTID office for a new battery. 
The display is blank 
If you have tried changing the battery, the display may be broken. Contact 
the Early ACTID office for a replacement pedometer. 
The display is stuck on one number 
Hold down the RESET button for five seconds. When the display goes blank, 
remove your finger from the button. Your display should now show '88888' 
and then '0'. If not, remove the battery. Put the battery back in. Your 
display should read '0'. 
V5DE PA. 19 Continued overleaf 
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Troubleshooting your pedometer continued EARIA wrinl 
The pedometer is wet or has been through the washing machine 
Remove the battery immediately. Allow the pedometer to dry out naturally 
(do not use a dryer or radiator) for at least 24 hours. Put a new battery in 
(These can be obtained from the Early ACTID office). 
The pedometer is not recording steps accurately 
In most cases, problems with pedometers accurately recording steps can be 
resolved by adjusting the pedometer's position on your body. To record 
accurately, it is essential that the pedometer remains upright, and not 
tilted . If your stomach protrudes, try positioning the pedometer on the side 
of your hip, where it should remain vertical. To test the pedometer's 
accuracy in a new position, follow the step test instructions on PA. 2. Repeat 
the test until you find the most accurate position. If it is still recording 
inaccurately, contact your Early ACTID nurse for a replacement pedometer. 
The pedometer will not stay in an upright position 
Contact your Early ACTIO nurse for an elastic belt that you can clip your 
pedometer on to. 
How do I wear a pedometer if I'm wearing a dress? 
The pedometer and security strap can be attached to the waistband of your 
underwear. Alternatively, obtain an elastic belt from your Early ACTID 
nurse. 
For other problems, contact your Early ACTIO nurse. 
PA. 20 
Facts about walking 
Benefits of walking 
0 Burns calories 
" Increases the metabolism, even when resting 
" Strengthens core muscles (back and stomach) 
" Tones legs 
" Improves fitness 
" Improves circulation 
0 Improves immune system 
" Strengthens bones and prevents osteoporosis 
" Improves blood lipids 
" Improves glycaemic control 
" Lowers blood pressure 
" Reduces risk of heart disease, stroke, and some cancers 
0 Reduces stress and anxiety 
" Increases energy 
" Improves quality of sleep 
" Improves mood 
" Can be done almost anywhere and by almost everyone 
" Requires no training or equipment 
" Is one of the simplest and safest forms of exercise 
Is free 
o 
i: t It 1.1 
t(i'll) 
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Facts about walking continued 
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If you are still not convinced that walking is real exercise, have a look at 
these quick facts: 
1. Walking one mile in fifteen minutes burns about the same number of 
calories as running a mile in 8.30 minutes. 
2. A brisk one-mile walk in 20 minutes burns around 100 calories - as much 
as swimming for 10 minutes, playing football for 12 minutes or doing 
aerobics for 16 minutes. 
3. Walking two miles a day, three times a week, can reduce your weight by 
one pound every three weeks. 
4. Every minute you spend walking adds between one and a half to two 
minutes to your life - about a2 for 1 trade off! 
5. Exercising for ten minutes, three times a day is as beneficial as 
exercising continuously for 30 minutes once a day. 
PA. 22 
b 
Staying safe: Foot care 
IN Will 1) 
Diabetes can sometimes affect the sensation in your feet and also the 
circulation to them. To prevent foot problems it is important that you: 
" Check your feet daily for areas of redness, hard skin, blisters and 
breaks in the skin. You are looking for: 
= Sores, cuts, bruises or injury; 
= Any colour change, swelling, warmth or redness; 
Calluses or changes in the shape of your feet. 
0 Wash your feet regularly and dry carefully between the toes. 
" Cut your toenails straight across (not down the sides), preferably 
after a bath when the nails are soft. Try not to cut your nails too 
short. 
0 Avoid walking barefoot. 
" Always wear shoes that fit well; have your feet measured regularly. 
" Always check inside your shoes for rough lining or loose objects 
before putting them on because there may be something inside your 
shoe that could hurt your foot. 
0 Be careful not to use anything hot on your feet. 
" If your feet are dry and cracked, use moisturising cream 
recommended by your nurse. 
" If you notice any changes to your feet, or think you may have a 
foot problem, contact your Early ACTIb nurse as soon as possible. 
""""""""""""""""""""""""0"""""""" 
Source: Avon diabetes 2006. Adapted from Footcure. 
Website (www. avondiabetes. nhs. uk) 
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i Staying safe: Foot care continued E lk RI Ail 1, 
Choosing the right footwear is an important part of foot care and is 
particularly important for those who are active. 
What is a good shoe? 
A good shoe is one that: 
" Is deep enough at the front so that your toes are free to move. 
" Has a thick bouncy flexible sole for cushioning. 
" Has a low chunky heel or low wedge for balance. 
" Holds the foot firmly in place by lace or strap for support. 
" Is preferably made of leather (but not patent which is too hard). 
" Has a smooth lining (stitching may rub). 
How do I buy a good shoe? 
" Be sure your feet are properly measured and fitted whenever you get 
new shoes as your feet can change size and shape. Shoes should fit 
both the length and width of your foot. 
" Ask for your feet to be measured whilst standing. 
" Try shoes on at the end of the day to allow for swelling. 
" Walk around the shop in the shoes: new shoes should feel comfortable 
straight away. 
" Try shoes on in your normal socks or tights. 
" If a podiatrist has given you an insole or orthotic, take them with you 
when trying on a new pair of shoes. 
" Go to a shop that has shoes in a wide range of sizes, including half sizes 
and different width fittings. 
"""""""""""""""""""""""""""""0"""0" 
Source: Avon diabetes 2006. Adapted from Ideal footware. 
Website (www. avondiabetes. nhs. uk) 
PA. 24 
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Staying safe: Prevention 
WHI) 
Being moderately active is usually very safe. In rare cases, however, 
problems can occur. We strongly recommend that you follow the advice 
below to prevent any problems. 
0 Start an activity programme slowly and build up gradually over a 
number of weeks. You increase your risk of injury if you try too much 
too soon. Increase the workload week by week to give your body time 
to adjust. 
0 Always tell someone where you are going and how long you are going to 
be there. 
" Drink plenty of water before, during and after any activity. 
" Always change your socks and wear appropriate and comfortable 
footwear. Check your feet daily and after activity for cuts and sores. 
If concerned, arrange to see a podiatrist. 
0 Always warm-up and cool down. Spend a few minutes before and after 
each session doing your activity but at a slower pace. 
At the end of each session, spend a few minutes stretching your 
muscles. This will prevent soreness and injury, and improve flexibility. 
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Staying safe: Illness 
0 Rest if you feel unwell and follow the steps below: 
EA 
If you have unexplained chest pain/tightness, extreme shortness of 
breath, numbness or pins and needles while you are active, STOP and 
SEEK URGENT MEDICAL HELP or DIAL 999. 
If you are suffering from a chesty cough, a bad cold, nausea, vomiting, 
flu or a temperature, do not exercise until the symptoms have gone 
for 24 hours. Restart gently and ease off if the symptoms start again. 
If in doubt, wait it out. One day off will not hurt your fitness but 
exercising when ill can set you back a week or longer. 
Remember: 
Activity is good for you, but more activity is not necessarily better for you 
without a gradual build up. View your daily activity as the most normal thing 
in the world - our bodies are made for movement. 
Activity is healthy, fun, sociable, normal and doesn't have to be expensive. 
Start slowly, increase gradually, try new activities, and get fit for life. 
""""""""""""""""0"""""0""""""""""" 
Source: Diabetes UK 2004. Information: Physical activity and diabetes. 
Website (http: //www. diabetes. org. uk/infocentre/inform/downloads/ 
physical activity. doc) 
PA. 26 
Staying safe: Hypos 
t("I'll) 
If you take Metformin or Glucobay alone (not treated with insulin), you 
are very unlikely to have a hypo. However, you may need food soon after you 
have been active. 
If you take insulin or sulphonylurea tablets, your planned activity should 
take into account the following: 
" Injection sites should be away from areas used during your chosen 
activity. 
" Fast-acting carbohydrate snacks should be to hand while being active, 
e. g. glucose tablets, Lucozade. 
" Monitor blood glucose levels before and after activity and take 
necessary steps to prevent hypoglycaemia. 
Take monitoring equipment if your activity will last for an hour or 
more. 
" Depending on the results of your pre-activity blood glucose test, you 
may well need to eat some starchy carbohydrate food before you 
start. However, if the test shows that your blood glucose level is 
13mmol/I or above, you must also test for ketones (test strips are 
available from your Early ACTID nurse). Even if ketones are not 
present, there may still not be enough insulin for your muscles to be 
able to mobilise the energy needed to exercise. Your blood glucose 
level will rise further as a response to the activity and yet, without 
insulin, still not provide the muscles with energy. Delay the training 
session until your insulin has taken effect and your blood glucose level 
has come down. 
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Staying safe: Hypos continued EtIt 
0 If ketones are present, this indicates that fat is being metabolise, 
for energy. If a positive ketone test accompanies a high blood 
glucose level, this may be a sign of ketoacidosis and you should see 
medical help immediately. 
" Delayed hypos (up to 36 hours) can occur as the muscles refuel 
after activity. Meal adjustments and bedtime snacks are advisable 
after intense activity. 
"""""""""""""""""""""""""""""""""" 
Source: Diabetes UK 2004. Information: Physical activity and diabetes. 
Website (http: //www. di(ibetes. org. uk/infocentre/inform/downloads/ 
physical activity. doc) 
PA. 28 
Staying safe: Stretching 
The aims of stretching are to gently lengthen muscles after any form of 
exercise, and to improve tissue elasticity and flexibility. If done correctly, 
stretching will help: 
0 Prevent soreness 
" Prevent injuries 
0 Maintain full range of movement 
0 Improve flexibility 
Stretching should always be done after any activity, once you have 
decreased your intensity, but are still warm. Move gently into the stretch 
position and hold (taking care NOT to bounce) the stretch for at least ten 
seconds, preferably between 15 and 30 seconds, until you feel the stretch 
ease off. 
You should feel a gentle pull in the muscles you are intending to stretch - 
not a searing pain. Stop immediately if you do feel any severe pain. Either 
adjust your position, or try a different stretch instead. It is advisable to 
use support, such as walls or chairs, to prevent overbalancing or strain. 
Breathe slowly and naturally. Try NOT to hold your breath. 
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Staying safe: Stretching continued 
Here are some safe stretches that your nurse can demonstrate. 
Calf stretch 
" Stand 2 to 3 ft. from a wall. Lean forward sup- 
porting your body weight with your bent arms. 
" Straighten your right leg behind. Press your heel 
to the floor. 










_ __ .. _ý L- _-_.. _ 
0 Hold the stretch for 15 to 30 seconds, whilst breathing steadily and 
then repeat on the other side. 





Stand with your legs hip-width apart. 
Raise your left arm and hold on to something for balance. 
Bend your right knee backwards. Reach behind with your right hand 
and hold your ankle or foot. 
Avoid pulling your heel towards your buttocks. 
Instead, press your hip forward. 
You should feel the stretch in the front of your 
right thigh. 
Hold the stretch for 15 to 30 seconds, whilst 




Staying safe: Stretching continued 
Waist, arm and shoulder stretch 
" Stand with your feet apart and knees slightly bent. -ý> 
" Hold your elbow with the hand of your opposite arm. WoW 
" Pull your elbow behind your head very gently. 
" Slowly lean to the side until you feel a mild stretch. ý` ` 
0 Hold the stretch for 15 to 30 seconds, whilst breathing 
steadily and then repeat on the other side. 
Hamstring (back of thigh) stretch 
0 Stand with your right leg in front of you with your foot flexed. The 
weight of your body will be carried by your left leg. 
0 Keeping your hips square (facing forward), bend your left knee and 
slowly push your buttocks out. 
" Keep your right leg straight and place your hands (to support your 
back) on the thigh of your left leg. 
0 Keep your back straight by keeping your abdominal muscles tight and 
your chest opened up. 
0 You should feel the stretch in the back of your 
right leg. 
" Hold the stretch for 15-30 seconds., while breath- 
ing steadily and then repeat on the other side. 
1 ý1 
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PA. 32 
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Physical activity history EARIA . (-NI) 
Current physical activity (Typical week-Type of activity, how often/long) 
Past physical activity (Type of activity, when, how often/long) 
What helped you succeed? 
What got in the way? 
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Physical activity history continued 
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i 
Why did you stop? 
PA. 34 
b 
Benefits of physical activity 
11% WUlD 
Being active is good for all of us but is especially important if you have 
diabetes. Here are some of the benefits that people get from physical 
activity. 
Physical health 
" Reduced risk of heart disease " Improved lung capacity 
" Reduced risk of some cancers 
" Lower blood pressure 
" Lower bad' cholesterol 
" Improved blood glucose levels 
" Improved insulin sensitivity 
" Improved circulation 
" Less chance of colds and flu 
" Better weight control 
" Improved appetite control 
" Reduced fat around the organs 
" Improved flexibility 
" Healthy and strong bones, joints 
and muscles 
Well-being 
" More energy 
" Improved mood 
" Reduced stress 
" Feeling productive 
" Increased self-esteem 
" Improved quality of sleep 
"A sense of achievement 
" Feeling good about your body 
Social 
" Able to play with children 
without being tired 
" Living a healthier and longer 
independent life 
" Encourages social interaction 
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Pros and cons of physical activity 
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iI 
You may have thought about other benefits of physical activity that are 
especially important to you. There may also be things that you feel are NOT 
so good about physical activity. Take a few moments now to list the pros 
and cons of physical activity that you consider most important, and that 
Now try to think about whether there are strategies you can use to minimise 
the things that are not so good . 
Record any ideas in the space below. 
PA. 36 
matter to you personally. You can add to this list throughout the study. 
p. 
Lifestyle activity 1.11 % It I Ail ("I'11) 
In addition to the activity that contributes to your weekly goal, it is 
recommended that you try to make active choices throughout the day. For 
example, you could choose to take the stairs instead of the lift or 
escalator. 
Using the table overleaf, take a few moments to list some active 
choices that you can substitute for current inactive choices. It is 
important that your active choices work for you and can fit into your 
lifestyle. 
Here is a sample entry 
Inactive choice Active choice 
1. Using the Iift at work 1. Taking the stairs 
2. Driving to the local shops 2. Walking to the local shops 
3. Getting the bus all the way to 3. Getting off the bus a stop 
work earlier 
V7DE PA. 37 Continued overleaf 
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Lifestyle activity continued I:. tItL 
You may find it useful to see "Opportunities to be active" for some ideas. 
Inactive choice I Active choice 
You can add to this list throughout the study. 
PA. 38 
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Opportunities to be active 
EMIA 
At home 
Q Try to do something active during television adverts. 
Q Get up and manually change the television channel instead of using the 
remote control. 
0 Walk while you talk on a cordless phone, or do 'step-ups' at the bottom 
of the stairs. 
Q Go up and down the stairs whenever the opportunity arises. 
Q Do housework to music, it's fun and the chores seem easier. 
Q Wash your car by hand instead of taking it to the car wash. 
Q Do some gardening. 




Q Use the stairs instead of the lift or escalator. 
Q Take the long way to the bathroom, using the stairs if possible. 
Q Walk to visit colleagues instead of calling or e-mailing them. 
Q Plan active meetings and walk while you talk. 
Q Take a 10-minute walk at lunchtime or during your break at work 
Ll 
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Opportunities to be active continued F: tItI: 
Leisure time 
Q Park the car further away from your destination. 
Q Actively play with children rather than sitting and watching, e. g. go to 
the park; play with a ball. 
Q Plan active occasions with your family, e. g. bike rides, swimming. 
Q Plan active social events, e. g. go dancing or bowling instead of going to 
dinner or the cinema. 
Q Walk with a partner or in groups of friends, e. g. arrange to walk a 
friend's dog. 
Q Join your local leisure centre. 
Q Take up an active hobby, such as line dancing, salsa, netball, football. 
Travelling 
Q Use public transport - you will walk more than if you drive. 
Q Get off the bus one or more stops earlier and walk the last distance. 
Q Walk or cycle to nearby shops or restaurants instead of driving. 
Q Park the car further away from your work place. 
Q Walk around the airport instead of using the moving travelator. 
Q Walk children to and from school instead of using the car. 
PA. 40 
Preventing relapses EARIA 
Making lifestyle changes are the first big steps to leading a healthier life 
and controlling your diabetes. Maintaining these changes as a permanent 
lifestyle is a huge achievement and requires a lot of commitment. 
Unfortunately, there can be many hurdles that get in the way of you 
maintaining changes, and there will be times when you don't follow your plans 
for being active. These are called LAPSES and are a normal part of change. 
Occasional lapses from time to time will not harm your progress. However, 
when these start to occur regularly, you might experience a RELAPSE -a 
permanent return to old habits. Taking time to think about what causes you 
to lapse, and how best to prevent, or react to lapses will reduce your risk of 
relapsing into lower physical activity levels. 
What causes you to tapse? 
Take a few moments to think about specific things that might cause you 
to lapse during your physical activity programme. These might include 
being busy at work or feeling tired, etc. In the table overleaf, write 
your personal triggers in the left hand column. Once you have listed 
these, brainstorm ideas to overcome them. Here is a sample entry. 
Triggers or risky situations that What can you do to prevent these 
can cause you to lapse lapses 
1. Busy at work 1. Plan time for physical activity or 
Walk to and from work 
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Preventing relapses continued 
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You might find it useful to see 'Overcoming barriers to physical activity. 
Triggers or risky situations that I What can you do to prevent these 
can cause you to lapse 
I 
lapses 
How to recover after a lapse 
" Stay calm and don't panic. One lapse does not mean you have failed, or 
that you have to wait to the next day or week to get back on track. Try 
to resume your day as if you had not had the lapse. 
" Replace negative thoughts with positive thoughts. Rather than feeling 
discouraged, guilty and angry, remind yourself of how much you have 
achieved so far. 
0 Learn and plan ahead. Try to think about how you can use the lapse as 
a learning experience. What were the triggers? How can you plan ahead 
and prevent future lapses? 
PA. 42 
Barriers to physical activity* 
We all have barriers that stop us from being more physically active. Take 
a few moments to think about what your own personal barriers are 







Most barriers can be easily overcome. For ideas, you may like to see 
'Overcoming barriers to physical activity' Take a few moments to 
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Overcoming barriers to physical activity continued 
BARRIER HOW TO OVERCOME IT 
Circumstantial 
Lack of time " Keep a time diary for a couple of days and identify 
available 10-minute time slots that can be used for 
physical activity. Complete a 'Personal time diary. 
0 Add physical activity to your daily routine. For example, 
walk or ride a bike to work or the local shops; walk 
children to school, walk the dog, exercise while you watch 
TV, park further away from your destination, etc. See 
'Opportunities to be active. 
" Make time for physical activity. For example, walk, jog, 
or swim during your lunch hour, or take activity breaks 
instead of coffee breaks. 
Lack of " Choose activities that require minimal facilities or 
resources equipment, such as walking, stair-climbing, dancing, etc. 
(financial, " Find out about inexpensive, convenient resources 
access to available in your local area (worksite programs, group 
facilities, no walks, etc. ). Use the worksheet' Local exercise 
safe place to opportunities' to record what's available in your area. 
exercise) 
" For safety, there are activities that you can do at home, 
in groups, or at supervised facilities. 
Weather " Develop a set of regular activities that are always 
conditions available regardless of weather (stair climbing, dancing, 
exercising with a home video, indoor swimming, using 
indoor exercise equipment, indoor games, indoor walking, 
local exercise classes, etc. ). 
Holiday " Look for opportunities to be active. Explore an area by 
walking. Make the most of swimming pools and access to 
other activity or exercise facilities. 
PA. 44 Continued overleaf 
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Overcoming barriers to physical activity continued EARIA %(i'II) 
BARRIER HOW TO OVERCOME IT 
Circumstantial continued 
Family " Exercise with the children: go for a walk together, play 
obligations energetic games, get an aerobic 
dance or exercise tape 
for children and exercise together. You can spend time 
together and still get your exercise. 
" Try to exercise when the children are not around (e. g., 
during school hours or their sleep time). 
" Use home equipment while the children are busy playing or 
sleeping. 
" Find a friend or family member to help with care, while 
you exercise. 
" Trade babysitting time with a friend, neighbour, or family 
member who also has small children. 
" Use exercise facilities that provide child care services. 
" Hire a babysitter and look at the cost as a worthwhile 
investment in your physical and mental health. 
Retirement " Look upon your retirement as an opportunity to become 
more active instead of less active. Spend more time 
gardening, walking the dog, and playing with your 
grandchildren. Children with short legs and grandparents 
with slower gaits are often great walking partners. 
" Learn a new skill you have always been interested in, such 
as ballroom dancing or swimming. 
" Now that you have the time, make regular physical activity 
a part of every day. Go for a walk every morning or every 
evening before dinner. Get yourself a stationary bike and 
ride every day while reading a favourite book or magazine. 
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Overcoming barriers to physical activity continued 
1 BARRIER HOW TO OVERCOME IT 
Physical 
Aches and " When you begin to exercise, you might experience some 
pains soreness in your muscles. This is normal. 
To reduce any 
discomfort, try stretching after each exercise session. 
" If you have joint pain, try activities that are non-weight 
bearing, such as swimming or cycling. 
" Being active will help build your muscles to protect your 
joints in the future. 
qb 
Tiredness " Schedule physical activity for times in the day when you 
feel more energetic. 
" Physical activity can increase your energy levels: try it! 
Lack of skill " Select activities requiring no new skills, such as walking, 
cycling, or stair climbing. 
" Exercise with friends who are at the same skill level as you 
are. 
" Find a friend who is willing to teach you some new skills. 
9 Take a class to develop new skills. 
Fear of " Start gradually, and stretch before and after each 
injury exercise session. 
" Walking has minimal risk of injury. 
Diabetes specific 
Foot " Maintain a good foot care routine, checking your feet daily, 
problems and after any exercise session for cuts or anything unusual. 
Contact your chiropodist or Early ACTID nurse if any 
changes occur. 
" Wear good-fitting shoes, appropriate for exercise. 
" If you have foot problems, avoid weight-bearing exercise 
and opt for swimming, cycling or rowing activities instead. 
" See'Foot cure in your information section. 
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Overcoming barriers to physical activity continued 
BARRIER HOW TO OVERCOME IT 
Diabetes specific continued 
Fear of hypo " Unless you inject insulin or take sulphonylurea tablets, you 
are very unlikely to have a hypo. 
" If you are taking insulin or sulphonylurea tablets, always 
have some fast-acting carbohydrate to hand. See 'Staying 
safe: Hypos'. 
Psychological 
Lack of " Remember the benefits of being active. Look back at your 
self - 'Pros and cons of physical activity. 
motivation " Plan ahead. Make physical activity a regular part of your 
daily or weekly schedule and write it in your diary. 
" Invite a friend to exercise with you on a regular basis and 
write it on both your diaries. 
" Join an exercise group or class. 
" Recognise the positive changes that you have made and 
consider all of your successes. Think back to how different 
things were at the start of the programme, and what you 
have gained as a result of your hard work. 
" Keep visible signs of your progress to see how far you have 
come. 
" Think about reward strategies for every goal you reach. 
Exercise is " Try listening to music during your activity. It will help keep 
boring or not your mind occupied. 
enjoyable " Walking or biking can take you past interesting scenery. 
" You don't have to "exercise". Start an active hobby that you 
do enjoy. 
" Find out what's on in your local area and record the 
information using 'Local exercise opportunities'. 
Too " Activity is for people of all ages and shapes. Exercise with 
embarrassed people you feel comfortable, to build your confidence. 
" Try to exercise in places where you feel comfortable. 
N7+DE PA. 47 Continued overleaf 
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Overcoming barriers to physical activity continued FIARII 
BARRIER HOW TO OVERCOME IT 
Social support 
No one to " Invite friends and family members to exercise with you. 
exercise Plan social activities involving exercise. 
with " Find out about local group walks or clubs and develop new 
friendships with physically active people. 
" Record useful information using 'Local exercise 
opportunities!. 
Family and " Explain to friends and family how important physical 
friends do activity is to the control of your diabetes and general 
not provide health. Ask them to support and recognise your efforts. 
support 
" Bring a family member or friend to your Early ACTIO 
meeting. 
" Complete the worksheet 'Peop/e to he/p you achieve 
your goad . 
PA. 48 
Personal time diary* 
b 
1": t it 1.1 
t('I'll) 
One of the most common barriers to an active lifestyle is thinking that 
you don't have enough time to exercise. It can sometimes be difficult to 
find opportunities to be active, so here is a task that will help you 
understand how you spend your time. By doing so, you'll identify 
opportunities for activity you might not have considered before. 
Select one typical weekday and one typical weekend day over the next 
week. Then, using the personal time diary worksheet, record how you 
spend each 2 hours during the 24-hour period. When recording your 
activities, calculate how many minutes you spend doing any type of 
physical activity, and how many minutes you spend being inactive. Go 
over your time diary and identify any opportunities to increase your 
activity. Any 10-minute slots will count towards your goal. 
Here is a sample entry. 
Time Task Minutes of' Minutes of Opportunities Minutes 
activity inactivity for activity 
4: 01 to Desk work 0 90 Walk part of 30 
6: 00pm Walk to bus 4 0 journey 
Bus journey 0 21 
Walk home 5 0 
6: 01 to Make/eat tea 0 30 
8: 00pm Sort paperwork 0 90 
8: 01 to Phone calls 0 30 Walk with a 30 
10: 00pm Watch TV 0 90 cordless phone 
TOTAL 9 351 TOTAL 60 
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Personal time diary* 
Date Day of week 
a 
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Personal time diary* ti EARIA 
Date bay of week 
Time Task Minutes of Minutes of Opportunities Minutes 
activity inactivity for activity 
Midnight 
, to 2: 00am 
2: 01 to 
4: 00am 
4: 01 to 
6: 00am 
6: 01 to 
8: 00am 
8: 01 to 
10: 00am 




2: 01 to 
4: 00pm 
4: 01 to 
6: 00pm 
6: 01 to 
8: 00pm 
8: 01 to 
10: 00pm 




People to help you achieve your goals* 
The role of social support can be very important in helping you reach your 
physical activity goals. Take a few moments to think of anyone who can 
help you stick with your physical activity programme. In the table 
overleaf, write down what they can do to help you. Sometimes, there 
might be things that you would like them NOT to do. 
For example, would you like someone to: 
Q Be active with you 
Q Listen to your successes and difficulties 
Q Encourage and motivate you to be active 
Q Offer expert advice (i. e. health professional, personal trainer, books, etc. ) 
Q Make it easier for you to be active (i. e. help with housework or look after 
those you are responsible for so you have time to do something active, etc. ) 
Q Other 
Q Other 
Here is a sample entry. 
Name What things would you like them What things would you like 
to do to help? them NOT to do? 
Partner 1. Exercise with me, e. g. 1. Encourage me to miss 
evening walks together. exercise sessions. 
2. Motivate me to exercise and 
support my efforts. 
V7+DE PA. 53 Continued overleaf 
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People to help you achieve your goals continued I. tItI; 
Name What things would you like 
them to do to help? 
What things would you like 
them NOT to do? 
You can add to this list throughout the study. 
PA. 54 
b 
Local exercise opportunities* EARIA 
Use this space to record any local exercise opportunities that might help 
you maintain an active lifestyle. For example, local group walks, group 
sports, opening times of exercise facilities. Your Early ACTIb nurse can 
help you find out about these opportunities. 
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Local exercise opportunities continued 
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Weight graph: Weeks 27-52 


















































Physical activity graph: Month 
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Reviewing your progress and planning ahead 
CONGRATULATIONS! 
You have completed your Early ACTID programme. 
Thank you for taking part in this study, and working hard to make long-term 
changes to your lifestyle. Today is an opportunity to review the things you 
have gained from making these changes, and to discuss ways of maintaining 
these changes as a way of life. By continuing with your new habits, you can 
continue to lose weight and/or maintain your new weight in the long term. 
Even without weight loss, the changes you have made will help you control 
your diabetes, both now and in the future, and help you to protect yourself 
against diabetes-related complications. 
Think of all the things you have changed and are still changing: write 
them down on the following pages to remind yourself. 
PR. 9 Continued overleaf 
Reviewing your progress continued EARIA 
ý(TI 
The types of food 
I have changed... 
The amount of food 
I have changed... 
How often I eat 
Now I. 
PR. 10 Continued overleaf 





I have changed... 
When I feel the urge to eat 
Now I. 
PR. 11 Continued overleaf 
Reviewing your progress continued 
The type of physical activity 
Now I 




How often I am physically active 
Now I... 
I 
PR. 12 Continued overleaf 
Reviewing your progress continued 
EARIA 
Now think about how all these positive changes to your eating habits 
and lifestyle have benefited you. 
My weight is... 
My waist measures... 
I feel.. 
Iam able to ... 
PR. 13 Continued overleaf 
Planning ahead 
ýrrilI 
Without making and maintaining these changes to your diet and 
lifestyle, it will be very difficult to continue towards your weight 
goals, and/or keep your new healthier weight. 
How to keep going 
Some clues to long-term weight loss come from people who have 
successfully lost weight and kept it off. Several studies have looked at 
these kinds of people and carefully examined what they do and how they 
behave. 
Dietary changes 
Firstly, these people all chose a low-fat diet, with more high fibre starchy 
foods and plenty of fruit and vegetables. They all ate regular meals and 
planned snacks and ate smaller portion sizes. You can refer back to visits 
4,6,9 and 10 to refresh yourself about these kinds of dietary changes. 
Goal setting 
These people also set themselves realistic goals, which we talked about at 
visit 4 and 5 and have mentioned throughout the programme. 
Self monitoring 
People who successfully managed their weight also regularly monitored 
their food intake, body weight, and daily physically activity. 
Throughout the study, you have regularly completed food diaries. We 
would encourage you to record a food diary from time to time to check 
PR. 14 Continued overleaf 
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Planning ahead continued 
E' %ICIII-I (11,1 1) 
that you are still on track with your dietary changes. You will be aware of 
the sorts of food and amounts of food that you need to be eating. Filling 
out a food diary at intervals will allow you to make a check on yourself and 
re-adjust if you need to. 
If you were in the Healthy eating p/us physical activity group, you will have 
been asked to record your daily physical activity with a diary. People who 
are regularly active, tend to monitor their physical activity (with a 
pedometer, and /or activity log), so they are able to track their progress 
and prevent relapse. We would encourage you to continue with this, so 
that you can be sure you're doing enough physical activity to look after 
your health, and help you manage your weight. 
Physical activity 
Numerous studies show that people who are regularly active are most 
successful at maintaining a healthier weight after weight loss, compared 
with people who rely on diet alone. 
Help and support 
Lastly, but still very important, people who were successful at reaching and 
maintaining a healthier weight sought help from people that would give 
them the support they needed. For example, friends, family, a self-help 
group (e. g. a slimming group) or a health professional. 
We would encourage you to think about who you have turned to during this 
programme and continue to seek their support as you carry on with your 
healthy eating and physical activity. 
PR. 15 Continued overleaf 
Planning ahead continued 
(110 
Use the space below to list the things that will help you to control 
your diabetes, maintain your new weight, or reach your goal weight. 
What do you plan to continue doing? 
What do you plan to do more of? 
What do you plan o do less of? 
What do you plan to start doing? 
What do you plan to stop doing? 









You can use this space to record any notes, questions or queries. 
V3G PN. 1 Continued overleaf 
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Personal notes continued 
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Information about the Early ACTID study 
VIVe University of MCI BRISTOL 
Early ACTID Study 
Joint Clinical Research Unit 
Level 5 Old Building, near Ward 29 
Bristol Royal Infirmary 
Marlborough Street 
BRISTOL BS2 8HW 
Tel: +44 (0117) 9282440 
Fax: +44 (0117) 9284470 
E mail: Early-ACTID@bristol. ac. uk 
The effects of diet and exercise in the management of Type 2 diabetes: A randomised controlled 
trial: The Early ACTID Study 
What is the Early ACTID study? 
Early ACTID stands for Early ACTivity In Diabetes. The study will investigate the effects of intensive 
dietary advice and increased exercise in the management of Type 2 diabetes, compared with usual care. 
Although we know a lot about how diet can control glucose levels and improve blood pressure and 
cholesterol, very little is known about how, or if exercise affects these factors. The Early ACTID study 
aims to answer these questions for the first time, and will be the largest diet and exercise trial in the world 
for people with type 2 diabetes. 
Who are we? 
The NHS and the charity Diabetes UK have funded the project, which has been designed by doctors and 
scientists from the University of Bristol who are specialists in diabetes and exercise. Early ACTID is 
being run from the Bristol Royal Infirmary and we are recruiting patients across the South-West region, 
with participants being seen at their local hospital. 
What will the Early ACTID study involve? 
The study aims to recruit 750 people from across the Southwest who have been newly diagnosed with 
type 2 diabetes within the last six to eight months. Individuals will be allocated to one of three groups: 
1. Control group: People in this group will receive usual care. 
2. Diet group: People in this group will receive regular help and advice on improving their diet 
3. Diet plus Exercise group: People in this group will receive the same dietary advice as the diet 
group, but in addition they will receive help to increase their daily levels of physical activity. 
Each participant will remain in the study for one year, whilst the study itself will last for three years. 
At the end of the study, we will be able to see whether exercise improves glucose control, blood 





Volunteer information sheet 
The Early ACTID participant record book 
What is the Early ACTID participant record book? 
The Early ACTID participant record book contains participant consent forms, information about the 
study, and charts for recording clinical measurements. The Early ACTID record book that is given to 
participants in the two intervention groups will contain additional material: 
Diet group: Information about diet, tasks to complete during nurse appointments, and charts to record 
their weight. 
Diet plus exercise group: Information about diet and exercise, tasks to complete during nurse 
appointments, and charts to record weight and physical activity. 
What is the purpose of the Early ACTID participant record book? 
The participant record book is based on psychological theories for health behaviour change. Its purpose is 
to: 
" Improve diabetes management by helping participants in the two intervention groups (Diet group 
and Diet plus exercise group) make healthy changes to their lifestyle. 
" Facilitate patient involvement in their care during the study and improve the quality of care 
provided 
" Improve communication between the participant and the Early AMD healthcare professionals 
looking after them. 
Why is it important for you to read through the materials? 
" The Early ACTID study is committed to producing information for our participants that is clear, 
easy to read and of good quality. 








Instructions for reading through the materials 
What will be involved? 
" You will be provided with the written materials that will be given to participants when they enter 
the diet and exercise group of the Early ACTID study. 
" We ask that you read through the materials and identify the following: 
" Words which are unclear or are unhelpful `jargon'. 
" Phrases or sentences which are unclear or seem too long. 
" Diagrams and instructions which are unclear or seem unhelpful. 
" Instructions for tasks that are unclear or seem unhelpful. 
" Information that does not seem relevant to diabetes. 
" Information that does not follow in a logical order. 
" Writing that is too small and is difficult to read. 
How will you provide feedback? 
" You can write on the materials, or attach extra pages with your comments: whichever method you 
prefer. 
" We recommend that you take approximately two weeks to look over the materials. 
" We would like to see you again to discuss your comments and thoughts about the participant 
record book. We would be very happy to meet you at the University of Bristol, Tyndall Avenue, 
Clifton, Bristol. This can be at a time convenient for you. If meeting is not convenient for you, 
we can provide a pre-paid envelope for you to return the reviewed documents by post. Please find 
the address at the bottom of following page. 
Are there any costs involved? 
" As we mentioned previously, we are looking for volunteers. However, we are happy to reimburse 
any reasonable travel costs to and from the university for meetings. 
" If you need to return the materials by post, we will provide a pre-paid envelope for you which 
does not require any stamps. 
" What is really important to us is your time and contribution to this research project, which is 
invaluable to us. 
What will happen with your comments? 
" All returned comments and marked participant record books will be compiled and an analysis 
undertaken to establish if there are any commonly identified problems. Where possible, 





Important notes about the participant record book 
" The version of the record book that has been given to you for reviewing differs from the final 
version that will be given to participants. The differences include: 
o Grey boxes at the top of some pages of your version. These boxes provide information 
for you that may help with the review process. 
o There are some pages that will appear in the final version, but have not been included in 
the version given to you. These include: 
  Information on healthy eating. These pages are still being developed and will be 
reviewed by other volunteers. 
  Duplicates of earlier pages in the booklet, which are in your version. 
o The final version of the record book will: 
Be presented in an A5 ring binder. 
  Have some colour on each page. 
  Be built up throughout the duration of the study. At each appointment with the 
nurse and dietitian, participants will be given new pages to insert into the record 
book ring binder. 
We would like to thank you for your interest in this study, and for volunteering your time to 
read through the materials. Your views are extremely important to us. 
If you have any queries or wish to discuss any aspect of the materials, please contact Kate Fitzsimons: 
Telephone: 07900 627412 or 0117 3311106 
Email: K. Fitzsimons@bristol. ac. uk 





Appendix 8. Standard operating procedure (SOP) developed by the researcher and used by nurses to deliver 
the intervention programmes 
SOP for Nurse Visit 3/Week -2 
Nurse objectives regarding diet and exercise 
" Collect ActiGraph, diary sheet and exercise questionnaire. 
" Provide participant record book (PRF) & visit 3 inserts. Discuss: 
Welcome & contact details 
Medication 
Early ACTID goals 
Food diary(x2) & instructions 
General health record 
" Give participant opportunity to ask questions. 
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PRF materials required for visit 3: 
" Participant Record File (PRF) ring binder 
" PRF inserts 
" Section divider & contents: Information (1 page) 
f Sub-section front page: Information: Personal (1 page) 
" I. 1 Welcome & Contact details (1 page) 
f 1.3 Medication (1 page) 
f 1.5 Early ACTID goals (1 page) 
f Sub-section front page: Information: Appointments (1 page) 
f Sub-section front page: Information: Glossary (1 page) 
f I. 19-I. 32. Glossary of terms (7 pages) 
HEALTHY EATING (YELLOW) 
f Section divider and contents: Healthy eating (1 page) 
f Sub-section front page: Healthy Eating: Keeping track (1 page) 
f HE. 1 Recording your food intake with a diary (1 page) 
f HE. 3 Food diary: Sample (1 page) 
f Sub-section front page: Healthy Eating: Food diary (1 page) 
f HE. 9 Food diary x2 (2 A4 pages) 
f HE. 11 Food and food associations (1 page) 
f Sub-section front page: Healthy Eating: Goals and plans (1 page) 
f Sub-section front page: Healthy Eating: Information sheets (1 page) 
PROGRESS REPORTS (BLUE) 
f Section divider & contents: Progress Reports (1 page) 
f PR. 1 General health record (I page) 
f Section divider & contents: Personal notes (I page) 
f PN. 1-6 Personal notes (3 pages) 
(Total inserts = 30) 
Before the visit: 
" Complete contact details on page 1.2 of PRF 
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Full instructions: Visit 3 (Nurse)/ Week -2 
1. Collect ActiGraph, diary sheet and exercise questionnaire. 
" Ensure ActiGraph was positioned correctly in pouch (upright). 
" Ensure correct ID and ActiGraph number are recorded on the diary sheet. 
" Ensure participant has answered the questions at the bottom of the diary sheet. 
" Ensure correct ID number is recorded on the exercise questionnaire. 
" Ensure all exercise questions have been answered by participant. 
2. Provide PRF and visit 3 inserts, 
" Let participant know that the PRF is theirs to keep and that they are free to write notes and questions 
in it. 
Advise participant that they will receive handouts at each session, which they will be helped with. 
These handouts should be kept in their PRF. 
" Emphasise that it will be important in helping them reach their goals. 
" Stress the importance of taking the PRF to all nurse and dietitian appointments throughout the study, 
but NOT to the doctor appointments. 
2.1. Talk through the `Welcome' (I. 1) and `Contact details' (1.2) inserts. 
f Advise that the best way to contact you is by pager. 
2.2. Complete the `Medication' (1.3) insert. 
f Go through and complete `Medication' insert (1.3), recording their current medications. 
Alternatively, ask participant to complete this at home. 
2.3. Discuss general `Early ACTID goals' (1.5). 
f Talk through `Early ACTID goals' insert (1.5). 
f Mention that they will receive extra goals if allocated diet or diet plus exercise group. 
2.4. Talk through the 'Food diary' (HE. 9-10 x2; HE. 11) and keeping track instructions (IIE. 14). 
f Use inserts the following inserts to explain how to complete the 4-day `Food diary' (HHE. 9-10). 
o `Recording your food intake with a diary' (HE. 1-2) 
o `Food diary: Sample' (HE. 3-4) 
f Talk through the `Food and food associations' (HE. 1 1) insert and highlight the importance of 
recording ALL columns of the food diary. 
f Ensure participant knows to record their food intake on 2 week days and 2 weekend days. 
f Advise participant to keep the diary in their PRF and to take to Visit 4 to discuss with dietitian. 
Briefly show participant `General health record' (PR. 1) insert. 
f Advise participant that completing the `General health record is optional, but may be useful if 
they would like to record their test results. 
3. Give participant opportunity to ask any questions. 
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SOP for Visit 5 (Nurse)/Week 2 
Nurse objectives regarding diet and exercise 
" Discuss what to expect in visit 5 with `Appointments overview' (1.16). 
" Discuss key aspects of the nurse-participant relationship and sign the related agreement, 
`Working together as a team' (I. 11-12). 
" Healthy eating 
Advise participant of option to monitor and record their weight using the chart (PR. 3) 
and graph (PR. 5). Use keeping track instruction inserts as guidelines (HE. 5-HE. 8). 
= Provide and go through healthy eating `Information sheets' (HE. 27-32). 
Agree healthy eating goals for following 2 weeks, completing `Healthy eating goals - 
agreed with your nurse' (HE. 17). 
" Physical activity 
Provide participant with pedometer and `Pedometers' (PA. 1-2) insert. 
Advise participant how to monitor and record daily physical activity using the keeping 
track section (PA. 3-PA. 8), `Diary (PA. 9-10) & 'Physical activity graph' (PR. 7) and 
they have at least 3 physical activity diaries. 
= Agree physical activity goals for following 2 weeks, completing `Physical activity 
goals' (PA. 15). 
-i Wear pedometer daily 
4 Complete `Physical activity diary' daily 
-> Complete `Physical activity graph' daily 
Provide `Troubleshooting your pedometer' (PA. 19-20) from the physical activity 
information sheets section. 




SOP for Visit 5 (Nurse)/Week 2 
Nurse objectives regarding diet and exercise 
" Discuss what to expect in visit 5 with `Appointments overview' (1.16). 
" Discuss key aspects of the nurse-participant relationship and sign the related agreement, 
`Working together as a team' (I. 11-12). 
" Healthy eating 
Advise participant of option to monitor and record their weight using the chart (PR. 3) 
and graph (PR. 5). Use keeping track instruction inserts as guidelines (HE. 5-HE. 8). 
Provide and go through healthy eating `Information sheets' (HE. 27-32). 
Agree healthy eating goals for following 2 weeks, completing `Healthy eating goals - 
agreed with your nurse' (HE. 17). 
" Physical activity 
Provide participant with pedometer and `Pedometers' (PA. 1-2) insert. 
Advise participant how to monitor and record daily physical activity using the keeping 
track section (PA. 3-PA. 8), `Diary (PA. 9-10) & 'Physical activity graph' (PR. 7) and 
they have at least 3 physical activity diaries. 
Agree physical activity goals for following 2 weeks, completing `Physical activity 
goals' (PA. 15). 
4 Wear pedometer daily 
4 Complete `Physical activity diary' daily 
- Complete `Physical activity graph' daily 
Provide `Troubleshooting your pedometer' (PA. 19-20) from the physical activity 
information sheets section. 
" Give participant the opportunity to ask any questions. 
ý, ý, ý. 
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Materials required for visit 5: 
" Pedometer 
" PRF inserts 
EW 1' 1 (ORANGE) 
f I. 11 Working together as a team (1 page) 
HEALTHY EATING (YELLOW) 
f HE. 5 Recording your weight (1 page) 
f HE. 7 Recording your weight on a graph (1 page) 
f HE. 9 Food diary x2 (2 A4 pages) 
f HE. 17 Healthy eating goals - agreed with your nurse (1 page) 
f HE. 27-32 Information sheets `Reviewing your food diary' - 'Key points... ' (3 pages) 
f Section divider & contents (2 pages) 
f Sub-section front page: Physical activity: Keeping track (1 page) 
f PA. ] Pedometers (1 page) 
f PA. 3 Recording your physical activity with a diary (1 page) 
f PA. 5 Physical activity diary: Sample (I page) 
f PA. 7 Recording your physical activity on a graph (I page) 
f Sub-section front page: Physical activity: Diary (I page) 
f PA. 9 Physical activity diary >3 (3 pages) 
f Sub-section front page: Physical activity: Goals and plans (1 page) 
f PA. 15 Physical activity goals (1 page) 
f Sub-section front page: Physical activity: Information sheets (1 page) 
f PA. 19 Troubleshooting your pedometer (I page) 
f Sub-section front page: Physical activity: Gaining confidence (I page) 
PROGRESS REPORTS (BLUE) MMMM 
f PR. 3 Weight chart (1 page) 
f PR. 5 Weight graph (1 page) 
f PR. 7 Physical activity graph (I page) 
(Total inserts = 28) 
Before the visit: 
" Check which group participant has been allocated 
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Full instructions: Visit 5 (Nurse)/Week 2 
1. Discuss what to expect in visit 5, using `Appointments overview' (1.16). 
" Advise participant what to expect 
" Advise participant that they will have an opportunity to ask any questions 
2. Discuss key aspects of the nurse-participant relationship and sign the related agreement, 
`Working together as a team' (I. 11-12). 
" State the nurse's responsibilities. 
" State the participant's responsibilities. 
" Ask if there are any other things that they would like to be added to either list. 
" Suggest that you both sign as a way of remembering how you will work together. 
3. Healthy Eating 
3.1 Provide `Recording your weight' (HE. 5) and 'Recording your weight on a graph' (H E. 7) and 
advise participant how to self-monitor weight. 
f Talk participant through recording their weight each week on the 'Weight chart' (PR. 3) and 
`Weight graph' (PR. 5). 
f Advise participant that monitoring weight is optional, but emphasise that generally people who 
successfully lose weight and maintain their weight loss are those who tend to monitor their weight 
to keep track of their progress. 
3.2 Provide healthy eating information sheets (HE. 27-32). 
f Talk through the following inserts: 
  'Reviewing your food diary' (HE. 27) 
  Changing eating behaviours' (HE28) 
  Setting goals' (HE. 29-3 l) 
  Key points to remember from this visit' (HE. 32) 
3.3 Agree healthy eating goals with participant, using `Healthy eating goals - agreed with your 
nurse' (HE. 17). 
f Agree goals for the following 2 weeks. 
f Ask participant to score their motivation and confidence for each goal 
f Both sign the insert. 
f Record agreed goals on the CRF. 
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4. Physical Activity 
4.1. Provide participant with pedometer and `Pedometers' (PA. 1-2) insert. 
f Briefly explain what the pedometer is and how it works using `Pedometers' (PA. 1-2 ). 
4.2. Advise participant how to monitor and record their daily physical activity using the keeping 
track section PA. 3-8, the `Physical activity diary' (PA. 9-10) and the `Physical activity graph' 
(PR. 7). 
f Talk participant through 'Recording your physical activity' (HE. 3) and 'Physical activity diary: 
Sample' (PA. 5). 
f Provide at least 3 'Physical activity diary' (PA. 9-10) inserts and emphasise why it's important to 
complete and bring these to their next session: 
o People who keep track tend to be more active, and more successful at making lasting 
changes. 
o Early ACTID needs to know how much physical activity participants are doing so that 
we can determine dose-response. Also, it's important to see how participants are 
achieving their physical activity, i. e. are people doing I bout lasting 30 minutes, or 3 
bouts of 10 minutes, and will this influence glucose and blood pressure control? 
f Ensure participant is aware that only activity sessions lasting 10 minutes should be recorded. 
f Ensure participant is happy using the physical activity diary 
f Talk though 'Recording your physical activity on a graph' (PA. 7-8) and explain how to plot total 
daily steps. 
4.3. Agree physical activity goals with participant, using `Physical activity goals' (PA. 15). 
f Agree and set goals for the following 2 weeks. These should be -self-monitoring goals: 
Wear pedometer during all waking hours 
= Keep daily physical activity diary of USUAL physical activity 
Plot daily steps on `Physical activity graph' (PR. 7) 
f Ask participant to score their motivation and confidence for each goal. 
f Both sign the insert. 
f Record agreed goals on the CRF. 
Provide `Troubleshooting your pedometer' (PA. 19). 
f Refer to `Troubleshooting for your pedometer' and advise participant to read this sheet if they 
encounter any problems with their pedometer. 
f Advise that if the problem is not resolved, the participant should contact you by pager or entail. 
5. Give participant the opportunity to ask any other questions, perhaps about the study in general. 
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SOP for Visit 6 (Nurse)/Week 4 
Nurse objectives regarding diet and exercise 
" Weigh participant. 
" Discuss what to expect in visit 6 with `Appointments overview' (I. 16). 
" Healthy Eating 
Review and discuss previous 'Healthy eating goals - agreed with your nurse' (HE. 17 ). 
set at visit 5. 
Review recent keeping track records (PR. 3-5) (if appropriate). 
Discuss and complete `Successes and difficulties (HE. 18). 
Review information sheets provided by dietitian: 
  `Healthy eating part IF (HE. 33-48). 
= Discuss 'Areas to focus on - agreed with your dietitian' (HE. 15). 
" Physical activity 
Review and discuss 'Physical activity goals' (PA. 15) set at visit 5. 
Review completed `Physical activity diary' (PA. 9- 10) sheets and 'Physical activity 
graph' (PR. 7/8). 
Discuss and complete `Successes and difficulties' (PA. 16). 
Provide and encourage participant to complete inserts for Gaining confidence 
subsection: 
  `Physical activity history' (PA. 33-34) 
  `Benefits of physical activity' & `Pros and cons' (PA35-36) 
Provide inserts for Goals and plans subsection (PA. 1 1-17). 
  'Setting physical activity goals' (PA. 11-12) 
  `Other brisk activities' (PA. 13) 
Agree 'Physical activity goals' (PA. 15) for following 2 weeks and agree a 'Physical 
activity plan' (PA. 17). 
-i Something active on at least 3-4 days 
4 60 minutes over 6 days 
Ensure participant has at least 3 `Physical activity diary' (PA. 9-10) inserts. 
= Provide physical activity information sheets (PA. 21-31). 
" Schedule visit 7 for 2 weeks' time (week 6). 
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Full instructions: Visit (nurse) 6/Week 4 
1. Weigh participant. 
2. Discuss what to expect in visit 6 with 'Appointments overview' (1.16). 
3. Healthy Eating 
3.1. Review and discuss previous `Healthy eating goals - agreed with your nurse' (HE. 17), set at 
visit 5. 
f With participant, briefly review goals set at visit 5. 
3.2. Review keeping track records (PR. 3-5) (if appropriate). 
f If participant was intending to monitor their weight, ask how they got on with keeping track. 
f Review their 'Weight chart' (PR. 3) and `Weight graph' (PR. 5) to check records are heine 
completed appropriately. 
  Congratulate on success with recording, if appropriate. 
  If participant is having difficulties, revise how to complete the records. 
f Record on the CRF if participant is happy with completing the records. If participant has 
encountered problems, record on the CRF and state what these were. 
f Record on the CRF what the self-monitored weekly weight was for previous weeks, as recorded 
on participant's `Keeping track chart'. 
3.3. Discuss and complete `Successes and difficulties' (HE. 18). 
f Ask participant how they have got on with reaching their healthy eating goal. 
f Based on participant's response, and evidence from the keeping track records: 
  Congratulate on success with any improvement in healthy eating/weight. 
  If participant feels they have not made much effort, try saying 'tell me a little about that' and 
'what would help you over the next few weeks? ' 
o With participant, brainstorm how to resolve problems and record on insert. 
  Record on the CRF if participant has encountered problems, and what strategies have been 
discussed to resolve problems. 
f Reinforce recent success/behavioural change. 
3.4. Review information sheets provided by dietitian 'Healthy eating part II' (11 H:. 33-48). 
f Ask participant if they have any questions about the information they received in their dietitian's 
appointment. 
3.5. Discuss `Areas to focus on - agreed with your dietitian' (HE. 15) agreed with the dietitian. 
f Ask participant how they intend to focus on these areas. 
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Full instructions: Visit (nurse) 6/Week 4 
1. Weigh participant. 
2. Discuss what to expect in visit 6 with `Appointments overview' (1.16). 
3. Healthy Eating 
3.1. Review and discuss previous `Healthy eating goals - agreed with your nurse' (HE. 17 ), set at 
visit 5. 
f With participant, briefly review goals set at visit 5. 
3.2. Review keeping track records (PR. 3-5) (if appropriate). 
f If participant was intending to monitor their weight, ask how they got on with keeping track. 
f Review their ' Weight chart' (PR. 3) and `Weight graph' (PR. 5) to check records are being 
completed appropriately. 
  Congratulate on success with recording, if appropriate. 
  If participant is having difficulties, revise how to complete the records. 
f Record on the CRF if participant is happy with completing the records. If participant has 
encountered problems, record on the CRF and state what these were. 
f Record on the CRF what the self-monitored weekly weight was for previous weeks, as recorded 
on participant's 'Keeping track chart'. 
3.3. Discuss and complete `Successes and difficulties' (HE. 18). 
f Ask participant how they have got on with reaching their healthy eating goals. 
f Based on participant's response, and evidence from the keeping track records: 
  Congratulate on success with any improvement in healthy eating/weight. 
  If participant feels they have not made much effort, try saying `tell me a little about that' and 
what would help you over the next few weeks? ' 
o With participant, brainstorm how to resolve problems and record on insert. 
  Record on the CRF if participant has encountered problems, and what strategies have been 
discussed to resolve problems. 
f Reinforce recent success/behavioural change. 
3.4. Review information sheets provided by dietitian `Healthy eating part 11' (11 E. 33-48). 
f Ask participant if they have any questions about the information they received in their dietitian' , 
appointment. 
3.5. Discuss `Areas to focus on - agreed with your dietitian' (HE. 15) agreed with the dietitian. 
f Ask participant how they intend to focus on these areas. 
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4. Physical activity 
4.1. Review and discuss 'Physical activity goals' (PA. 15) agreed at visit 5. 
f With participant, briefly review goals set at visit 5. 
4.2. Review and discuss the 2 completed 'Physical activity diaries' and 'Physical activity graph'. 
f Ask participant how they have got on with: 
  Using their pedometer. 
  Completing the `Physical activity diary'. 
  Plotting their daily steps on the 'Physical Activity Graph'. 
f Check the diary and the daily activity graph are being completed appropriately. 
4.3. Discuss and complete `Successes and difficulties' (PA. 16) 
f Discuss successes and difficulties and record on insert. 
f Congratulate on good completion, if appropriate. 
f If participant is having difficulties, revise how to complete the records, and if necessary plot their 
steps on their 'physical activity graph' (PR. 7-8). 
f Record on the CRF if they were happy with completing the records. If they encountered problems, 
record on the CRF and state what these were. 
4.4. Provide and complete inserts for Gaining confidence subsection: 
f `Physical activity history' (PA. 33-34) 
  Ask participant what physical activity they do in a typical week and record on the insert. 
  Ask about past activity behaviour and record on insert. 
  Ask about likes and dislikes and record on insert. 
f `Benefits of physical activity' & 'Pros and cons' (PA35-36) 
  Briefly talk through PA. 35 
  Work through PA. 36, encouraging participant to record their perceived pros and cons of 
increasing their physical activity. 
  Encourage participant to brainstorm strategies to minimise the cons. 
  Ask participant for consent to record these pros and cons on their CRI= and take action 
accordingly. 
4.5. Provide inserts for Goals and plans subsection (PA. 11-17) 
f 'Setting physical activity goals' (PA. 1 1-12 ) 
  Talk through PA I 1-12 
  Emphasise the importance of making small gradual increases over a number of weeks. 
  Advise that an additional 30 minutes of walking should approximately increase daily steps by 
3(X)0-3600. 
f 'Other brisk activities' (PA. 13) 
  Encourage participant to tick those that they already do, or realistically could do. 
4.6. Agree `Physical activity goals' (PA. 15) for following 2 weeks and agree a 'Physical activity 
plan' (PA. 17). 
f Discuss and agree suitable goals for following 2 weeks, until visit 7. Ideally, these should include: 




Doing 60 minutes of moderate-intensity activity over 6 days of the week after 
f Ask participant how they intend to reach these goals, considering when, where and how they will 
be active. 
f Encourage participant to develop an action plan using their 'Physical activity plan' (PA. 17-18) 
insert. 
f Ask participant to record goals on the `Physical activity goals' (PA. 15) insert. 
f Ask participant to score their motivation and confidence for each goal. 
f Record participant's weekly goals, motivation and confidence on the CRF and state whether the 
goals are on target (see above). If not on target, state why. 
4.7. Ensure participant has at least 3 `Physical activity diary' (PA. 9- 10) inserts. 
4.8. Provide physical activity information sheets (PA. 21-31). 
f Advise participant to look at these at home. 
5. Schedule visit 7 for 2 weeks' time (week 6). 
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Visit 7 (Nurse)/Week 6 
Nurse objectives regarding diet and exercise 
" Weigh participant. 
" Advise participant what to expect in visit 7, with `Appointments overview' (I. 16). 
" Healthy eting 
Review and discuss previous 'Areas to focus on - agreed with your dietitian' (HE. 1 S ). 
set at visit 6. 
Review 'Keeping track' records (PR. 3 & PR. 5). 
> Discuss 'Successes and difficulties'. 
Provide and complete inserts for Information sheets subsection: 
  'Triggers and cues for eating' (PA. 49-54) 
=>Agree new 'Healthy eating goals -agreed with your nurse' (HE. 17) for following 2 
weeks. 
" Physical activity 
Review and discuss 'Physical activity goals' (PA. 15) set at visit 6. 
Review completed 'Physical activity diary' (PA. 9-10) sheets and 'Physical activity 
graph' (PR. 7/8). 
Discuss 'Successes and difficulties' (PA. 16). 
Use optional materials from `Gaining confidence' subsection if participant has 
encountered difficulties and barriers. 
Provide and encourage participant to complete inserts for 'Gaining confidence' 
subsection: 
  `Lifestyle activity' 
  `Opportunities to be active' 
Agree 'Physical activity goals' (PA. 15) and a 'Physical activity plan' (PA. 17) for 
following 2 weeks. 
-i Doing 90 minutes over 5 days or more for the following week 
-i Doing 120 minutes over 5 days or more for the week after 
Ensure participant has at least 3 'Physical activity diary' (PA. 9- 10) inserts. 
Provide `Physical activity graph' (PR. 7-8), if appropriate. 
Schedule visit 8 for week 8. 
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Materials required for visit 7: 
" PRF inserts 
INFORMATION (ORANGE) 
f N/A 
HEALTHY EATING (YELLOW) 
f HE. 17-18 Healthy eating goals - agreed with your nurse (1 page) 
f HE. 49-54 Triggers and cues for eating (3 pages) 
PHYSICAL ACTIVITY (RED) 
f PA. 9 Physical activity diary 2! 3 (53 pages) 
f PA. 15 Physical activity goals (1 page) 
f PA. 17 Physical activity plan (1 page) 
f PA. 37 Lifestyle activity (I page) 
f PA. 39 Opportunities to be active (1 page) 
f PA. 43-48* Barriers to physical activity* (3 pages) 
f PA. 49-52* Personal time diary* (2 pages) 
f PA. 53* People to help you achieve your goals* (1 page) 
f PA. 55* Local exercise opportunities* (1 page) 
f PR. 7 Physical activity graph (1 page) 
(Total inserts = <20, of which 7 are optional) 
* Optional inserts for helping participant to overcome perceived barriers 
Before the visit: 
Review successes and difficulties identified in visit 6 
Review healthy eating and physical activity goals set at visit 6 
" Enter physical activity diary data 
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Full instructions: Visit (nurse) 7/Week 6 
1. Weigh participant. 
2. Advise participant what to expect in visit 7, with 'Appointments overview' (1.16). 
3. Healthy eating 
3.1. Review and discuss previous `Areas to focus on - agreed with your dietitian' (HE. 15), set at 
visit 6. 
f With participant, briefly review areas to focus on agreed with dietitian at visit 6. 
3.2. Review `Keeping track' records (PR. 3-5) (if appropriate). 
f If participant was intending to monitor their weight, ask how they got on with keeping track. 
f' Review their `Weight chart' (PR. 3) and `Weight graph' (PR. 5) to check records are being 
completed appropriately. 
  Congratulate on success with recording, if appropriate. 
  If participant is having difficulties, revise how to complete the records. 
f Record on the CRF if participant is happy with completing the records. If participant has 
encountered problems, record on the CRF and state what these were. 
f Record on the CRF what the self-monitored weekly weight was for previous weeks, as recorded 
on participant's 'Keeping track chart'. 
3.3. Discuss `Successes and difficulties'. 
Ask participant how they have got on with reaching their healthy eating goals. 
f '_ Based on participant's response, and evidence from the keeping track records: 
Congratulate on success with any improvement in healthy eating/weight. 
If participant feels they have not made much effort, try saying `tell me a little about that' and 
`what would help you over the next few weeks? ' 
o With participant, brainstorm how to resolve problems and record on insert. 
 . Record on the CRF if participant has encountered problems, and what strategies have been 
discussed to resolve problems. 
Reinforce recent success/behavioural change. 
3.4. Provide and complete inserts for Information sheets subsection: 
  `Triggers and cues for eating' (PA. 49-54) 
3.5. Agree new 'Healthy eating goals - agreed with your nurse' (HE. 17) for following 2 weeks. 
f Discuss and agree healthy eating goals for the following 2 weeks until visit 8. 
f Ask participant how they intend to reach these goals. 
f Ask participant to record goals on insert `Healthy eating goals' (HE. 17). 
f Ask participant to score their motivation and confidence for each goal. 
Record participant's weekly goals and their motivation and confidence on the CRF. 
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4. Physical activity 
4.1. Review and discuss 'Physical activity goals' (PA. 15) set at visit 6. 
f With participant, briefly review goals set at visit 6. 
4.2. Review completed 'Physical activity diary' (PA. 9-10) sheets and `Physical activity graph' 
(PR. 7/8). 
f Ask participant how they have got on with: 
  Using their pedometer. 
  Completing the `Physical activity diary'. 
  Plotting their daily steps on the `Physical Activity Graph'. 
f Check the diary and the daily activity graph are being completed appropriately. 
43. Discuss 'Successes and difficulties' (PA. 16). 
f. Congratulate on success with any increase in physical activity. 
f Ask participant to record any successes on the insert. These can include wearing their pedometer 
during waking hours, completing the `Keeping track' records, any increase in physical activity, 
reaching their physical activity goal (Total weekly minutes). 
f Record these successes on the CRF. 
f If participant has not reached goals or feels they have not made much effort, try saying 'tell me a 
little about that' and 'What would help you over the next few weeks? ' 
f Ask participant to record any difficulties on the insert. 
f Record these difficulties on the CRF. 
4.4. Use optional materials from `Gaining confidence' subsection if participant has encountered 
difficulties and barriers. 
f If participant is having difficulties increasing barriers, use the optional materials to overcome 
barriers: 
`Barriers to physical activity'* (PA. 43-48) 
`Personal time diary' * (PA. 49-52) 
`People to help you achieve your goals' * (PA. 53) 
`Local exercise opportunities' * (PA. 55) 
f Record on the CRF which inserts were used. 
4.5. Provide and complete inserts for 'Gaining confidence' subsection: 
f `Lifestyle activity' (PA. 37) 
  Ask participant to consider any changes they could make, swapping inactive choices for active 
choices, e. g. taking the stairs instead of the lift or escalator. Encourage participant to complete 
the table on PA. 38. 
  Use `Opportunities to be active' for ideas 
`Opportunities to be active' (PA. 39) 
  Encourage participant to tick those that are realistic. 
4.6. Agree `Physical activity goals' (PA. 15) and a 'Physical activity plan' (PA. 17) for following 2 
weeks. 
f Discuss and agree suitable goals for following 2 weeks, until visit 8. Ideally, these should include: 
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Doing 90 minutes over 5 days or more for the following week 
Doing 120 minutes over 5 days or more for the week after 
f Ask participant how they intend to reach these goals, considering when, where and how they will 
be active. 
f Encourage participant to develop an action plan using their `Physical activity plan' (PA. 17-18) 
insert. 
f Ask participant to record goals on the `Physical activity goals' (PA. 15) insert. 
f Ask participant to score their motivation and confidence for each goal. 
Record participant's weekly goals, motivation and confidence on the CRF and state whether the 
goals are on target (see above). If not on target, state why. 
4.7. Ensure participant has at least 3 `Physical activity diary' (PA. 9.10) Inserts. 
4.8. Provide `Physical activity graph' (PR. 7-8), if appropriate. 
5. Schedule visit 8 for week 8 
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Visit 8 (Nurse)AVeek 8 
Nurse objectives regarding diet and exercise 
" Weigh participant. 
" Advise participant what to expect in visit 8, with `Appointments orerview' (1.16-17). 
" Healthy eating 
Review and discuss previous `Healthy eating goals- agreed with your nurse' (11E. 17), 
set at visit 7. 
= Review `Keeping track' records (PR. 3 & PR. 5) 
Discuss `Successes and difficulties' (HE. 18). 
Provide and complete inserts for Information sheets subsection: 
  `Relapses and coping will: difficult situations' (IIE. 55-60) 
Agree new `Healthy eating goals -agreed with your nurse' (11E. 17) for following 6 
weeks 
= Provide food diary x2 
" Physical activity 
Review and discuss 'Physical activity goals' (PA. 15) Set at visit 7. 
Review completed `Physical activity diary' (PA. 9.10) sheets and 'Physical activity 
graph' (PR. 7/8). 
Discuss 'Successes and difficulties' (PA. 16). 
Use optional materials from `Gaining confidence' subsection if participant has 
encountered difficulties and barriers. 
= Provide and encourage participant to complete inserts for 'Gaining confidence' 
subsection: 
" 'Lapses' (PA. 41-42) 
Agree `Physical activity goals' (PA. 15) and a `Physical activity plan' (PA. 17) for 
following 6 weeks. 
3 Doing 150 minutes over 5 days or more for the following week 
- At least 150 minutes over 5 days or more thereafter 
Ensure participant has at least 6 `Physical activity diary' (PA. 9-10) inserts. 
Provide `Physical activity graph' (PR. 7.8), if appropriate. 
" Schedule telephone call for week 10. 
" Schedule visit 9 for week 14. 
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Materials required for visit 8: 
" PRF inserts 
INFOI&ATION (ORANGE) 
f N/A 
HEALTHY EATING (YELLOW) 
f HE. 17-18 Healthy eating goals - agreed with your nurse (1 page i 
f HE. 55-60 Relapses and coping with difficult situations (3 pages) 
f HE. 9 Food diary x2 (2 A4 pages) 
PHYSICAL ACTIVITY (RED) 
f PA. 9 Physical activity diary >6 (6 pages) 
f PA. 15 Physical activity goals (1 page) 
f PA. 17 Physical activity plan (1 page) 
f PA. 41 Preventing relapses (1 page) 
f PA. 43-48* Barriers to physical activity* (3 pages) 
f PA. 49-52* Personal time diary* (2 pages) 
f PA. 53* People to help you achieve your goals" (I page 
f PA. 55* Local exercise opportunities* (1 page) 
PROGRESS REFIORTS (BLUE) 
f PR. 7 Physical activity graph (I page) 
(Total inserts = 23, of which 7 are optional) 
* Optional inserts for helping participant to overcome pereci\cd harrier, 
Before the visit: 
" Review successes and difficulties identified in visit 7 
" Review healthy eating and physical activity goals set at visit 7 




Full instructions: Visit (nurse) 8/Week 8 
1. Weigh participant. 
2. Advise participant what to expect in visit 8, with `Appointments overview' (I. 16.17). 
3. Healthy eating 
3.1. With participant, briefly review goals set at visit 7. 
f Review and discuss previous `Healthy eating goals- agreed with your nurse' (HE. 17), set at visit 
7 
3.2. Review 'Keeping track' records (PR. 3 & PR. 5) 
f If participant was intending to monitor their weight, ask how they got on with keeping track. 
f Review their `Weight chart' (PR. 3) and `Weight graph' (PR. 5) to check records are being 
completed appropriately. 
  Congratulate on success with recording, if appropriate. 
  If participant is having difficulties, revise how to complete the records. 
f Record on the CRF if participant is happy with completing the records. If participant has 
encountered problems, record on the CRF and state what these were. 
f Record on the CRF what the self-monitored weekly weight was for previous weeks, as recorded 
on participant's `Keeping track chart'. 
3.3. Discuss `Successes and difficulties' (HE. 18). 
f Ask participant how they have got on with reaching their healthy eating goals. 
f Based on participant's response, and evidence from the keeping track records: 
  Congratulate on success with any improvement in healthy eating/weight. 
  If participant feels they have not made much effort, try saying `tell me a little about that' and 
`what would help you over the next few weeks? ' 
o With participant, brainstorm how to resolve problems and record on insert. 
  Record on the CRF if participant has encountered problems, and what strategies have been 
discussed to resolve problems. 
f Reinforce recent success/behavioural change. 
3.4. Provide and complete inserts for Information sheets subsection: 
f `Relapses and coping with difficult situations' (HE. 55-60) 
3.5. Agree new 'Healthy eating goals - agreed with your nurse' (HE. 17) for following 6 weeks 
f Discuss and agree healthy eating goals for the following 6 weeks until visit 9. 
f Ask participant how they intend to reach these goals. 
f Ask participant to record goals on insert `Healthy eating goals' (HE. 17). 
f Ask participant to score their motivation and confidence for each goal. 
f Record participant's weekly goals and their motivation and confidence on the CRF. 
3.6. Provide food diary x2 
4. Physical activity 
4.1. Review and discuss `Physical activity goals' (PA. 15) set at visit 7. 
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f With participant, briefly review goals set at visit 7. 
4.2. Review completed `Physical activity diary' (PA. 9-10) sheets and `Physical activity graph' 
(PR. 7/8). 
f Ask participant how they have got on with: 
Using their pedometer. 
Completing the `Physical activity diary'. 
Plotting their daily steps on the `Physical Activity Graph'. 
f Check the diary and the daily activity graph are being completed appropriately. 
4.3. Discuss 'Successes and difficulties' (PA. 16). 
f Congratulate on success with any increase in physical activity. 
f Ask participant to record any successes on the insert. These can include wearing their pedometer 
during waking hours, completing the `Keeping track' records, any increase in physical activity, 
reaching their physical activity goal (Total weekly minutes). 
f Record these successes on the CRF. 
f If participant has not reached goals or feels they have not made much effort, try saying `tell me a 
little about that' and `What would help you over the next few weeks? ' 
f Ask participant to record any difficulties on the insert. 
f Record these difficulties on the CRF. 
4.4. Use optional materials from 'Gaining confidence' subsection if participant has encountered 
difficulties and barriers. 
f If participant is having difficulties increasing barriers, use the optional materials to overcome 
barriers: 
=> `Barriers to physical activity'* (PA. 43-48) 
= `Personal time diary'* (PA. 49-52) 
= `People to help you achieve your goals'* (PA. 53) 
`Local exercise opportunities'* (PA. 55) 
f Record on the CRF which inserts were used. 
4.5. Provide and encourage participant to complete inserts for 'Gaining confidence' subsection: 
f `Lapses' (PA. 41-42) 
4.6. Agree 'Physical activity goals' (PA. 15) and a 'Physical activity plan' (PA. 17) for following 6 
weeks. 
f Discuss and agree suitable goals for following 6 weeks, until visit 9. Ideally, these should include: 
Doing an extra 150 minutes over 5 days or more for the following week 
At least an extra 150 minutes over 5 days or more thereafter 
f SOP for Visit 8 continued 
f Ask participant how they intend to reach these goals, considering when, where and how they will 
be active. 
f Encourage participant to develop an action plan using their `Physical activity plan' (PA. 17-18) 
insert. 
f Ask participant to record goals on the `Physical activity goals' (PA. 15) insert. 
f Ask participant to score their motivation and confidence for each goal. 
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f Record participant's weekly goals, motivation and confidence on the CRF and state whether the 
goals are on target (see above). If not on target, state why. 
4.7. Ensure participant has at least 6 `Physical activity diary ' (PA. 9-10) inserts. 
4.8. Provide `Physical activity graph' (PR. 7-8), if appropriate. 
5. Schedule telephone call for week 10. 
6. Schedule visit 9 for week 14. 
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Visit 9 (Nurse)/Week 9 
Nurse objectives regarding diet and exercise 
" Weigh participant. 
" Advise participant what to expect in visit 9, with `Appointments overview' (1.16-17). 
" Healthy eating 
Review and discuss previous `Healthy eating goals- agreed with your nurse' (HE. 17), 
set at visit 8. 
Review `Keeping track' records (PR. 3 & PR. 5) 
Discuss `Successes and difficulties' (HE. 18). 
= Review information sheets provided by dietitian: 
  `Portion sizes and food labels' (HE. 61-72) 
Discuss `Areas to focus on - agreed with your dietitian' (HE 15). 
" Physical activity 
Review and discuss `Physical activity goals' (PA. 15) set at visit 8. 
= Review completed `Physical activity diary' (PA. 9-10) sheets and `Physical activity 
graph' (PR. 7/8). 
Discuss `Successes and difficulties' (PA. 16). 
Use optional materials from `Gaining confidence' subsection if participant has 
encountered difficulties and barriers. 
Agree `Physical activity goals' (PA. 15) and a `Physical activity plan' (PA. 17) for 
following 6 weeks. 
- At least 150 minutes over and above BL 
Ensure participant has at least 6 `Physical activity diary' (PA. 9-10) inserts. 
Provide `Physical activity graph' (PR. 7-8), if appropriate. 
" Schedule visit 10 for week 20. 
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= HEALTHY EATING (YELLOW) 
f N/A 
PHYSICAL 1 
f PA. 9 Physical activity diary >6 (6 pages) 
f PA. 15 Physical activity goals (1 page) 
f PA. 17 Physical activity plan (1 page) 
f PA. 43-48* Barriers to physical activity* (3 pages) 
f PA. 49-52* Personal time diary* (2 pages) 
f PA. 53* People to help you achieve your goals* (1 page) 
f PA. 55* Local exercise opportunities* (1 page) 
PROGRESS 
f PR. 7 Physical activity graph (I page) 
(Total inserts = 16, of which 7 are optional) 
* Optional inserts for helping participant to overcome perceived barriers 
Before the visit: 
" Review successes and difficulties identified in visit 8 
" Review healthy eating and physical activity goals set at visit 8 
" Enter physical activity diary data 
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Full instructions: Visit (nurse) 9/Week 9 
1. Weigh participant. 
2. Advise participant what to expect in visit 9, with `Appointments overview' (1.16-17). 
3. Healthy eating 
3.1. With participant, briefly review goals set at visit 8. 
f Review and discuss previous `Healthy eating goals- agreed with your nurse' (HE. 17), set at visit 
8. 
3.2. Review 'Keeping track' records (PR. 3 & PR. S). 
f If participant was intending to monitor their weight, ask how they got on with keeping track. 
f Review their `Weight chart' (PR. 3) and `Weight graph' (PR. 5) to check records are being 
completed appropriately. 
  Congratulate on success with recording, if appropriate. 
  If participant is having difficulties, revise how to complete the records. 
f Record on the CRF if participant is happy with completing the records. If participant has 
encountered problems, record on the CRF and state what these were. 
f Record on the CRF what the self-monitored weekly weight was for previous weeks, as recorded 
on participant's `Keeping track chart'. 
3.3. Discuss `Successes and difficulties' (HE. 18). 
f Ask participant how they have got on with reaching their healthy eating goals. 
f Based on participant's response, and evidence from the keeping track records: 
  Congratulate on success with any improvement in healthy eating/weight. 
  If participant feels they have not made much effort, try saying `tell me a little about that' and 
`what would help you over the next few weeks? ' 
o With participant, brainstorm how to resolve problems and record on insert. 
  Record on the CRF if participant has encountered problems, and what strategies have been 
discussed to resolve problems. 
f Reinforce recent success/behavioural change. 
3.4. Review information sheets `Portion sizes and food labels' (HE. 61-72) provided by dietitian. 
" Ask participant if they have any questions about the information they received in their dietitian's 
appointment. 
3.5. Discuss `Areas to focus on - agreed with your dietitian' (HE15). 
f Ask participant how they intend to focus on these areas. 
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4. Physical activity 
4.1. Review and discuss `Physical activity goals' (PA. 15) set at visit 8. 
f With participant, briefly review goals set at visit 8. 
4.2. Review completed `Physical activity diary' (PA. 9.10) sheets and `Physical activity graph' 
(PR. 7/8). 
f Ask participant how they have got on with: 
  Using their pedometer. 
  Completing the `Physical activity diary'. 
  Plotting their daily steps on the `Physical Activity Graph'. 
f Check the diary and the daily activity graph are being completed appropriately. 
4.3. Discuss 'Successes and difficulties' (PA. 16). 
f Congratulate on success with any increase in physical activity. 
f Ask participant to record any successes on the insert. These can include wearing their pedometer 
during waking hours, completing the 'Keeping track' records, any increase in physical activity, 
reaching their physical activity goal (Total weekly minutes). 
f Record these successes on the CRF. 
f If participant has not reached goals or feels they have not made much effort, try saying 'tell me a 
little about that' and 'What would help you over the next few weeks? ' 
f Ask participant to record any difficulties on the insert. 
f Record these difficulties on the CRF. 
4.4. Use optional materials from 'Gaining confidence' subsection if participant has encountered 
difficulties and barriers. 
f If participant is having difficulties increasing barriers, use the optional materials to overcome 
barriers: 
=> `Barriers to physical activity'* (PA. 43-48) 
`Personal time diary'* (PA. 49-52) 
`People to help you achieve your goals' * (PA. 53) 
= `Local exercise opportunities' * (PA. 55) 
f Record on the CRF which inserts were used. 
4.5. Agree `Physical activity goals' (PA. 15) and a `Physical activity plan' (PA. 17) for following 6 
weeks. 
f Discuss and agree suitable goals for following 6 weeks, until visit 10. Ideally, these should 
include: 
At least 150 minutes over and above what was done at BL. 
f Ask participant how they intend to reach these goals, considering when, where and how they will be active. 
f Encourage participant to develop an action plan using their `Physical activity plan' (PA. 17-18) 
insert. 
f Ask participant to record goals on the `Physical activity goals' (PA. 15) insert. 
f Ask participant to score their motivation and confidence for each goal. 
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f Record participant's weekly goals, motivation and confidence on the CRF and state whether the 
goals are on target (see above). If not on target, state why. 
4.6. Ensure participant has at least 6 'Physical activity diary ' (PA. 9-10) inserts. 
4.7. Provide `Physical activity graph' (PR. 7-8), if appropriate. 
5. Schedule visit 10 for week 20. 
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Visit 10 (Nurse)/Week 10 
Nurse objectives regarding diet and exercise 
" Weigh participant. 
" Advise participant what to expect in visit 10, with `Appointments overview' (1.16-17). 
" Healthy eating 
Review and discuss previous `Areas to focus on - agreed with your dietitian' (HE. 15), 
set at visit 9. 
Review `Keeping track' records (PR. 3 & PR. 5) 
Discuss `Successes and difficulties'. 
Provide and complete inserts for Information sheets subsection: 
  `Eating and shopping habits' (HE. 73-75) 
" Agree new `Healthy eating goals -agreed with your nurse' (HE. 17) for following 8 
weeks. 
" Physical activity 
Review and discuss `Physical activity goals' (PA. 15) set at visit 9. 
Review completed `Physical activity diary' (PA. 9-10) sheets and `Physical activity 
graph' (PR. 7/8). 
Discuss `Successes and difficulties' (PA. 16). 
Use optional materials from `Gaining confidence' subsection if participant has 
encountered difficulties and barriers. 
Agree `Physical activity goals' (PA. 15) and a `Physical activity plan' (PA. 17) for 
following weeks. 
4 At least and extra 150 minutes over 5 days 
Ensure participant has at least 8 `Physical activity diary' (PA. 9-10) inserts. 
Provide `Physical activity graph' (PR. 7-8), if appropriate. 
" Ensure participant has 6-month fitness test booked. 




Materials required for visit 10: 
" PRF inserts 
f N/A 
= HEALTHY EATING (YELLOW) 
f HE. 17-18 Healthy eating goals - agreed with your nurse (1 page) 
f HE. 73-75 Eating and shopping habits (2 pages) 
PHYSICAL ACTIVITY (RED) 
f PA. 9 Physical activity diary >6 (6 pages) 
f PA. 15 Physical activity goals (1 page) 
f PA. 17 Physical activity plan (1 page) 
f PA. 43-48* Barriers to physical activity* (3 pages) 
f PA. 49-52* Personal time diary* (2 pages) 
f PA. 53* People to help you achieve your goals* (I page) 
f PA. 55* Local exercise opportunities* (1 page) 
PROGRESS REPORTS (BLUE) 
f PR. 7 Physical activity graph (1 page) 
(Total inserts = 19, of which 7 are optional) 
* Optional inserts for helping participant to overcome perceived barriers 
Before the visit: 
" Review successes and difficulties identified in visit 9 
" Review healthy eating and physical activity goals set at visit 9 
" Enter physical activity diary data 
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Full instructions: Visit (nurse) 10/Week 20 
1. Weigh participant. 
2. Advise participant what to expect in visit 9, with 'Appointments overview' (1.16-17). 
3. Healthy eating 
3.1. Review and discuss previous `Areas to focus on - agreed with your dietitian' (HHE. 15), set at 
f visit 9. 
f With participant, briefly review areas to focus on agreed with dietitian. 
3.2. Review `Keeping track' records (PR. 3 & PR. 5). 
f If participant was intending to monitor their weight, ask how they got on with keeping track. 
f Review their `Weight chart' (PR. 3) and `Weight graph' (PR. 5) to check records are being 
completed appropriately. 
  Congratulate on success with recording, if appropriate. 
  If participant is having difficulties, revise how to complete the records. 
f Record on the CRF if participant is happy with completing the records. If participant has 
encountered problems, record on the CRF and state what these were. 
f Record on the CRF what the self-monitored weekly weight was for previous weeks, as recorded 
= on participant's `Keeping track chart'. 
3.3. Discuss `Successes and difficulties'. 
f Ask participant how they have got on with reaching their healthy eating goals. 
f Based on participant's response, and evidence from the keeping track records: 
  Congratulate on success with any improvement in healthy eating/weight. 
If participant feels they have not made much effort, try saying `tell me a little about that' and 
'what would help you over the next few weeks? ' 
o With participant, brainstorm how to resolve problems and record on insert. 
Record on the CRF if participant has encountered problems, and what strategies have been 
discussed to resolve problems. 
Reinforce recent success/behavioural change. 
3.4. Provide and complete inserts for Information sheets subsection: 
f. `Eating and shopping habits' (HE. 73-75). 
3.5. Agree new 'Healthy eating goals - agreed with your nurse' (HE. 17) for following 8 weeks. 
f Discuss and agree healthy eating goals for the following 8 weeks until visit 12. 
i Ask participant how they intend to reach these goals. 
Ask participant to record goals on insert `Healthy eating goals' (HE. 17). 
f Ask participant to score their motivation and confidence for each goal. 
f Record participant's weekly goals and their motivation and confidence on the CRF. 
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Full instructions: Visit (nurse) 10/Week 20 
1. Weigh participant. 
2. Advise participant what to expect in visit 9, with 'Appointments overview' (1.16-17). 
3. Healthy eating 
3.1. Review and discuss previous `Areas to focus on - agreed with your dietitian' (HE. 15), set at 
visit 9. 
f With participant, briefly review areas to focus on agreed with dietitian. 
3.2. Review 'Keeping track' records (PR. 3 & PR. 5). 
f If participant was intending to monitor their weight, ask how they got on with keeping track. 
f Review their `Weight chart' (PR. 3) and `Weight graph' (PR. 5) to check records are being 
completed appropriately. 
  Congratulate on success with recording, if appropriate. 
  If participant is having difficulties, revise how to complete the records. 
f Record on the CRF if participant is happy with completing the records. If participant has 
encountered problems, record on the CRF and state what these were. 
f Record on the CRF what the self-monitored weekly weight was for previous weeks, as recorded 
on participant's `Keeping track chart'. 
3.3. Discuss `Successes and difficulties'. 
f Ask participant how they have got on with reaching their healthy eating goals. 
f Based on participant's response, and evidence from the keeping track records: 
  Congratulate on success with any improvement in healthy eating/weight. 
  If participant feels they have not made much effort, try saying `tell me a little about that' and 
`what would help you over the next few weeks? ' 
o With participant, brainstorm how to resolve problems and record on insert. 
  Record on the CRF if participant has encountered problems, and what strategies have been 
discussed to resolve problems. 
f Reinforce recent success/behavioural change. 
3.4. Provide and complete inserts for Information sheets subsection: 
f `Eating and shopping habits' (HE. 73-75). 
3.5. Agree new `Healthy eating goals - agreed with your nurse' (HE. 17) for following 8 weeks. 
f Discuss and agree healthy eating goals for the following 8 weeks until visit 12. 
f Ask participant how they intend to reach these goals. 
f Ask participant to record goals on insert `Healthy eating goals' (HE. 17). 
f Ask participant to score their motivation and confidence for each goal. 
f Record participant's weekly goals and their motivation and confidence on the CRF. 
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4. Physical activity 
4.1. Review and discuss 'Physical activity goals' (PA. 15) set at visit 9. 
f With participant, briefly review goals set at visit 9. 
4.2. Review completed `Physical activity diary' (PA. 9-10) sheets and 'Physical activity graph' 
(PR. 7/8). 
f Ask participant how they have got on with: 
  Using their pedometer. 
  Completing the `Physical activity diary'. 
  Plotting their daily steps on the `Physical Activity Graph'. 
f Check the diary and the daily activity graph are being completed appropriately. 
4.3. Discuss `Successes and difficulties' (PA. 16). 
f Congratulate on success with any increase in physical activity. 
f Ask participant to record any successes on the insert. These can include wearing their pedometer 
during waking hours, completing the 'Keeping track' records, any increase in physical activity, 
reaching their physical activity goal (Total weekly minutes). 
f Record these successes on the CRF. 
f If participant has not reached goals or feels they have not made much effort, try saying `tell me a 
little about that' and `What would help you over the next few weeks? ' 
f Ask participant to record any difficulties on the insert. 
f Record these difficulties on the CRF. 
4.4. Use optional materials from 'Gaining confidence' subsection if participant has encountered 
difficulties and barriers. 
f If participant is having difficulties increasing barriers, use the optional materials to overcome 
barriers: 
`Barriers to physical activity'* (PA. 43-48) 
`Personal time diary'* (PA. 49-52) 
`People to help you achieve your goals' * (PA. 53) 
`Local exercise opportunities'* (PA. 55) 
f Record on the CRF which inserts were used. 
4.5. Agree `Physical activity goals' (PA. 15) and a `Physical activity plan' (PA. 17) for following 8 
weeks. 
f Discuss and agree suitable goals for following 6 weeks, until visit 10. Ideally, these should 
include: 
At least 150 minutes over and above what was done at BL. 
f Ask participant how they intend to reach these goals, considering when, where and how they will be active. 
f Encourage participant to develop an action plan using their `Physical activity plan' (PA. 17-18) 
insert. 
f Ask participant to record goals on the 'Physical activity goals' (PA. 15) insert. 




f Record participant's weekly goals, motivation and confidence on the CRF and state whether the 
goals are on target (see above). If not on target, state why. 
4.6. Ensure participant has at least 8 `Physical activity diary ' (PA. 9-10) inserts. 
4.7. Provide `Physical activity graph' (PR. 7-8), if appropriate. 
5. Ensure participant has 6-month fitness test booked for week 26. 
6. Schedule visit 12 for week 28. 
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Appendix 9. An example of the physical activity database which is used to assess compliance with the physical 
activity study goal 




Day of week Time (hrs: mins) Steps 
Time monitor on 














session End of day 
Monday 07: 40 1 07: 5b 00: 16 0 





00: 00 0 
Tuesday 00: 19 0 





00: 00 0 
Wednesday 00: 50 0 





00: 00 0 
Thursday 13: 30 13: 50 00: 20 0 





00: 00 0 
Friday 00: 28 0 





00: 00 0 
Saturday 10: 00 10: 8 00: 38 0 





00: 00 0 
Sunday 01: 06 0 
00: 00 0 
00: 00 
01: 06 -- 0 
9543 
00: 00 0 
TOTALS Weekly t, 05: 59 Weeh , ;,,;. 53577 
nrs: mins 
No. of days walking was recorded in diary 
BASELINE VALUES FROM VISIT 6 hrs: mins 
Weekly total (Walking) 03: 23 
Daily average (Walking) 0029 
LONG-TERM GOALS SET AT VISIT 6 
Weekly target is at least an extra 02: 30 
Uijv target is an extra 00: 30 on at least 5.7 days 
Weekly target amounts to a total of 
Uaily target amounts to a total of Sr on at least 5/7 days 
CURRENT AMOUNT OF WALKING 
Weekly total (Walking) 
L" average (Walking) 
DIFFERENCE BETWEEN BASELINE & CURRENT LEVELS 
WeeKty difference ((; urrent-UL values) 02: 36 















3000 on at least 57 days 






Example of the summary sheet on the database 
WEEK SINCE RANDOMISATION BL at 2/3 Tar ets 4 5 6 
TIME SPENT BRISK WALKING 
Total time spent per week (hrs: mins) 03: 23 05: 54 05: 59 05: 33 
Average time spent per day (hrs: mins) 00: 29 *r 00: 50 00: 51 00: 47 
No. of days time target achieved (> extra 30mins) N/A 2 2 2 
Difference between weekly current & BL values (hrs: mins) N/A 02: 31 02: 36 02: 10 
Difference between daily current & BL values (hrs: mins) N, A 00: 21 00: 22 00: 18 
ACCUMULATED STEPS 
Total steps per week 38536 50099 53577 45908 
Average steps per day 5505 7157 7654 7651 
No. of days step target achieved N/A 2 3 3 
Difference between weekly current & BL values N/A 11563 15041 7372 
Difference between daily current & BL values N/A 1652 2149 2146 
TIME SPENT DOING OTHER MODERATE ACTIVITIES 
Total time spent per week (hrs: mins) 01: 2, 01: 40 01: 00 01: 50 
Average time spent per day (hrs: mins) 00: 1. 00: 14 00: 08 00: 15 
Difference between weekly current & BL values (hrs: mins) N/A 00: 11 ###### 00: 21 
Difference between daily current & BL values N/A 00: 01 ###### 00: 03 
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Appendix 10. Participant information sheets: Physical activity 
:. 1 it l. 1 
k(F11) 
Participant Information Sheet 
ActiGraph Activity Monitor 
Mk University of 
loci BRISTOL 
Early ACTID Study 
Joint Clinical Research Unit 
Level 5 Old Building, near Ward 29 
Bristol Royal Infirmary 
Marlborough Street 
BRISTOL BS2 8HW 
Tel: +44 (0117) 9282440 
Fax: +44 (0117) 9284470 
E mail: Early-ACTID @bristol . ac. uk 
What is an ActiGraph activity monitor? 
An ActiGraph activity monitor is a small electronic device that will measure your physical 
activity by continually monitoring and recording the movements of the body. 
What is the purpose of the activity monitor? 
This study aims to investigate the effect of physical activity on glucose level, blood pressure 
and cholesterol in people who have type 2 diabetes. To determine these effects, it is 
important that we accurately measure your physical activity at the start of the study, and then 
at 6 months and 1 year, so we can monitor any changes to your activity level. 
How does the activity monitor measure my physical activity? 
When worn securely on your waist with an elastic belt, the ActiGraph activity monitor moves 
only as your body moves. When in the correct upright position, components inside the 
monitor are able to record the range of your movements using units called counts. The 
ActiGraph then sums the counts every 60 seconds to provide minute-by-minute information 
about your level of activity. 
How do I wear the ActiGraph monitor? 
The ActiGraph monitor is enclosed in a pouch that is worn on either 
an elastic belt around your waist, which should be adjusted to the 
appropriate size for you, or your own personal belt. The ActiGraph 
monitor should be positioned on your hip, as shown in the picture. 
You may wear the elastic belt either under or over the top of your clothing. 
ActiGraph to measure your physical activity accurately, it is important 
upright, and held snugly against your body. 
In order for the 
that you keep it 
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When should I wear the ActiGraph monitor? 
The ActiGraph monitor should be worn during ALL waking hours, from the start of your day 
until just before bed. The ActiGraph is not waterproof however, so you should remove it 
whilst washing or swimming. 
You should start wearing the ActiGraph as soon as you get up on the day after your fitness 
assessment. We need information about your physical activity level for I full week, so you 
should continue to wear the ActiGraph monitor for 7 consecutive days. 
Once you have worn it for seven full days, please take the ActiGraph off and keep it in a safe 
place until you return it to the nurse at your next Early ACTID appointment. It is important 
that we have this information before you start the trial, so please remember to take the 
ActiGraph with you to your baseline measurement appointment with the nurse. 
How will the ActiGraph monitor know when to start recording my activity? 
The ActiGraph has been pre-programmed to start recording your activity from 5am the 
morning after your fitness assessment, unless alternative arrangements have been agreed. 
Should I change my activity level during the 7 days whilst wearing the ActiGraph 
monitor? 
It is very important that the information collected by your ActiGraph monitor reflects your 
USUAL level of physical activity, so please maintain your USUAL lifestyle whilst wearing 
the monitor. 
Do I need to do anything else whilst wearing the ActiGraph monitor? 
Your ActiGraph comes with a diary sheet, which you should use to record any physical 
activity you do that the ActiGraph is unable to record or accurately measure, i. e. water-based 
activities such as swimming, or seated exercise such as cycling. This is important so we do 
not miscalculate your activity level. Please return your completed diary sheet with the 
ActiGraph to your nurse at the next appointment. 
Troubleshooting 
What happens if I get the ActiGraph wet? 
The ActiGraph is NOT waterproof, so please try not to get it wet. 
What should I do if I forget to put the ActiGraph on? 
Please put the ActiGraph on as soon as you remember, and then record the time on your diary 
sheet. 
If you have problems with your ActiGraph, please contact Kate Fitzsimons: 
Telephone: 0117 3311106 
Email: K. Fitzsimons@bristol. ac. uk 
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Instructions for recording your physical activity on the diary sheet 
" The diary sheet should be completed every day during the seven days that you wear your 
ActiGraph monitor. 
" The following information should be recorded: 
The day of the week. 
The date. 
The time you put the ActiGraph monitor on at the start of the day. 
The time you start an activity session that CAN NOT be recorded or 
accurately measured by the ActiGraph monitor, i. e. when it is removed during 
water-based activities, or worn during seated exercise of a moderate intensity 
(e. g. cycling). 
The type of activity you are doing, e. g. swimming, aqua aerobics, cycling etc. 
= The duration of the activity not recorded or accurately measured by the 
ActiGraph monitor (in minutes). 
The time you take the ActiGraph monitor off at the end of the day. 
Here is an example 
Da Weekda Date 
Time 
ActiGraph 




Activity not re 3' ed or 
accurately measured by` 
ActiGra h monitor 






I Thursday 17/11/05 07: 30 16: 00 Swimming 20 22: 00 
2 Friday 18/11/05 07: 45 22: 20 
2 Saturday 19/11105 09: 25 11: 00 Cycling 10 23: 45 
KEY POINTS 
Q Do not remove the ActiGraph from its pouch once you start wearing it. 
O Wear the ActiGraph over your right hip during ALL waking hours, putting it on as soon 
as you get up, and removing it just before you go to bed. 
Q Wear the ActiGraph for 7 consecutive days. 
Q Maintain your usual lifestyle whilst wearing the ActiGraph. 
Q Return the ActiGraph and diary sheet (2"d nage only) to your next Early ACTID 
appointment. 
Q If the ActiGraph falls out of the pouch make sure you replace it the correct way up, with the black button in the top left corner, as shown in the picture on the first page. 
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Appendix 11. ActiGraph data reduction protocol 
ActiGraph data processing 
Macro 
f Run macro 
o Path (w: \data\TT\act) 
o Start name (eg. 1606) 
o End name (e. g. 1609) 
o Countif value [2100 = cut point for MVPA (moderate to vigorous physical activity)] 
Sheet labelled `Raw' 
f Raw data from running macro 
Sheet labelled `Raw + time' 
f Insert hourly time in 1' column 
Sheet labelled `Cases by days' 
f Insert new column for Day 
f Time in TO column 
f Highlight in yellow the row representing the start of each day (5AM) (days 1-7) 
f Highlight in red the representing the start of each day (days 8+) 
f Cases grouped by 1" Day of wearing AG 
Sheet labelled `Mon Aligned' 
f Cut and paste cases to appropriate start day 
f Cut and paste data to start at Monday 
Sheet labelled `Daily sum data' 
f Insert 4 rows at the end of each day 
f Row 1: Sum for 24hrs the total counts and minutes of MVPA (=SUM(C3: C26)) 
f Row 2: Count the number of hours the ActiGraph was worn (=COUNTIF(C3: C26, ">O")) 
f Row 3: Mean counts per hour(=Total counts/Number of hours worn) and minutes of MVPA (=Total minutes of 
MVPA/Number of hours worn) 
Sheet labelled 'Daily sum data+Clean' 
f On days where AG was worn for <10hrs, replace all hourly counts and MVPA with '0' 
f `0' = missing data for counts 
Sheet labelled `Cleaned sum only' 
f Copy and paste special `values' the Daily sum data+Clean 
Sheet labelled `Sum grpd' 
f Align counts and mvpa into one column (Copy and paste data beneath, then delete first counts column and shift 
cells left. Delete all MVPA columns as duplicate data) 
f Group data by category, e. g. Mon Sum, Tues Sum, Wed Sum; Mon Hrs worn, Tues Hrs worn, Wed Iirs worn. 
Sheet labelled `Sum grpd trans' 
f Copy and paste special 'transposed' Sum grpd data 
Sheet labelled `MVPA missing' 
f2 copies of Sum grpd trans (one beneath the other) 
f In mvpa and mvpaph cells of 2"° copy, use IF function for coding MVPA as '999' when daily summed counts =0 
(=IF(D4=0[Daily counts], "999", AE4[mvpa]) (999 will show in mvpa for days that AG was worn for <l0hrs) 
Sheet labelled 'SPSS ready' 
f MVPA missing data copied and pasted special as values 








Participant Information Sheet 
Fitness Assessment 
Bristol 
What is fitness? 
91k University of 
OMBRISTOL 
Early ACTID Study 
Joint Clinical Research Unit 
Level 5 Old Building, near Ward 29 
Bristol Royal Infirmary 
Marlborough Street 
BRISTOL BS2 8HW 
Tel: +44 (0117) 9282440 
Fax: +44 (0117) 9284470 
E mail: Early-ACTID@bristol. ac. uk 
We would like you to take part in a test to determine how fit you are. Your fitness level (also 
known as cardiorespiratory or aerobic fitness) is a measure of how easily your blood and lungs 
deliver fuel to the muscles during exercise. A person's level of fitness is a good indicator of 
health, as being fit protects against the development of many diseases, including coronary heart 
disease, obesity, type 2 diabetes mellitus (T2DM) and some forms of cancer. 
What is the purpose of the fitness assessment? 
Although we know that people who are physically active and/or fit are less likely to develop 
diabetes, we do not know how important these factors are in people who already have diabetes. 
By measuring your fitness and physical activity over the course of the study we will be able to 
find out how important each of these factors are in helping you to manage your glucose 
control, blood pressure and cholesterol levels. 
How will my fitness level be measured? 
We will ask you to walk as briskly as you can for 1 mile on an indoor track. During the test 
you will wear a monitor to record your heart rate, and we will measure how long it takes you to 
walk the mile. If you are unable to walk for 1 mile, we will calculate your level of fitness 
based on the time it takes you to walk 1/4 or 1/z mile, whichever is the furthest distance you 
cover. 
What will happen at the fitness assessment appointment? 
When you arrive, the person carrying out the assessment will take you to the area where the 
test will take place. Prior to the test, they will talk you through exactly what is required and 
answer any questions that you may have. Providing you are happy to go ahead with the test, 
you will be given a heart rate monitor to wear. This is a watch that you wear on your wrist and 
an elastic belt that is worn next to your skin around your chest. The watch displays your heart 




When you are ready to begin, you will be asked to warm up by walking round one lap of the 
track, gradually picking up the pace. At various points, you will be asked to rate how hard you 
feel you are exercising (see page 8), so that we can establish an appropriate walking pace that 
is tailored to your own personal ability. Once you cross the start line after the warm-up lap, we 
will start timing. At the end of each lap, we will let you know the number of laps you have 
completed and ask you to read aloud the heart rate displayed on the watch. Once you have 
finished, you will be advised to walk at a slower pace to cool down and allow your heart rate to 
stabilise. 
At the end of this appointment, you will be provided with an activity monitor to wear for 7 
consecutive days. You will also be given a physical activity diary and an exercise questionnaire 
to complete at home. These items should be returned to your nurse at your next visit. 
How long will my appointment take? 
Your appointment should take between 30 and 40 minutes. Please allow longer if you will be 
using the changing and shower facilities. 
What should I bring to the appointment? 
Please arrive wearing casual clothing and comfortable, supportive shoes appropriate for 
walking a long distance. We also advise that you bring some water to stay hydrated and a 
small snack for afterwards, e. g. a banana. If you have asthma and use an inhaler, please bring it 
with you. 
What should I do to prepare for the assessment? 
To prepare for the fitness assessment, we would like you to: 
" Maintain your usual level of physical activity prior to the assessment. 
" Drink plenty of fluids over the 24-hour period before the test. 
" Get an adequate amount of sleep (6-8 hours) the night before the test. 
" Avoid exercise or strenuous physical activity the day of the test. 
" Avoid tobacco, alcohol, and caffeine for 3 hours prior to the test. 
" Have a light snack 2-3 hours before the test, avoiding anything too heavy that might 
cause indigestion. 
" Read the `Rating how hard you are exercising' sheet on page 8, so that you are familiar with the scale when you arrive for your appointment. 
Are there any risks involved with the assessment? 
If you are unused to walking briskly, you may notice some muscle tenderness in the days 
following the assessment. This is normal, and is caused by your muscles recovering after 
working harder than usual. 
Where will the assessment take place? 
Your fitness assessment will take place on the indoor track at the: 
Centre for Sport, Exercise and Health, University of Bristol 
Tyndall Avenue 
Clifton 
Bristol, BS8 1TP 
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What facilities will be available? 
Changing and Shower facilities 
" There will be changing and shower facilities available at the centre. 
Food 
" There is a Chandos Deli on the ground floor of the centre, which sells a selection of 
sandwiches, wraps, salads, snacks, and hot and cold drinks. 
Parking 
" There is (limited) pay and display car parking outside and nearby the Centre for Sport, 
Exercise and Health. A free parking space outside Hawthorns (a 1-2 minute walk from 
the Centre) can be arranged for the duration of your appointment, although this MUST 
be booked in advance. If this is required, your nurse will give you a parking certificate 
that should be clearly displayed in your vehicle for the duration of your fitness 
appointment. If your nurse has given you a certificate, please park in either the 
forecourt or at the rear of Hawthorns (this is labelled on the precinct map). 
" There are bike racks to secure bicycles, mopeds and motorbikes at the side of the 
building. 
How can I get to the Centre for Sport, Exercise and Health? 
A map of the University precinct is attached on page 4. The entrance to the Centre for Sport, 
Exercise and Health is on Tyndall Avenue (4F on precinct map, see arrow). 
By Car 
A map of Bristol is attached on page 5. 
From the M32 Exit the M4 at junction 19 marked for the M32. Follow the M32 into Bristol. 
The motorway terminates a few hundred metres from a major T junction. Carry straight on 
from the end of the motorway and turn right at the junction (following signs to Bus Station and 
Clifton). You will come to a roundabout where you should take the second exit (following 
signs to Bus Station, Royal Infirmary and Clifton). Go straight on over several sets of traffic 
lights. Just after the entrance to the multi storey car park on your left, turn right into Woodland 
Road. At the top of the hill you will see Hawthorns on your left. Pre-booked parking is 
available in either the forecourt or at the rear of Hawthorns. 
By Bus 
There is a free Hospital and University Shuttle Bus for staff and visitors that runs between 
Bristol Temple Meads Train Station, the city centre, Bristol General Hospital and Bristol Royal 
Infirmary, and the University of Bristol. It operates a continuous service between the hours of 
06.30-17.45 on Monday to Friday, with a frequency of between 10 and 24 minutes. A 
timetable and route map is attached on pages 6 and 7. The stop closest to the Centre for Sport, 
Exercise and Health is just outside Hawthorns and is numbered 10 on the route map. 
Frequent local buses also run regularly from Temple Meads Train Station, Broadmead, and 
the City Centre to the top of Park Street (6D on precinct map/Opposite Brown's Restaurant) 
and Elton Road, outside the Hawthorns (4E on precinct map) (Bus service 9/9A). 
By Train 
The Centre for Sport, Exercise and Health is approximately 1.6 miles away from Temple 
Meads Train Station and 6 miles from Parkway station. For information on local trains, please 
call National Rail Enquiries on 08457 48 49 50. 
For further information on planning your journey, please call Travel Line on 0870 608 2 608, 
or log on to http: //www. trayelbristol. ord 
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What should I do if I have further questions about the fitness assessment? 
If you have further questions, or need to cancel or reschedule your fitness appointnment, please 
contact your Early ACTID nurse, or Kate Fitzsimons by telephone (0117 3311106) or email 
(K. Fitzsimons(a)bristol. ac. uk). 
Map of University of Bristol Precinct 
Hawthorns Parking (41) Centre for Sport, Exercise and Health (3) 
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Hospital and University 
shuttle bus service 
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KEY TO BUS STOPS 
THE SHUTTLE BUS Bristol General Hospital 
SE RVI CE ristol Temple Meads rail station 
mple Way (for Central Health Clinic) 
is 
ew Primark/Old C&A 
Fý 
D ebenhams is 
house of Fraser CONVENIENT J 
I 
us station/Dental and Eye Hospitals 6.30am to 5.45pm weekdays 
RI (opposite main entrance) 
r0. ottom of Woodland Road is 
he Hawthor ns GU AR 
yndalls Park Children's Centre every 24 minutes 
(also for Bristol Homoeopathic Hospital) 
O St Michael's Hospital has 
U MORE CHOICE OF STOPS Bristol Oncology Centre including Temple Meads rail station BRI (main entrance) 
House of Fraser and will help to 
Bristol & West building - city centre REDUCE CONGESTION 
Bristol General Hospital in the city centre. 
MONDAY TO FRIDAYS TIMETABLE 
637 - 733 - 7: 57 821 - 8.45 - 9: 09 - 9: 33 
-- 7: 12 7: 43 8.00 8: 10 8: 30 8: 40 8: 55 - 9: 19 9.30 9: 43 6: 41 7: 15 7: 47 8: 03 8: 13 8: 35 8: 45 8: 59 - 9: 23 9.35 9: 47 
6: 42 7: 17 7: 49 8: 05 8: 15 8: 37 8 47 9: 01 925 9.37 9: 49 
6: 43 7: 18 7: 50 8: 06 8: 16 8: 38 8.48 9: 02 - 9: 26 9.38 9: 50 
6: 44 7: 19 7.51 8: 07 8: 17 8: 39 8: 49 9.03 - 927 9: 39 9: 51 
6: 47 7: 22 7: 54 8: 10 8: 20 8: 42 8: 52 9: 06 - 9: 30 9.42 9.54 
-- 7: 23 7: 55 8: 12 8: 22 8: 44 8: 54 9: 07 - 9: 31 9: 43 9: 55 
6: 49 7: 28 8: 01 8: 15 8: 25 8: 45 8: 55 9: 13 - 9: 37 9: 49 10: 01 
6: 50 7: 30 8.03 8: 17 8: 27 8: 49 8: 59 9: 15 - 9: 39 9: 51 10: 03 
6.52 7: 32 8.05 8.19 8.29 8: 51 9.01 9: 17 - 9: 41 9: 53 10: 05 
6: 53 7: 33 8: 06 8: 20 8.30 8.62 9.02 9.18 - 9: 42 9.54 10: 06 
- 8: 08 - 8: 32 8.56 - 9: 20 - 9: 44 - 10.08 
6: 56 7: 37 8: 11 -- 8: 35 8.59 - 9: 23 - 9: 47 9: 59 10.11 
6: 59 7: 41 8: 15 - 8: 39 9 03 - 9: 27 - 9: 51 10: 03 10: 15 
7: 01 - 8: 17 - 8: 41 9.05 - 9.29 - 9: 53 10: 05 10: 17 
- 8: 21 - 8: 45 9.09 - 9: 33 - 9: 57 10: 09 10: 21 
9.57 1021 10: 45 11: 09 1t 33 11: 57 12: 21 12: 45 13.09 13: 33 13: 57 
10.07 10.31 10: 55 11: 19 11: 43 12: 07 12: 31 12.55 13: 19 13: 43 14: 07 
1011 10: 35 10: 59 11: 23 11: 47 12: 11 12: 35 12: 59 13: 23 13: 47 14: 11 
10: 13 1037 11: 01 11: 25 11: 49 12: 13 12: 37 13.01 13: 25 13: 49 14: 13 
10: 14 10: 38 11: 02 11: 26 11: 50 1214 12: 38 13: 02 13: 26 13: 60 14: 14 
10: 15 10: 39 11: 03 11: 27 11: 51 12: 15 12: 39 13: 03 13: 27 13: 51 14: 15 
10: 18 10: 42 11: 06 11: 30 11: 54 12: 18 12: 42 13: 06 13: 30 13: 54 14: 18 
10: 19 10: 43 11.07 11: 31 11: 55 12: 19 12: 43 13.07 13: 31 13: 55 14: 19 
10: 25 10: 49 11: 13 11: 37 12: 01 12: 25 12: 49 13: 13 13: 37 14: 01 14: 25 
10.27 10: 51 11: 15 11: 39 12: 03 1227 12: 51 13.15 13: 39 14: 03 14: 27 
10: 29 10: 53 11: 17 11: 41 12: 05 12: 29 12: 53 13: 17 13: 41 14.05 14: 29 
10: 30 10.. 54 11: 18 11: 42 12: 06 12: 30 12: 54 13: 18 13: 42 14.06 14: 30 
10: 32 - 11: 20 11: 44 12: 08 12: 32 - 13: 20 -- 14.08 - 
10: 35 10.59 11: 23 11: 47 12: 11 12: 35 1259 13.23 13: 47 14: 11 14: 35 
10: 39 11: 03 11: 27 11: 51 12.15 12: 39 13: 03 13: 27 13: 51 14: 15 14: 39 
10: 41 11: 05 11: 29 11: 53 12: 17 12: 41 13.05 13: 29 13.53 14: 17 14: 41 
10 :45 11: 09 11: 33 11: 57 12: 21 12.45 13: 09 13: 33 13: 57 14.21 14: 45 
1421 14: 45 15: 09 15.21 15: 45 16: 00 160 16: 33 - 16: 57 -- 
14: 31 14: 55 15: 19 15: 31 15: 55 16: 05 16: 19 16: 50 17: 00 17: 07 17: 30 
14: 35 14: 59 1513 15: 35 15: 59 16: 09 1623 16: 54 - 17: 11 - 14: 37 15: 01 1525 15: 37 16: 01 16: 11 16.25 16: 56 -- 17: 13 - 1438 15: 02 15.26 15: 38 16.02 16: 12 1626 16.57 - 17: 14 - 14: 39 15: 03 1517 15: 39 16: 03 16: 13 1627 16: 68 -- 17: 15 - 14, A2 15.06 1530 15: 42 16: 06 16: 16 1630 17: 01 - 17: 18 - 14.43 15: 07 15: 31 15: 43 16: 07 16: 18 16: 31 17: 06 - 17: 19 - 14: 49 15: 13 15: 37 15: 49 16: 13 16: 21 16: 37 17: 10 - 17: 25 - 14.51 15: 15 15: 39 15: 51 16: 15 16: 30 1639 17: 12 - 17: 27 - 14: 53 15: 17 15: 41 15: 53 16: 17 16: 32 16: 41 17.14 -. 17: 29 -- 14: 54 15: 18 15: 42 15: 54 16: 18 16: 33 16: 42 17: 15 -- 17: 30 - 14: 56 15: 20 - 15: 56 16: 20 - 16: 44 -- . - - -- 14.59 1523 15: 47 15: 59 16: 23 16: 38 16.47 17: 18 - 17: 35 - 15.03 15: 27 15: 51 16: 03 16: 27 16: 42 16: 51 17: 22 -. - 17.39 -- 15: 05 15: 29 - 16: 05 16: 29 16.45 16: 53 1724 - BTM' 15: 09 15: 33 - 16: 09 16: 33 - 16: 57 -- 17: 15 17: 45 17: 40 
'These services will stop at Bristol Temple Meads after House of Fraser 
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Rating how hard you are exercising 
" 
E\RLY 
AC '1 I) 
During the fitness test, we would like you to rate how hard you feel you are working. This rating 
should reflect how heavy and strenuous the exercise feels to you, both physically and mentally. 
During the warm-up lap, and then throughout the walk test, we will ask you to rate how you feel 
on the scale of 6-20. This will give you a good idea of the intensity level of your activity, and 
you can use this information to speed up or slow down your pace to reach the desired range. 
During the walk test, we would like you to be working between 13 and 15 on this scale. 
Please familiarise yourself with this scale before your appointment. 
SCALE EFFORT DESCRIPTION EXAMPLE 
6 20 Very, very light Rest 
7 30 
8 40 
9 50 Very light Gentle walking 
10 55 
11 60 Fairly light 
12 65 
13 70 Somewhat hard k steady pace - OK to continue 
14 75 
15 80 Hard 
16 85 
17 90 Very hard You can go on, but you have to push 
yourself - You feel very tired 
18 95 
19 100 Very, very hard The most strenuous exercise you have ever 
experienced 




Appendix 13. Standard operating procedure used to administer 1-mile walk fitness tests 
Fitness test: 1 mile (1609m) walk test 
Locations 
Bristol: Centre for Sport. Exercise and Health (Mondays & Wednesdays) 
Cost: Free 
Indoor track: 118.4meters 
01 mile/1609m = [13.5895 lapsl 13 laps (1539.2m) + 69.8m 
Taunton: Wellington Leisure Centre (Every other Thursday I am-3pm) 
Cost: £40/hr (2hrs every other week) = £2080 per annum / £6240 for 3 years 
Studio - 
01 mile/1609m =127.74 laas127 laps (1566m) + 43meters 
Gloucester: GL1 Centre (Every other Tuesday loam-l pm) 
Cost: Free 
Martial arts room: 11.2x14.5m = 47m perimeter 
"1 mile/1609.3m = [34.24 laasl 35 laps (1645m) + 35.7 meters 
Items required for test 
Equipment 
"2 Polar heart rate monitor transmitters, 2 receiver watches and multiple straps 
" Digital stop watch with split and lap timing 
" Clip board 
" Initialised ActiGraph monitor(s), elastic belt(s) & pouch(es) 
" Sterile wipes 
" Seating 
Paperwork 
" Appointment diary 
" Standard Operating Procedure (SOP) 
" RPE Scale 
" Fitness test data entry sheet 
" ActiGraph participant information sheet and diary + instructions 
" Exercise Questionnaires 
Food and drink 
" Water and plastic cups 
" Glucose tablets 




" 1-mile walk time 










Before participant arrives: 
1. Charge and initialise ActiGraph monitor & record monitor number & participant details 
2. Complete Data entry sheet with participant details provided by nurse 
3. Advise reception of participant appointments 
4. Ensure all equipment is to hand 
5. Ensure you have the means to request emergency help (e. g. emergency phone, radio etc. ) 
Before the test: 
1. Confirm `Participant information' on data entry form. 
2. Complete 'Health and safety' section on data entry form. 
-> Has participant eaten within the last 3 hours? 
-ý Is participant wearing appropriate footwear? 
-ý Is there any other relevant information you should discuss with participant? 
3. Provide Polar Heart Rate monitor 
Dampen the electrodes of the Polar transmitter strap and ask participant to put this on next to the skin around 
the chest. Assist if necessary. 
-a Ask participant to put the receiver watch on their wrist and check the heart rate is being monitored correctly. 
If the watch is too small, ask participant to hold the watch instead. 
-4 Ensure participant knows to read out HR from watch at the end of each lap and also when asked to do so. If 
participant is unable to do this, confirm that they should display the watch so that you can read it after each 
lap (note that participant should continue to walk briskly). 
4. Complete `l-mile walk test preparation' section on data entry form 
--ý Is the HR monitor worn correctly and working 
-ý Who will read the HR during the 1-mile walk 
-> Does participant understand the following: 
f The `Rating how hard you are exercising' sheet and scale, given in their fitness information pack. 
f How hard they should be exercising during the test, i. e. between 13 and 15 on the scale. 
f How to signal if they need assistance, or to stop the test for any reason during the test. (Ensure participant 
understands that if they feel unwell or want to stop the test at any point they should raise their hand. 
Explain that you will go over to where the participant is and assist them. ) 
f How many laps they are required to walk to cover the 1-mile distance. 
f The finish point and cool-down procedure (1-2 laps at slower pace, followed by optional stretches). 
5. Confirm participant is happy to proceed with the test. 
Warm-up lap: 
1. Advise participant that you will walk a warm-up lap together, gradually building up the pace. 
2. Begin the warm-up lap. 
3. Ask participant for RPE towards end of lap and record on data entry form. Advise participant of appropriate 
pace for the 1 -mile, relative to the warm-up. (i. e. to increase pace to reach 13-15 on scale) 
4. Briefly stop before starting test and encourage participant to walk on the spot to maintain heart rate. 
5. Record the 'post warm-up HR' on data entry form. 
6. Record `Time started' on data entry form. 
7. Check participant is ok to start. 
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Instructions for carrying out the test: 
1. Advise participant they are free to begin and you will start the stopwatch when they cross the start line. 
2. Press the `start' button on the stopwatch as soon as participant's foot crosses the line. 
3. At the end of each lap, simultaneously: 
-a Press the stopwatch button to split timing. 
On the data entry form, record: 
f `time' elapsed since the start 
-ý Ask participant to read aloud the HR displayed on receiver watch. 
Record `HR' on the data entry form. 
-ý When appropriate, ask participant `how 
hard do you feel you are exercising? '. Record'RPE' on data entry 
form. 
-4 Advise participant of the number of laps completed and provide standardised encouragement: 
"2 laps down, well done/excellent/good/you're doing well/that's great. " 
-4 Once the participant has just 4 laps to go, advise of the number remaining: 
"4 laps to go, well done/excellent/good/you're doing well/that's great. " 
4. At I mile (1609 meters): 
--> Press the stopwatch button to split timing and record 
`final time' on the data entry sheet. 
-ý Ask participant to read aloud the `HR' and record this on the 
data entry sheet. 
-> Ask for RPE of final lap and for the overall walk. Record'RPE' on data entry 
form. 
-ý Check participant is ok and advise them to walk one or two 
laps at a slower pace to cool down. 
After the test: 
1. Complete the `final data' section on the data entry form. 
-+ Record the final time, IIR, lap, and distance walked. 
-+ Record whether 1 mile was completed. If not completed, record code (see page 4). 
2. Once HR has stabilised, encourage participant to perform stretches for the hamstrings, quadriceps and calves. 
Perform these stretches with the participant and offer verbal instruction. 
3. Retrieve HR transmitter strap and receiver watch. Tick appropriate box on data entry form. 
4. If feedback is requested, give participant Time taken to complete test, and their %IIR,,,.,, during the test. 
5. Provide ActiGraph monitor, ActiGraph information sheets and diary. 
-a Explain how to use these, emphasising the importance of maintaining usual lifestyle, and advise participant 
to return monitor and diary at next nurse appointment. 
-+ Record `ActiGraph number' on data entry form. 
6. Provide Exercise questionnaire. Advise that this should be completed at home and returned at next nurse 
appointment. 
7. Offer participant use of shower and changing facilities. 
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r,. ae. fn r. fng cc r.. et 
: Test not started 
Al Technical malfunction (HR monitor) 
A2 Technical malfunction (Stopwatch) 
A3 Physical condition 
A4 Partici ant's request 
A5 Inappropriate clothing/footwear 
A6 Site problem 
A7 Other 
ý1i dle nöt camp lete l 
Technical's ;,; r 
AA1 Technical malfunction (HR monitor) 
AA2 Technical malfunction (Stopwatch) 
Ph 'sical 
Cardio/res irato 
AA3 Breathing problems 
AA4 Chest/heart problems 
AA5 Other 
Mucsuloskeletal 
AA6 Physical condition (Muscle soreness/cramp etc. ) 
AA7 Physical condition (Joint pain) 
AA8 Physical condition (Foot pain) 
AA9 Physical condition (Previous injury) 
AA10 Physical condition (Injury) 
AAl I Physical tiredness 
AA12 Other 
Diabetes related 
AA13 Physical condition (Hypo) 
AA14 Other 
Other 
AA15 Other -State 
request Participant 
AAl6 Participant's request 
Clothin' 
AA17 Inappropriate footwear/clothing 
Site` 







Heart rate monitor fails to record heart rate 
If this occurs at the start of the test: 
o Stop, and check Electrodes are damp 
o Change transmitter strap 
o Change receiver watch 
o Restart test 
= If during test: 
o Request that participant completes test 
o Continue to record the time using the stopwatch 
o Use the last HR recorded and obtain average to predict VO2max 
Stopwatch fails to record time 
If this occurs at start of the test: 
o Stop, try to reset stopwatch 
o Use different stopwatch 
o Restart test 
If this occurs during test and you have another stopwatch to hand: 
o Start other stopwatch immediately and record the time elapsed on the first stopwatch, 
o Once participant has completed test, add times on both watches for time taken to complete mile. 
= If this occurs during test and you do not have another stopwatch to hand: 
o Terminate test 
o Use total time taken to complete the distance covered. Divide by distance (meters) and multiply by 1609 
(meters) to obtain estimated time to complete 1 mile. 
o Enter most recent HR into equation to predict fitness. 
Indications for stopping the test: 
" Onset of chest pain or angina-like symptoms 
" Unusual or severe shortness of breath 
Physical or verbal manifestations of severe fatigue 
" Feeling faint, lightheaded or dizzy 
" Sudden musculoskeletal problems or injury 
" Participant's request 
" Failure of stopwatch 
" Fire alarm 
Hypos: 
Unsure if hypo: 
o Test glucose with blood glucose monitor 
o If below 4mmol/L give 2 glucose tablets 
o If above 4, give medium acting carbohydrate 
o If normal, encourage participant to sit and recover 
= Feeling faint, lightheaded or dizzy: 
o Advise participant to stop and sit down. 
o Suggest testing glucose (See above for action) 
Conscious and capable of swallowing: 
o Give participant 3 glucose tablets immediately. If symptoms persist after 5-10minutes, give 2 more 
glucose tablets. 
o When symptoms pass, encourage participant to eat medium acting carbohydrate within 10 minutes 
(Bananalbiscuit) 
Unconscious and breathing 
o Loosen tight clothing 
o Place in recovery position and Call 999 & assistance from centre staff 
Unconscious and not breathing 




" Weakness - Feeling faint, lightheaded or dizzy: 
" Excessive sweating 
" Tingling of lips, tongue or fingers 
" Headache 
" Becoming pale 
" Intense hunger 
" Irritability 
" Lack of concentration 
" Confusion 
Time Ideal blood glucose levels 
Before meals 4-7mmolL 




If the casualty appears unconscious check this by shouting `Can you hear me? ', `Open your eyes' and gently 
shaking their shoulders. 
If there is no response, shout for help then follow the ABC Procedure below: 
Airway 
Open the airway by placing one hand on the casualty's forehead and gently tilting the head 
back. 
Check the mouth for obstructions and then lift the chin using 2 fingers only. 
Breathine 
" Spend 10 seconds checking to see if the casualty is breathing: ý-s t 
" Look to see if the chest is rising and falling. Listen for breathing. 
" Feel for breath against your cheek. 
If the casualty is breathing, place them in the recovery position. 
" Check for other life-threatening conditions. 
For any other casualty who is not breathing, call an ambulance, then return to casualty and begin sequence again. 
" Give 2 Rescue Breaths. 
Circulation 
Spend 10 seconds checking for signs of circulation: look, listen and feel for breathing, coughing, movement or 
any other signs of life. 
Conscious and Breathing 
" Check circulation (including a check for severe bleeding) 
" Treat any injuries 
" Get help if necessary 
Unconscious but Breathing 
" Place the casualty in the Recovery Position. 
" Check circulation (including a check for severe bleeding) 
" Treat any life-threatening conditions 
" Call for an ambulance 
Unconscious, not breathing but has circulation 
" Call for an ambulance 
" On return to casualty follow the resuscitation sequence again, acting on your findings. 
" Check for circulation every 10 breaths. 
Unconscious, not breathing and has no circulation 
0 If circulation is absent, and the condition is not due to injury, drowning or choking: 
o Call an ambulance, then return to casualty and follow resuscitation sequence again, acting on your findings. 
" Continue to give chest compressions together with Rescue Breaths (CPR) until help arrives. 
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Appendix 14. Fitness test data entry form 
I 
FITNESS ASSESSMENT: BRISTOL EHS RUNNING TRACK 
(118.4m x 13.59 laps) 
VISIT INFORMATION 
Office use 
Entered 0 Date 
VO2mc« score R-code 
1O2©3O4O5060 
visit Location EHS Staff -ý 
. 
Date r_-ý II 2006 Time ](24 ) 
PARTICIPANT INFORMATION 
Pt. ID t se Centre 
Gender Age wrs PA rating q'nnaire 
HEALTH & SAFETY 
PARQ Information 
Has participant eaten within last 3 hours? 0YaN If no, is blood sugar ok8 
Is participant wearing appropriate footwear for walk test? 171Y [J N 
Is there any other information that you should know before staring the walk test? II YN 
If yes, please state 
1 MILE WALK TEST PREPARATION 
Is the HR monitor wom correctly and working? Y (J N 
Who wil read the HR during the test? Pt. a Staff 
Does participant understand: 
The 'rating how hard you are exercising' sheet and scale? Y ýN 
That during the walk, they should work between 13 & 15 on the scale? (j Y N 
How to signal for assistance or early termination? Y [] N 
How many laps equals a mile distance? Y N 
The finish point and cool down procedure? Y N 
How many laps equals a mile distance? Y aN 
The finish point and cool down procedure? Y N 
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I MILE WALK TEST DATA 4 HR , ý` 
50 110 
Wok test started MYN if no, record non-started code 60 132 
70 154 
80 176 
Time started Pre warm-up 90 198 
100 220 
APS; DISTANCE ýý TIME py" LAPS 
Completed Meers MNes AM ns a x Secs ý T(me ' (bpm) RPE o go COMMENTS 
Post W41 118.4 13.59 
1 118.40 -12.6 
2 236.80 11.6 
3 355.20 10.6 
Liu Em- ? ff Bell 
4 473.60 9.6 
5 592.00 8.6 rß 
6 710.40 7.6" 
7 828.80 6.6', 
8 947.20 5.6.? 




11 1302.40 2.6 
12 1420.80 7 1.6 




. ýý . Overall rating 0 
FINAL DATA aTIM 
`mm HR bpm top Dist 
1-Mle completed aYaN If no, record non-completion code 
Polar HR monitor removed ED YN 
Was participant offered stretches? MY JJ N 
Comments 
ACTIGRAPH 
ActiGraph No. or, not provided code 
m 
Have the Information sheets and diary been provided? aYN 
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Appendix 16. Training undertaken during PhD 
Course Title Organising body Dates 
Multivariate statistical methods University of Bristol 3hrs weekly, January- 
March 2007 
Good Practice in clinical research United Bristol Healthcare trust Ihrs weekly, November- 
December 2006 
Statistics in education 
Presentations and publication 
Data management for research data analysis 
Protocol, ethics and project management 
Questionnaire design 




Motivational interviewing in health and 
social care: Practitioner workshop 
University of Bristol ihrs weekly lectures, 
October-December 2006 
United Bristol Healthcare trust 1 day, March 2006 
United Bristol Healthcare trust I day, March 2006 
United Bristol Healthcare trust I day, February 2006 
United Bristol Healthcare trust I day, February 2006 
University of Bristol 1 day, January 2006 
United Bristol Healthcare trust I day, January 2006 
University of Bristol 1 day, June 2005 
University of Bristol 1 day, June 2005 
Dr. Stephen Rolinick & Dr. 2 days, June 2005 
Gary Rose 
Physical activity counselling in general and Bases, University of Dundee 1 day, November 2004 
clinical populations workshop 
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Appendix 17. Conference contributions and publications resulting from PhD work 
Presentations 
American College of Sports Medicine (2007): Physical activity and cardiorespiratory fitness in adults with newly 
diagnosed Type 2 Diabetes: The Early ACTID Study (Poster) 
Diabetes UK Annual Professional Conference (2007): Physical activity in adults with newly diagnosed Type 2 
diabetes: The Early ACTID Study (Poster) 
Diabetes UK Primary Care Conference (2005): One touch empowerment developed (Workshop leader) 
Publications 
Fitzsimons KJ, Cooper AR, Andrews R. (2007) Physical activity and cardiorespiratory fitness in adults with newly 
diagnosed Type 2 diabetes: The Early ACTID Study. Medicine and Science in Sports and Exercise 39(5): S236 
Fitzsimons KJ, Cooper AR, Andrews R. (2007) Physical activity in adults with newly diagnosed Type 2 diabetes: 
The Early ACTID Study. Diabetic Medicine 24(S 1): 64 
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